Group Annual Report 2012 - ERGO Versicherungsgruppe AG
Group Annual Report 2012 - ERGO Versicherungsgruppe AG
Group Annual Report 2012 - ERGO Versicherungsgruppe AG
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>2012</strong><br />
<strong>Group</strong> <strong>Annual</strong> <strong>Report</strong>
Management <strong>Report</strong><br />
Overview of <strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>2012</strong> 2011 Change previous<br />
year (%)<br />
Total premium income € million 18,562 20,270 − 8.4<br />
Gross premiums written € million 17,091 18,519 − 7.7<br />
Expenses for claims and benefits (gross) € million 17,556 17,369 1.1<br />
Investment result € million 5,262 4,116 27.8<br />
Operating result € million 951 806 17.9<br />
Consolidated result € million 289 349 − 17.2<br />
Investments € million 125,390 117,309 6.9<br />
Technical provisions (net) € million 120,859 113,977 6.0<br />
Equity € million 4,587 3,827 19.9<br />
Full-time representatives 17,862 19,087 − 6.4<br />
Salaried employees 29,768 31,311 − 4.9<br />
<strong>ERGO</strong> is one of the major insurance groups in Germany<br />
and Europe. We have a presence in more than 30 countries<br />
worldwide, but the focus of our activities is on the European<br />
and Asian regions. <strong>ERGO</strong> offers a broad range in<br />
insurance, pension provision and services, and is one<br />
of the leading insurers across all segments in its home<br />
market of Germany. Around 48,000 people work for our<br />
<strong>Group</strong>, either as salaried employees or as full-time selfemployed<br />
sales partners. In <strong>2012</strong>, premiums amounted to<br />
over € 18 billion and insurance benefits for our customers<br />
accounted for more than € 17 billion.<br />
Our customers determine the way we operate. <strong>ERGO</strong> is strictly<br />
geared towards the wishes and needs of its customers,<br />
and intends to improve this still further by pursuing a<br />
close dialogue with them. We are implementing our claim<br />
“To insure is to understand” by providing advice and<br />
products which meet the needs of our customers as well<br />
as understanding and picking up on customers’ personal<br />
concerns. This is enhanced by a clear and understandable<br />
communication, innovative services and swift support in<br />
the event of damage or loss.<br />
Our customers can choose which form of contact with<br />
<strong>ERGO</strong> suits them best, as we have the right sales channel<br />
for every customer: Self-employed insurance sales<br />
partners, staff working in direct sales, as well as insurance<br />
brokers and strong cooperation partners – both in Germany<br />
and abroad – respond to the needs of private and corporate<br />
customers alike. We maintain partnerships with the<br />
major European bank UniCredit <strong>Group</strong> and other banks,<br />
both in Germany as well as in various European countries.<br />
<strong>ERGO</strong> is part of Munich Re, one of the leading global reinsurers<br />
and risk carriers. Within Munich Re, <strong>ERGO</strong> is the<br />
specialist for primary insurance, i. e. for insuring private and<br />
corporate customers directly, both in Germany and abroad.<br />
The group’s investments of € 214 billion, of which € 125 billion<br />
is accounted for by <strong>ERGO</strong>, are managed primarily by the<br />
joint asset management and fund company ME<strong>AG</strong>.
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Group</strong> <strong>Annual</strong> <strong>Report</strong>
Contents<br />
3 Letter by the Chairman of the Board of Management<br />
6 <strong>Report</strong> of the Supervisory Board on the <strong>2012</strong> financial year<br />
Management <strong>Report</strong><br />
10 The <strong>ERGO</strong> Insurance <strong>Group</strong><br />
14 The <strong>ERGO</strong> Insurance <strong>Group</strong> – Governing bodies<br />
16 Business environment<br />
19 Business performance<br />
23 Assets and financial position<br />
27 Other success factors<br />
31 Risk report<br />
42 Opportunities report<br />
44 Prospects<br />
Consolidated<br />
Financial Statements 48 Consolidated balance sheet as at 31 December <strong>2012</strong><br />
50 Consolidated income statement for the financial year <strong>2012</strong><br />
51 Statement of recognised income and expense<br />
52 <strong>Group</strong> statement of changes in equity<br />
54 Consolidated cash flow statement for the financial year <strong>2012</strong><br />
55 Principles of presentation and consolidation<br />
74 Notes to the consolidated balance sheet – assets<br />
95 Notes to the consolidated balance sheet – equity and liabilities<br />
110 Notes to the consolidated income statement<br />
118 Disclosures on risks from insurance contracts and financial<br />
instruments<br />
130 Other information<br />
136 List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />
Section 313 para. 2 of the German Commercial Code (HGB)<br />
148 Auditor’s report
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
3<br />
Letter by the Chairman of<br />
the Board of Management<br />
Dear Readers,<br />
“Rescue routine” was the German word of the year <strong>2012</strong>. This means that the top spot has<br />
been claimed for the third time in five years by a term reflecting the turbulence on the<br />
capital markets, following “financial crisis” in 2008 and “stress test” in 2011. This shows<br />
how much the unpredictability of the markets continues to affect our everyday lives. The<br />
effects of the financial and national debt crises for companies and citizens are becoming<br />
ever clearer. This makes special demands on us not only in the management of our investments<br />
but also increasingly in our core business as an insurer.<br />
Our major investment portfolio still features investments that yield higher rates of return<br />
than can currently be achieved. In addition, we took early action to hedge against the risk<br />
of falling interest rates which will enable us to hold out for a long time in a climate where<br />
low interest rates prevail. After all, we make promises of benefits to customers that often<br />
last a lifetime, so we have to be able to make good on our promises even if interest rates<br />
remain extremely low.<br />
Dr. Torsten Oletzky<br />
Chairman of the Board of Management<br />
<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />
As a result, sustainable security takes precedence over returns on investment. This is<br />
why we have continued to lower policyholders’ bonuses for new German life insurance<br />
contracts. And our new unisex tariffs for health insurance feature lower technical interest<br />
rates. As lower capital yields are already taken into account during the calculation process,<br />
premium rates are higher as a result.<br />
For many customers, life insurance remains the best route to pursue in terms of private<br />
old-age provision. However, due to low interest rates, they are no longer able to fulfil<br />
customer expectations as they once did. <strong>Annual</strong> guarantees are expensive and have an<br />
adverse impact on the rate of return. This is why we will provide new product concepts in<br />
the future. Our guarantees have the main task to fulfil our customers’ demands in terms<br />
of planning security for their old age. At the same time, we will make our new products<br />
more flexible so that they adapt more successfully to the different stages in a person’s life.<br />
The new product generation will be launched this year.<br />
The fact that we have lowered the conditions of single-premium life insurance policies<br />
out of prudence already for <strong>2012</strong> has affected our new business. A lower life insurance<br />
business and sales of daughter companies in the previous year led to a decrease of 8.4%<br />
in total premium income, down to € 18.6 billion (20.3 bn). By contrast, the operating result<br />
was up significantly by 17.9% to € 951 million (806 m). The investment result recorded a
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Letter by the Chairman of 4<br />
the Board of Management<br />
major increase to € 5.3 billion (4.1 bn), while net returns rose from 3.4% to 4.1%. One of the<br />
major reasons for this increase was the cessation of the adverse effects of the previous<br />
year. The combined ratio of 95.8 (94.4)% in the German non-life segment did not live up<br />
to our high demands. However, at 100.5 (105.1)%, the combined ratio for international<br />
business developed favourably. Overall, the operating performance corresponded to our<br />
expectations.<br />
At € 417 million, the consolidated result before provisions for restructuring costs was<br />
slightly above our target. Taking these provisions into account, we achieved a result of<br />
€ 289 million (349 m). The provisions were set up in order to provide for the restructuring<br />
of our sales organisations. In order to introduce a consistent advisory process, reduce<br />
complexity and save on overheads, we started to streamline structures in our sales<br />
department in <strong>2012</strong>.<br />
We intend to merge five German sales organisations into two units under the umbrella<br />
of an <strong>ERGO</strong> sales company which will enable us to manage and support our sales teams<br />
consistently, bundle recruitment and will ensure a more homogeneous brand appearance.<br />
All these are important requirements for the proper use of resources and for efficient<br />
workflows. However, the related cut of up to 700 salaried sales posts and 650 in-house<br />
posts has been a hard decision to make. In cooperation with our co-determination bodies,<br />
we are attempting to find fair, socially responsible solutions for those affected. I sincerely<br />
hope that we are able to find appropriate solutions.<br />
In <strong>2012</strong>, our sales representatives were also the focus in terms of implementing our brand<br />
promise “To insure is to understand”. The mutual development of a consistent advisory<br />
process means that customer requirements are taken into account in every respect. If our<br />
sales partners are able to provide advice and conduct sales at the same high level, our<br />
customers will obtain the best possible insurance for all situations in life. In my opinion,<br />
you do not need to be an independent advisor in order to provide excellent insurance<br />
advice.<br />
This year’s Customer <strong>Report</strong> will also focus on how our sales partners advise and support<br />
our customers. The report describes how we implement our brand promise in terms of<br />
sales and other areas, and puts the focus on customers and their queries. The positive<br />
feedback that followed the first <strong>ERGO</strong> Customer <strong>Report</strong> in May <strong>2012</strong> gave us the reassurance<br />
that we are on the right track with this approach.<br />
In <strong>2012</strong>, we continued to improve the clarity of our customer communication with further<br />
revisions to customer letters as well as to terms and conditions of insurance policies.<br />
We have a special committee to ensure that our communication remains clear. It is now<br />
easier than ever to understand what we cover and what we do not – so that our customers<br />
always know what to expect from us. This is only fair and also prevents misunderstandings<br />
from arising. We are particularly proud of our TÜV certification for “Clear Communication”.<br />
In order to attain this certification, all of our customer communication was subject to<br />
external auditing by the technical inspection agency TÜV Saarland.<br />
Our understanding of “To insure is to understand” also includes being ready to respond<br />
to criticism. In summer <strong>2012</strong>, we were subject to allegations that we did not fully report<br />
on instances of misconduct in our sales organisations. Even if not all allegations were<br />
substantiated, we learnt that we did not fulfil our own demands on transparency in every<br />
respect. As a consequence, we published the results of our internal audit into claims of<br />
misconduct on incentive trips and other sales events on our website in October <strong>2012</strong>.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Letter by the Chairman of 5<br />
the Board of Management<br />
We also listed the actions we have taken so that everyone can form an opinion on these<br />
events. We will continue to maintain this transparency and openness.<br />
When it comes to products, we are increasingly gearing them towards the expectations<br />
and requirements of our customers. Our new accident insurance package offers complete<br />
support with lots of assistance services and one-to-one advice. When developing the<br />
product, our colleagues listened closely to people who had experienced accidents to guide<br />
them. This approach has met with approval: the product has gone down well with our<br />
customers. And when we notice that a product no longer conforms to the expectations of<br />
our customers, we adapt it or discontinue it.<br />
As far as our international business is concerned, we are continuing to pursue our<br />
expansion in Asia and are increasingly benefiting from our years of preparation and local<br />
presence. After a five‐year preparatory period, a team has been working in the Chinese<br />
province of Shandong since spring <strong>2012</strong> to set up the <strong>ERGO</strong> China Life Insurance. The joint<br />
venture with the Shandong State-owned Assets Investment Holding Company as a strong<br />
local partner is intended to go into business this year as soon as the final approval has<br />
been obtained from the local authorities.<br />
In India, we agreed on a joint venture in life insurance in November <strong>2012</strong> with the wellpositioned<br />
Avantha <strong>Group</strong> conglomerate – an excellent addition to our successful market<br />
presence in non‐life insurance with the joint venture HDFC <strong>ERGO</strong>. By contrast, we have sold<br />
<strong>ERGO</strong> Daum Direct in the difficult South Korean market.<br />
These are the main topics that shaped <strong>2012</strong> for us, and we will continue to work on many<br />
of them this year too. Our employees and management alike have driven the Company<br />
onwards with their conscientious work, commitment and excellent ideas. Our expert sales<br />
partners are fully dedicated to our customers. I would like to thank each and every one of<br />
them for their hard work. I am sure that we have created a solid foundation for success<br />
both for this year and the years to come.<br />
As an insurer, we depend heavily on the trust our customers have in us. If people ask why<br />
we deserve this trust, I say to them: because customers are always our focus, and they<br />
sense how much we value them. Because we take on challenges and are prepared to<br />
change with the times. Because we think ahead, try to take action in good time, and learn<br />
from our mistakes.<br />
And we will do everything we can to earn and merit this trust in the future.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
6<br />
<strong>Report</strong> of the Supervisory Board<br />
on the <strong>2012</strong> financial year<br />
The Supervisory Board reviewed the Company’s situation in detail during the reporting<br />
period. It monitored the management’s activities in accordance with legislation and<br />
the Company’s Articles of Association and advised the Board of Management regarding<br />
management of the Company. We were also involved in all major decisions. The Board of<br />
Management informed us regularly and in detail about important topics such as corporate<br />
planning, business development and the Company’s current situation. We were also<br />
consulted concerning corporate strategy.<br />
Dr. Nikolaus von Bomhard<br />
Chairman of the Supervisory Board<br />
of <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />
In the year under review, the Supervisory Board convened for three scheduled and two<br />
extraordinary meetings, which were attended by almost all members. In addition, the<br />
various committees (Standing Committee, Audit Committee and Board Committee) met,<br />
and the respective Chairpersons regularly reported in detail on their work. They were<br />
also available to answer any questions. The Nomination Committee and the Conference<br />
Committee as decreed by Section 27, para. 3, of the German Co-Determination Act<br />
( MitbestG) did not have to meet.<br />
The Board of Management also informed us in between sessions about important issues<br />
and significant upcoming decisions. Furthermore, as Chairman of the Supervisory Board,<br />
I was in regular contact with the Chairman of the Board of Management and discussed<br />
with him <strong>ERGO</strong>’s strategy, risk and capital management as well as current business<br />
develop ments. The subject of these discussions included the allegations made against<br />
<strong>ERGO</strong> by the press again in summer <strong>2012</strong>. These allegations were made known in 2011<br />
and subsequently clarified in detail.<br />
Main issues<br />
During the balance sheet meeting held on 20 March <strong>2012</strong>, the Supervisory Board was<br />
given a detailed review of the 2011 financial statement as well as being informed of<br />
<strong>ERGO</strong>’s business development. The Chief Risk Officer also informed us in detail of <strong>ERGO</strong>’s<br />
risk strategy and risk situation. In addition, the Board of Management reported on<br />
preparations for the introduction of the new Solvency II regulatory system. During the<br />
session held on 3 August <strong>2012</strong> we debated the profitability of classic life insurance in the<br />
context of the current economic and political environment in Germany.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Supervisory Board report 7<br />
on the <strong>2012</strong> financial year<br />
We were told about the plans for a new <strong>ERGO</strong> life insurance product line, which is due to<br />
be launched in 2013. Finally, in its meeting on 4 December <strong>2012</strong>, the Supervisory Board<br />
discussed the reports by the Board of Management regarding the development and risk<br />
exposure of <strong>ERGO</strong>’s investments. Other topics included developments in the non‐life and<br />
international segments. We also discussed the Labour Director’s HR <strong>Report</strong>.<br />
In two extraordinary meetings held on 4 June and 30 October <strong>2012</strong>, the Supervisory Board<br />
discussed the results of the audits investigating allegations made against <strong>ERGO</strong> by the<br />
press as well as the measures adopted by the Board of Management in response to these<br />
allegations. The Board of Management presented the measures implemented so far and<br />
those to be adopted, along with more information about the topic of transparency on the<br />
<strong>ERGO</strong> website.<br />
In addition, during its meetings on 3 August and 4 December <strong>2012</strong>, the Supervisory Board<br />
discussed the “Future of Sales” Initiative, including the planned strategic realignment of<br />
<strong>ERGO</strong>’s sales organisations. In its meeting on 4 December <strong>2012</strong>, the Standing Committee<br />
approved and passed the transactions and measures concerning the <strong>Group</strong>’s organisation.<br />
Furthermore, the Board of Management informed us about a joint venture set up in China<br />
between <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> and life insurer <strong>ERGO</strong> Lebensversicherung <strong>AG</strong><br />
with a state investment company as a local partner, as well as a joint venture in the Life<br />
segment in India with the Avantha <strong>Group</strong>. It also outlined the sale of shares in <strong>ERGO</strong> Daum<br />
Direct in South Korea. In addition, we were told about the conclusion of a domination<br />
agreement between MunichFinancial<strong>Group</strong> GmbH – a 100% subsidiary of Münchener<br />
Rückversicherungs-Gesellschaft <strong>AG</strong> – and <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong>. The contract was<br />
entered in the commercial register on 20 November and came into force on that date.<br />
Besides decisions regarding the extension of appointments to the Board of Management<br />
that were due to expire, we also addressed the topic of remuneration for the members<br />
of the Board of Management. The plenum made a decision on the amount of variable<br />
remuneration based on the annual performance in the 2011 financial year and for the<br />
2009 mid-term incentive plan. Furthermore, the assessment base and targets for variable<br />
remuneration were stipulated for the <strong>2012</strong> financial year. We also discussed changes to<br />
the remuneration system as of 1 January 2013 and passed the resolution accordingly.<br />
On this basis, we were able to establish the assessment base and targets for variable<br />
remuneration for the 2013 financial year.<br />
Corporate governance<br />
The <strong>ERGO</strong> Supervisory Board attaches great importance to good corporate governance.<br />
We took a close look at the efficiency of our operations by means of a questionnaire in the<br />
reporting year and discussed the various suggestions for improving the efficiency of the<br />
Supervisory Board.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Supervisory Board report 8<br />
on the <strong>2012</strong> financial year<br />
Company and <strong>Group</strong> financial statements<br />
KPMG Bayerische Treuhandgesellschaft Aktiengesellschaft Wirtschaftsprüfungs gesellschaft<br />
Steuerberatungsgesellschaft, Munich, audited the annual financial statements prepared<br />
by the Board of Management, including the management report and the consolidated<br />
financial statements, including the <strong>Group</strong> management report for the <strong>2012</strong> financial year,<br />
and awarded them an unqualified auditor’s opinion.<br />
At a meeting held on 11 March 2013, the Supervisory Board’s Audit Committee discussed<br />
these documents at length, having examined them in advance. We then discussed<br />
in detail the annual financial statements and the consolidated financial statements,<br />
the management report and the <strong>Group</strong> management report, along with the reports<br />
by the external auditor at the balance sheet meeting, which was also attended by<br />
representatives of the auditing company, who made a statement. We had no objections.<br />
We approved the annual financial statements and consolidated financial statements for<br />
<strong>2012</strong>, which have now been endorsed. We reviewed the Board of Management’s proposal<br />
for the appropriation of profits and have approved it.<br />
Changes to the Supervisory Board<br />
Ms Ira Gloe-Semler, Mr Hans-Peter Claußen and Mr Ralph Eisenhauer stepped down from<br />
the Supervisory Board either during the year under review or at the end of the year. We<br />
wish to thank them for their dedication and in some cases many years of service on<br />
our Board. Ms Martina Scholze, Dr. Anne Horstmann and Mr Volker Kallé have joined the<br />
Supervisory Board as their replacements or as legally appointed members.<br />
Our gratitude to the Board of Management and staff<br />
The Supervisory Board would like to thank the members of the Board of Management and<br />
all Company employees as well as the staff of all companies within the <strong>ERGO</strong> Insurance<br />
<strong>Group</strong> for their huge personal commitment in a reporting year that was shaped by many<br />
changes and challenges.<br />
Düsseldorf, 19 March 2013<br />
On behalf of the Supervisory Board<br />
Dr. Nikolaus von Bomhard<br />
Chairman of the Supervisory Board<br />
of <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong>
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
10<br />
Management <strong>Report</strong><br />
The <strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>ERGO</strong> is one of the major insurance groups in Germany<br />
and Europe. We have a presence in more than 30 countries<br />
worldwide, but the focus of our activities is on European<br />
and Asian regions. <strong>ERGO</strong> offers a broad range of insurance,<br />
pension provisions and services. In its home market<br />
of Germany, <strong>ERGO</strong> ranks among the leading providers<br />
across all segments. Around 48,000 people work for our<br />
<strong>Group</strong>, either as salaried employees or as full-time selfemployed<br />
sales partners. In <strong>2012</strong>, premiums amounted to<br />
over € 18 billion and insurance benefits for our customers<br />
accounted for more than € 17 billion.<br />
Our customers can choose which form of contact with<br />
<strong>ERGO</strong> suits them best, as we have the right sales channel<br />
for every customer: self-employed insurance sales partners,<br />
staff working in direct sales, insurance brokers and strong<br />
cooperation partners – both in Germany and abroad –<br />
respond to the needs of private and corporate customers<br />
alike. We maintain sales partnerships with the major<br />
European bank UniCredit <strong>Group</strong> and other banks, both in<br />
Germany and other European countries.<br />
<strong>ERGO</strong> is part of Munich Re, one of the leading global<br />
reinsurers and risk carriers. Within Munich Re, <strong>ERGO</strong> is the<br />
specialist for primary insurance, i. e. for insuring private and<br />
corporate customers directly, both in Germany and abroad.<br />
The group’s investments of € 214 billion, of which € 125 billion<br />
is accounted for by <strong>ERGO</strong>, are managed primarily by the<br />
joint asset management and fund company ME<strong>AG</strong>.<br />
As an integral part of Munich Re, <strong>ERGO</strong> is integrated into<br />
the core processes of Munich Re in terms of regulatory and<br />
corporate law, e. g. group strategy and corporate policy,<br />
capital and financial planning, risk management, controlling,<br />
reporting and accounting, or in general regarding significant<br />
legal transactions and measures. In <strong>2012</strong>, a domination<br />
agreement was concluded between MunichReFinancial<strong>Group</strong><br />
GmbH – which is wholly owned by Münchener Rückversicherung<br />
<strong>AG</strong> – and <strong>ERGO</strong> Versicherungs gruppe <strong>AG</strong>. A group<br />
directive regulates the responsibilities and competences<br />
between the group executive management of Munich Re and<br />
<strong>ERGO</strong> in decisions of primary importance.<br />
This consolidated management report summarises the<br />
business activities of our <strong>Group</strong>. There is a general overview<br />
of <strong>ERGO</strong>’s performance on pages 19–22, which includes<br />
information on the following divisions: Life Germany,<br />
Health, Property-Casualty Germany, Direct Insurance,<br />
Travel Insurance and International.<br />
Our brand strategy<br />
In our domestic market of Germany, we offer life and<br />
property-casualty products under the <strong>ERGO</strong> brand. This<br />
product range is supplemented by our specialist insurers –<br />
DKV for health insurance, D.A.S. for legal protection and<br />
ERV for travel insurance.<br />
We are primarily represented on the international market<br />
by the <strong>ERGO</strong> brand and are actively giving the brand a<br />
higher profile. In line with this strategy, we renamed<br />
companies in Austria, Slovenia, Croatia and the Czech<br />
Republic during the reporting period. Over the course of<br />
the current year, we merged companies in Hungary and<br />
Slovakia; the merged companies now operate under the<br />
<strong>ERGO</strong> brand.<br />
Our brand communicates a clear promise to our customers:<br />
“To insure is to understand.” This promise represents a<br />
consistent approach that takes customers’ requirements<br />
into account in all areas of business. It consists of needsbased<br />
advice which understands and picks up on the<br />
customers’ concerns along with clear and easy-to-understand<br />
communication, innovative services and prompt<br />
support in the event of loss or damage.<br />
At the same time we are working towards further fulfilling<br />
our customers’ expectations and invite them and others<br />
to give us feedback which we analyse self-critically. Using<br />
the online <strong>ERGO</strong> Customer Workshop or as a member of<br />
the <strong>ERGO</strong> Customer Advisory Board, consumers can help<br />
to shape our products and services by contributing their<br />
suggestions and wishes.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>11<br />
The <strong>ERGO</strong> Insurance <strong>Group</strong><br />
During the reporting period we published the first <strong>ERGO</strong><br />
Customer <strong>Report</strong>. We have received numerous suggestions,<br />
ideas and criticism from consumers in the form of letters,<br />
conversations, e-mails,online feedback forms and via<br />
Facebook. These comments were condensed into 179<br />
questions, which we then answered.<br />
The <strong>ERGO</strong> Customer Advocate represents the interests of<br />
our customers within the Company. He takes on the role of<br />
mediator in cases where a customer feels that he has not<br />
been treated fairly and is not getting anywhere. Together<br />
with the <strong>Group</strong>’s size and financial strength, <strong>ERGO</strong>’s strong<br />
customer orientation makes it a long-term reliable partner<br />
for customers.<br />
Our management style and objectives<br />
Our Company is managed strictly with the customer, service<br />
and profitability in mind. The focus here is on integrated<br />
management of the divisions and their administrative<br />
processes, modern risk management comprising asset<br />
liability management, and value and risk-based management<br />
of all business activities.<br />
Our activities include various business models, providing<br />
all types of life, annuity and health cover and virtually all<br />
aspects of property-casualty insurance as well as legal<br />
protection cover.<br />
Value-based management<br />
Our objective is to analyse risks from every conceivable angle<br />
and to assess and diversify them, thereby creating lasting<br />
value for shareholders, customers and staff. The guiding<br />
principle of our entrepreneurial thinking and activity is to<br />
increase the value of our Company on a lasting basis, which<br />
also includes our active capital manage ment. We pursue this<br />
goal primarily by consistently applying value-based management<br />
systems which we constantly refine. Economic earnings<br />
are instrumental to answering the uestion of whether or<br />
not we have created value over a given period. They consider,<br />
for example, the costs of the relevant risk capital and the<br />
long-term nature of the business, and correspond to the<br />
change to the economic equity over a specified period of<br />
time.<br />
The framework for any business activity is our risk strategy,<br />
derived from the business strategy, from which we extract<br />
a detailed network of limitations and reporting thresholds.<br />
Besides value-based parameters, we observe a range of<br />
important additional conditions in managing our business.<br />
They include rules of local accounting systems, tax<br />
aspects, liquidity requirements and regulatory parameters.<br />
Our value-based management is characterised by the<br />
following aspects:<br />
• We assess business activities not only according to their<br />
earnings potential but also relative to the extent of the<br />
risks assumed, which is decisive in measuring added<br />
value as well. This is why we have implemented high<br />
quality standards for underwriting, pricing, cumulative<br />
controls and claims management. Only the risk–return<br />
relationship reveals how beneficial an activity is from<br />
the shareholder point of view.<br />
• With value-based performance indicators we ensure<br />
the economic view and the necessary comparability of<br />
alternative initiatives and prioritise these.<br />
• We closely link strategy and operative planning.<br />
Property-casualty insurance:<br />
combined ratio and economic earnings<br />
Across property-casualty insurance and other segments,<br />
which are by and large distinguished by their short-term<br />
business nature, we largely consider two factors: combined<br />
ratio and economic earnings.<br />
The combined ratio describes the percentage ratio<br />
between the sum of expenses for claims and benefits to<br />
customers (net) plus operating expenses (net) to earned<br />
premiums (net).<br />
When interpreting the combined ratio, the particular<br />
circumstances of the class of business in question have<br />
to be taken into account. The composition of the portfolio<br />
is of great significance, as is the degree to which the<br />
claims burden fluctuates over time. The time lag between<br />
premiums being received and claims being paid is of key<br />
significance. The more extended this period is, the longer<br />
the premiums received can be invested in the capital<br />
markets.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>12<br />
The <strong>ERGO</strong> Insurance <strong>Group</strong><br />
Higher combined ratios in classes of business with comparatively<br />
late claims notifications and long claims settlement<br />
processes (e. g. liability insurance) regularly go hand<br />
in hand with higher results from investments, which in<br />
turn cover the provisions for outstanding claims. These<br />
returns are not reflected in the combined ratio. For this<br />
reason, while we aim to keep the combined ratio as low<br />
as possible, it is not a sufficiently significant variable when<br />
considered on its own.<br />
The economic value creation is of decisive importance,<br />
which cannot be described properly with the combined<br />
ratio alone. The economic value added is determined<br />
internally – in compliance with the prospective regulatory<br />
system “Solvency II” – using economic earnings. Value<br />
added is characterised by the fact that value creation is<br />
not evaluated on the basis of current and forecast profits<br />
alone, but also by taking into account the amount of<br />
risks taken.<br />
The starting point for calculating economic earnings is<br />
the change in economic equity within a period of time.<br />
Determining factors are primarily the IFRS result, the<br />
change to the balance sheet and off-balance sheet<br />
reserves on the assets and liability side, as well as risk<br />
capital costs for the risks insured. The change in economic<br />
equity is adjusted according to capital measures, such as<br />
dividends. Additional adjustments concern the change<br />
of items, which are not included in the economic capital,<br />
yet still bear influence on the economic value added.<br />
An example of this is the construction of goodwill value<br />
following an acquisition.<br />
Life and Health:<br />
market-consistent embedded value<br />
Life and health insurance products are characterised<br />
by their long-term nature and the distribution of results<br />
over the duration of the policies. For valuing such longterm<br />
portfolios whose performance cannot be reasonably<br />
measured on the basis of a single year, we follow<br />
the Principles of Market Consistent Embedded Value<br />
(MCEV) © , the current version of which was published by<br />
the European Insurance CFO Forum in October 2009.<br />
MCEV comprises a company’s equity and the value of<br />
in-force covered business. The latter is the present value of<br />
future net profits from the insurance portfolio and related<br />
investments calculated using financial and actuarial<br />
methods, taking into consideration the time value of<br />
the financial options and guarantees and the explicitly<br />
determined costs of capital.<br />
MCEV relates to the portfolio as at the valuation date. It<br />
encompasses more than 97% of our life insurance and<br />
long-term health insurance business. By contrast, MCEV<br />
does not include the value of future new business. However,<br />
the valuation is made under the assumption of<br />
continued operations. Options and guarantees – especially<br />
for the policyholders – are explicitly valued using stochastic<br />
simulations. MCEV reflects the present value of all cash<br />
flows for all important currency regions on the basis of the<br />
swap rates and the implicit volatilities at the valuation date<br />
of 31 December <strong>2012</strong>. Assets that are traded on the capital<br />
markets are valued on the basis of the market values<br />
observed at the valuation date.<br />
The development of the insurance portfolio is modelled<br />
by applying the current expectations for biometrics (e. g.<br />
mortality and morbidity), lapses and costs. The participation<br />
of policyholders in surplus is modelled according to the<br />
current planning and in line with the statutory regulations,<br />
and these are included in the valuation. For the individual<br />
companies, we use tax rates and calculations based on<br />
national regulations; tax loss carry-forwards are also<br />
included in the calculation. The cost of capital essentially<br />
includes costs for the not explicitly modelled risks of the<br />
business.<br />
The change in MCEV within one year – excluding effects<br />
of exchange-rate fluctuations, acquisition and sale of<br />
companies, dividends and capital injections – is shown<br />
as the total embedded value earnings. These are used<br />
under the term Economic Earnings to manage life and<br />
health insurance. If the total embedded value earnings<br />
are adjusted by also including the influences of changes<br />
in capital market parameters, such as changes to the rate<br />
of interest, the term is known as the operating embedded<br />
value earnings, which are a measure of the operative<br />
business performance for one year.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>13<br />
The <strong>ERGO</strong> Insurance <strong>Group</strong><br />
Managing investments<br />
The main focus of our investment strategy is assetliability<br />
management, in which we take into account key<br />
characteristics of underwriting and other liabilities in<br />
structuring our investment portfolio and measure investment<br />
risks not only in absolute terms, but also in relation<br />
to changes of value in our liabilities. Changes in economic<br />
factors are likely to influence the value of our capital<br />
investments, just as they will have an impact on the value<br />
of technical provisions and liabilities. This reduces our<br />
vulnerability to the effect of capital market fluctuations<br />
and stabilises our own equity. For this purpose, we mirror<br />
important features of the liabilities, such as maturity<br />
patterns, currency structures, and inflation sensitivities, on<br />
the assets side of the balance sheet by acquiring investments<br />
with similar characteristics if possible. In terms<br />
of currency positioning, exchange-rate fluctuations thus<br />
affect assets and liabilities in equal measure. Currency<br />
conversion losses on assets are largely offset economically<br />
by gains made by converting technical liabilities. In<br />
this approach, any deviations from the structure of our<br />
liabilities are made consciously taking due account of our<br />
risk-bearing capacity and the risk spreads achievable. To<br />
a limited extent, we also align our investment portfolio<br />
in such a way that it increases in value in line with rising<br />
inflation rates. To achieve this, we invest in inflationsensitive<br />
asset classes such as inflation-linked bonds and<br />
inflation-linked swaps, as well as real assets.<br />
Non-financial performance measures<br />
In addition to these purely financial performance factors,<br />
non-financial performance measures such as innovation,<br />
speed of processes, staff-training level as well as customer<br />
satisfaction, sales service and productivity also play a<br />
part. A company can only be successful over the long<br />
term if it operates sustainably and takes account of such<br />
future- oriented qualitative factors. This is why our strategic<br />
management focuses on the five target groups, namely<br />
customers, sales partners, staff, society and investors.<br />
We promote an entrepreneurial culture among our staff<br />
through the clear allocation of responsibility and accountability,<br />
making clear how much the individual, unit and<br />
field of business contribute to increasing value. Our incentive<br />
systems for executives and the Board of Management<br />
therefore also encourage value creation: the higher a staff<br />
member or executive is positioned in the management<br />
hierarchy, the more dependent their remuneration is on<br />
performance. <strong>ERGO</strong> Insurance <strong>Group</strong> Board members and<br />
executives have targets according to economic earnings.<br />
Furthermore, the customer satisfaction index, Net Promotor<br />
Score, is a key controlling variable for <strong>ERGO</strong> which extends<br />
into the targets and awarding of bonuses to members of<br />
the Board of Management.<br />
To configure our economic asset-liability management<br />
as effectively as possible, we also use derivative financial<br />
instruments to hedge against fluctuations in the interest<br />
rate, equity and currency markets. Under IFRS accounting,<br />
we recognise these in profit or loss, i. e. as income or<br />
expense in the income statement. This type of recording<br />
is not done with related underlying trans actions. Despite<br />
our economically well-balanced insurance and investment<br />
portfolios, accounting inconsistencies of this kind and other<br />
differences between the economic and balance sheet<br />
perspectives can give rise to considerable fluctuations in<br />
our IFRS investment, currency and consolidated results,<br />
particularly in times of greater volatility on the capital<br />
markets. Financial derivatives are explained in further detail<br />
in the notes on the consolidated financial statements [6l].
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
14<br />
Management <strong>Report</strong><br />
The <strong>ERGO</strong> Insurance <strong>Group</strong> – Governing bodies<br />
Supervisory Board<br />
Dr. Nikolaus von Bomhard, Chairman<br />
Chairman of the Board of Management of<br />
Münchener Rückversicherungs-Gesellschaft <strong>AG</strong><br />
Michael David, Deputy Chairman<br />
Insurance employee<br />
Dr. Christine Bortenlänger<br />
Managing Director of<br />
Deutsches Aktieninstitut in Frankfurt<br />
Hans-Peter Claußen, until 31 August <strong>2012</strong><br />
Insurance employee<br />
Ralph Eisenhauer, until 31 December <strong>2012</strong><br />
Executive employee<br />
Frank Fassin<br />
District Chairman Financial Services ver.di NRW<br />
Prof. Dr. Nadine Gatzert<br />
Professor for Insurance Economics at the<br />
Friedrich-Alexander University in Erlangen-Nuremberg<br />
Ira Gloe-Semler, until 20 March <strong>2012</strong><br />
Associated Union of Workers Secretary ver.di<br />
Dr. Heiner Hasford<br />
Member of the Board of Management of<br />
Münchener Rückversicherungs-Gesellschaft <strong>AG</strong> (retired)<br />
Dieter Herzog<br />
Insurance employee<br />
Dr. Anne Horstmann, since 1 September <strong>2012</strong><br />
Insurance employee<br />
Dr. Lothar Meyer<br />
Chairman of the Board of Management of<br />
<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> (retired)<br />
Dr. Markus Miele<br />
Managing Partner of Miele & Cie. KG<br />
Silvia Müller<br />
Insurance employee<br />
Marco Nörenberg<br />
Insurance employee<br />
Bernd Otten<br />
Head of Corporate Office Münchener Rückversicherungs-<br />
Gesellschaft <strong>AG</strong><br />
Prof. Dr. Bernd Raffelhüschen<br />
Director of the Institute of Public Finance of the<br />
Albert-Ludwigs-University of Freiburg<br />
Martina Scholze, since 27 April <strong>2012</strong><br />
Trade Union Secretary of Financial Services <strong>Group</strong> of ver.di<br />
Richard Sommer<br />
Former Head of the Federal <strong>Group</strong> Insurance of ver.di<br />
Dr. Theodor Weimer<br />
Spokesman of the Board of Management<br />
of Unicredit Bank <strong>AG</strong><br />
Heinz Wink<br />
IT employee<br />
Prof. Dr. Klaus L. Wübbenhorst<br />
Managing Director of WB Consult GmbH<br />
Volker Kallé, since 1 January 2013<br />
Executive employee
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>15<br />
The <strong>ERGO</strong> Insurance <strong>Group</strong><br />
Governing bodies<br />
Audit Committee<br />
Dr. Heiner Hasford<br />
Dr. Theodor Weimer<br />
Heinz Wink<br />
Board Committee<br />
Dr. Nikolaus von Bomhard<br />
Hans-Peter Claußen, until 30 April <strong>2012</strong><br />
Dieter Herzog, since 1 May <strong>2012</strong><br />
Dr. Markus Miele<br />
Nomination Committee<br />
Dr. Nikolaus von Bomhard<br />
Dr. Lothar Meyer<br />
Dr. Markus Miele<br />
Standing Committee<br />
Dr. Nikolaus von Bomhard<br />
Michael David<br />
Dr. Lothar Meyer<br />
Dr. Markus Miele<br />
Marco Nörenberg<br />
Conference Committee<br />
Dr. Nikolaus von Bomhard<br />
Michael David<br />
Dr. Heiner Hasford<br />
Richard Sommer<br />
Board of Management<br />
Dr. Torsten Oletzky, Chairman<br />
<strong>Group</strong> Development<br />
Communications<br />
<strong>ERGO</strong> Customer Advocate<br />
Legal Affairs, Compliance<br />
Internal Auditing<br />
Dr. Bettina Anders<br />
IT Germany as well as Comprehensive Questions<br />
of Principle, Customer Service, Company Organisation<br />
Dr. Daniel von Borries<br />
Finances and Investments<br />
Life Insurance Germany<br />
ME<strong>AG</strong>/<strong>ERGO</strong>-Interface<br />
Christian Diedrich<br />
Non-Life Insurance<br />
(Property-Casualty, Legal Protection) Germany<br />
Dr. Ulf Mainzer, Labour Director<br />
Domestic Human Resources as well as<br />
Comprehensive Questions of Principle,<br />
General Services, Facility and Materials<br />
Management/Purchasing and Logistics<br />
Germany<br />
Dr. Jochen Messemer<br />
International Operations<br />
(except for Travel Insurance)<br />
Dr. Clemens Muth<br />
Health Insurance (including Travel Insurance)<br />
Dr. Rolf Wiswesser<br />
Sales Germany, Competence Centre Bank Sales Germany,<br />
Marketing, Brand Management<br />
Dr. Christoph Jurecka<br />
Accounting, Taxes, Planning and Controlling,<br />
Risk Management
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
16<br />
Management <strong>Report</strong><br />
Business environment<br />
Our business environment is being shaped by a number of<br />
global trends with a long-term impact. Demographic shifts<br />
are giving rise to fundamental developments and posing<br />
enormous challenges for social security and healthcare<br />
systems, particularly in industrialised countries. Increasing<br />
life expectancy is placing a burden on pay-as-you-go social<br />
security systems, a situation aggravated further by falling<br />
birth rates. Europeans will therefore only be able to maintain<br />
their old-age provision and first-class medical care in<br />
the medium term if they take out additional private cover.<br />
This presents a great opportunity for the private insurance<br />
industry. However, consistently low interest rates are<br />
threatening the success of long-term savings.<br />
Developing and emerging countries are experiencing rapid<br />
population growth and, at the same time, a swift rise in<br />
prosperity among large sections of the population. As a<br />
result, the emerging Asian economies in particular are gaining<br />
in global importance. Correspondingly, the economic and<br />
geopolitical weight of industrialised countries is declining.<br />
Worldwide economic integration, technological progress and<br />
digitalisation are accelerating the globalisation of capital<br />
flows and supply chains, and increasing the complexity of<br />
the world economy.<br />
In this environment, we are seeing a rising number of<br />
major events which impact on the insurance industry.<br />
Insured losses are rising disproportionately to economic<br />
activity. We believe that climate change is responsible,<br />
alongside advancing urbanisation and a concentration<br />
of assets in exposed regions. This is producing new risk<br />
potentials and accumulation risks that make it imperative<br />
to constantly refine our underwriting.<br />
Companies like <strong>ERGO</strong>, which are among the leaders in<br />
terms of risk management, are able to take advantage of<br />
the opportunities arising from this global trend. With our<br />
sound risk awareness, we are able to hold our ground even<br />
in a complex and volatile environment.<br />
General economic trend<br />
Global economic growth weakened for a further consecutive<br />
year in <strong>2012</strong>, due in large part to the still-smouldering<br />
state debt and banking crisis in the Eurozone. The eurozone<br />
as a whole had already slid into a recession in late 2011<br />
from which it was unable to free itself during the period of<br />
review. Budget consolidation measures curbed growth, and<br />
at the same time the rate of unemployment continued to<br />
rise, reaching a record level.<br />
Chinese economic growth slowed down considerably, due<br />
in part to receding global demand for export. The performance<br />
of the Japanese economy also weakened over the<br />
course of the year. Meanwhile, the moderate economic<br />
growth of the USA buttressed the global economy.<br />
At the beginning of the year, the Euvrozone crisis appeared<br />
to have very little impact on the German economy, though<br />
the economy faltered in the second half of the year.<br />
German price-adjusted GDP rose by just 0.7% in <strong>2012</strong><br />
( provisional estimate from the Federal Bureau of Statistics<br />
of 15 January 2013). The trend on the German employment<br />
market, however, remained positive. The average unemployment<br />
rate for the year was 6.8%. Average inflation on<br />
consumer prices in Germany was 2.0% in <strong>2012</strong>.<br />
Capital market trends<br />
Political events, particularly within the European Economic<br />
and Monetary Union, and measures adopted by the central<br />
banks were the driving forces behind capital market<br />
develop ments, including large fluctuations. Periods of high<br />
demand for high-risk securities alternated with periods of<br />
risk aversion. Overall, for most of the asset classes trends<br />
were positive.<br />
Over the past year, the overall positive development for<br />
virtually all types of securities belied the major fluctuations<br />
of <strong>2012</strong>. The main driving force behind these fluctuations<br />
in the international markets was the ongoing state debt
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>17<br />
Business environment<br />
crisis in the Eurozone. At the beginning of the year, some<br />
government bonds in countries on the European periphery<br />
recorded considerable gains. We attribute this development<br />
to the generous provision of liquidity from the<br />
European Central Bank (ECB), which also greatly benefited<br />
high-risk securities such as shares. However, the crisis<br />
intensified in the second quarter due to uncertainty about<br />
the outcome of the Greek elections, the adjustment of the<br />
goals to reduce Spain’s budget deficit and debates on the<br />
possibility of certain countries leaving the euro. As a result,<br />
the returns on most “safe haven” bonds reached new lows.<br />
Plans to set up a Eurozone banking union and the ECB’s<br />
announcement of its intention to possibly buy up all shortterm<br />
government bonds from countries on the European<br />
periphery led to lower returns on peripheral bonds and a<br />
marked recovery on the stock market in the second half of<br />
the year. All in all, <strong>2012</strong> was a positive year for shares. The<br />
Euro Stoxx 50 price index was up by 13.8% and the DAX<br />
performance index increased by 29.1%.<br />
Yet demand remained high for safe-haven securities, such<br />
as German government bonds. The already low return on<br />
ten-year German government bonds fell a further 50 basis<br />
points to 1.3% by the end of the year. This change in<br />
interest rates made some considerable gains possible on<br />
the bond markets.<br />
Central banks outside the Eurozone also relaxed their<br />
monetary policy due to weak economic growth on a<br />
global scale. The US Federal Reserve announced a further<br />
bond-purchasing programme, which will be maintained<br />
until the situation on the employment market improves<br />
substantially.<br />
The trend in the insurance industry<br />
At the end of <strong>2012</strong>, insurers in several EU countries introduced<br />
the new unisex tariffs, meaning that gender is no<br />
longer a factor in the calculation of premiums and benefits<br />
in terms of risk differentiation, following a verdict passed<br />
by the European Court of Justice in 2011. The court viewed<br />
different premiums for men and women as undue discrimination.<br />
For example, life insurance companies may<br />
no longer take into account the observed difference in life<br />
expectancies of men and women. This ruling is valid for all<br />
policies signed since 21 December <strong>2012</strong>.<br />
The overall economic trend has a strong effect on the<br />
development of premiums in the insurance industry, especially<br />
for property-casualty insurance. In the case of life<br />
and health insurance, additional important factors are the<br />
influence of capital markets and changes to the legal and<br />
tax frameworks. This means that the European insurance<br />
markets operate according to very different parameters.<br />
In line with the focal point of our business, the following<br />
sections take a closer look at trends in our domestic market<br />
of Germany.<br />
On the whole, insurance premiums in Germany rose by 1.5%<br />
in <strong>2012</strong>. The figures here and below are based on provisional<br />
estimates provided by the German Insurance Association<br />
and the German Association of Private Health Insurers.<br />
The market figures are based on gross figures established<br />
in accordance with the German Commercial Code (HGB),<br />
meaning they are not necessarily comparable with figures<br />
calculated according to IFRS or net of reinsurance.<br />
Life insurance in <strong>2012</strong><br />
Life insurance in Germany (including pension and retirement<br />
funds) continued to suffer from the adverse conditions<br />
experienced on the capital markets in <strong>2012</strong>. Persistently<br />
low interest rates have led to a reduction of bonus rates<br />
across the industry. This particularly influenced the market<br />
for single-premium products. New business with regular<br />
premiums was also down on last year. Widespread economic<br />
uncertainty has prompted customers to be cautious<br />
of long-term commitments. New business was down by 2%<br />
across the market. The top priority for customers is the security<br />
of their private old-age provision, making guaranteed<br />
components very important to them. Insurance against the<br />
financial impact of occupational disability and the need for<br />
nursing care also recorded a marked increase in business.<br />
Total premium income was up slightly by 0.8% to € 83.8 billion<br />
(83.2 bn) across the industry, due to a lower number of<br />
policies expiring. The previous year saw a large amount of<br />
scheduled maturities. Many of these policies were taken out<br />
in 1999 because of the planned tax reforms at that time.<br />
The amount paid out to life insurance customers therefore<br />
dropped to € 75 billion 85 bn).
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>18<br />
Business environment<br />
The German Federal Court of Justice ruled against various<br />
life insurers, rendering certain terms of insurance invalid<br />
in several verdicts during the period covered by this report.<br />
These included terms governing the surrender value,<br />
cancellation fee and the calculation of acquisition costs<br />
applied to new policies from 2002 to 2007. The cancellation<br />
fee clause may also affect tariffs from 2008 onwards.<br />
Private health insurance in <strong>2012</strong><br />
The share of private health insurance in the wider health<br />
insurance market stabilised in <strong>2012</strong> despite difficult market<br />
conditions. According to initial provisional forecasts, private<br />
health insurance achieved growth of 3.4% in premium<br />
income, amounting to € 35.9 billion (34.7 bn). Private health<br />
insurers’ benefits, including settlement expenses, rose by<br />
around 4.8% to € 23.9 billion (22.8 bn).<br />
The new amendments to the law governing financial<br />
services mediation and property include a limit on commission<br />
amounts paid to agents and an extension of the<br />
cancellation liability periods, both of which have been in<br />
force since 1 April <strong>2012</strong>. In addition, the state has been<br />
paying the premiums on behalf of the disadvantaged<br />
directly to the respective private health insurer since this<br />
date. In return, the insurance companies have agreed in<br />
recognition of regulatory admissibility to forego premiums<br />
payable by 31 January <strong>2012</strong> due to the extent of the gap in<br />
statutory cover.<br />
Property-casualty insurance in <strong>2012</strong><br />
Since the economic situation of private households and<br />
businesses continues to improve, property-casualty insurance<br />
recorded a healthy rise of 3.7% in premium income<br />
in <strong>2012</strong> to € 58.7 billion (56.6 bn). Once again, all lines of<br />
business made a contribution. However, this was mainly<br />
due to rises in premium rates and adjustments to clauses<br />
rather than an increase in the number of insured risks.<br />
Motor insurance grew by an impressive 5.1%, although it<br />
still has a way to go before producing a technical profit.<br />
The rates of growth of liability insurance (+ 2.0%), legal<br />
protection insurance (+ 1.5%) and accident insurance<br />
(+ 1.0%) were all below average. Premium income recorded<br />
for transport and aviation insurance was up by 3.5%,<br />
property insurance lines of business rose by 4.3%.<br />
Claims expenditure rose proportionately to the increase in<br />
premiums. On the one hand, damages related to natural<br />
hazards in <strong>2012</strong> were down on the previous year. On the<br />
other, extreme frost in February and a number of other<br />
major damaging events caused a great deal of destruction.<br />
An explosion in a chemical factory has been the largest<br />
single insurance claim in Germany to date. The combined<br />
ratio across the market is expected to remain virtually<br />
unchanged at 98%.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
19<br />
Management <strong>Report</strong><br />
Business performance<br />
<strong>2012</strong> was a year dominated by challenging economic<br />
conditions and good progress in major projects for <strong>ERGO</strong><br />
Insurance <strong>Group</strong>. The state debt crisis in the Eurozone has<br />
continued, leading to shrinking economies in certain countries,<br />
including some where we are active, such as Greece.<br />
Interest rates fell yet further for government bonds which<br />
have been considered safe by market participants.<br />
In our home market of Germany, we have begun an<br />
extensive reorganisation of our sales forces. We aim to<br />
introduce a uniform advisory procedure, reducing complexity<br />
and therefore cutting costs. This major project is set<br />
to be completed during the course of the next two years.<br />
This will result in savings from as early as 2014; from 2015<br />
these should amount to over € 160 million gross per year.<br />
The project, however, has placed the current year’s result<br />
under considerable strain. In the fourth quarter of <strong>2012</strong>,<br />
we booked the provisions for the restructuring costs which<br />
impacted our net result by an amount of €− 128 million.<br />
We have considerably increased profits in our international<br />
business. Our operating result abroad has more than<br />
doubled, leading to a considerable net result. Our restructuring<br />
measures of the past few years are now yielding<br />
results.<br />
The consolidated result for <strong>ERGO</strong> Insurance <strong>Group</strong><br />
amounted to € 289 million (349 m). We had aimed for<br />
around € 400 million and would have achieved this figure,<br />
but for the one-off costs of restructuring. This is clearly<br />
shown in the stark increase in operating profit, up by 17.9%<br />
to € 951 million (806 m).<br />
We determine figures for long-term business in the<br />
life and health insurance segments according to strict<br />
market-consistent methods. We still do not apply interest<br />
surcharges or liquidity premiums. The market-consistent<br />
embedded value (MCEV) determined in this way, rose to<br />
€ 2.7 billion (0.9 bn). Contributing to this was the fact that<br />
risk premiums recorded on fixed interest-bearing securities,<br />
especially those for government bonds in peripheral Eurozone<br />
countries, had fallen at the end of <strong>2012</strong>. An additional<br />
factor was the first-time inclusion of <strong>ERGO</strong> Direkt Krankenversicherung<br />
in the MCEV calculation. The total embedded<br />
value earnings came to € 1.5 billion (− 3.0 bn). The value of<br />
new business climbed to € 146 million (37 m).<br />
Premium income<br />
<strong>ERGO</strong> Insurance <strong>Group</strong>’s total premium income was 8.4%<br />
lower in the reporting year than the preceding year, at<br />
€ 18.6 billion (€ 20.3 bn). This significant drop is as much<br />
a result of disposals as it is due to organic effects. By the<br />
end of 2011 we had sold our international health insurer to<br />
Munich Health Holding <strong>AG</strong>. We had also sold our Portuguese<br />
subsidiaries by the end of 2011, and in October <strong>2012</strong>, we sold<br />
<strong>ERGO</strong> Daum Direct in South Korea. This divestment explains<br />
6.1% percentage points of the drop. Furthermore, we sold<br />
considerably less single-premium life insurance policies in<br />
Germany and Austria and underwrote a significantly lower<br />
volume of the single-premium MaxiZins product in direct<br />
insurance. This is due to low interest rates and fiscal changes<br />
in Austria. Gross premiums written – in contrast to total<br />
premiums they do not include the savings premiums from<br />
unit-linked life insurance and capitalisation products – was<br />
€ 17.1 billion (€ 18.5 bn), a drop of 7.7%.<br />
<strong>ERGO</strong> Insurance <strong>Group</strong> <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Change<br />
%<br />
Total premium income 18,562 20,270 − 8.4<br />
Gross premiums written 17,091 18,519 − 7.7<br />
Investment result 5,262 4,116 27.8<br />
Net insurance benefits 1 16,744 16,703 0.2<br />
Net operating expenses 3,512 3,814 − 7.9<br />
Consolidated result 289 349 − 17.2<br />
1 Incl. policyholders’ profit participation
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>20<br />
Business performance<br />
Total premium income <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Change<br />
%<br />
Life Germany 4,754 4,955 − 4.1<br />
Health 4,932 5,975 − 17.4<br />
Property-casualty Germany 3,138 3,087 1.6<br />
Direct insurance 1,212 1,422 − 14.8<br />
Travel insurance 460 485 − 5.2<br />
International 4,066 4,346 − 6.4<br />
Total premiums 18,562 20,270 − 8.4<br />
For business within Germany, total premium income reached<br />
€ 14.2 billion (€ 14.6 bn) (− 2.3%), while gross premiums<br />
written in accordance with IFRS were € 13.2 billion (€ 13.3 bn)<br />
(− 0.9%). For international business, total premium income<br />
stood at € 4.3 billion (€ 5.7 bn) (− 24.1%), while gross premiums<br />
written in accordance with IFRS were € 3.9 billion (5.2 bn)<br />
(− 24.9%).<br />
The German life insurance business saw gross premiums<br />
written fall by 5.6% to € 3.9 billion (€ 4.2 bn). Both this and<br />
the 4.1% drop in total premiums can be largely traced<br />
back to less single-premium business. Due to the low rate<br />
of interest, we are very cautious about the conditions we<br />
offer our customers. Overall, single-premium business was<br />
down by 11.5% to € 939 million (1,061 m). The continuing<br />
economic uncertainty and the drop in the technical interest<br />
rate to 1.75% as of 1 January <strong>2012</strong> was also reflected<br />
in new business based on regular premiums: reaching only<br />
€ 307 million (€ 314 m), it was 2.0% down on last year’s<br />
figures. When measured in terms of APE (annual premium<br />
equivalent, i. e. regular premiums plus a tenth of single<br />
premiums), new business fell by 4.4%.<br />
As a result of the aforementioned divestment of international<br />
health subsidiaries, gross premiums written in the<br />
health segment were 17.4% lower. The remaining domestic<br />
business grew slightly by 0.5% to € 4.93 billion (€ 4.91 bn).<br />
Premium rate adjustments in <strong>2012</strong> were very low – something<br />
our customers were very pleased about. At € 176 million<br />
(225 m), the new business was significantly lower<br />
than last year’s figures (− 21.6%). In 2011, the abolition<br />
of the three-year waiting period when taking out health<br />
insurance has had a positive impact on the number of<br />
new intakes in comprehensive health insurance at the<br />
beginning of the year.<br />
In Germany, gross premiums written for property- casualty<br />
insurance increased by 1.6%. At 6.0%, commercial/<br />
industrial insurance business once again recorded the<br />
highest rise. In the area of private property insurance,<br />
we registered a 1.9% increase in premiums and a 0.4%<br />
increase in motor insurance. Despite a slight decrease of<br />
1.2% in the number of insured vehicles, the profitability of<br />
the portfolio has improved overall. There were also slight<br />
decreases in premium income in the areas of legal protection<br />
insurance (− 0.4%) and in personal accident insurance<br />
(− 1.6%). The latter was primarily due to lower premiums<br />
in personal accident insurance with premium refunds<br />
(ROP). We discontinued this product in late <strong>2012</strong> because<br />
we wanted our accident insurance products to focus more<br />
on ensuring quality of life with their extensive assistance<br />
services. This is no longer possible for ROP products as a<br />
result of the low interest-rate income currently achievable<br />
on investments.<br />
Total premium income for the direct insurance business was<br />
down by 14.8%. This is due to the MaxiZins capitalisation<br />
product: to reflect the low interest rates on the capital<br />
markets, we also lowered interest, which alone resulted in a<br />
decrease in premium income of € 242 million as compared to<br />
the previous year. By contrast, gross premiums written were<br />
up by 3.5% to € 957 million (€ 924 m). Total premium income<br />
from life insurance fell by 25.9%. The only health insurance<br />
we offer as direct insurance is supplementary, an area<br />
which registered solid growth of 15.7%, primarily as a result<br />
of premium rate adjustments. Property-casualty insurance<br />
increased by 1.0%.<br />
Gross premiums written for travel insurance were 5.2% less<br />
than the previous year, also because unprofitable contracts<br />
were not extended. In Germany, a decline of 1.2% was<br />
recorded, while international business fell by 8.1%.<br />
The fact that total premium income in the International<br />
business was lower than the previous year (− 6.4%) is due<br />
to the effects described above, namely, sale of daughter
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>21<br />
Business performance<br />
Investment result <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Change<br />
%<br />
Regular income 4,813 5,042 − 4.5<br />
Write-ups/write-downs 109 − 1,041 110.4<br />
Realised gains/losses 35 708 − 95.1<br />
Other income/expenses 305 − 594 151.3<br />
Total 5,262 4,116 27.8<br />
companies, lower single-premium business and strictly<br />
profit-oriented underwriting. Total premium income was<br />
therefore 8.5% down on the previous year for life insurance<br />
and 4.8% lower for property-casualty insurance.<br />
Benefits and costs<br />
Benefits for our clients in the reporting year amounted<br />
to € 17.6 billion (€ 17.4 bn). For our own account, i. e. after<br />
the deduction of the reinsurers’ share, the figure stood<br />
at € 16.74 billion (€ 16.70 bn), up by 0.2%. The fact that<br />
these developments differ from the premium income is<br />
primarily due to the net investment income. As a result of<br />
lower write-downs, this figure was much higher than in<br />
the previous year. The net value of unrealised gains and<br />
losses in unit-linked life insurance was particularly positive<br />
in the year under review, following negative performance<br />
the previous year. As a result, total transfers to provisions<br />
for future policy benefits were higher overall. Expenditure<br />
on premium refunds was significantly higher than for<br />
the previous year; this was also due to an increase in the<br />
expected share for policyholders entitled to bonuses in the<br />
German life insurance business in the future.<br />
Net claims expenditure was 10.5% below last year’s<br />
total. Even when adjusted for the sale of daughter companies,<br />
net claims would have been below the previous<br />
year’s figure. This was primarily due to German life insurance<br />
(− 14.6%). In the health segment, there was a slight<br />
decrease (− 1.6%), while German property-casualty insurance<br />
(including legal protection) recorded an increase of<br />
3.4%. The combined ratio there was 95.8% (94.4%) for the<br />
year under review. Improvements in motor insurance were<br />
up against high levels of frost damage from the late cold<br />
snap in February and some coincidental cases of major<br />
damage in the summer. In the year under review, we also<br />
restructured our reinsurance relations with Munich Re concerning<br />
property-casualty insurance, and quite a number<br />
of contracts were commuted. In addition, we made risk<br />
provisions within the range of actuarial estimates and have<br />
also made higher provisions for claims in specific lines of<br />
business.<br />
In <strong>2012</strong>, the German Federal Court of Justice ruled against<br />
various life insurers, rendering their terms of insurance<br />
invalid in several verdicts (see chapter ‘Business environment’).<br />
<strong>ERGO</strong> Lebensversicherung <strong>AG</strong> was one of the<br />
companies directly affected from a ruling. Since the rulings<br />
were decisions in principle, the other companies of the<br />
<strong>ERGO</strong> <strong>Group</strong> will also not continue to apply the terms of<br />
insurance in question. We adjusted provisions set up before<br />
<strong>2012</strong> accordingly.<br />
The developments in our international business have been<br />
very positive; here, we were able to improve our combined<br />
ratio significantly. At 100.5% (105.1%), we were almost<br />
able to achieve the level required for technical profit. The<br />
range of measures implemented over the past few years to<br />
improve earnings are starting to take effect. We achieved<br />
exceptional technical profit in both Poland and Greece in<br />
<strong>2012</strong>. Results are also starting to improve notably in Turkey,<br />
though there is still a good amount of progress to be made<br />
in the current year.<br />
At € 3.5 billion (€ 3.8 bn), net operating expenditure was<br />
7.9% down on the previous year. This is roughly equivalent<br />
to the net premium income earned (− 7.5%). Gross acquisition<br />
costs also fell by 7.9%, with gross administrative<br />
expenses down by 3.0%. Once again we were forced to<br />
amortise deferred acquisition costs because of continually<br />
low interest rates.<br />
Investment result<br />
The investment result increased by a healthy 27.8% during<br />
the <strong>2012</strong> financial year to € 5.3 billion (€ 4.1 bn). Returns<br />
based on the average amount of investments at market<br />
value stood at 4.1% (3.4%). The improvement is largely<br />
due to the fact that there were no longer similar negative<br />
effects as in the previous year, notably the write-downs<br />
on Greek government bonds or the negative net value of<br />
unrealised gains and losses in unit-linked life insurance.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>22<br />
Business performance<br />
The situation on the capital markets became somewhat<br />
better in the second half of <strong>2012</strong>. However, this applied<br />
more to stock markets. At the end of the year the yield<br />
curve for German government bonds lay above the previous<br />
year’s value only for very short durations. The return<br />
on ten-year German government bonds lost 51 basis points<br />
over the course of the year, bringing it to 1.32%. Once<br />
again, negative nominal returns were recorded in single<br />
cases. These low interest rates are causing us major problems<br />
as an institutional investor, since guarantees and<br />
interest rates on our investments are extremely important<br />
when it comes to old-age provision and health insurance.<br />
These demand a high degree of security and return. We<br />
therefore placed the bulk of our investments, amounting to<br />
€ 125 billion (€ 117 bn), into a broad range of fixed-interest<br />
securities and loans. A breakdown of our investment<br />
portfolio and major developments is detailed in the next<br />
chapter of this report.<br />
With this in mind, an assessment of our investment results<br />
is a double-edged sword. Regular income was 4.5% down<br />
on last year’s figure at € 4.8 billion (€ 5.0 bn). This is the<br />
result of the falling average interest rate for our portfolio.<br />
However, the extraordinary result, the net value of writeups<br />
and write-downs on capital investments as well as<br />
gains and losses from divestments, developed positively.<br />
It came to € 798 million (€− 538 m), once again a clearly<br />
positive figure. At € 603 million (€− 263 m), the net figure<br />
for unrealised gains and losses from unit-linked life insurance<br />
had a significant impact. The portfolio of interest-rate<br />
derivatives we hold to hedge the risk of sustained low<br />
interest rates increased in value too. This led to earnings<br />
of € 166 million (€ 368 m). The impact on the consolidated<br />
result was € 42 million (€ 83 m).<br />
appropriated to the technical result. For further details<br />
on calculating the technical interest income in particular<br />
business segments, please refer to [25] in the Notes.<br />
After the technical interest income has been deducted,<br />
the non-technical result essentially comprises that part of<br />
the investment result which does not constitute benefits<br />
to customers. This rose to € 295 million (€ 84 m) alongside<br />
the improved investment result. By contrast, the technical<br />
result dropped by 9.2% to € 656 million (€ 723 m). One<br />
of the reasons for this was the sale of companies in the<br />
previous year.<br />
The consolidated result was € 289 million (€ 349 m). It is<br />
important to note that provisions for restructuring costs for<br />
the reorganisation of our German sales forces reduced the<br />
result by € 128 million. If our results were adjusted for this<br />
effect, we would have achieved our goal of € 400 million.<br />
The cost of restructuring is spread over the following<br />
domestic business fields: Life insurance Germany, Health<br />
insurance, Property-casualty insurance Germany and<br />
<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> as the parent company. As<br />
a result, and due to the strain incurred by continually low<br />
interest rates, the result for the Life insurance Germany<br />
was slightly negative. The fall in profits in Health insurance<br />
can be largely attributed to major gains from divestments<br />
in the previous year from the sale of international companies,<br />
an event which was not repeated during the year<br />
under review. There were partially sharp rises in profits<br />
recorded for Property-casualty insurance Germany, International<br />
business, Direct insurance and Travel insurance.<br />
The developments in our international business have been<br />
particularly positive.<br />
Results<br />
The operating result was up by an impressive 17.9% to<br />
€ 951 million (€ 806 m). This is made up of the technical<br />
and non-technical results. A technical interest income is<br />
Events after the balance sheet cut-off date<br />
No events have occurred since the balance sheet cut-off<br />
date which require separate disclosure.<br />
Investment result by type of investment <strong>2012</strong> 2011 Change<br />
€ million € million %<br />
Land and buildings, including buildings on third-party land 183 170 7.6<br />
Investments in affiliated companies and associates 45 475 − 90.5<br />
Loans 2,303 2,202 4.6<br />
Other securities 2,390 1,816 31.6<br />
Other investments 341 − 547 162.3<br />
Total 5,262 4,116 27.8
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
23<br />
Management <strong>Report</strong><br />
Assets and financial position<br />
Our capital structure is essentially determined by our insurance<br />
activities: the liabilities side of the balance sheet is<br />
dominated by technical provisions (85.2% of the balance<br />
sheet total including unit-linked business), i. e. future payout<br />
commitments to our clients. Equity (3.1% of the balance<br />
sheet total) and strategic debt capital items (0.8% of the<br />
balance sheet total) are the most important sources of funds<br />
on the liabilities side. The assets side of the balance sheet is<br />
dominated by capital investments, which essentially serve to<br />
cover technical provisions.<br />
Equity and capital management<br />
Debt capital<br />
Subordinated capital and strategic debt complete our<br />
financial resources. They reduce our capital costs and<br />
ensure that sufficient liquidity is available at all times.<br />
The subordinated capital recorded on our balance sheet<br />
primarily comes from Munich Re (see also [14] in the<br />
Notes).<br />
Our liabilities are mainly deposits from business ceded<br />
to reinsurance (40.8%) and for direct insurance business<br />
(35.5%).<br />
Equity rose sharply to € 4.6 billion (3.8 bn) by the end of<br />
the reporting year. As well as retained earnings, “other<br />
reserves” in particular increased in value. The latter<br />
includes gains and losses recorded on the balance sheet<br />
and attributable to our shareholders, which rose considerably<br />
due to declining interest rates and increasing share<br />
prices. We report on the developments of our valuation<br />
reserves – on- and off-balance-sheet – later on in this<br />
chapter.<br />
We practise active capital management, which ensures<br />
that <strong>ERGO</strong>’s equity base is maintained at an appropriate<br />
level. We determine our capital requirements using our risk<br />
models and the requirements laid out by the regulatory<br />
bodies. Subordinated capital is also taking on an increasingly<br />
important role in our capital management and is<br />
partially classified as equity. Overall, our equity should<br />
not exceed the level required to run the business. This is<br />
because, through our incorporation into Munich Re’s groupwide<br />
capital management, we benefit from the group’s<br />
overall financial strength.<br />
There is no supervision at <strong>ERGO</strong> <strong>Group</strong> level because this<br />
takes place at the level of Munich Re. <strong>ERGO</strong>’s financial<br />
strength and that of its major subsidiaries are assessed<br />
by leading rating agencies. These ratings are high and are<br />
published on the <strong>ERGO</strong> website: www.ergo.com.<br />
Technical provisions<br />
Technical provisions are largely attributable to personal<br />
lines business, in particular from Life insurance Germany<br />
(51%) and Health insurance (28%) business. Detailed<br />
information on provisions can be found on pages 97 et<br />
seq. of the Notes to these financial statements.<br />
In the case of obligations arising from insurance business,<br />
we are unable to predict the time and amount of payment<br />
with certainty. The pattern of pay-outs of technical<br />
provisions over time varies enormously from one line of<br />
business to another. As regards travel insurance, business<br />
is extremely short-term. On average, final settlement<br />
of claims takes just a few days. In the area of propertycasualty<br />
insurance, a large portion of the reserves put<br />
aside is paid out within a year. For liability insurance, however,<br />
substantial amounts may accrue decades after the<br />
policy was taken out. In life and health insurance we use<br />
premiums to set up actuarial and ageing provisions, which<br />
make up the lion’s share of technical provisions.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>24<br />
Assets and financial position<br />
Investments<br />
As far as our investment strategy is concerned, our principle<br />
is to focus on the structure of our liabilities – essentially<br />
our technical obligations. On this basis, we develop an<br />
optimal investment strategy for each company, taking<br />
particular account of the capital strength of the company<br />
in question or its risk-bearing capacity.<br />
With our asset liability management (for more information,<br />
see the risk report) we strive to stabilise our balance sheet<br />
against fluctuations on the capital markets. We therefore<br />
focus on important liability characteristics such as maturity<br />
and currency structures or sensitivities to inflation when<br />
acquiring specific investments. We limit currency risks by<br />
covering expected liabilities wherever possible with investments<br />
in the corresponding currency. In order to make<br />
investment management as effective as possible, we also<br />
employ financial derivatives in order to hedge against<br />
fluctuations in interest rates and share prices.<br />
When applying this approach, we are aware of differences<br />
to the structure of our commitments and take account of<br />
the risk-bearing capacity and risk premium. At the same<br />
time, we of course comply with regulatory, accounting<br />
and tax requirements. Our aim is to guarantee maximum<br />
security, profitability and constant liquidity through appropriate<br />
mixing and spreading of investments.<br />
Taking account of the strategies developed in the strategic<br />
asset allocation department, the operating companies<br />
formulate mandates defining our investment categories,<br />
quality and limits. We also include key figures and threshold<br />
values for controlling purposes in these mandates.<br />
When investing, we consider social, ethical and ecological<br />
principles. Both our existing and new investments in shares<br />
and corporate, bank and government bonds must fulfil<br />
certain sustainability criteria. As such, we have primarily<br />
invested in the companies which are named on the Dow<br />
Jones Sustainability, FTSE 4 Good, ASPI and ESI lists, or<br />
which fulfil the criteria of rating agencies specialising in<br />
sustainability (e. g. oekom research). This continuous process<br />
is systematically applied and carried out by ME<strong>AG</strong>. We<br />
are of the firm opinion that for the long term, it is effective<br />
in terms of risk and profitability to consider sustainability<br />
criteria when making investments.<br />
Major developments and structure of<br />
investment categories<br />
At the end of the reporting year, our investments totalled<br />
€ 125 billion (117 bn) which is equivalent to a 6.9% rise. This<br />
amount includes € 6.0 billion (5.1 bn) (+ 17.0%) in investments<br />
for the account and at the risk of life insurance<br />
policyholders. The following information on the make-up of<br />
our investments relates to the investment portfolio, i. e. not<br />
including investments for the account or at the risk of life<br />
insurance policyholders.<br />
The vast majority of our investments is made up of fixedinterest<br />
securities, loans and short-term fixed-interest<br />
investments. We pay particular attention to the security<br />
of these investments. During the year under review, we<br />
sought to selectively reduce the number of government<br />
bonds in peripheral Eurozone countries. In an effort to<br />
spread our investment portfolio, we are increasingly investing<br />
outside the Eurozone. We add corporate bonds to<br />
increase the return.<br />
The duration until maturity of our bond portfolios increased<br />
slightly once again in <strong>2012</strong>. It reflects the average duration<br />
of our capital commitments and stood at 7.8 (7.1) on the<br />
balance sheet cut-off date.<br />
Our entire portfolio of interest-bearing investments is still<br />
characterised by its good rating structure. This is described<br />
in more detail in the Notes to the consolidated financial<br />
statements from page 80 onwards.<br />
We use special hedging instruments for life insurance in<br />
order to reach the level of interest guaranteed to our customers<br />
in the face of persistently low interest rates. In so<br />
doing, we regularly adapt the maturities of our hedges to<br />
coincide with changes in cash flows from our insurance<br />
business. We include changes in the value of such derivatives<br />
in profit or loss in our IFRS accounting, i. e. as income<br />
or expenditure in our income statement.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>25<br />
Assets and financial position<br />
Type of investments <strong>2012</strong> 2011<br />
€ million € million<br />
Land and buildings, including buildings on third-party land 2,271 2,347<br />
Investments in affiliated companies and associates 528 544<br />
Loans 54,373 53,215<br />
Other securities 60,560 54,672<br />
Other investments 1,701 1,440<br />
Total 119,433 112,217<br />
Investments for the benefit of life insurance policyholders who bear the investment risk 5,957 5,092<br />
The focus of our stock portfolio remains on shares in the<br />
Euro Stoxx 50 index. As our investment policy is geared<br />
towards secure investments, only a small proportion,<br />
€ 3.8 billion (2.9 bn), of our investments is to be found<br />
in shares. This figure includes shares in associated and<br />
affiliated companies. The value of our property portfolio<br />
amounted to an unchanged € 2.8 billion on the balance<br />
sheet cut-off date.<br />
Valuation reserves<br />
Capital market trends have a direct effect on our unrealised<br />
gains and losses as well as off-balance-sheet valuation<br />
reserves. <strong>2012</strong> saw interest rates continue to fall on the<br />
most creditworthy investments and share prices rise which<br />
led to increases in both our balance-sheet and off-balancesheet<br />
valuation reserves.<br />
The net value of unrealised gains and losses on non-fixedinterest<br />
securities calculated at market value rose in the<br />
year under review to € 0.3 billion (€ 0.1 bn). The main contributors<br />
to this are shares and investment funds. Risk-free<br />
interest rates at the end of <strong>2012</strong> were well down on those<br />
at the end of the previous year. At the same time, risk surcharges<br />
on government bonds from some Eurozone countries<br />
fell. As a result, the net value of unrealised gains and<br />
losses from our fixed-interest securities in the “available<br />
for sale” category rose sharply to € 4.8 billion (€ 0.9 bn).<br />
We record loans at amortised cost. The valuation reserves<br />
on these items rose to € 8.8 billion (€ 3.6 bn). Overall, our<br />
off-balance-sheet valuation reserves increased to € 10.0 billion<br />
(€ 4.9 bn).<br />
Investments<br />
Our investment in the expansion of our business in Asia<br />
continued in <strong>2012</strong>. We are actively pursuing the set-up of<br />
our joint venture in China; the life insurer is likely to commence<br />
operations in 2013 once the final licence has been<br />
received from the public authorities. And we signed a contract<br />
in India with the business conglomerate Avantha to<br />
set up a joint venture in the life insurance segment too.<br />
These investments have been funded using capital from<br />
normal operations.<br />
Analysis of the cash flow statement<br />
The cash flow of the <strong>ERGO</strong> <strong>Group</strong> is highly dependent on<br />
our business as a primary insurer: we generally receive the<br />
premiums for taking on the risk first, and then make payments<br />
at a later date in the event of benefits or claims.<br />
The significance of the capital flow statement is therefore<br />
somewhat limited.<br />
The cash flow statement (see page 54) was prepared in<br />
line with the indirect method and has been adjusted for<br />
changes in the consolidated group as well as exchange<br />
rate effects.<br />
The inflow of funds from operating business stood at<br />
€ 3.7 billion (1.9 bn). The calculation is based on the consolidated<br />
result of € 289 million (349 m). The major changes<br />
to the items Change in technical provisions (€+ 1.5 bn),<br />
Gains/losses on the disposal of investments (€+ 0.7 bn) and<br />
Other non-cash income and expenses (€− 2.3 bn) mainly
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>26<br />
Assets and financial position<br />
stem from factors of influence on the investment side.<br />
Consequently, the improved investment income and the<br />
increase in valuation reserves had a corresponding impact<br />
on the provision for premium refunds and provisions for<br />
unit-linked life insurance. The cash flow from operating<br />
activities was dramatically affected by gains from the<br />
disposal of affiliated companies last year. It is mainly<br />
write-downs and write-ups on investments which are<br />
reflected in other non-cash income and expenses; there<br />
were high write-downs last year whereas the year under<br />
review was particularly dominated by higher unrealised<br />
gains in unit-linked life insurance.<br />
The other two items worthy of mention are the change in<br />
other receivables and liabilities (€+ 1.3 bn) and the change<br />
in other balance sheet items (€+ 0.7 bn). The former was<br />
dominated by the previous year’s effect: in 2011 short-term<br />
loans from Munich Re expired which formed part of the<br />
restructuring of our debt capital. Factors which resulted in<br />
the change in other balance sheet items include reserves<br />
for the reorganisation of our sales forces as well as the<br />
increase in pension provisions because we had reduced the<br />
technical rate of interest.<br />
The cash outflow from investing activities of € 3.5 billion<br />
(€ 2.7 bn) is generally determined by payments for<br />
the acquisition of other investments or investments in<br />
unit-linked life insurance; they amounted to € 3.15 billion<br />
(3.14 bn) and € 362 million (489 m) respectively. In addition,<br />
last year saw cash inflows of € 951 million following<br />
the sale of affiliated companies; this item only accounted<br />
for € 12 million in the reporting period.<br />
Last year the cash flow stemming from financing activities<br />
was dominated by the restructuring of subordinated<br />
loans from Munich Re and high dividend payments during<br />
the 2010 financial year. Overall, there was a cash outflow<br />
stemming from financing activities of € 80 million (cash<br />
inflow of € 297 m).<br />
Overall, the level of cash and cash equivalents, which<br />
covers operating balances with banks, cheques and cash<br />
in hand, rose in <strong>2012</strong> to € 1.1 billion (0.9 bn).
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
27<br />
Management <strong>Report</strong><br />
Other success factors<br />
We also intend to secure long-term economic success for<br />
our <strong>Group</strong> with factors which cannot always be measured<br />
using financial variables. We take corporate responsibility<br />
very seriously in regard to our customers, staff and sales<br />
partners, as well as the environment and the society we<br />
live and work in.<br />
We therefore conduct business sustainably, seeking to<br />
reconcile economic, environmental and social factors. This<br />
corresponds with the long-term nature of our business.<br />
As part of Munich Re, we were among the first companies<br />
to sign the United Nations Environment Programme<br />
Finance Initiative’s Principles for Sustainable Insurance.<br />
These principles were presented at the UN Conference on<br />
Sustain able Development in Rio de Janeiro in June <strong>2012</strong><br />
and provide us with guidance on how to take sustainability<br />
criteria into account in our core business.<br />
In <strong>2012</strong>, we significantly expanded our reporting on<br />
corporate responsibility at <strong>ERGO</strong>. Having introduced our<br />
comprehensive web pages at the beginning of the year,<br />
we then published our first Sustainability <strong>Report</strong> in autumn.<br />
The report describes how we understand our responsibility<br />
to our customers, staff, the environment and society.<br />
A comprehensive facts and figures section shows the<br />
current progress of our activities. Our Sustainability <strong>Report</strong><br />
was audited in accordance with the Global <strong>Report</strong>ing<br />
Initiative (GRI) and will appear annually in future.<br />
Responsible management<br />
Clear rules on the conduct of staff and sales partners<br />
are essential to strengthening public trust in <strong>ERGO</strong> and<br />
preventing damage to our reputation. After serious cases<br />
of misconduct were brought to light in 2011, we set up a<br />
separate Compliance Unit at the beginning of <strong>2012</strong>, directly<br />
answerable to the Chairman of the Board, and expanded<br />
it step by step throughout the year. Our Chief Compliance<br />
Officer leads the team in developing guidelines and advising<br />
staff and sales partners on how to implement them<br />
properly. If an employee or sales partner suspects abuse<br />
or serious breaches of the guidelines, he or she may also<br />
inform an external ombudsman.<br />
Negative reporting took its toll on <strong>ERGO</strong>’s reputation once<br />
more in <strong>2012</strong>. The media made agents’ misconduct on<br />
incentive trips a topic of discussion. We had to face the<br />
accusation that we had not addressed the issue openly<br />
enough in 2011 and therefore lacked credibility. In order to<br />
regain this lost trust, we provided transparency in September<br />
<strong>2012</strong> by publishing all known cases of misconduct on<br />
incentive trips on the Internet alongside the consequences<br />
drawn and the disciplinary measures <strong>ERGO</strong> had taken. We<br />
also updated the results of published investigations of<br />
allegations concerning the insurance business.<br />
We hope to regain lost trust with our openness. We also<br />
aim to convince both our customers and the general public<br />
of our quality through consistent implementation of our<br />
brand promise, “To insure is to understand”, and through<br />
first-class service.<br />
Customers and customer relationships<br />
Our products and services are geared towards all customer<br />
groups – private customers as well as small and mediumsized<br />
businesses and industrial clients. <strong>ERGO</strong> offers them<br />
products and services for old-age provision and saving<br />
schemes as well as protection of property, health, legal<br />
cover and travel insurance. In addition, our sales partners<br />
sell fund products supplied by ME<strong>AG</strong>, which is the asset<br />
manager of Munich Re and <strong>ERGO</strong>. We also offer bank products<br />
from our cooperation partner UniCredit <strong>Group</strong> and<br />
other banks. Other partners’ products and our comprehensive<br />
services and advice complete our portfolio.<br />
Our brand promise, “To insure is to understand”, means we<br />
make our customers and their needs the focal point of our<br />
business. We highly value clear and easy-to-understand<br />
language and constant dialogue with our customers. We<br />
have clear-language criteria which have been verified by<br />
external experts in communication. Based on these criteria,
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>28<br />
Other success factors<br />
we are reviewing our entire communication with our<br />
customers and are training our staff accordingly. Our<br />
Company is pursuing easy-to-understand, clear communication<br />
and its full integration into all our processes at<br />
all times. We successfully submitted all of our customer<br />
communication to an external audit: The inspection<br />
agency TÜV Saarland awarded us their seal of “Comprehensible<br />
communication” in February 2013.<br />
Our customers’ opinions are important to us. By expressing<br />
their wishes regarding our products and services, our<br />
customers help us continually improve what we offer.<br />
For example, we launched our new accident insurance in<br />
<strong>2012</strong>, developed according to our customers’ requests and<br />
expectations, and included assistance services in certain<br />
products. These services vary according to the customer’s<br />
individual situation and how serious their injury is. Our<br />
continuous advice service helps and guides victims of<br />
accidents. We also carried out comprehensive studies on<br />
our customers’ expectations in terms of security, flexibility<br />
and earnings in order to develop <strong>ERGO</strong>’s latest generation<br />
of life insurance products, which will be launched in 2013.<br />
As members of our Customer Advisory Board, participants<br />
in our Customer Workshop or on the Internet, consumers<br />
can provide us with extensive feedback. In the case of<br />
conflicts which the customer does not consider to have<br />
been solved by the Company, the <strong>ERGO</strong> Customer Advocate<br />
is available to clear up misunderstandings. He represents<br />
the interests of our customers within the Company.<br />
Our sales partners place great value on advice, support and<br />
service – and not just during their sales pitch. We set great<br />
store by the quality of our advice and see ourselves as an<br />
all-round problem solver for our customers long after the<br />
contract has been signed.<br />
Staff<br />
Our staff provide the basis for our success with their<br />
expertise, motivation and commitment, which is why we<br />
are dedicated to investing in developing their skills.<br />
The diversity of our staff is visible in their different mindsets,<br />
attitudes, experience, knowledge and skills. This is a<br />
great asset to our Company and an important foundation<br />
for our future success as a business. We laid down our<br />
common goal in Munich Re’s Diversity Policy in 2011: a<br />
working environment that values this diversity, promotes<br />
its various aspects and emphasises it for the good of the<br />
Company.<br />
We are always looking to develop our initiatives further.<br />
For example, in <strong>2012</strong> we reintroduced our development<br />
and mentoring programme for women and started a new<br />
HR process to guide employees through maternity/paternity<br />
leave. As part of our efforts to improve the balance<br />
between work and family life, we are currently running<br />
a pilot project to test the feasibility of managers working<br />
part time. Our diversity seminar for trainees won the<br />
InnoWard <strong>2012</strong>, the prize for education in the German<br />
insurance industry.<br />
Our management mission statement describes the<br />
conduct we expect of people with management<br />
responsibilities at <strong>ERGO</strong>. This includes valuing employees,<br />
using straightforward language, clearly defining goals,<br />
demonstrating enthusiasm and a willingness to participate<br />
in dialogue. This mission statement is a permanent<br />
feature of our training programme for managers. We have<br />
standardised the process of selecting, developing and<br />
supporting our top management staff across the <strong>Group</strong>.<br />
With cross-sector talent management and <strong>Group</strong>-wide<br />
succession planning, we wish to develop outstanding<br />
managers with a degree of loyalty that binds them to the<br />
Company.<br />
Ensuring that our staff and sales partners have qualifications<br />
which meet the needs of our industry still has a<br />
high priority in the context of our HR policy. Our goal is to<br />
extend our high level of quality and performance in order<br />
to reinforce our competitive position even further. This<br />
is why we are constantly adapting all of our training and<br />
further education opportunities to meet the Company’s<br />
current and future requirements for qualified and motivated<br />
long-term employees.<br />
In <strong>2012</strong>, members of the <strong>ERGO</strong> Insurance <strong>Group</strong> and its<br />
agencies in Germany trained 1,485 (1,551) school leavers,<br />
which is equivalent to a ratio of trainees to total working<br />
staff on par with the previous year at 6.5%. A special<br />
international trainee programme promotes the hiring and<br />
development of university graduates.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>29<br />
Other success factors<br />
<strong>ERGO</strong> launched a quality and efficiency programme in its<br />
German sales organisations in <strong>2012</strong>. We wish to standardise<br />
the different advisory and support processes and provide<br />
technical support, reduce complexity and cut costs. In<br />
order to achieve this goal, we shall merge – under a single<br />
<strong>ERGO</strong> sales company – five tied agents’ sales organisations<br />
into two units.<br />
As we have already announced, this restructuring will<br />
result in the loss of up to 700 salaried sales posts and up<br />
to 650 in-house posts in Germany. This is a consequence<br />
of streamlining the sales forces down to 120 regional head<br />
offices and of the realignment of the supporting in-house<br />
units. We plan to implement this by the beginning of 2014<br />
and do it in a socially acceptable way. The management<br />
and the works councils agreed on how to proceed and a<br />
contingency programme in February 2013.<br />
At the end of the reporting year there were 29,768 (31,311)<br />
salaried employees working for the <strong>ERGO</strong> Insurance <strong>Group</strong>,<br />
of which 24,166 (25,352) were employed in in-house<br />
positions and 5,602 (5,959) were salaried field sales staff.<br />
The average age of our employees is 41.3 (40.6), and the<br />
average length of service 12.2 (11.4) years. The percentage<br />
of women stood at 56.9% (56.4%).<br />
Social commitment<br />
<strong>ERGO</strong> and its subsidiaries have been committed to the<br />
communities we work in for years. Today, we focus on<br />
sponsoring all kinds of education and support social projects.<br />
Music, sport and health education all contribute to<br />
personal development and are therefore important components<br />
of a good education. We particularly want to open<br />
up opportunities and future prospects for children and<br />
teenagers, and allow them to take responsibility for their<br />
own lives.<br />
We want our social commitment to education to contribute<br />
to the future viability of our society. For example, the <strong>ERGO</strong><br />
“Jugend & Zukunft” (Youth and Future) foundation advises<br />
socially disadvantaged teenagers on the transition from<br />
school to training and work. <strong>ERGO</strong> Austria promotes learning<br />
and tutoring for children from disadvantaged families<br />
by donating to the “Wiener Lerntafel” (Vienna educational<br />
charity). We also support projects and initiatives which use<br />
innovative concepts to improve education for children and<br />
young people.<br />
We foster children’s musical skills as well as talented<br />
youngsters. For example, we support the local Düsseldorf<br />
project, “SingPause”, where trained singers regularly sing<br />
with primary school pupils. As part of the “Klasse in Sport”<br />
(Great at Sports) initiative, we sponsor daily qualified<br />
physical education at 26 primary schools across Germany<br />
because sport has been proven to aid children’s physical<br />
and cognitive development. The focus of our health projects<br />
is on prevention, education and exercise. For example,<br />
<strong>ERGO</strong> provides “mammobuses” in Estonia to provide<br />
women with information about breast cancer and free<br />
screening (mammography).<br />
As a large company, we are able to help others who need<br />
support, and we are happy to do so because it is a longstanding<br />
tradition within our Company. One example of<br />
social commitment is our integration of disabled employees,<br />
such as at <strong>ERGO</strong> Hestia in Poland, where employees<br />
with physical disabilities advise customers over the phone<br />
in the customer services department. In Germany, D.A.S.<br />
collaborates with a company specialising in the integration<br />
of disabled staff. This helps severely disabled employees to<br />
establish themselves in the business world with qualified<br />
administrative tasks. Our staff, too, are committed to helping<br />
others: for example, in Germany, the staff charitable<br />
association “ergo:wir helfen” (Ergo: we help) supports various<br />
social projects by donating the portion of salaries or<br />
commissions that comes after the decimal point.<br />
Environment<br />
Protecting the environment and natural sources of life has<br />
been an important concern for <strong>ERGO</strong> for many years, and<br />
we see it as being part and parcel of our social responsibility.<br />
In parts of the <strong>Group</strong>, we have been using an environment<br />
management system which complies with the globally<br />
accepted ISO 14001 standard for over ten years and<br />
we have it assessed by external experts on a regular basis.<br />
To ensure we use energy and resources as efficiently as<br />
possible, we are continually expanding this system: Munich<br />
was another large-scale German office to be certified in<br />
<strong>2012</strong>. <strong>ERGO</strong> uses the environment management system to<br />
consistently and systematically assess and minimise the<br />
use of energy and resources and the production of waste in<br />
its offices.<br />
We invest in the use of energy-efficient technologies such<br />
as gas-powered combined heat and power plants and<br />
cutting-edge cooling systems. We have been using carbonneutral<br />
electricity at all of our major German offices since<br />
2011.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>30<br />
Other success factors<br />
We also wish to reduce the emissions caused by our business<br />
travel. Train journeys within Germany have been carbon<br />
neutral since 2011. We are also gradually including more<br />
low-emission vehicles in our fleet and encourage our drivers<br />
to drive in an environmentally friendly manner: As of <strong>2012</strong>,<br />
ecological and safety training is obligatory for all drivers of<br />
fleet vehicles. We are working to improve our environmental<br />
record at our other offices in Germany and abroad. Our goal:<br />
by the end of 2015, operations across the entire <strong>ERGO</strong> <strong>Group</strong><br />
should be climate-neutral.<br />
As part of our duties imposed by the United Nations<br />
“Global Compact” environmental initiative, which <strong>ERGO</strong><br />
as part of Munich Re has signed, we regularly check our<br />
potential for improvement, including synergy effects.<br />
We continue to collect more and more data from our<br />
international companies, with the goal of providing ever<br />
more comprehensive environmental data. As part of the<br />
“Global Compact” initiative, Munich Re publishes an annual<br />
progress report on its website, which also covers developments<br />
at <strong>ERGO</strong>.<br />
Renewable energy is growing ever more significant due to<br />
the fact that fossil fuels are limited and the demand for<br />
environmental and climate protection is on the rise. <strong>ERGO</strong><br />
is doing its part by offering innovative insurance solutions,<br />
including those that cover loss of income from underperforming<br />
photovoltaic systems due to limited radiation<br />
or faulty components. We also support the environmental<br />
awareness of our customers with sustainable products<br />
and investment funds. When it comes to motor insurance,<br />
we promote vehicles with exceptionally low CO 2<br />
emissions<br />
through an eco tariff. We advise our corporate customers<br />
on how to avoid environmental damage, for which we also<br />
offer cover. As regards life insurance, our customers can<br />
invest in sustainable funds and a climate fund for their<br />
old-age provision and saving schemes.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
31<br />
Management <strong>Report</strong><br />
Risk report<br />
Objectives of risk management<br />
Risk management is an important element of corporate<br />
management. One part of risk management is the early<br />
recognition of developments which could endanger the<br />
Company’s existence (Section 91, para. 2 of the German<br />
Stock Companies Act, AktG). An additional aim is to retain<br />
the financial strength required to meet our obligations to<br />
customers and to create sustainable value for our shareholders.<br />
Another goal is to safeguard <strong>ERGO</strong>’s reputation<br />
and that of all the individual companies. This is achieved by<br />
means of risk management that encompasses all divisions.<br />
In this respect, we adhere to the German Control and<br />
Transparency Law (KonTraG) as well as to the requirements<br />
of Section 64a of the German Insurance Supervision Act<br />
(V<strong>AG</strong>).<br />
Organisational set-up of risk management<br />
<strong>ERGO</strong> Insurance <strong>Group</strong> has developed specific systems and<br />
committees to ensure efficient risk management. The term<br />
‘risk governance’ is used to refer to all organisations and<br />
principles to do with risk. This is how we encourage the<br />
preservation and further development of a balanced riskand-control<br />
culture in respect to all categories of risk. Our<br />
Integrated Risk Management (IRM) unit is charged with<br />
securing risk management across the <strong>Group</strong>. There are<br />
decentralised risk management structures in place to help<br />
the IRM unit with this. The Chief Risk Officer (CRO) is at the<br />
top of the risk management hierarchy, with various decentralised<br />
risk officers reporting to him. The duties of the<br />
CRO include the identification, assessment and monitoring<br />
of risks, as well as reporting them to the Risk Committee,<br />
which is a standing committee of <strong>ERGO</strong> Insurance <strong>Group</strong>’s<br />
Board of Management. The committee is responsible for<br />
setting up and monitoring risk management strategies,<br />
systems and processes. It also ensures that the entire<br />
risk management system, consisting of risk criteria, limits<br />
and governance processes, complies with the regulatory<br />
requirements and the guidelines applicable throughout the<br />
<strong>Group</strong>. This structure enables us to recognise risks early<br />
and to manage them actively.<br />
Risk strategy<br />
Our risk strategy is derived from our business strategy and<br />
presents the risks arising from it. The Board of Management<br />
checks and approves the risk strategy annually and<br />
discusses it with the Supervisory Board. Our risk strategy<br />
defines <strong>ERGO</strong> Insurance <strong>Group</strong>’s upper risk threshold as<br />
it contains specifications and decisions on risk tolerance<br />
which are geared towards the capital and liquidity available<br />
and earnings volatility. Risk strategy is an important<br />
basis for our operative and strategic planning. Moreover,<br />
we derive limits from it, which we monitor carefully. In<br />
order to derive these limits, we take into consideration<br />
criteria relating to the whole Company and our entire<br />
insurance portfolio, as well as defining supplementary<br />
criteria to limit and managing peak risks, concentrations,<br />
loss accumulation and systematic risks.<br />
Risk management is important not only for limiting risks,<br />
but also for making use of business opportunities. Calibrating,<br />
or fine-tuning, the limits set out in our risk strategy<br />
takes into account the interests of both our customers and<br />
our shareholders. The most important part of this is ensuring<br />
the strength of our financial resources. Then there are<br />
supplementary limits for particular risks, such as concentration<br />
limits for natural catastrophes or pandemic risks,<br />
and criteria for market, credit and liquidity risks.<br />
In the event of capital bottlenecks or conflicts with the<br />
limit system, fixed escalation and decision-making processes<br />
are pursued which ensure that business interests<br />
and risk management aspects are brought into line. Where<br />
appropriate, we take action to reduce the risk, using<br />
reinsurance for example.<br />
Risk management cycle<br />
Risk management in an operational environment includes<br />
the identification, analysis, assessment and measurement<br />
of risks. Aspects of this include the reports on these areas<br />
of risk, limiting risk in the sense of reducing it to an acceptable<br />
amount, and monitoring risk.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>32<br />
Risk report<br />
Our risk management processes ensure we monitor all<br />
risks on an ongoing basis and actively manage them<br />
wherever necessary.<br />
Risk identification: Suitable systems and quantitative<br />
indicators are used to (quantitative component). Bottomup<br />
and top-down risk surveying are also used and supplemented<br />
by expert opinions (qualitative component). Our<br />
ad-hoc reporting process enables employees of the <strong>ERGO</strong><br />
Insurance <strong>Group</strong> to report risks to the central IRM unit at<br />
any time.<br />
Risk analysis and assessment at the highest level are<br />
the responsibility of the central IRM unit. They are carried<br />
out in close collaboration with many experts from different<br />
parts of the <strong>ERGO</strong> Insurance <strong>Group</strong>. This enables us to<br />
obtain an assessment that is both quantitative and qualitative,<br />
and which also takes into account possible interdependencies<br />
between the risks.<br />
In order to measure risk, we use specific instruments for<br />
each business segment, which we constantly continue to<br />
develop. Our primary risk measures are based on economic<br />
principles and therefore best reflect the risk in our portfolio.<br />
Our risk model results are regularly checked against<br />
those of the regulatory bodies and rating agencies. This<br />
takes place at various levels such as the different business<br />
segments, companies, types of risk, geographical locations<br />
and business lines.<br />
We regularly compare our risk model results to those of<br />
other businesses and take part in industry surveys to test<br />
our instruments and fine-tune them further. In addition,<br />
we also compare our model with the latest capital requirements<br />
of Solvency II and participate in industry-wide<br />
quantitative impact studies.<br />
Risk limitation is part of our risk strategy and included in<br />
the ‘limit and trigger manual’ used throughout the <strong>Group</strong>.<br />
Risk-reducing measures are decided and implemented on<br />
the basis of the defined upper risk threshold.<br />
We differentiate between quantitative and qualitative<br />
indicators when monitoring risk. Quantitative indicators<br />
are monitored centrally, whilst qualitative measures are<br />
monitored both centrally and locally according to the size<br />
and category of the risk.<br />
Control and monitoring systems<br />
In <strong>2012</strong>, we developed our internal risk control system<br />
(IKS) further with the particular aim of including more of<br />
our subsidiaries abroad. Our IKS is a uniform operational<br />
risk management system applicable throughout the <strong>Group</strong>.<br />
It includes <strong>Group</strong> management requirements as well local<br />
legal and regulatory requirements. The Board of Management<br />
is responsible for the IKS and, structurally, it falls into<br />
the responsibility of the IRM unit. Responsibility for individual<br />
risks and controls lie with the relevant experts and<br />
employees in the various units. By incorporating staff in<br />
this way, we have reinforced the basis for a uniform understanding<br />
of risk within the <strong>Group</strong> and have improved our<br />
awareness of risk and how to control it.<br />
The holistic management approach of the IKS means that<br />
we can achieve a rise in efficacy and efficiency in identifying,<br />
analysing, assessing and documenting major risks and<br />
key controlling aspects. The clear allocation of responsibilities<br />
for aspects of risk and its control and management<br />
creates transparency. By systematically linking major<br />
risks and processes, a risk map has been developed for<br />
<strong>ERGO</strong> Insurance <strong>Group</strong> which indicates all the relevant<br />
risk checkpoints.<br />
The efficacy of the IKS in major processes and applications<br />
is regularly assessed by the <strong>Group</strong>’s internal auditors as<br />
part of audit planning over several years.<br />
Risk reporting<br />
We do not just fulfil current legal requirements with our<br />
risk reporting. We use it to create transparency within<br />
the <strong>Group</strong> for management and supervisory bodies, and<br />
to inform the public of our operations. The IRM unit is<br />
responsible for our risk reporting.<br />
Internal risk reporting informs management of the risk situation<br />
in terms of the individual risk categories quarterly.<br />
If a significant change in the risk situation occurs, or an<br />
exceptional event or case of damage, a report is written<br />
and delivered to the management immediately so that they<br />
can react to dangerous developments quickly. Our aim is to<br />
be able to recognise even weak signals and negative trends<br />
quickly and take appropriate countermeasures.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>33<br />
Risk report<br />
Our external risk reporting is aimed at providing a comprehensible<br />
insight into <strong>ERGO</strong>’s risk situation. This includes<br />
information on our risk management methods and processes,<br />
risk governance and specific risks affecting the<br />
Company.<br />
Major risks<br />
We deem major risks as those which can have a permanent<br />
negative impact on the whole of <strong>ERGO</strong> <strong>Group</strong>’s assets,<br />
financial situation or profitability. This definition has been<br />
strictly applied – taking individual risk tolerance into consideration<br />
– to individual business segments and legal<br />
entities. It is our IRM unit which makes the final decision<br />
on whether a risk be considered major for a particular<br />
entity. In order to do this, the team takes particular note<br />
of how the risks could affect our financial strength and<br />
earnings volatility, as these are our principal criteria.<br />
This risk report is then drawn up based on the calculations<br />
and accounting principles used by our Company. We are<br />
fully compliant with the German Accounting Standard<br />
DRS 5−20.<br />
As set out by the DRS 5−20, we divide our overall risk into<br />
five categories:<br />
• Technical risks<br />
• Risks from default on receivables<br />
from insurance business<br />
• Investment risks<br />
• Operational risks<br />
• Other risks<br />
Technical risks<br />
Management of technical risks takes a central role. The<br />
key elements of this include checking risk patterns and<br />
continually monitoring accounting principles for the<br />
purpose of calculating technical provisions. Premiums and<br />
reserves are calculated using carefully selected accounting<br />
principles.<br />
We underwrite insurance for private and corporate clients,<br />
which results in a heterogeneous portfolio of risks incurred.<br />
Each line of business and business division has its own<br />
general parameters for calculating tariffs and underwriting<br />
at individual company level in order to ensure a balanced<br />
portfolio among all those insured. Each actuarial office<br />
ensures that the calculation of tariffs is carried out properly<br />
and that sufficient provisions are set up to meet any<br />
obligation incurred.<br />
These measures and processes mean that the risks<br />
incurred in the business undertaken by our companies are<br />
managed adequately. We regularly use processes separate<br />
from those mentioned above in order to measure their<br />
suitability, and where appropriate, we adapt them further.<br />
However carefully we calculate our tariffs, and despite<br />
more-than-adequate reserves by current standards, further<br />
risks may arise. We monitor these new risks continually in<br />
order to limit them. This way, we are able to take appropriate<br />
countermeasures in good time when the level of risk<br />
increases. Further risks may include, for instance, the <strong>ERGO</strong><br />
Insurance <strong>Group</strong> in its entirety or individual operational<br />
insurance companies experiencing exceptionally high<br />
levels of claims or due to an accumulation of loss-entailing<br />
occurrences. The interaction of risks of change and risk<br />
concentrations may also lead to considerable potential for<br />
losses. This not only involves regional concentrations but<br />
can also occur either within a line of business or across<br />
several lines.<br />
The IRM unit is in charge of identifying, assessing, monitoring<br />
and coordinating cumulative risks and concentrations<br />
which occur across multiple business segments and balance<br />
sheets. In order to do this, the IRM unit operates in close<br />
collaboration with specialists in the various business segments.<br />
It informs the risk committee of the consequences<br />
of risk cumulations across the entire <strong>Group</strong>.<br />
These types of risk are observed using scenarios and<br />
model calculations which are there to provide information<br />
regarding the maximum total liability of the <strong>ERGO</strong> Insurance<br />
<strong>Group</strong> based on a corresponding extreme scenario.<br />
To protect the <strong>Group</strong> from disproportionate liability and<br />
fluctuations in revenue we take out reinsurance. We take<br />
both the situation within the particular legal entity and<br />
integration within the <strong>Group</strong> into account when making<br />
these decisions.<br />
Good creditworthiness is our prime criterion when choosing<br />
our reinsurer. This allows us to limit the contingency risk<br />
and risks concerning cash flow fluctuations. Our outwards<br />
reinsurance is mainly placed within the Munich Re <strong>Group</strong>.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>34<br />
Risk report<br />
Life insurance Health insurance Property-casualty insurance<br />
Biometric risk Biometric risk Premium risk<br />
Interest-rate risk Lapse risk Large loss and cumulative loss risk<br />
Other market risk Claims risk Reserve risk<br />
Lapse risk Technical interest-rate risk Interest-rate risk<br />
The table above depicts the specific features of the underwriting<br />
risks in our operational insurance companies<br />
depending on the particular area of business.<br />
A differentiated analysis of the technical risks and relevant<br />
factors specific to the business segment in question, as<br />
well as explanations of their management, can be found<br />
in the Notes to the Consolidated Financial Statements<br />
from page 118. This complies with the requirements of the<br />
German Accounting Standard IFRS 4.<br />
Risks from default on receivables from<br />
insurance business<br />
Receivables from reinsurers, agents and customers are<br />
always subject to risk from default. In the case of nonpayment<br />
of premiums, the insurer experiences a high<br />
level of liability. This is particularly problematic in the case<br />
of comprehensive health insurance, since the insurer no<br />
longer has the right to terminate the contract. The total<br />
amount of premium instalments which have not been paid<br />
is constantly monitored according to several criteria in<br />
order to be able to recognise at an early stage whether it<br />
could lead to a relevant impairment or put a strain on all<br />
policyholders.<br />
On the balance sheet cut-off date, accounts receivable,<br />
where payment had been due for more than 90 days,<br />
accounted for € 320 million (244 m). To hedge the risk, we<br />
have taken precautionary measures by making adjustments<br />
to the value of receivables. Over the past three<br />
years, value adjustments have been made, amounting to<br />
an average of 10.4% (9.7%) of the existing receivables on<br />
the cut-off date. This share is equivalent to an average of<br />
0.8% (0.7%) of premiums earned over a period of three<br />
years.<br />
Experience has shown our precautionary measures to be<br />
adequate.<br />
41.3% (50.9%) of our accounts receivable stem from<br />
Munich Re, which have been awarded the second highest<br />
rating by the international rating agency Standard &<br />
Poor’s. Overall, and based on the rating classification<br />
from Standard & Poor’s, the spread of receivables from<br />
reinsurers can be seen in the table below:<br />
Investment risks<br />
Investments undertaken by <strong>ERGO</strong> Insurance <strong>Group</strong> can be<br />
grouped into four investment categories: interest-bearing<br />
investments, shares, property and shareholdings. Besides<br />
the criteria of return, security and credit rating, aspects<br />
of liquidity, diversification and, above all, underwriting<br />
obligations are also taken into consideration. The assetliability<br />
teams (AL teams) are responsible for asset-liability<br />
manage ment. For every operational entity, members<br />
of these committees include representatives from the<br />
actuarial office, strategic asset allocation, investment<br />
control, the IRM unit and the asset management company<br />
ME<strong>AG</strong>, part of Munich Re. Basic investment decisions<br />
(strategic asset allocation) are taken at an individual<br />
company level. Mandates are then formulated by the<br />
<strong>ERGO</strong> investment management unit from these strategic<br />
directives, with ME<strong>AG</strong> acting in an advisory capacity.<br />
These mandates take into account tax, balance sheet and<br />
regulatory considerations and define investment categories,<br />
quality and thresholds. Moreover, key figures and<br />
threshold values for tax purposes are prescribed in the<br />
mandates. ME<strong>AG</strong> is responsible for putting these mandates<br />
into practice. The AL teams are in charge of monitoring<br />
the guidelines laid out in the mandates and advising on<br />
strategic investment decisions.<br />
Receivables from reinsurers according to rating classes <strong>2012</strong> 2011<br />
€ million € million<br />
Rating class 1 (AAA) − 2<br />
Rating class 2 (AA) 68 65<br />
Rating class 3 (A) 2 19<br />
Rating class 4 (BBB and less) − 1<br />
No rating 19 8<br />
Total 89 94
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>35<br />
Risk report<br />
We monitor investments which we manage ourselves<br />
based on projections and internal reporting. These include<br />
property loans, mortgages, remortgages, policy loans, staff<br />
loans, loans to officials, deposits retained, surpluses from<br />
unit-linked life insurance policies and some shareholdings<br />
and property investments. This is also true for investments<br />
managed by ME<strong>AG</strong>. Any deviations from the projections are<br />
looked into by the AL team where deemed necessary.<br />
ME<strong>AG</strong> monitors compliance with the guidelines set out in<br />
our mandates for specific parts of the business on a daily<br />
basis using our comprehensive early-warning system.<br />
We have implemented triggers for the various sources of<br />
risk, whose activation initiates a predefined process. The<br />
trigger landscape, which is in operation throughout the<br />
<strong>Group</strong>, differentiates between three danger levels involving<br />
different measures.<br />
The levels are derived from the risk tolerance of the company<br />
in question. The early-warning system is supplemented<br />
by analyses of long-term trends and scenarios,<br />
particularly as regards interest-rate and share markets.<br />
Proactive risk management has enabled a considerable<br />
reduction in the adverse effects of the financial and<br />
national debt crises on the <strong>ERGO</strong> Insurance <strong>Group</strong>. Over<br />
the last couple of years, we have significantly reduced the<br />
percentage of investments our companies hold in equities.<br />
In <strong>2012</strong>, these remained at the low levels recorded in previous<br />
years. Permanent monitoring of the risk of default by<br />
a contract partner is ensured by means of a <strong>Group</strong>-wide<br />
counterparty limit system.<br />
We continued to develop our risk management activities<br />
in the area of capital investments during <strong>2012</strong>. Improvements<br />
in the way liquidity, market and credit risks are<br />
taken into account by our early-warning systems are once<br />
again of particular note. The counterparty risk due to overthe-counter<br />
derivatives has, in the past, been reduced by<br />
implementing collateral management.<br />
The following account of our capital investment risks<br />
complies with the German Accounting Standard IFRS 7.<br />
Our main capital investment risks are market, credit and<br />
liquidity risks.<br />
Market risks<br />
A market risk is defined as the risk of losses or adverse<br />
effects on the financial strength of a company as a result<br />
of price amendments and fluctuations on the capital<br />
markets. Market risks form the lion’s share of capital<br />
investment risks. Market risks include, among other things,<br />
the risk of changes to the interest rate and their consequences,<br />
share price risk, the risk of changes in property<br />
prices, exchange rate risk, asset-liability mismatch risk and<br />
the credit spread risk resulting from worsening creditworthiness.<br />
Causes of possible reductions in market value vary<br />
from investment category to investment category.<br />
Fluctuations in market price not only affect our capital<br />
investments, they also influence our underwriting<br />
liabilities. This is particularly noticeable in the case of life<br />
insurance. The fact that the interest rate is sometimes<br />
guaranteed for a longer period, and the numerous options<br />
which policyholders have with traditional life insurance<br />
policies result in a major dependence on the value of<br />
liabilities on the capital markets.<br />
Market risks are handled by applying appropriate limiting<br />
and early-warning systems as well as our asset-liability<br />
management. This is done by limiting the divergences of<br />
current investments from those which are economically<br />
necessary to cover underwriting liabilities, a so-called<br />
replicating portfolio. In addition, risk-relevant restrictions<br />
for investments are taken into account, which stem from<br />
accounting in line with the German Commercial Code (HGB)<br />
or IFRS.<br />
At 94.1% (94.1%), the majority of our investments are<br />
interest-bearing. Consequently, the development of<br />
general interest-rate levels and the issuer-specific credit<br />
spreads have a considerable effect on the value of the<br />
investments and investment income. To secure investment<br />
returns in the long term, our activities in asset-liability<br />
management are regularly adjusted in line with current<br />
market conditions.<br />
We are pursuing a defensive investment strategy due to<br />
the expected continuance of volatile developments on the<br />
market. Financial derivatives are used to extend the investment<br />
horizon for interest-bearing investments and the<br />
risks run by investing in the stock markets.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>36<br />
Risk report<br />
Up-to-date market values for property are not always<br />
available. Consequently, surveys or other appropriate and<br />
generally recognised and verified assessment procedures<br />
are necessary. Adjustments are made to figures insofar<br />
as value impairments are deemed to be of a permanent<br />
nature.<br />
Currency risks are mainly hedged using forward exchange<br />
transactions. Additional risks stem mainly from long-term<br />
investments where there are no adequate or economically<br />
viable hedging mechanisms available. We monitor these<br />
risks on a permanent basis to enable us to take action<br />
against developments in good time. Exchange rate gains<br />
or losses recorded in accordance with IFRS are calculated<br />
by separating the change in market value in the original<br />
currency on the one hand and the effects of the exchange<br />
rate written against the income statement on the other.<br />
Potential risks due to fluctuations in the market value<br />
of investments are regularly assessed using so-called<br />
stress tests. These stress tests take into account blanket<br />
fluctuations in the market value of interest-bearing investments,<br />
shares and currencies. An example of a scenario<br />
analysis is in the Notes under “Market risks from financial<br />
instruments”.<br />
A host of other tools are also used to determine the<br />
potential market risk. In particular, a forecast is made<br />
of investment income on the next balance sheet cut-off<br />
date subject to changing capital market conditions. Based<br />
on the rating and quality of our investments, we do not<br />
see recognisable threats to the existence of the <strong>ERGO</strong><br />
Insurance <strong>Group</strong> or its obligations to its policyholders.<br />
Credit risk<br />
Credit risks stem from the danger that debtors are unable<br />
to keep up with their payment obligations or that deteriorations<br />
in creditworthiness lead to economic losses.<br />
As regards our fixed-interest investments, we keep the<br />
associated credit risk in check by choosing issuers of<br />
adequate quality and taking note of the contracting<br />
party’s limits. The rating undertaken by external rating<br />
agencies is only one of a number of risk criteria taken into<br />
account. We also conduct our own analyses, and issuers’<br />
ratings undergo an internal plausibility test. Both our own<br />
assessment and that of the external rating agency have<br />
to be positive for an investment to pass the risk appraisal<br />
procedure. The high demands we make of our issuers are<br />
reflected in our investment principles, which are applicable<br />
throughout the <strong>Group</strong>. Our securities portfolio is distinguished<br />
by the fact that most of the securities are from<br />
issuers of outstanding creditworthiness.<br />
88.3% (91.0%) of our interest-bearing investments received<br />
at least the third-highest rating available, “strong”, at the<br />
end of the financial year. See also sections [6g] to [6i] in<br />
the Notes. As a comparison, this is equivalent to an “A”<br />
rating from Standard & Poor’s. The table below shows how<br />
this is spread across the different types of securities.<br />
The diversification of <strong>ERGO</strong> Insurance <strong>Group</strong>’s investments<br />
is deemed adequate. The risk of default on fixed-interest<br />
investments increases in proportion to a decrease in the<br />
debtor’s creditworthiness. Debtors of low creditworthiness<br />
must therefore offer a higher coupon or level of interest<br />
to remain attractive despite the risk of default. Our risk<br />
manage ment strategy features appropriate trigger calculations<br />
to deal with the risk of a decrease in creditworthiness.<br />
The majority of our interest-bearing investments are<br />
securities not listed on the stock market. We determine<br />
the market value of these securities using yield curves and<br />
taking into account cautious credit spreads specific to the<br />
issuer. In the case of stock-listed interest-bearing investments,<br />
we use official rates.<br />
We have implemented a counterparty limit system throughout<br />
the <strong>Group</strong> in order to monitor and manage the risk<br />
Bonds portfolio according to individual categories Share in all Rating at least<br />
(31 December <strong>2012</strong>) interest-bearing investments % category “strong” % 1<br />
Bank bonds/loans against promissory notes 7.5 53.8<br />
Covered bonds/pfandbriefs 40.6 98.5<br />
Government bonds 40.0 88.7<br />
Corporate bonds 5.6 49.4<br />
Other 6.2 96.4<br />
1 This is equivalent to an “A” rating from Standard & Poor’s.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>37<br />
Risk report<br />
of default. The contracting party’s limits depend on their<br />
financial situation and the level of risk tolerance defined by<br />
the Board of Management. We coped with the critical situation<br />
of the banks and government bonds during the <strong>2012</strong><br />
financial year by continually checking the upper thresholds<br />
of our limits and reducing certain limits and implementing<br />
collateral management. In <strong>2012</strong>, we made further progress<br />
with the project we started in 2011 aiming at trading OTC<br />
derivatives via a central independent party. This project is<br />
based on a European Parliamentary regulation, the European<br />
Market Infrastructure Regulation (EMIR), and once<br />
the general regulatory conditions have been finalised, we<br />
expect to be able to start doing business in 2013. Our overall<br />
exposure in the financial sector – measured at market<br />
values – amounted to € 63.6 bn at the end of the financial<br />
year, of which € 54.9 bn (86.3%) is collateralised.<br />
We continually monitor the subordinate securities,<br />
dormant equity holdings and profit participation certificates<br />
in our portfolio for risk-control purposes.<br />
Our investments in peripheral Eurozone countries with<br />
high levels of national debt (Ireland, Italy, Spain) amount<br />
to 3.6% of our total investments. We reduced our involvement<br />
in the peripheral Eurozone countries further in <strong>2012</strong>,<br />
and totally withdrew from Greece and Portugal. The euro<br />
national debt crisis is expected to continue in 2013 even<br />
though the battery of political countermeasures has<br />
increased and the European Central Bank has introduced<br />
new instruments. Yet the critical situation in certain countries,<br />
particularly around the Mediterranean, continues to<br />
worsen. Budget consolidation, recession and high unemployment<br />
are testing the political will and the ability of<br />
nations to react to countermeasures.<br />
The following table shows the market and par value<br />
distribution of our exposure to government bonds in<br />
certain countries.<br />
We wrote down the value of our interest-bearing<br />
investments by € 14 m in the year under review, which is<br />
equivalent to 0.01% of total investments.<br />
Liquidity risks<br />
We must be in a position to meet our payment obligations<br />
at all times. This is ensured by our detailed liquidity<br />
planning. We use our asset-liability management to control<br />
cash flows from our investment portfolio and receipt of<br />
premiums in terms of time and quantity. This means they<br />
are sufficient to meet the liabilities incurred by our insurance<br />
contracts. In addition, we maintain a liquidity reserve.<br />
This protects us from unexpected liquidity bottlenecks,<br />
such as a sudden increase in cancellations. Liquidity risks<br />
are integrated into our control and limit system, which we<br />
update annually.<br />
Major hedging operations<br />
At <strong>ERGO</strong> Insurance <strong>Group</strong>, we mainly use financial derivatives<br />
to hedge market risks to our capital investments. The<br />
main risks in this area are interest-rate fluctuations and<br />
currency risks. We use our risk management system intensively<br />
to counter these, and, as already mentioned, use<br />
financial derivatives too.<br />
A permanently low interest rate brings with it the risk that<br />
outflows must be reinvested at a lower rate of interest. We<br />
cope with this reinvestment risk by continually developing<br />
our hedging strategies using derivatives. For companies<br />
offering personal insurance, we thus have a minimum<br />
reinvest ment interest rate in the case of falling interest<br />
rates. This is an important aspect of ensuring that we are<br />
able to fulfil our technical payment obligations in the long<br />
term. Since the low interest period is still ongoing, the interest<br />
yield on reinvestments made in <strong>2012</strong> benefited again<br />
from these hedging operations. According to the balance<br />
sheet requirements of the respective financial instruments,<br />
fluctuations in market values are either recorded in the<br />
revaluation reserve or the income statement.<br />
Government bonds and government-guaranteed securities -<br />
selected countries (31 December <strong>2012</strong>)<br />
Fair values<br />
€ million<br />
Carrying amounts<br />
€ million<br />
Portugal – –<br />
Republic of Ireland 1,084 1,025<br />
Italy 2,552 2,520<br />
Greece – –<br />
Spain 973 1,298
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>38<br />
Risk report<br />
We mainly hedge the risk of exchange rate fluctuations to<br />
capital investments in foreign currencies using derivatives.<br />
We monitor these financial derivatives using a trigger<br />
system on the one hand, and they also form part of the<br />
qualitative components of the risk controlling of the <strong>ERGO</strong><br />
Insurance <strong>Group</strong>’s investments and financial participations.<br />
This is the context in which we appraise the market, credit<br />
and liquidity risks. We use our counterparty limit system to<br />
monitor the issuer risk. The counterparty risk arising from<br />
the products is spread across several creditworthy issuers.<br />
We reduce this risk further by depositing covered bonds<br />
(pfandbriefs) as collateral. In addition, we reach agreements<br />
with the counterparties on collateral management,<br />
thus protecting claims from business based on derivatives.<br />
These hedging operations are fulfilling their role. We are<br />
not currently aware of any major risks posed by the hedging<br />
operations themselves.<br />
Operational risks<br />
The <strong>ERGO</strong> Insurance <strong>Group</strong> considers operational risks as<br />
risks of losses associated with inappropriate procedures,<br />
technological breakdowns, human error or external events.<br />
We minimise these risks using systematic risk management<br />
aimed at their causes. It is one of the goals we as a<br />
Company have declared and consistently pursue to sensitise<br />
our staff to possible risks and therefore establish a<br />
certain risk culture.<br />
HR risks could include bottlenecking of staff. We reduce<br />
this risk using measures including HR advertising, tests to<br />
measure employees’ potential, human resources development<br />
and systematic succession planning. We use modern<br />
management tools and adequate monetary and nonmonetary<br />
incentives to motivate our staff.<br />
Companies are under increasing threat from white-collar<br />
crime (fraud). Our code of conduct sets out the rules and<br />
principles for correct and responsible behaviour. This code<br />
is valid for all legal representatives, managers and other<br />
staff.<br />
We have a separate code of conduct for our self-employed<br />
agents in Germany. In addition, all <strong>ERGO</strong> businesses<br />
in Germany and abroad have rules and principles for<br />
adequate and effective fraud prevention, detection and<br />
response. In cases of serious fraud, there is a special<br />
process to report this to the <strong>ERGO</strong> Fraud Prevention Officer.<br />
The number of reported cases of fraud in Germany and<br />
abroad shows our increasing sensitivity in this area as well<br />
as progress in our ever more consistent treatment and<br />
sanctioning of these occurrences. At least once a quarter,<br />
a report is submitted to the <strong>ERGO</strong> Board of Management<br />
and one to the <strong>ERGO</strong> Supervisory Board’s audit committee<br />
every six months.<br />
Due to the extent to which information technology (IT)<br />
systems have become vital to our work, we are also<br />
exposed to IT risks, particularly system failures and interruptions<br />
in service, the loss of data and external hacking.<br />
We combat these risks with a comprehensive system of<br />
precautionary measures, such as plans for emergencies,<br />
back-up solutions and controlled access. Management of<br />
our IT systems and the risks associated with them is the<br />
responsibility of IT<strong>ERGO</strong>, a member of the <strong>ERGO</strong> Insurance<br />
<strong>Group</strong>.<br />
The implementation of crisis management as a major part<br />
of our business continuity management is practically complete.<br />
We are continuing to developing this by implementing<br />
training and practice measures. We are developing<br />
emergency and recovery plans for the processes necessary<br />
to <strong>ERGO</strong>’s business and integrating them into the local<br />
emergency plans.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>39<br />
Risk report<br />
Other risks<br />
Changes to law and regulations<br />
Changes to law and regulations can have a substantial<br />
impact on the Company. Over the course of time, these<br />
changes result in opportunities as well as risks, which is<br />
why we constantly monitor these developments. Furthermore,<br />
risks are addressed by being actively involved in<br />
industry bodies and committees.<br />
An example of a particularly significant change in law is<br />
the European Court of Justice’s (ECJ) verdict of 1 March<br />
2011 on the subject of price differences based on gender<br />
in insurance. On the basis of this, the court repealed the<br />
ruling permitting Member States to allow differentiated<br />
pricing of insurance products and premiums according to<br />
gender as of 21 December <strong>2012</strong>. This also applies if the<br />
differences come from a valid calculation of risk, based<br />
on accurate and relevant mathematical and statistical<br />
insurance data. The Member States’ laws on this, including<br />
Germany’s, must be altered to accommodate the new<br />
ruling. This verdict means considerable changes to how the<br />
prices of insurance products and premiums are calculated.<br />
The actuary in charge considers the risks arising from the<br />
changes to actuarial practice to have been sufficiently<br />
contained or eliminated through our actuarial analysis and<br />
application of the German Actuarial Association’s (DAV)<br />
advice. Even following the successful implementation of<br />
the gender verdict, a change in the gender make-up of our<br />
customer base could still change our technical risk. We<br />
limit this risk using conservative calculations and actuarial<br />
analyses. We reduce the technical interest rate risk in the<br />
long term by using a technical interest rate which stands at<br />
2.75% for the new unisex tariffs, meaning that <strong>ERGO</strong> is not<br />
exposed to any further risks from the unisex tariffs.<br />
One of the sociopolitical risks we face is national health<br />
insurance (“Bürgerversicherung”), which is a threat to<br />
private health insurance. By introducing compulsory public<br />
health insurance for all, such a national health insurance<br />
scheme would, at the very least, put an end to new business<br />
in comprehensive health insurance. Obstacles posed<br />
by the constitution are likely to prevent current holders<br />
of private health insurance from being required to join<br />
the public scheme. We have been monitoring this risk for<br />
several years and have publicly spoken out about the disadvantages<br />
of implementing such a system. Equivalent<br />
proposals have been made in the area of long-term<br />
nursing care insurance.<br />
Individual court verdicts may be legally binding for our<br />
companies and affect our reputation. We assess the possible<br />
outcomes of ongoing processes and their impact on<br />
our obligations in realtime. If potential monetary obligations<br />
are identified, we react to these immediately using<br />
appropriate provisions.<br />
The progress of the European Union’s Solvency II project<br />
was one of the reasons that future regulatory requirements<br />
became somewhat clearer in <strong>2012</strong>, although they still hold<br />
some major uncertainties, particularly in respect to the<br />
implementation timeframe. The developments laid out in<br />
Pillar 1 of Solvency II have already advanced a long way,<br />
with the exception of the central aspect of the assessment<br />
of technical liabilities. The issues which have not yet been<br />
decided upon are ones with far-reaching consequences for<br />
capitalisation under Solvency II, particularly on life insurance.<br />
This results in the risk that our life insurance businesses<br />
may not be able to fulfil their capital requirements.<br />
We expect further substantiation of transition deadlines<br />
from Solvency I to Solvency II and the future powers of the<br />
EIOPA when the Omnibus II Directive is adopted. Before<br />
this takes place, a European study of the effects of Omnibus<br />
II on policyholders, regulatory bodies and insurance<br />
companies (long-term guarantee assessment) is due to be<br />
carried out. The current plan is to integrate the Solvency II<br />
regime into national law by mid− 2013 and for it to come<br />
into force from 2014. However, further delays are to be<br />
expected, possibly several years beyond 2014.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>40<br />
Risk report<br />
The implementation of Solvency II on a national level will<br />
also alter German regulatory laws. We are continually<br />
monitoring the amendment process of the German Insurance<br />
Supervision Act (V<strong>AG</strong>) to incorporate the requirements<br />
of Solvency II, which began in the middle of the second<br />
quarter in 2011 and has been suspended at present. The<br />
reason for this is that the Solvency II project is still running<br />
and there are still decisions to be made at a European level.<br />
This means that the final integration into national law still<br />
poses some uncertainties.<br />
The German Parliamentary Finance Committee has however<br />
decided to integrate certain parts of the updates<br />
to the V<strong>AG</strong> into the Accompanying Act to the SEPA Bank<br />
Transfer Act (‘SEPA-Begleitgesetz’). These topics include:<br />
• Implementation of the ECJ’s ruling on unisex tariffs<br />
• Adjustment of the rules on participation in<br />
valuation reserves<br />
• Partial collectivisation of provisions for premium refunds<br />
• Extension of the time period allowed in which to transfer<br />
the undetermined provisions for premium refunds<br />
from free assets to tied assets<br />
The German Upper House (Bundesrat) has referred the<br />
Accompanying Act to the SEPA Bank Transfer Act to the<br />
Conciliation Committee. It is currently very doubtful as to<br />
whether this act will be implemented in its current form.<br />
The outcome of the conciliation process is not expected<br />
until spring 2013 at the earliest. We are continually<br />
monitoring these developments and are preparing an<br />
appropriate implementation process.<br />
On an international level, we are currently working on<br />
additional regulatory requirements for organisations<br />
declared to be systemically important financial institutions<br />
(SIFI). The scope of requirements specific to SIFIs<br />
can range from the duty to provide additional reports to<br />
increased equity requirements. Systemic relevance does<br />
not refer to the significance of a particular industry to the<br />
national economy in this instance, but rather to the potential<br />
impact of the insolvency of a particular company on<br />
the global real economy. The Financial Stability Board (FSB)<br />
is the primary body involved in these discussions, of which<br />
the banking industry is the current focus. The study of the<br />
insurance sector is to take place separately to that of the<br />
banks, and is to be led by the International Association of<br />
Insurance Supervisors (IAIS). The IAIS is currently working<br />
on a method of identifying G-SIIs (global systemically<br />
important insurers). A first overview of the companies identified<br />
as G-SIIs is expected to be published in April 2013.<br />
The insurance industry is of the understanding that its core<br />
business does not entail any systemic risks.<br />
Strategic risks<br />
We define strategic risks as those arising from bad business<br />
decisions, the poor implementation of decisions or a lack<br />
of ability to adapt to changes in our business environment.<br />
Strategic risks occur in the context of the Company’s and<br />
its business divisions’ existing and new earnings potentials.<br />
These risks generally arise early on and in conjunction<br />
with other risks and can lead to a significant long-term<br />
reduction in corporate value. We combat strategic risks by<br />
closely combining our strategic decision-making process<br />
with our risk management. This includes cultural and<br />
organisational aspects.<br />
Risks to our reputation<br />
We define a risk to our reputation as the risk of damage<br />
caused by the Company being perceived more negatively.<br />
How the public, customers, shareholders, employees and<br />
business partners perceive us is relevant, as is the case for<br />
other interested parties such as regulatory bodies.<br />
Reputation risks are monitored and managed using our<br />
internal risk control system (IKS). We further reinforced<br />
our compliance procedures in the Company in <strong>2012</strong>. Since<br />
then, we have had a separate Compliance Unit reporting<br />
directly to the Chairman of the Board. The unit reviews<br />
the Company’s guidelines on proper conduct of staff and<br />
provides advice on the implementation of these guidelines.<br />
We have introduced a uniform advice process for our sales<br />
organisations which takes the full breadth of customers’<br />
interests into account and aims to ensure a consistently<br />
high standard of advice.<br />
There are legal disputes between several former insurance<br />
intermediaries and <strong>ERGO</strong> Lebensversicherung <strong>AG</strong>, most<br />
of which have now been concluded. In connection with<br />
far-reaching claims by the former intermediaries, serious<br />
allegations have been levelled in the media since May<br />
2011, including reports of misconduct on incentive trips<br />
and errors in the sale of insurance products at <strong>ERGO</strong>. These<br />
cases have been extensively investigated by our internal
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>41<br />
Risk report<br />
audit function. <strong>ERGO</strong> has initiated the rectification of errors<br />
and has established reserves for any liabilities arising. In<br />
relation to all these events, additional claims for damages<br />
against <strong>ERGO</strong> and Munich Re have been announced.<br />
Financial burdens and reputational damage for <strong>Group</strong><br />
companies as a result of these allegations cannot be ruled<br />
out in future either.<br />
There are currently a number of lawsuits pending against<br />
various Ideenkapital companies. The plaintiffs are fund<br />
investors, who for the main part are asserting defects in<br />
prospectuses and products. The claims filed so far amount<br />
to a total of around € 6 m. Ideenkapital is defending itself<br />
against these claims. The possibility of further suits cannot<br />
be excluded.<br />
Emerging risks<br />
Our early risk warning system also covers emerging<br />
risks. These risks arise as a consequence of a change in<br />
conditions, be they legal, socio-political, geographical or<br />
technical. Such changes can affect our portfolio in ways<br />
we may not yet understand or recognise. By definition, the<br />
extent and likelihood of damages in relation to emerging<br />
risks bear a high degree of uncertainty. The Emerging Risk<br />
Think Tank, a group of experts at Munich Re, identifies,<br />
assesses and analyses new risks to the MR <strong>Group</strong>. <strong>ERGO</strong>’s<br />
IRM unit participates in the Emerging Risk Think Tank’s<br />
regular meetings. Topics which are particularly relevant to<br />
the <strong>ERGO</strong> Insurance <strong>Group</strong> or certain individual companies<br />
are analysed and assessed in more detail.<br />
Summary of the risk position<br />
All in all, we have come to the conclusion that neither the<br />
<strong>ERGO</strong> Insurance <strong>Group</strong>’s existence nor our policyholders’<br />
interests have been endangered at any point. Furthermore,<br />
we are not currently aware of any developments<br />
which could adversely affect the continued operations,<br />
net assets, financial or earnings situation of our Company<br />
in the long run. The individual insurance organisations<br />
belonging to the <strong>ERGO</strong> Insurance <strong>Group</strong> are subject to the<br />
regulatory requirements in the countries where they are<br />
active. The <strong>ERGO</strong> Insurance <strong>Group</strong>’s insurance companies<br />
all fulfilled the appropriate local solvency requirements<br />
in <strong>2012</strong> with the exception of one international company.<br />
For this company the increase in capital required will be<br />
undertaken in the current business year. All of the <strong>Group</strong>’s<br />
companies exhibit sufficient coverage of tied assets.<br />
We are able to guarantee the functionality of our risk<br />
management system to a high level. The structures and<br />
processes we have implemented allow us to recognise the<br />
development of risks early and instigate the appropriate<br />
management processes.<br />
We continually monitor our capital investments using a<br />
<strong>Group</strong>-wide early-warning system which encompasses<br />
various key figures for the risks and earnings of each company.<br />
This allows us to ensure that solvency requirements<br />
are met and that we have sufficient protection for our<br />
equity at both <strong>Group</strong> and individual company levels. It also<br />
helps us to manage our income. The <strong>Group</strong>’s risk management<br />
system is in essence the collaboration between<br />
central risk management and the risk management units<br />
in each company. We therefore judge the <strong>ERGO</strong> Insurance<br />
<strong>Group</strong>’s risk position to be manageable, controlled and<br />
viable.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
42<br />
Management <strong>Report</strong><br />
Opportunities report<br />
As a major international insurance group, we offer an<br />
extensive array of insurance, provision and services, and<br />
the opportunities and risks for our business are just as<br />
diverse. In the chapter entitled ‘Prospects’, we offer an<br />
overview of how our business will probably develop under<br />
realistic parameters. We endeavour to address global<br />
trends with a long-term impact as extensively as possible.<br />
However, surprising and unforeseen events can never be<br />
ruled out completely. To protect ourselves against risks, we<br />
have established a sophisticated risk management system<br />
described in detail in our risk report. At the same time, we<br />
are also well prepared to seize unexpected opportunities to<br />
the benefit of our Company.<br />
It is clear, for example, that enhanced business opportunities<br />
will result for us if important macroeconomic parameters<br />
develop better than expected. Rapid stabilisation of the<br />
situation in the Eurozone could yield positive results and<br />
trigger an increase in premium income in most classes of<br />
insurance. Besides this, such a development could lead to<br />
a gradual normalisation of the bond markets and thus to<br />
a slow rise in yields on German government bonds. This<br />
would result in burdens on our investment result in the<br />
short term, but also bring higher returns in the long run,<br />
thus benefiting our long-term insurance business.<br />
Other trends and upheavals with an impact on our customers’<br />
demand for insurance or our portfolio include technological<br />
progress, demographic shifts and changes in the<br />
legal environment, in particular regulatory interventions.<br />
This not only leads to risks but also to opportunities, which<br />
we are keen to utilise.<br />
As a result of the need to provide for a rapidly ageing population,<br />
opportunities are arising within the life and health<br />
insurance sectors. The trend for annuity insurance, which<br />
has been apparent for a number of years now, looks likely<br />
to continue. Within the current climate of low interest rates<br />
and rapidly fluctuating capital markets, traditional life<br />
insurance products with annual guarantees are presenting<br />
a significant challenge to us. We are therefore developing<br />
a new generation of products that we will bring onto the<br />
market during the course of the year. Thanks to their intelligent<br />
combination of guarantees, return prospects and<br />
flexibility, we see a great deal of market potential.<br />
In health insurance, long-term nursing care is becoming<br />
the focus of attention. During the reporting period, the<br />
German legislature decided to begin funding private<br />
nursing care, something which could have a subsequent<br />
positive impact on the market. As the market leader for<br />
supplementary insurance, this is undoubtedly something<br />
we intend to participate in.<br />
Our accident insurance product, introduced in <strong>2012</strong>, offers<br />
a multitude of assistance services which aim to maintain<br />
quality of life for people involved in accidents. We are<br />
seizing opportunities which arise as a result of changes<br />
to family or household size. Alternative energy sources<br />
are resulting in an increased need for cover for property<br />
insurance – this includes both damage to equipment<br />
and loss of earnings. We are increasingly offering cover<br />
within the single European market, especially for industrial<br />
businesses.<br />
With our brand promise “To insure is to understand”, <strong>ERGO</strong><br />
stands out positively in the market and we expect to be<br />
able to strengthen and expand our position. In our industry<br />
which is quite complex for consumers, consumers often<br />
feel their wishes and concerns regarding insurance are not<br />
taken seriously. Surveys show that they bemoan the lack of<br />
transparency in products and services. Regulatory authorities<br />
strengthen consumer rights. Our aim is therefore to<br />
respond to customer calls for transparency, authenticity<br />
and simplicity in an accurate and timely fashion. With our<br />
clear and easy-to-understand communication, we will<br />
create the basis for a partnership-based approach.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>43<br />
Opportunities report<br />
Customers are increasingly purchasing insurance cover<br />
using a range of different channels. <strong>ERGO</strong>’s sales already<br />
cover a wide array of options and we have the right sales<br />
channel for everyone: self-employed insurance sales partners,<br />
staff working in direct sales, as well as insurance<br />
brokers and strong cooperation partners – both in Germany<br />
and abroad – respond to the needs of private and corporate<br />
customers alike. We maintain sales partnerships with<br />
the major European bank UniCredit and other banks, both<br />
in Germany as well as in various European countries. We<br />
believe that the prospects for growth lie primarily in bank<br />
sales and direct marketing.<br />
We also see indirect benefits from a rising level of regulations.<br />
When risks from long-term life and health insurance<br />
contracts are made easier to measure and thus more<br />
transparent, and have to be backed with the requisite<br />
capital, competitive discipline should improve and the<br />
products offered should be limited to those that generate<br />
value for customers and providers. As a result, life insurance,<br />
which is particularly challenging when market interest<br />
rates are low, could become more attractive for us<br />
again in the long term.<br />
The rapid development of emerging markets also presents<br />
opportunities for expanding profitably and further diversifying<br />
our business portfolio. We are already involved in<br />
promising joint ventures in selected emerging markets in<br />
Asia: in property insurance with HDFC <strong>ERGO</strong> in India and<br />
with the Global Insurance Company in Vietnam. Furthermore,<br />
in November <strong>2012</strong>, we formed a joint venture in<br />
India for life insurance with the well-positioned Avantha<br />
<strong>Group</strong> conglomerate. Since spring <strong>2012</strong>, we have been<br />
working intensively on setting up <strong>ERGO</strong> China Life Insurance,<br />
a joint venture with the Shandong state-owned<br />
Assets Investment Holding Company as a strong local<br />
partner. We are also using our expertise in products and<br />
sales channels within emerging European markets in order<br />
to launch the best business models on the respective<br />
market and therefore further expand our international<br />
business.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
44<br />
Management <strong>Report</strong><br />
Prospects<br />
The following assessment and comments on the likely<br />
development of our Company, including the main opportunities<br />
and risks, are made to the best of our knowledge<br />
and belief. They are based on a host of findings currently<br />
available relating to prospects for the industry, future<br />
economic and political parameters, as well as trends and<br />
the main factors influencing them. All of this may of course<br />
change in the future without this being foreseeable at the<br />
present time. The actual development of the Company and<br />
its results might therefore diverge considerably from the<br />
forecasts. This section also includes information on how<br />
the actual results for the year covered by this report differ<br />
from the predictions made last year.<br />
All in all, looking ahead at the next two financial years, we<br />
continue to anticipate a positive trend for the business of<br />
the <strong>ERGO</strong> Insurance <strong>Group</strong>. This assessment is based on a<br />
number of expectations which take into account the main<br />
opportunities and risks, our economic environment and our<br />
strategic alignment.<br />
Comparison of our predictions for <strong>2012</strong> with<br />
the results for <strong>ERGO</strong> from <strong>2012</strong><br />
Based on our predictions for last year, premium income<br />
did not quite reach the forecast amount, though we did<br />
meet expectations in profits, when adjusted to allow for<br />
restructuring costs.<br />
Total premium income amounted to € 18.6 billion, down on<br />
the expected € 19 billion. This is largely down to less singlepremium<br />
business in life insurance.<br />
In the area of health, growth was down on market figures<br />
as forecast (+ 3.4%). This was to be expected due to our low<br />
level of premium rate adjustments. Market growth, as well<br />
as our own, was lower than foreseen.<br />
expected a market growth of 1−2%. We also failed to meet<br />
our target in our combined ratio: we had hoped to bring it<br />
down to well under 95%, but it currently stands at 95.8%.<br />
In addition to a number of coincidental cases of major<br />
damage, we made risk provisions for outstanding claims<br />
within the range of actuarial estimates.<br />
Our gross premiums written in direct insurance grew, as<br />
expected. We forecast lower growth in travel insurance<br />
than in previous years. However, premium income fell by<br />
5.2% in the year under review.<br />
We projected that premiums would remain stable in international<br />
business, after making adjustments for disposals<br />
of affiliated companies; however, we did not achieve this.<br />
This was largely due to the conditions in the life insurance<br />
sector which developed worse than expected.<br />
We achieved our forecast for the consolidated result if the<br />
profit of € 289 million is adjusted by € 128 million for the<br />
effects stemming from the restructuring of our sales forces<br />
in Germany. This gives a result of € 417 million. We forecast<br />
a net profit of € 400 million in our last annual report.<br />
Economic environment<br />
Global economic growth is again likely to be only moderate<br />
in 2013. The consolidation of public finances and high<br />
unemployment will probably result in slower economic<br />
momentum in many industrialised countries. In the eurozone,<br />
we expect at most a slight recovery on an annual<br />
basis; for the USA we predict only modest growth. In the<br />
emerging economies, particularly China, India and Brazil,<br />
growth should be stronger than in <strong>2012</strong>. Inflation rates will<br />
consequently be moderate in most industrialised countries<br />
and will only reach a somewhat higher level in a few<br />
emerging countries.<br />
We had hoped that our property-casualty insurance in<br />
Germany would grow faster than the market. However, we<br />
did not achieve this goal with our 1.6% growth, compared<br />
to the assumed market growth of 3.7%; although we<br />
We forecast low economic growth and continued moderate<br />
inflation for Germany in 2013. In these circumstances,<br />
premium income can only be expected to grow modestly.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>45<br />
Prospects<br />
We expect that the world economy will expand more<br />
quickly after 2013. Nevertheless, the economic outlook is<br />
clouded by great uncertainty.<br />
A sharp downturn or even an extended period of stagnation<br />
cannot be completely excluded in a number of industrialised<br />
countries. A sustained low-interest-rate environment<br />
would substantially impair the situation of life insurance<br />
companies. The high levels of debt in many countries, an<br />
escalation of the US budgetary dispute, or upheavals in<br />
the eurozone could further destabilise the global financial<br />
system and the world economy to the detriment of the<br />
insurance industry.<br />
If there was a surprisingly strong economic recovery, the<br />
substantial interventions of the central banks and related<br />
expansion of the money supply might result in higher<br />
inflation, with corresponding inflation in claims costs for<br />
insurers.<br />
Capital markets<br />
A slow upturn in economic activity over the course of 2013 –<br />
driven by further expansive measures of the European<br />
Central Bank (ECB) in connection with a gradually receding<br />
credit crunch in the eurozone – should improve the position<br />
on the markets for risky assets. In turn, yields on German<br />
government bonds, which are currently extremely low,<br />
should rise again. Based on the very low volatility of the stock<br />
markets recently, greater fluctuations can be expected, as<br />
political uncertainty – e. g. through Italian elections – is still<br />
high. Moreover, some market participants now anticipate<br />
that Spain will submit an official application for assistance in<br />
2013 so as to qualify for unlimited bond-buying by the ECB.<br />
Further fiscal policy decisions which could induce major market<br />
movements are also due to be taken in the US. Given the<br />
continuing state debt crisis in the eurozone and the greater<br />
dynamism of the economy in the US, the US dollar should<br />
gain in attractiveness against the euro.<br />
Insurance industry<br />
The conditions in the individual European and Asian<br />
markets where we are active are very varied. Therefore,<br />
this section will concentrate on the detailed development<br />
of the part of our business which takes place in our home<br />
market of Germany, as this is the main focus of our<br />
Company.<br />
Life insurance in 2013 and 2014<br />
The life insurance market is likely to continue to be a difficult<br />
environment in which to work because of the European<br />
state debt crisis and the period of low interest rates on the<br />
financial markets. It is not only the customer who is struggling<br />
to find attractive investment opportunities for good,<br />
secure old-age provision, but simply that the possibilities<br />
are very limited, even for us insurers. For this reason, almost<br />
all life insurers have lowered the bonus rates for customers<br />
for 2013. This step, in combination with the large amount<br />
of additional interest reserves (‘Zins zusatzreserve’) set up in<br />
<strong>2012</strong>, increases the stability of the industry.<br />
We believe that over the next few years we will continue<br />
to see demand for products which pay out in the form of a<br />
pension, both in the traditional form and as more modern<br />
unit-linked products. Security is important to people, so the<br />
significance of the guaranteed amounts unit-linked products<br />
offer will increase. The industry will probably increase its<br />
use of innovative investment opportunities in order to provide<br />
the guaranteed amounts and returns that customers<br />
expect. In addition, insurance against the risks of disability<br />
or long-term nursing care is expected to remain important.<br />
The German Insurance Association (GDV) forecasts a stable<br />
development in premium income in 2013. There is some<br />
uncertainty as concerns the level of demand to be expected<br />
for the new unisex tariff products.<br />
Private health insurance in 2013 and 2014<br />
The introduction of the new unisex tariffs has changed the<br />
basic components of our calculations for new business in<br />
private health insurance. Many companies are using this<br />
changeover to revise their tariffs and update their product<br />
range. Various companies, including <strong>ERGO</strong>, are reducing their<br />
technical interest rates for new business. This is another<br />
area where only time will tell how customers will react to<br />
the new products.<br />
The German Bundestag passed the Restructuring of Care<br />
Act (PNG) on 29 June <strong>2012</strong> which includes the introduction<br />
of state-supported supplementary long-term nursing care<br />
insurance. This sets out a state contribution of € 60 per year
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Management <strong>Report</strong>46<br />
Prospects<br />
to independent care provision schemes starting in 2013.<br />
Such state-supported schemes are subject to obligation to<br />
contract and do not take risk assessment or the exclusion<br />
of benefits into account.<br />
Growth in private health insurance should remain on par<br />
with previous year’s level.<br />
Property-casualty insurance in 2013 and 2014<br />
We project further stable growth in property-casualty<br />
insurance premium income. This projection is based on the<br />
assumption that private households’ and businesses’ situations<br />
will continue to improve despite the weak economy.<br />
We foresee a rise in motor insurance premiums due to poor<br />
combined ratios across the industry. The migration of portfolios<br />
towards higher no-claims classes and cheaper tariff<br />
groups is not expected to have a large effect. We do not<br />
foresee any large changes to our private property business.<br />
Growth will only be possible through the adjustment of<br />
premiums for inflation. Growth in commercial segments<br />
could be similar to that in private property. We forecast<br />
little growth in legal protection insurance since premium<br />
adjustments here are hardly possible. The consequences of<br />
the adjustments to the Lawyers’ Remuneration Act remain<br />
to be seen.<br />
All in all, property-casualty insurers can expect growth in<br />
premium income of around 2.5%.<br />
Performance of the <strong>ERGO</strong> Insurance <strong>Group</strong><br />
in 2013 and 2014<br />
The German life insurance industry remains a difficult<br />
environment because of historically low interest rates, and<br />
further development will largely depend on the volatile<br />
single-premium business. It remains to be seen whether<br />
customers will understand that the reduction of profit<br />
participation was necessary in order to ensure long-term<br />
security. However, we expect our new products to be<br />
successful.<br />
The adjustments we will be making to our private health<br />
insurance premiums on 1 April 2013 will be more marked<br />
than those in the previous year. The prices for new business<br />
will also increase significantly compared to last year<br />
which is largely due to the adjustment in the technical<br />
interest rate and the introduction of the unisex tariffs. New<br />
business may be affected by the price increases and by<br />
political debates on private health insurance. We expect<br />
further growth in supplementary insurance, partly owing<br />
to the introduction of the new state-subsidised long-term<br />
care insurance. Therefore, we believe that there will be a<br />
slight growth in premiums in this business sector.<br />
We are looking to achieve stable premium income in the<br />
area of German property-casualty insurance. We continue<br />
to attach great importance to risk commensurate prices,<br />
which in our business with commercial and industrial<br />
clients are not always attainable in the current market<br />
environment. On the other hand, there is still potential for<br />
us to make up some ground in motor insurance. We are<br />
making our plans based on us achieving a combined ratio<br />
under 95%.<br />
Our direct insurer should be able to again increase its<br />
gross premiums written in 2013. The driving force for this<br />
should once again be health insurance. As concerns total<br />
premiums, it must be noted that due to the interest rate<br />
situation, the development of our MaxiZins product cannot<br />
be accurately predicted.<br />
We wish to continue our risk-based and profit-based<br />
underwriting policy in travel insurance. Based on this, and<br />
the difficult economic situation in Europe, we forecast a<br />
slight reduction in premiums.<br />
We should return to growth in our international business in<br />
2013 despite no longer recording premiums for the South<br />
Korean <strong>ERGO</strong> Daum Direct, which we sold in the year under<br />
review. Our combined ratio should fall below 100%.<br />
<strong>ERGO</strong> Insurance <strong>Group</strong> forecasts total premium income<br />
of about € 18.5 billion. Even in 2014, the adverse market<br />
conditions for life insurance will impede significant growth.<br />
We expect a <strong>Group</strong> profit of between € 350–450 million in<br />
2013. For 2014, this figure should rise slightly.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
48<br />
Consolidated Financial Statements<br />
Consolidated balance sheet as at 31 December <strong>2012</strong><br />
Assets<br />
A. Intangible assets<br />
Notes to the<br />
consolidated<br />
financial<br />
statements<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
I. Goodwill [1] p. 74 205.7 205.6<br />
II. Other intangible assets [2] p. 76 519.0 551.7<br />
B. Investments<br />
724.7 757.4<br />
I. Land and buildings, including buildings on third-party land [3] p. 78 2,270.8 2,347.1<br />
Thereof: held for sale − 11.1<br />
II. Investments in affiliated companies and associates [4] p. 79 528.2 543.6<br />
Thereof: associates accounted for using the equity method 441.9 410.6<br />
III. Loans [5] p. 79 54,373.3 53,214.6<br />
IV. Other securities [6] p. 80<br />
1. Held to maturity 7.3 13.4<br />
2. Available for sale 59,200.3 53,589.9<br />
3. At fair value through profit or loss 1,352.1 1,068.2<br />
60,559.7 54,671.6<br />
V. Other investments [7] p. 89 1,701.0 1,440.1<br />
119,433.0 112,217.0<br />
C. Investments for the benefit of life insurance policyholders<br />
who bear the investment risk 5,957.0 5,092.0<br />
D. Reinsurers’ share in technical provisions [8] p. 89 4,560.6 4,775.7<br />
E. Receivables<br />
I. Current tax receivables 231.6 257.5<br />
II. Other receivables [9] p. 90 4,422.0 4,332.2<br />
4,653.6 4,589.7<br />
F. Cash at banks, cheques and cash in hand 1,102.7 920.8<br />
G. Deferred acquisition costs [10] p. 91<br />
– Gross 6,362.9 6,413.7<br />
– Reinsurers’ share 224.5 249.7<br />
– Net 6,138.4 6,164.0<br />
H. Deferred tax assets [11] p. 91 2,401.0 2,506.1<br />
I. Other assets [12] p. 93 2,237.0 2,323.5<br />
Total assets 147,208.0 139,346.2
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements49<br />
Consolidated balance sheet as at 31 December <strong>2012</strong><br />
Equity and liabilities<br />
Notes to the<br />
consolidated<br />
financial<br />
statements<br />
A. Equity [13] p. 95<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
I. Issued capital and capital reserve 841.4 841.4<br />
II. Retained earnings 2,257.2 2,270.9<br />
III. Other reserves 1,065.1 211.5<br />
IV. Consolidated result attributable to <strong>ERGO</strong> equity holders 276.0 334.2<br />
V. Non-controlling interests 146.9 168.9<br />
4,586.7 3,826.8<br />
B. Subordinated liabilities [14] p. 97 1,045.1 1,041.7<br />
C. Gross technical provisions<br />
I. Unearned premiums [15] p. 97 1,869.9 1,833.8<br />
II. Provision for future policy benefits [16] p. 98 95,544.2 94,012.3<br />
III. Provision for outstanding claims [17] p. 99 8,049.4 7,561.8<br />
IV. Provision for premium refunds and policyholders’ dividends [18] p. 102 13,602.9 9,853.9<br />
V. Other technical provisions [19] p. 103 95.5 119.0<br />
119,161.9 113,380.8<br />
D. Gross technical provisions for life insurance policies where<br />
the investment risk is borne by the policyholders [20] p. 103 6,257.2 5,371.9<br />
E. Other accrued liabilities<br />
I. Provisions for post-employment benefits [21] p. 104 1,780.7 1,190.9<br />
II. Other provisions [22] p. 107 1,509.2 1,306.7<br />
F. Liabilities<br />
3,289.9 2,497.5<br />
I. Current tax liabilities 683.1 766.9<br />
II. Other liabilities [23] p. 108 9,362.3 9,677.6<br />
10,045.4 10,444.5<br />
G. Deferred tax liabilities [11] p. 91 2,821.8 2,783.0<br />
Total equity and liabilities 147,208.0 139,346.2
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
50<br />
Consolidated Financial Statements<br />
Consolidated income statement for<br />
the financial year <strong>2012</strong><br />
Notes to the<br />
consolidated<br />
<strong>2012</strong><br />
€ million<br />
2011 1<br />
€ million<br />
financial<br />
statements<br />
1. Gross premiums written [24] p. 110 17,091.3 18,518.7<br />
2. Earned premiums<br />
– Gross 17,041.4 18,335.3<br />
– Ceded share 1,002.2 1,004.0<br />
– Net 16,039.1 17,331.3<br />
3. Income from technical interest [25] p. 112 4,873.9 3,908.1<br />
4. Expenses for claims and benefits [26] p. 113<br />
– Gross 17,556.0 17,369.2<br />
– Ceded share 811.5 666.1<br />
– Net 16,744.4 16,703.1<br />
5. Operating expenses [27] p. 113<br />
– Gross 3,800.2 4,058.6<br />
– Ceded share 287.8 244.9<br />
– Net 3,512.3 3,813.6<br />
6. Technical result (2.–5.) 656.2 722.8<br />
7. Investment result [28] p. 114<br />
– Investment income 6,819.4 7,674.5<br />
– Investment expenses 1,557.7 3,558.5<br />
– Total 5,261.7 4,116.0<br />
Thereof: income from associates accounted for using the equity method 66.2 47.0<br />
8. Other operating income [29] p. 116 352.4 359.6<br />
9. Other operating expenses [29] p. 116 445.5 484.0<br />
10. Deduction of income from technical interest − 4,873.9 − 3,908.1<br />
11. Non-technical result (7.–10.) 294.8 83.5<br />
12. Operating result 951.0 806.3<br />
13. Other non-operating result [30] p. 116 − 503.3 − 315.2<br />
14. Impairment losses of goodwill [31] p. 116 − 21.4<br />
15. Finance costs [32] p. 116 81.8 65.8<br />
16. Taxes on income [33] p. 117 76.6 54.5<br />
17. Consolidated result 289.3 349.4<br />
Thereof:<br />
– Attributable to <strong>ERGO</strong> equity holders 276.0 334.2<br />
– Attributable to non-controlling interests 13.3 15.3<br />
1 Previous year’s figures adjusted pursuant to IAS 8, see chapter “Principles of presentation and consolidation”
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
51<br />
Consolidated Financial Statements<br />
Statement of recognised income and expense<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Consolidated result 289.3 349.4<br />
Currency translation<br />
Gains (losses) recognised in equity 41.3 − 35.4<br />
Included in the income statement 1 − 7.1 − 8.2<br />
Unrealised gains and losses on investments<br />
Gains (losses) recognised in equity 886.3 54.1<br />
Included in the income statement 1 − 57.8 − 59.9<br />
Change resulting from valuation at equity<br />
Gains (losses) recognised in equity − 0.7 −<br />
Included in the income statement 1 − −<br />
Change resulting from cash flow hedges<br />
Gains (losses) recognised in equity − 0.3 1.5<br />
Included in the income statement 1 0.7 5.4<br />
Actuarial gains and losses on defined benefit plans − 348.1 31.5<br />
Other changes 5.6 − 8.4<br />
Income and expense recognised directly in equity 519.9 − 19.4<br />
Total recognised income and expense 809.2 330.1<br />
Thereof:<br />
− Attributable to <strong>ERGO</strong> equity holders 795.3 319.3<br />
− Attributable to non-controlling interests 13.9 10.8<br />
1 Consolidated income statement
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
52<br />
Consolidated Financial Statements<br />
<strong>Group</strong> statement of changes in equity<br />
Development of equity<br />
Issued capital and<br />
capital reserve<br />
Equity attributable<br />
to <strong>ERGO</strong> equity holders<br />
Retained earnings<br />
€ million € million<br />
Status at 31 December 2010 841.4 2,170.0<br />
Allocation to retained earnings − 343.8<br />
Consolidated result − −<br />
Income and expense recognised directly in equity − 28.9<br />
Currency translation − −<br />
Unrealised gains and losses on investments − −<br />
Change resulting from valuation at equity − −<br />
Change resulting from hedges − −<br />
Actuarial gains and losses on defined benefit plans − 29.4<br />
Other changes − − 0.5<br />
Total recognised income and expense − 28.9<br />
Change in shareholdings in subsidiaries − − 1.5<br />
Change in consolidated group − −<br />
Dividend − − 270.3<br />
Status at 31 December 2011 841.4 2,270.9<br />
Allocation to retained earnings − 334.2<br />
Consolidated result − −<br />
Income and expense recognised directly in equity − − 334.3<br />
Currency translation − −<br />
Unrealised gains and losses on investments − −<br />
Change resulting from valuation at equity − − 0.7<br />
Change resulting from hedges − −<br />
Actuarial gains and losses on defined benefit plans − − 340.2<br />
Other changes − 6.6<br />
Total recognised income and expense − − 334.3<br />
Change in shareholdings in subsidiaries − − 13.6<br />
Change in consolidated group − −<br />
Dividend − −<br />
Status at 31 December <strong>2012</strong> 841.4 2,257.2
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements53<br />
<strong>Group</strong> statement of changes in equity<br />
Equity attributable<br />
to <strong>ERGO</strong> equity holders<br />
Non-controlling<br />
interests<br />
Total equity<br />
Other reserves<br />
Consolidated<br />
Unrealised gains<br />
and losses<br />
Reserve from<br />
currency translation<br />
Valuation result<br />
from hedges<br />
result<br />
€ million € million € million € million € million € million<br />
323.2 − 65.9 − 2.1 343.8 175.0 3,785.4<br />
− − − − 343.8 − −<br />
− − − 334.2 15.3 349.4<br />
− 5.7 − 44.9 6.8 − − 4.5 − 19.4<br />
− − 44.9 − − 1.3 − 43.6<br />
− 5.7 − − − − 0.1 − 5.8<br />
− − − − − −<br />
− − 6.8 − 0.1 6.9<br />
− − − − 2.1 31.5<br />
− − − − − 7.9 − 8.4<br />
− 5.7 − 44.9 6.8 334.2 10.8 330.1<br />
− − − − − 0.6 − 2.1<br />
− − − − − 11.1 − 11.1<br />
− − − − − 5.2 − 275.4<br />
317.5 − 110.7 4.7 334.2 168.9 3,826.8<br />
− − − − 334.2 − −<br />
− − − 276.0 13.3 289.3<br />
818.9 34.2 0.5 − 0.6 519.9<br />
− 34.2 − − − 34.2<br />
818.9 − − − 9.6 828.5<br />
− − − − − − 0.7<br />
− − 0.5 − − 0.1 0.4<br />
− − − − − 7.9 − 348.1<br />
− − − − − 1.0 5.6<br />
818.9 34.2 0.5 276.0 13.9 809.2<br />
− − − − − 33.0 − 46.6<br />
− − − − − −<br />
− − − − − 2.8 − 2.8<br />
1,136.4 − 76.5 5.2 276.0 146.9 4,586.7
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
54<br />
Consolidated Financial Statements<br />
Consolidated cash flow statement<br />
for the financial year <strong>2012</strong><br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Consolidated result 289.3 349.4<br />
Net change in technical provisions 4,123.0 2,658.1<br />
Change in deferred acquisition costs 48.1 49.2<br />
Change in deposits retained and accounts receivable and payable − 77.4 − 153.0<br />
Change in other receivables and liabilities − 407.5 − 1,747.4<br />
Gains and losses on the disposal of investments − 34.9 − 708.1<br />
Change in securities held for trading − 99.6 − 44.2<br />
Change in other balance sheet items 684.3 23.1<br />
Other income/expenses without impact on cash flow − 806.0 1,462.8<br />
I. Cash flows from operating activities 3,719.2 1,890.0<br />
Inflows from losing control of consolidated subsidiaries 12.2 951.4<br />
Outflows from obtaining control of consolidated subsidiaries − − 24.0<br />
Change from the acquisition, sale and maturities of other investments − 3,148.6 − 3,138.0<br />
Change from the acquisition and sale of investments for unit-linked life insurance − 361.6 − 489.4<br />
Other 6.6 14.9<br />
II. Cash flows from investing activities − 3,491.4 − 2,685.1<br />
Inflows from increases in capital and from non-controlling interests − −<br />
Outflows to ownership interests and non-controlling interests − 42.6 − 35.1<br />
Dividend payments − 2.8 − 275.4<br />
Change from other financing activities − 34.8 607.0<br />
III. Cash flows from financing activities − 80.2 296.4<br />
Cash flows for the financial year (I. + II. + III.) 147.5 − 498.6<br />
Effect of exchange rate changes on cash 34.4 − 20.2<br />
Cash at the beginning of the financial year 920.8 1,439.5<br />
Cash at the end of the financial year 1,102.7 920.8<br />
Additional information:<br />
Income tax paid (net) − 225.6 − 139.4<br />
Interest paid 321.9 368.5<br />
Interest received 4,391.2 4,632.5<br />
Dividends received 157.8 195.6
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
55<br />
Consolidated Financial Statements<br />
Principles of presentation and consolidation<br />
International accounting rules<br />
The consolidated financial statements of <strong>ERGO</strong> Insurance<br />
<strong>Group</strong> were prepared on the basis of Section 315 a para. 3<br />
of the HGB (German Commercial Code) in conjunction with<br />
Section 315 a, para. 1 of the HGB as well as in conjunction<br />
with Article 4 of the Regulation (EC) no. 1606/2002 of the<br />
European Parliament and Council of 19 July 2002 concerning<br />
the application of international accounting standards.<br />
The international accounting standards stated in Articles 2,<br />
3 and 6 of the aforementioned Regulation were observed,<br />
as well as the rules designated in Section 315 a, para. 1<br />
of the HGB. The consolidated financial statements also<br />
comply with all requirements as laid down by the IFRS.<br />
The standards adopted by the International Accounting<br />
Standards Board (IASB) have been referred to as “International<br />
Financial <strong>Report</strong>ing Standards” (IFRS) since 2002;<br />
the standards from previous years continue to be referred to<br />
as “International Accounting Standards” (IAS).<br />
The underwriting items are recognised and measured in<br />
accordance with the regulations governing IFRS 4 (as it<br />
was initially applied on 1 January 2005) on the basis of<br />
US GAAP (United States Generally Accepted Accounting<br />
Principles).<br />
Consolidated group<br />
In accordance with IAS 27, the consolidated financial statements<br />
include <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> ( parent company)<br />
and all entities where <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />
owns, directly or indirectly, the majority of the voting rights<br />
or where it has the actual ability to control ( subsidiaries).<br />
Special purpose entities, such as special funds, are included<br />
in the consolidated financial statements according to SIC 12<br />
if, from an economic point of view, they are controlled by<br />
<strong>ERGO</strong>.<br />
Following a licence issued by the relevant regulatory<br />
authorities in April <strong>2012</strong>, <strong>ERGO</strong> Insurance <strong>Group</strong>, together<br />
with the Shandong State-owned Assets Investment Holding<br />
Company (SSAIH), commenced the set-up of the company<br />
<strong>ERGO</strong> China Life Insurance Co., Ltd., Jinan, Shandong<br />
Province. This is intended primarily to provide life insurance<br />
to private customers in the Chinese province of Shandong.<br />
<strong>ERGO</strong> Insurance <strong>Group</strong> and SSAIH both own half of the<br />
shares in the new company. Business operations are likely<br />
to commence in the first half of 2013, provided that further<br />
approval has been obtained by the authorities there.<br />
<strong>ERGO</strong> Insurance <strong>Group</strong> signed an agreement with the<br />
Avantha <strong>Group</strong> in India on 1 November <strong>2012</strong> to set up a<br />
joint venture. The new company will provide life insurance<br />
for private customers. The registered offices of the<br />
future “Avantha <strong>ERGO</strong> Life Insurance Company” will be<br />
based in Mumbai. Business is due to start early in 2014<br />
provided that the authorities have issued the licence. <strong>ERGO</strong><br />
Insurance <strong>Group</strong> will initially have a 26% stake in the new<br />
company.<br />
In the first quarter of <strong>2012</strong> <strong>ERGO</strong> Insurance <strong>Group</strong> took the<br />
decision to sell its fully consolidated subsidiary San Marino<br />
Life Impresa sammarinese di assicurazione sulla vita<br />
S. p. A., San Marino. An agreement concerning the sale of<br />
the company with economic effect as of July <strong>2012</strong> was<br />
signed in the second quarter of <strong>2012</strong>; the sales price was<br />
€ 5 million.<br />
In the second quarter of <strong>2012</strong> <strong>ERGO</strong> Insurance <strong>Group</strong><br />
disposed of its shares, with economic effect as of October<br />
<strong>2012</strong>, in its fully consolidated subsidiary <strong>ERGO</strong> Daum Direct<br />
General Insurance Co. Ltd., Seoul. The disposal of the company<br />
resulted in a loss of € 25.2 million, which was recorded<br />
under investment results in the <strong>Group</strong>’s income statement.<br />
In addition, a loss of € 6.9 million, which was contained<br />
income and expense recognised directly in equity, was to<br />
be reclassified from other reserves to other non-operating<br />
result.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements56<br />
Principles of presentation and consolidation<br />
The following table shows the cash flows and net<br />
assets resulting from the takeover and loss of control of<br />
consolidated subsidiaries or other operations:<br />
Net assets obtained <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Goodwill − −<br />
Other intangible assets − −<br />
Investments − 33.0<br />
Cash − 1.7<br />
Other assets − 1.0<br />
Technical provisions (net) − −<br />
Other liabilities − − 0.1<br />
Total − 35.6<br />
Cash flows arising from obtaining control <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Total consideration for obtaining control − − 25.7<br />
Non-cash consideration for obtaining control − −<br />
Cash consideration for obtaining control − − 25.7<br />
Cash over which control was obtained − 1.7<br />
Total − − 24.0<br />
Net assets lost <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Goodwill − 49.5<br />
Other intangible assets 3.6 13.6<br />
Investments 216.3 1,955.2<br />
Cash 1.1 62.6<br />
Other assets 33.6 405.0<br />
Technical provisions (net) − 188.8 − 1,596.6<br />
Other liabilities − 27.3 − 521.8<br />
Total 38.6 367.4<br />
Cash flows arising from losing control <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Total consideration for losing control 13.4 1,045.7<br />
Non-cash consideration for losing control − −<br />
Cash consideration for losing control 13.4 1,045.7<br />
Cash over which control was lost − 1.1 − 94.2<br />
Total 12.2 951.4<br />
Number of consolidated subsidiaries 1 Germany International Total<br />
Development during the financial year<br />
31 December previous year 63 98 161<br />
Additions 3 3 6<br />
Reductions 2 − 10 10<br />
31 December financial year 66 91 157<br />
1 In addition, 36 German and 2 international special funds were included in the consolidated group.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements57<br />
Principles of presentation and consolidation<br />
Number of companies valued at equity Germany International Total<br />
Development during the financial year<br />
31 December previous year 19 13 32<br />
Additions 2 1 3<br />
Reductions − 1 1<br />
31 December financial year 21 13 34<br />
A list of the entire shareholdings is available in the Section<br />
entitled “List of shareholdings as at 31 December <strong>2012</strong> in<br />
accordance with Section 313, para. 2 of the German Commercial<br />
Code (HGB)”.<br />
Consolidation methods<br />
The annual financial statements of subsidiaries and special<br />
purpose entities incorporated into the <strong>Group</strong> are subject to<br />
standard accounting and valuation methods. As a general<br />
rule, the balance sheet cut-off date of companies included<br />
in the consolidated financial statements is 31 December.<br />
Some special funds have other balance sheet dates; these<br />
funds are consolidated on 31 December on the basis of<br />
interim financial statements.<br />
The consolidation of capital is done using the purchase<br />
method. In order to determine the equity capital at the<br />
time of acquisition, the assets and liabilities of the subsidiary<br />
or special fund are measured at fair value. The<br />
considera tion transferred in exchange for the acquired<br />
shares is netted against the equity capital apportionable to<br />
the <strong>Group</strong> at the time of acquisition; any residual positive<br />
amount is capitalised as goodwill.<br />
Profits earned by subsidiaries or special purpose entities<br />
after their first consolidation are included in <strong>Group</strong> equity.<br />
Receivables and liabilities as well as income and expenses<br />
relating to intra-<strong>Group</strong> transactions are eliminated insofar<br />
as they are not of minor importance.<br />
Pursuant to IAS 28, associates are generally all entities<br />
which are not subsidiaries or joint ventures and where<br />
there is the opportunity of exercising substantial influence<br />
on the business or financial policy.<br />
In case of participating interests of between 20% and 50%<br />
of the voting rights, the entities in question are deemed to<br />
be associated companies unless it can be clearly demonstrated<br />
that there is no significant influence.<br />
Recognition and measurement<br />
Use of judgement and estimates in recognition<br />
and measurement<br />
In the course of preparing the consolidated financial<br />
statements we have to use our judgement in applying<br />
accounting and valuation methods and to make estimates<br />
and assumptions. These affect the year-end items shown<br />
in the consolidated balance sheet, the consolidated<br />
income statement and disclosures of contingent assets<br />
and liabilities.<br />
The use of estimates is of utmost importance for technical<br />
provisions, since the valuation is based constantly on<br />
models and the trend in future cash flows of insurance<br />
policies is not entirely predictable. Nevertheless, arbitrary<br />
decisions and estimates also play an essential role with<br />
other items.<br />
Our internal processes are geared to determine amounts<br />
as accurately as possible, taking into account all the<br />
relevant information. Determination of these values is<br />
based on management’s best knowledge regarding the<br />
respective facts on the balance sheet date. Nevertheless, it<br />
is in the nature of these items that estimates may have to<br />
be adjusted over the course of time to take account of new<br />
knowledge.<br />
Owing to the uncertainties surrounding estimates any<br />
discretionary judgements also contain a subjective component.<br />
This may result in comparable items being measured<br />
differently by <strong>ERGO</strong> Insurance <strong>Group</strong> and another company,<br />
especially as the range of realistic assumptions can differ<br />
tremendously in individual cases. However, this does<br />
not mean that the valuation has not been done properly –<br />
merely that it reflects differing knowledge and assessments<br />
of future developments.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements58<br />
Principles of presentation and consolidation<br />
Discretionary judgements and estimates are of particular<br />
significance for the following items and are described in<br />
more detail in the respective explanatory notes:<br />
• Goodwill and other intangible assets<br />
• Fair values and impairments of financial instruments<br />
• Deferred acquisition costs<br />
• Technical provisions<br />
• Pension provisions<br />
• Deferred tax<br />
• Contingent liabilities<br />
Currency of the report<br />
The currency of the report is the euro (€). Figures are shown<br />
in millions of euros, and shown with figures after the decimal<br />
point. Figures in brackets refer to the previous year.<br />
Figures for previous year<br />
Changes in line with the provisions governing IAS 8 and<br />
the modification in calculating the technical interest made<br />
it necessary to make adjustments retrospectively to the<br />
consolidated income statement for the 2011 financial year<br />
and the corresponding items in the Notes to the consolidated<br />
financial statements, see section on “Changes in accounting<br />
policies”. Otherwise, last year’s figures were determined<br />
in the same way as for those in the <strong>2012</strong> financial year.<br />
Changes in accounting policies<br />
Application of the recognition, measurement and disclosure<br />
methods follows the principle of consistency. In the financial<br />
year <strong>2012</strong>, the following new IFRSs had to be applied for<br />
the first time:<br />
The amendments to IFRS 7 (rev. 10/2010), Financial Instruments:<br />
Disclosures, Improving Disclosures about Financial<br />
Instruments, contain more extensive disclosure requirements<br />
regarding the transfer of financial assets. The aim<br />
of these amendments is to make more transparent the<br />
influence of such transactions on the entity’s risk exposure<br />
and hence its financial situation. This change currently has<br />
no practical relevance for <strong>ERGO</strong>.<br />
The amendments to IAS 12 (rev. 12/2010), Taxes on Income,<br />
Deferred Tax: Recovery of Underlying Assets, address the<br />
issue that the measurement of deferred tax items depends<br />
on whether the carrying amount of an asset is expected<br />
to be recovered through use or through sale. In practice,<br />
the two are often difficult to distinguish. The amendments<br />
provide a solution through the introduction of a rebuttable<br />
presumption that recovery of the carrying amount will<br />
normally be through sale. These amendments are mandatory<br />
for financial years beginning on or after 1 January<br />
<strong>2012</strong>, and were adopted into EU law in December <strong>2012</strong>. As<br />
the clarification currently has no practical significance for<br />
<strong>ERGO</strong>, no consequences resulted from this delay.<br />
Our method of calculating technical interest has been<br />
modified in the primary insurance segments since <strong>2012</strong>.<br />
This particularly affects the life insurance business. In<br />
addition to the components used hitherto, the deposits<br />
retained on ceded business are now also taken into<br />
account as a basis for the technical interest. Thus the<br />
portion of investment income that corresponds to the<br />
deposit interest expense is included as a new component in<br />
the calculation of the technical interest and reallocated to<br />
the technical result. Pursuant to IAS 8.22, the modification<br />
has been applied with retroactive effect and the previous<br />
year’s figures have been adjusted accordingly. This change<br />
provides for a more accurate presentation of the technical<br />
result. As a result of the change, the income from technical<br />
interest in the financial year <strong>2012</strong> is higher than it would<br />
have been under the previous method. It is impracticable<br />
to determine the exact increase for the current period, but<br />
there was an increase of € 55.3 m for the same period last<br />
year, which includes the effect from the retroactive adjustment<br />
of a consolidated entry. In addition, the estimate<br />
for policyholders’ bonuses has been refined and has been<br />
used pursuant to IAS 8.32 as from <strong>2012</strong> for future periods.<br />
This adjustment has no effect on the consolidated balance<br />
sheet.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements59<br />
Principles of presentation and consolidation<br />
Consolidated income statement 2011<br />
as originally<br />
Changes from<br />
adjustments<br />
2011<br />
adjusted<br />
recognised pursuant to IAS 8<br />
1. Gross premiums written 18,639.2 − 120.4 18,518.7<br />
2. Earned premiums<br />
– Gross 18,455.7 − 120.4 18,335.3<br />
– Ceded share 1,004.0 − 1,004.0<br />
– Net 17,451.8 − 120.4 17,331.3<br />
3. Income from technical interest 3,852.8 55.3 3,908.1<br />
4. Expenses for claims and benefits<br />
– Gross 17,489.6 − 120.4 17,369.2<br />
– Ceded share 666.1 − 666.1<br />
– Net 16,823.5 − 120.4 16,703.1<br />
6. Technical result (2.–5.) 667.4 55.3 722.8<br />
10. Deduction of income from technical interest − 3,852.8 − 55.3 − 3,908.1<br />
11. Non-technical result (7.–10.) 138.9 − 55.3 83.5<br />
The net level premiums for the products of our foreign<br />
subsidiaries that fall under FAS 97 were previously shown<br />
in accordance with local accounting regulations. We have<br />
now recognised these net level premiums as a deposit,<br />
without impact on profit or loss, in accordance with the<br />
rules of FAS 97. Pursuant to IAS 8.41, the modification<br />
has been applied with retroactive effect and the previous<br />
year’s figures have been adjusted accordingly. This adjustment<br />
has no effect on the consolidated balance sheet. The<br />
adjustment made to insurance benefits mainly concerns<br />
the change within the provision for future policy benefits in<br />
addition to payments for insured incidents.<br />
The table lists the effects on the consolidated income<br />
statement for the 2011 financial year.<br />
Standards not yet in force and changes to standards<br />
All standards or changes in standards that have not yet<br />
entered into force will be applied by <strong>ERGO</strong> for the first time<br />
as from the mandatory effective date for entities domiciled<br />
in the European Union.<br />
Under the amendment to IAS 1 (rev. 06/2011), Presentation<br />
of Financial Statements, Presentation of Items of Other<br />
Comprehensive Income, “other comprehensive income”<br />
must now be divided into items that will be reclassified to<br />
profit or loss at a later date and items that will not. The<br />
purpose of this amendment is to improve the presentation<br />
of these items and align the approaches under IFRS and US<br />
GAAP. The amendments are mandatory for financial years<br />
beginning on or after 1 July <strong>2012</strong>, and were adopted into<br />
EU law in June <strong>2012</strong>.<br />
Unless mentioned separately below, the following standards<br />
are mandatory for financial years beginning on or<br />
after 1 January 2013. Only the amendments published<br />
as part of the IFRS <strong>Annual</strong> Improvement Process and the<br />
revised IFRS 9, Financial Instruments, as well as the related<br />
changes to the group-specific standards (IFRS 10, IFRS 11,<br />
IFRS 12 and IAS 27) have not yet been adopted into European<br />
law. The other standards were adopted in June or<br />
December <strong>2012</strong>.<br />
IFRS 9 (11/2009 and rev. 10/2010), Financial Instruments,<br />
replaces the current requirements of IAS 39 relating to recognition<br />
and measurement of financial instruments. Given<br />
its complexity, the overall project has been subdivided into<br />
three phases. The new rules in IFRS 9 that have thus far<br />
been adopted from the first phase of the project mainly<br />
concern the classification and measurement of financial<br />
instruments. Under these rules, financial assets will in<br />
future be divided into only two primary measurement categories:<br />
amortised cost and fair value through profit or loss.<br />
The distinction is to be made on the basis of the reporting<br />
entity’s business model and the contractual cash flows of<br />
the assets. In addition, for equity instruments there will be<br />
the option of measurement at fair value without affecting<br />
the income statement, although then it will not be permissible<br />
for value changes recognised in other comprehensive
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements60<br />
Principles of presentation and consolidation<br />
income to be subsequently transferred to profit or loss.<br />
There also remains the possibility of voluntary measurement<br />
at fair value (fair value option). For financial liabilities,<br />
there are no changes in the measurement rules except<br />
that if the fair value option is applied, value changes<br />
attribut able to a change in the entity’s credit risk must be<br />
recognised without impact on profit or loss in future.<br />
The two other phases of the project are concerned with<br />
rules for recognising impairments and for hedge accounting.<br />
While the discussion regarding hedge accounting has<br />
practically been concluded and the new rules are to be<br />
integrated into IFRS 9 in the short term, the IASB will first<br />
be publishing another exposure draft for the rules regarding<br />
recognition of impairments.<br />
Besides this, in November <strong>2012</strong>, the IASB published an<br />
exposure draft providing for a further change in the new<br />
measurement rules. This is designed to make it possible to<br />
continue measuring certain debt instruments at fair value<br />
without impact on profit or loss, depending on the contractual<br />
cash flows and an additionally defined business model<br />
that contains an intention to sell.<br />
Originally, IFRS 9 envisaged that the new provisions would<br />
be mandatorily effective as from 2013. Since discussions<br />
of the still outstanding project phases are taking longer<br />
than originally planned, the mandatory effective date<br />
of a standard amending IFRS 9 and IFRS 7 (rev. 12/2011)<br />
has been deferred to financial years beginning on or after<br />
1 January 2015.<br />
IFRS 10 (05/2011), Consolidated Financial Statements,<br />
supersedes the provisions of IAS 27 and SIC 12 and creates<br />
a uniform definition for control, irrespective of whether<br />
this control is based on company law or on contractual or<br />
economic circumstances. There are no longer independent<br />
provisions for structured entities (special purpose entities).<br />
A situation of control exists when an investor has the ability<br />
to direct an investee’s relevant activities and is exposed<br />
to the returns from those activities. Furthermore, IFRS 10<br />
addresses issues that have not been dealt with until now,<br />
including the regulation that a situation of control exists<br />
even if an investor holds less than a majority of the voting<br />
rights but regularly has a de facto majority of voting rights<br />
at the annual general meetings. The effects of the new<br />
standard on <strong>ERGO</strong>’s consolidated companies are currently<br />
being reviewed.<br />
IFRS 11 (05/2011), Joint Arrangements, defines joint operations<br />
and joint ventures and specifies how they are to be<br />
recognised in the balance sheet. The changes compared<br />
with IAS 31, Interest in Joint Ventures, mainly concern the<br />
elimination of the option of proportionate consolidation<br />
for joint ventures, the amended definition of joint control,<br />
and the extended scope of application of joint operations.<br />
These may now include arrangements structured through<br />
a separate vehicle. The elimination of the option of proportionate<br />
consolidation will have no impact on <strong>ERGO</strong>, as we<br />
do not avail ourselves of this option and already apply the<br />
equity method. The effects of the two other changes are<br />
currently being analysed.<br />
IFRS 12 (05/2011), Disclosure of Interests in Other Entities,<br />
combines the disclosures regarding facts and circumstances<br />
governed by IFRS 10, 11 and IAS 28. The objective<br />
of the standard is to provide information on the type and<br />
risk of interests in other entities and their implication for<br />
the consolidated financial statements. As a consequence,<br />
the information provided needs to be more comprehensive<br />
than hitherto. In particular, IFRS 12 requires disclosures<br />
relating to unconsolidated structured entities, non-controlling<br />
interests, discretionary judgements and assumptions<br />
in evaluating the nature of interests in other entities,<br />
as well as detailed information on each significant joint<br />
arrangement. The precise extent to which <strong>ERGO</strong> is affected<br />
by the extended disclosure requirements is currently being<br />
examined.<br />
IAS 27 (rev. 05/2011), Separate Financial Statements, now<br />
deals only with balance sheet recognition of investments<br />
in subsidiaries, joint ventures and associates in separate<br />
single-entity financial statements in accordance with IFRS,<br />
including the relevant disclosures in the notes. The definition<br />
of control, and balance sheet recognition of subsidiaries<br />
in consolidated financial statements is now regulated<br />
by IFRS 10. The standard has no effect on <strong>ERGO</strong>, as the provisions<br />
for single-entity financial statements in accordance<br />
with IFRS have remained unchanged.<br />
IAS 28 (rev. 05/2011), Investments in Associates and Joint<br />
Ventures, specifically includes amendments following<br />
from the publication of IFRS 11 and IFRS 12. Among other<br />
things, the standard integrates the balance sheet recognition<br />
of joint ventures and circumstances previously governed<br />
by SIC 13, Jointly Controlled Entities – Non-Monetary<br />
Contributions by Venturers. Furthermore, investments in
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements61<br />
Principles of presentation and consolidation<br />
associates or joint ventures held by open-ended investment<br />
funds or for unit-linked insurance, for example, are<br />
no longer excluded from the standard’s scope of application.<br />
Rather, there is now an option to measure these at<br />
fair value with impact on profit or loss. The amendments<br />
do not have any major implications for <strong>ERGO</strong>.<br />
As mandated by the IASB, application of IFRS 10, IFRS 11<br />
and IFRS 12 and the amendments to IAS 27 and IAS 28<br />
would be mandatory for financial years beginning on or<br />
after 1 January 2013. When the standards were adopted<br />
into European law, the mandatory effective date was<br />
deferred by one year, so that the standards concerned<br />
have to be applied for the first time by entities domiciled<br />
in the European Union for financial years beginning on or<br />
after 1 January 2014; voluntary application before that<br />
date is permitted.<br />
In June <strong>2012</strong>, the IASB adopted IFRS Consolidated Financial<br />
Statements, Joint Arrangements, and Disclosure of Interests<br />
in Other Entities – Transition Guidance (Amendments<br />
to IFRS 10, IFRS 11 and IFRS 12) (06/<strong>2012</strong>), which clarifies<br />
that the requirement to provide adjusted comparative<br />
information on first-time application is limited to the<br />
preceding comparative period only. Insofar as first-time<br />
application does not result in any change in the need to<br />
consolidate an entity at the date of first-time application,<br />
no adjusted comparative information for prior periods<br />
is necessary. In addition, the requirement to provide<br />
adjusted comparative information for prior periods is<br />
removed for unconsolidated structured entities. The effects<br />
of the changes on <strong>ERGO</strong> are currently being analysed.<br />
The amendments are generally mandatory for financial<br />
years beginning on or after 1 January 2013. However, we<br />
expect that when they are adopted into European law, the<br />
mandatory effective date in the European Union will be<br />
deferred by one year for these amendments as well.<br />
The IFRS Investment Entities (Amendments to IFRS 10,<br />
IFRS 12 and IAS 27) (10/<strong>2012</strong>) introduces a definition of the<br />
term “investment entities” and specifies that such entities<br />
are generally excepted from the requirement to consolidate<br />
their subsidiaries in future. Rather, they are required<br />
to measure them at fair value through profit or loss. The<br />
exception from the consolidation requirement does not<br />
apply to parents of investment entities that are not themselves<br />
investment entities. Besides this, additional disclosure<br />
requirements for investment entities are provided<br />
for. The amendments, whose application is mandatory for<br />
financial years beginning on or after 1 January 2014, are<br />
not relevant for <strong>ERGO</strong>.<br />
IFRS 13 (05/2011), Fair Value Measurement, provides guidance<br />
on measuring items at fair value if another standard<br />
prescribes fair value measurement or fair value disclosure<br />
in the notes to the financial statements. The standard thus<br />
does not determine what items need to be measured at<br />
fair value. IFRS 13 revises the definition of fair value, defining<br />
it as the price that would be received to sell an asset or<br />
paid to transfer a liability in an orderly transaction between<br />
market participants at the measurement date. The standard<br />
includes detailed information on how to determine<br />
the fair value for different types of assets and liabilities. In<br />
addition, the standard requires further disclosures in the<br />
notes – for instance, the fair value hierarchy thus far only<br />
required for financial instruments under IFRS 7 has now<br />
been extended to include all items measured at fair value.<br />
On the basis of IFRS 13, we have verified whether <strong>ERGO</strong>’s<br />
fair value measurement is in compliance with the new<br />
provisions, and we will make any adjustments in measurement<br />
necessary. The new disclosures in the notes also<br />
need to be implemented.<br />
The amendments published as part of the IFRS <strong>Annual</strong><br />
Improvement Process in May <strong>2012</strong> concern IFRS 1, Firsttime<br />
Adoption of International Financial <strong>Report</strong>ing Standards,<br />
which as such is not relevant for <strong>ERGO</strong>, as well as<br />
IAS 1, Presentation of Financial Statements, IAS 16, Property,<br />
Plant and Equipment, IAS 32, Financial Instruments:<br />
Presentation, and IAS 34, Interim Financial <strong>Report</strong>ing,<br />
and the knock-on change in the interpretation IFRIC 2,<br />
Members’ Shares in Co-operative Entities and Similar<br />
Instruments. Only the amendment to IAS 1, Presentation<br />
of Financial Statements, is of practical significance<br />
for <strong>ERGO</strong>, and this simplifies the rules currently in place.<br />
Where a retro spective change in accounting policies or a<br />
retrospective adjustment or reallocation of items under<br />
IAS 8 requires publication of a binding third comparative<br />
balance sheet, it is no longer necessary to make the<br />
relevant disclosures in the notes.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements62<br />
Principles of presentation and consolidation<br />
As a result of the amendments to IAS 19 (rev. 06/2011),<br />
Employee Benefits, the option for deferring the recognition<br />
of actuarial gains and losses, in particular the “corridor<br />
approach”, has been eliminated. These gains and losses<br />
must now be recognised in equity with no effect on profit<br />
or loss. Furthermore, the past service cost for retroactive<br />
changes in a defined benefit plan is to be immediately<br />
recognised in the income statement. The return on plan<br />
assets is now to be determined on the basis of the rate<br />
used to discount the present value of defined benefit obligations.<br />
The administrative costs and taxes payable by<br />
the plan are to be deducted from the return. The requirements<br />
regarding the asset ceiling have been integrated<br />
and further specified. Moreover, additional disclosures in<br />
the notes are required, e. g. analysing pension obligations<br />
in terms of their risks and sensitivities for the actuarial<br />
assumptions. The amendments will not have any major<br />
effects on <strong>ERGO</strong>. The extended disclosures in the notes<br />
need to be implemented.<br />
The amendments to IAS 32 (rev. 12/2011), Financial<br />
Instruments: Presentation – Offsetting Financial Assets<br />
and Financial Liabilities, and IFRS 7 (rev. 12/2011), Financial<br />
Instruments: Disclosures – Offsetting Financial Assets and<br />
Financial Liabilities, clarify some issues in relation to the<br />
admissibility of offsetting financial assets and financial<br />
liabilities. They also require additional disclosures in the<br />
notes to the financial statements. These additional disclosures<br />
comprise gross and net amounts related to offsetting<br />
as well as amounts for existing rights to offset that<br />
do not satisfy the offsetting criteria. The new disclosures<br />
are mandatory for annual periods beginning on or after<br />
1 January 2013 and the clarifications for annual periods<br />
beginning on or after 1 January 2014. We are currently<br />
proceeding on the assumption that these changes will<br />
have no practical significance for <strong>ERGO</strong>.<br />
IFRIC Interpretation 20 (10/2011), Stripping Costs in the<br />
Production Phase of a Surface Mine, clarifies when production<br />
stripping should lead to the recognition of an asset<br />
and how that asset should be measured, both initially and<br />
in subsequent periods. This interpretation has no practical<br />
relevance for <strong>ERGO</strong>.<br />
Non-current assets and disposal groups classified as<br />
“held for sale” and sold in the reporting period<br />
Non-current assets and disposal groups classified as “held<br />
for sale” are recognised at the lower of carrying amount or<br />
fair value less sales cost and shown separately on the consolidated<br />
balance sheet.<br />
In the fourth quarter of 2011 we sold, with economic<br />
impact in March <strong>2012</strong>, an investment property used by a<br />
third party with a carrying value of € 11,1 million. The sales<br />
price was € 51.9 million.<br />
We sold interests in fully consolidated subsidiaries during<br />
the <strong>2012</strong> financial year. For further details concerning<br />
these transactions, please refer to the Notes on the scope<br />
of consolidation on page 55.<br />
Assets<br />
Intangible assets<br />
Goodwill resulting from the first-time consolidation of<br />
subsidiaries is tested for impairment at least annually,<br />
in accordance with IAS 36. We additionally carry out adhoc<br />
impairment tests if there are indications of impairment.<br />
For impairment testing, the goodwill is allocated to<br />
the cash-generating units or groups of cash-generating<br />
units expected to derive benefit from the synergies of the<br />
business combination. To ascertain whether there is any<br />
impairment, the carrying amount (including allocated<br />
goodwill) of a cash-generating unit or a group of cashgenerating<br />
units is compared with that unit’s or group’s<br />
recoverable amount. The recoverable amount is the greater<br />
of the fair value less costs to sell and the value in use. If<br />
this recoverable amount is lower than the carrying amount,<br />
a write-down is made on the goodwill. If the amount of<br />
the impairment of a cash-generating unit or group of cashgenerating<br />
units is greater than the carrying amount of the<br />
goodwill allocated, the difference is generally allocated pro<br />
rata between the other relevant assets of the unit or group<br />
of units on the basis of their carrying amounts. However,<br />
the carrying amount may not be reduced below the highest<br />
of fair value less costs to sell, the value in use, and zero.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements63<br />
Principles of presentation and consolidation<br />
The other intangible assets mainly comprise acquired<br />
insurance portfolios, acquired and self-developed software,<br />
and acquired sales networks and client bases.<br />
Acquired insurance portfolios are recognised at their<br />
present value on acquisition (PVFP – present value of<br />
future profits). This is determined as the present value of<br />
expected profits from the portfolio acquired, without consideration<br />
of new business and tax effects. The acquired<br />
insurance portfolios are amortised in accordance with<br />
the realisation of the profits from the insurance portfolios<br />
underlying the PVFP calculation. They are regularly<br />
tested for impairment in accordance with IFRS 4 (liability<br />
adequacy test); cf. notes on liabilities item C: Gross technical<br />
provisions. Write-downs are recognised under operating<br />
expenses.<br />
Self-developed and other software, acquired sales networks,<br />
client bases and brand names are carried at cost.<br />
Self-developed and other software is amortised on a<br />
straightline basis at a rate of 20–33% over its useful life –<br />
three to five years – or in exceptional circumstances at a<br />
rate of 10% over a period of up to ten years. The useful<br />
lives and depreciation rates of the acquired sales networks<br />
and client bases are 2–17 years or 6–50%, and those of the<br />
brand names 1–30 years or 3–100%; the items in question<br />
are amortised consistently in accordance with the straightline<br />
method. Write-downs or write-ups are made if<br />
required. Write-downs and write-ups are distributed in<br />
the consolidated income statement between investment<br />
expenses, expenses for claims and benefits and operating<br />
expenses. If it is not possible to allocate the write-downs<br />
and write-ups to the functional areas, they are shown<br />
under other non-operating expenses or income.<br />
Investments<br />
Land and buildings shown under investments comprise<br />
property used by third parties and are carried at cost.<br />
Maintenance expenses are recognised as an expense.<br />
Structural measures equivalent to 5% or more of the<br />
historical cost of a building are generally assessed with<br />
regard to whether they have to be capitalised. Buildings are<br />
depreciated on a straight-line basis in accordance with the<br />
component approach, depending on the weighted useful<br />
life for their specific building class. The underlying useful<br />
lives mainly range between 40 and 55 years. If the recoverable<br />
amount of land and buildings falls below their carrying<br />
amount, the carrying amount is written down to the<br />
recoverable amount. Impairment losses are recognised as<br />
investment expense in the consolidated income statement,<br />
and reversals of impairment losses as investment income.<br />
Investments in affiliated companies that we do not consolidate<br />
because they are not material are generally carried<br />
at their fair values. If the investments are quoted on a<br />
stock exchange, we use the share prices at the balance<br />
sheet date; for unquoted investments, the fair value is<br />
measured using the discounted earnings or net asset value<br />
method. Unrealised gains or losses are recognised directly<br />
in other reserves after deduction of deferred taxes and<br />
amounts apportionable to policyholders of life and health<br />
insurers on realisation (provision for deferred premium<br />
refunds).<br />
Investments in associates are valued by the equity method<br />
at the <strong>Group</strong>’s proportionate share of their net assets.<br />
The associate’s earnings attributable to the <strong>Group</strong> are<br />
included in the investment result. As a rule, the equity and<br />
annual result from the most recent individual or consolidated<br />
financial statements of the associate are used; in<br />
the case of the annual financial statements of significant<br />
associates, appropriate adjustments are made to conform<br />
them to <strong>ERGO</strong>’s accounting policies, in accordance with<br />
IAS 28.27; exceptional transactions of material importance<br />
for a true and fair picture of the associate’s financial<br />
position are recognised in the same financial year. Investments<br />
in associates that are not material for assessing
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements64<br />
Principles of presentation and consolidation<br />
the <strong>Group</strong>’s financial position are generally accounted for<br />
at fair value. To determine the fair value, we use the share<br />
prices at the balance sheet date if the investments are<br />
quoted on a stock exchange; for unquoted investments,<br />
the fair value is measured using the discounted earnings<br />
or net asset value method. Changes in the fair value are<br />
recognised in “other reserves” under unrealised gains and<br />
losses after taking into account deferred taxes and those<br />
amounts at life and health insurers which, when realised,<br />
are due to policyholders (provision for deferred premium<br />
refunds).<br />
Loans are non-derivative financial assets with fixed or determinable<br />
payments that are not quoted in an active market.<br />
They are measured at amortised cost in accordance with<br />
the effective interest method. Write-downs for impairments<br />
are made in cases where the repayment of a loan<br />
can no longer be expected.<br />
Fixed-interest securities held to maturity are measured at<br />
amortised cost in accordance with the effective interest<br />
method.<br />
Fixed-interest or non-fixed-interest securities available<br />
for sale that are not designated as at fair value through<br />
profit or loss or recognised under loans are accounted for<br />
at fair value, with resulting changes in value recognised in<br />
equity with no effect on profit or loss. If no quoted prices<br />
in an active market are available, fair values are based<br />
on recognised valuation methods in line with the present<br />
value principle. Unrealised gains or losses are calculated<br />
taking into account interest accrued and, after deduction<br />
of deferred taxes and the amounts apportionable to<br />
policyholders by the life and health insurers on realisation<br />
(provision for deferred premium refunds), are recognised<br />
directly in equity under “other reserves”.<br />
Securities at fair value through profit or loss comprise<br />
securities held for trading and securities designated as at<br />
fair value through profit or loss. Securities held for trading<br />
are all fixed-interest and non-fixed-interest securities that<br />
we have acquired for trading purposes to earn short-term<br />
profits from price changes and differences. In addition,<br />
they include all derivative financial instruments with<br />
positive fair values which we have acquired to manage and<br />
hedge risks but which do not meet the requirements of<br />
IAS 39 for hedge accounting, and the positive fair values of<br />
insurance derivatives and of derivative components separated<br />
from the underlying insurance contract. Securities<br />
designated as at fair value through profit or loss comprise<br />
structured securities. This designation may only be made<br />
at the time of acquisition; reallocation to this category in<br />
later periods is not possible.<br />
Securities at fair value through profit or loss are accounted<br />
for at fair value at the balance sheet date. If no quoted<br />
prices in an active market are available, fair values particularly<br />
with derivatives) are based on recognised valuation<br />
methods. <strong>ERGO</strong> uses a range of valuation models for this<br />
purpose, details of which may be obtained from the following<br />
table below.<br />
All unrealised gains and losses from such valuation are<br />
included in the investment result.<br />
Other investments comprise deposits with banks, deposits<br />
retained on assumed reinsurance business and investments<br />
in renewable energies. Deposits with banks are<br />
measured at amortised cost in line with the effective interest<br />
method. Deposits retained are recorded at face value.<br />
Investments in renewable energies are generally recorded<br />
at amortised cost; the items in question are amortised on<br />
a straight-line basis with at least 5% over the useful life of<br />
20 years at the most
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements65<br />
Principles of presentation and consolidation<br />
Valuation models<br />
Derivatives Pricing method Parameters Pricing model<br />
Equity and index risks<br />
Stock options traded on<br />
the stock exchange<br />
Quoted price – –<br />
OTC stock options Theoretical price Listing of underlying shares,<br />
effective volatilities, money-market<br />
interest rate, dividend yield<br />
Equity forwards Theoretical price Money-market interest rate,<br />
share price, dividend yield<br />
Equity / index futures Quoted price − −<br />
Interest-rate risks<br />
Interest-rate swaps Theoretical price Swap curve, money-market<br />
interest-rate curve<br />
Swaptions / interestrate<br />
guarantee<br />
Theoretical price<br />
At-the-money volatility matrix<br />
and skew, swap curve, moneymarket<br />
interest-rate curve<br />
Interest-rate currency swaps Theoretical price Swap curve, money-market<br />
interest-rate curve,<br />
currency spot rates<br />
Interest-rate futures Quoted price − −<br />
Inflation swaps Theoretical price Zero-coupon inflation swap rates,<br />
money-market interest-rate curve,<br />
swap curve<br />
Bond futures Quoted price − −<br />
Quoted options on bond futures Quoted price − −<br />
Currency risks<br />
Currency options Theoretical price At-the-money volatility, currency<br />
spot rates, money-market interestrate<br />
curve<br />
Currency forwards Theoretical price Currency spot rates,<br />
money-market interest-rate curve<br />
Other transactions<br />
Insurance derivatives<br />
(excluding variable annuities)<br />
Insurance derivatives<br />
(variable annuities)<br />
Theoretical price<br />
Theoretical price<br />
Market values of the cat bonds,<br />
interest-rate curve<br />
Biometric and lapse rates,<br />
volatilities,<br />
interest-rate curve,<br />
currency spot rates<br />
Credit default swaps Theoretical price Credit spreads,<br />
recovery rates,<br />
interest-rate curve<br />
Total return swaps on<br />
commodities<br />
Black-Scholes (European); Cox,<br />
Ross and Rubinstein (American),<br />
Monte Carlo simulation<br />
Present-value method<br />
Present-value method<br />
Black-76<br />
Present-value method<br />
Present-value method<br />
Garman-Kohlhagen<br />
Present-value method<br />
Present-value method<br />
Present-value method<br />
Present-value method<br />
ISDA CDS Standard Model<br />
Theoretical price Listing of underlying index Index ratio calculation<br />
Commodity options Theoretical price Listing of underlying shares,<br />
effective volatilities,<br />
money-market interest rate<br />
Black-Scholes (European); Cox,<br />
Ross and Rubinstein (American)
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements66<br />
Principles of presentation and consolidation<br />
Repurchase agreements and securities lending<br />
Under repurchase agreements we, as the lender, acquire<br />
securities with the obligation to sell them back to the<br />
borrower at a later date. As the risks and rewards from the<br />
securities remain with the borrower, they are not posted<br />
as such in our accounts but are shown as a receivable<br />
from the borrower under “other investments, deposits<br />
with banks”. Interest income from these transactions is<br />
recognised in the investment result.<br />
Securities that we lend by way of securities lending continue<br />
to be recognised in our balance sheet, as the main risks<br />
and rewards remain with <strong>ERGO</strong>; securities that we have<br />
borrowed are accounted for by the lender. Interest income<br />
from these transactions is recognised in the investment<br />
result.<br />
Recognition of financial instruments<br />
Financial assets are accounted for at the settlement date.<br />
Determining fair values<br />
IAS 39 defines the fair value of a financial instrument<br />
as the amount for which a financial asset could be<br />
exchanged, or a financial liability settled, between knowledge<br />
able, willing parties in an arm’s length transaction.<br />
All financial instruments recognised at fair value are allocated<br />
to one of the valuation hierarchy levels of IFRS 7.<br />
This valuation hierarchy provides for three levels. The initial<br />
basis for the allocation is the economic investment class.<br />
Only if this does not result in an appropriate allocation do<br />
we deviate from such an approach in individual cases.<br />
The allocation reflects which of the fair values derive from<br />
transactions in the market and where valuation is based on<br />
models because market transactions are lacking.<br />
In the case of Level 1, valuation is based on unadjusted<br />
quoted prices in active markets for identical financial<br />
assets which <strong>ERGO</strong> can refer to at the balance sheet date.<br />
A market is deemed active if transactions take place with<br />
sufficient frequency and in sufficient quantity for price<br />
information to be available on an ongoing basis. Since a<br />
quoted price in an active market is the most reliable indicator<br />
of fair value, this should always be used if available.<br />
The financial instruments we have allocated to this level<br />
mainly comprise equities, investment funds (except property<br />
funds) and fixed-interest securities (bearer bonds) for<br />
which either a stock market price is available or prices are<br />
provided by a price quoter on the basis of actual market<br />
transactions. We have also allocated derivatives traded on<br />
the stock market to Level 1.<br />
Assets allocated to Level 2 are valued using models based<br />
on observable market data. For this, we use inputs directly<br />
or indirectly observable in the market, other than quoted<br />
prices. If the financial instrument concerned has a fixed<br />
contract period, the inputs used for valuation must be<br />
observable for the whole of this period. The financial<br />
instruments we have allocated to this level mainly comprise<br />
borrowers’ note loans, covered bonds, subordinated<br />
securities and derivatives not traded on the stock market.<br />
For assets allocated to Level 3, we use valuation techniques<br />
not based on inputs observable in the market. This<br />
is only permissible insofar as no observable market data<br />
are available. The inputs used reflect <strong>ERGO</strong>’s assumptions<br />
regarding the factors which market players would consider<br />
in their pricing. We use the best available information for<br />
this, including internal company data. The financial instruments<br />
allocated to this level of the fair value hierarchy<br />
largely comprise investments in private equity, in renewable<br />
energy (RENT) as well as in real-estate funds, certain<br />
credit structures, and investments in affiliated companies<br />
and associates measured at fair value. We also allocate<br />
insurance derivatives and derivative components that are<br />
separated from the host insurance contract to Level 3.<br />
Owing to their leverage effect, changes in individual inputs<br />
may significantly affect the fair value shown for instruments<br />
measured under Level 3. If we make such adjustments in<br />
measuring fair value in the individual case, we explain the<br />
resultant effects.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements67<br />
Principles of presentation and consolidation<br />
Net investment result<br />
The net investment result comprises regular income,<br />
income from write-ups, gains and losses on the disposal<br />
of investments, other income, write-downs of investments,<br />
management expenses, interest charges and other<br />
expenses. Regular income and expenses from investments<br />
not measured at fair value through profit or loss are calculated<br />
in accordance with the effective interest method, i. e.<br />
any premiums or discounts are deducted from or added<br />
to the acquisition costs, with impact on profit or loss, until<br />
maturity.<br />
Impairment<br />
At each balance sheet date, we assess whether there is<br />
any substantial objective evidence of impairment in a<br />
financial asset or group of financial assets. Impairments<br />
in value are recognised as an expense in the income<br />
statement. IAS 39.59 contains a list of factors providing<br />
evidence of impairment of such financial assets. In<br />
addition, IAS 39.61 states that for equity investments, a<br />
significant or prolonged decline in the fair value of the<br />
investment below its acquisition cost is objective evidence<br />
of impairment. These rules are given more concrete form<br />
by means of internal guidelines. For equities quoted on<br />
the stock exchange, we assume a significant decline in fair<br />
value if the market value at the review date is at least 20%<br />
below the average purchase price or has been lower than<br />
this amount for at least six months. In the case of fixedinterest<br />
securities and loans, the main basis for establishing<br />
impairment is an indication of substantial financial<br />
difficulty on the part of the issuer, the current market<br />
situation or media reports on the issuer.<br />
We determine acquisition cost on the basis of the average<br />
purchase price. In the case of an impairment, a writedown<br />
is made to the fair value at the balance sheet date,<br />
i. e. generally the publicly quoted market price. If there is<br />
a further fall in the fair value of equity investments that<br />
have already been written down once, a further writedown<br />
recognised in the income statement is made again<br />
immediately. Such impairments recognised in profit or<br />
loss may not be reversed through profit or loss. If, in a<br />
subsequent period, the reasons for the impairment of<br />
fixed-interest securities or loans cease to apply, the impairment<br />
is reversed, with impact on the income statement.<br />
The resultant carrying amount may not exceed the original<br />
amortised cost.<br />
In impairment tests of our financial assets (with the<br />
exception of equity investments), we generally first assess<br />
whether objective evidence of impairment exists for items<br />
that are individually significant. If this is not the case,<br />
as well as in cases of individually insignificant items, the<br />
impairment test is carried out collectively on the basis<br />
of groups of similar financial assets. Assets that are individually<br />
assessed for impairment are not included in the<br />
collective assessment. The amount of the probable loss is<br />
measured as the difference between the amortised cost of<br />
the asset or group of assets and the present value of estimated<br />
future cash flows. The impairment thus determined<br />
is recognised as an expense. We generally deduct impairments<br />
directly from the items concerned on the assets<br />
side without using a value adjustment account. If, in a<br />
subsequent period, the reasons for the impairment cease<br />
to apply, the impairment is reversed, with impact on the<br />
income statement. The resultant carrying amount may not<br />
exceed the original amortised cost.<br />
Investments for the benefit of life insurance policyholders<br />
who bear the investment risk<br />
These are investments for policyholders under unit-linked<br />
life insurances. They are measured at fair value. Unrealised<br />
gains or losses from changes in fair value are included in<br />
the investment result. These are matched by corresponding<br />
changes in the technical provisions (equity and liabilities<br />
item D: Gross technical provisions for life insurance policies<br />
where the investment risk is borne by the policyholders),<br />
which are included in the technical result. The change in<br />
technical provisions also includes changes from additional<br />
premium components. Recognising these investments at<br />
fair value, with impact on profit or loss, avoids valuation<br />
mismatches that would otherwise occur due to different<br />
measurement of the corresponding provisions.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements68<br />
Principles of presentation and consolidation<br />
Ceded share of technical provisions<br />
The share of technical provisions for business ceded by us<br />
is determined from the respective technical provisions in<br />
accordance with the terms of the reinsurance agreements;<br />
cf. the notes on equity and liabilities item C: Gross technical<br />
provisions. Appropriate allowance is made for the credit<br />
risk.<br />
Receivables<br />
Current tax receivables and other receivables are accounted<br />
for at nominal value. Adjustments are undertaken where<br />
there is an indication of substantial impairments; see Notes<br />
on assets, Item B: Investments – Impairment.<br />
Current tax receivables comprise current taxes on income<br />
of the individual companies, based on their respective<br />
national taxation. Other tax receivables are shown under<br />
“other receivables”.<br />
Cash at banks, cheques and cash in hand<br />
Cash and cheques are accounted for at face value.<br />
Deferred acquisition costs<br />
Deferred acquisition costs comprise commissions and<br />
other variable costs directly connected with acquisition or<br />
renewal of insurance contracts. In life business and longterm<br />
health insurance, acquisition costs are capitalised<br />
and amortised over the duration of the contracts. This is<br />
done either proportionally to the premium income (FAS 60)<br />
or proportionally to the respective contracts’ expected<br />
gross profit margins calculated for the relevant year of the<br />
contract term (FAS 97, 120). The allocation of individual<br />
contracts to the FASs concerned is shown in the notes on<br />
equity and liabilities item C: Gross technical provisions.<br />
In determining the amount of amortisation, we take into<br />
account an actuarial interest rate and changes resulting<br />
from the disposal or withdrawal of contracts from the portfolio.<br />
In property-casualty business and short-term health<br />
insurance, the deferred acquisition costs are amortised on<br />
a straight-line basis over the average term of the policies,<br />
from one to five years. Deferred acquisition costs are regularly<br />
tested for impairment using a liability adequacy test<br />
as per IFRS 4; cf. Notes on equity and liabilities item C:<br />
Gross technical provisions.<br />
Deferred tax assets<br />
Under IAS 12, deferred tax assets must be recognised in<br />
cases where asset items have to be valued lower, or liability<br />
items higher, in the consolidated balance sheet than<br />
in the tax accounts of the <strong>Group</strong> company concerned and<br />
these differences will be eliminated at a later date with a<br />
corresponding effect on taxable income (temporary differences).<br />
Also included are tax assets deriving from tax<br />
loss carry-forwards. We take into account the tax rates of<br />
the countries concerned and the consolidated company’s<br />
respective tax situation; in some cases, for purposes of<br />
simplification, we use uniform tax rates for individual circumstances<br />
or subsidiaries. Changes in tax rates and tax<br />
legislation that have already been adopted by the government<br />
at the balance sheet date are taken into account.<br />
Deferred tax assets are recognised if a realisation is<br />
probable.<br />
Other assets<br />
Other assets are generally carried at amortised cost. The<br />
owner-occupied property recognised under other assets<br />
is accounted for as outlined under the Notes on assets,<br />
item B: Investments – Land and buildings. Plant and equipment<br />
is amortised mainly on a straight-line basis, the<br />
underlying useful lives ranging between 1 and 50 years.<br />
Impairment losses, and impairment losses reversed, in the<br />
<strong>Group</strong>’s owner-occupied property and plant and equipment<br />
are distributed between the underwriting functional areas.<br />
Equity and liabilities<br />
Equity<br />
The item “issued capital and capital reserve” contains the<br />
amounts that <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> equity holders<br />
have paid in on shares. The capital reserve is reduced<br />
by the externally generated costs directly connected<br />
with equity capital measures, after taking tax effects into<br />
account.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements69<br />
Principles of presentation and consolidation<br />
Under retained earnings, we show the profits which<br />
consolidated companies have earned and retained since<br />
becoming part of the <strong>Group</strong> and income and expenses<br />
resulting from changes in the consolidated group. In<br />
addition, the adjustment amount resulting from changes<br />
in accounting policies for earlier periods not included in the<br />
consolidated financial statements is recorded in the opening<br />
balance of the retained earnings for the earliest prior<br />
period reported.<br />
Other reserves contain unrealised gains and losses resulting<br />
from the recognition of other securities available for<br />
sale at fair value and from investments in non-consolidated<br />
affiliated companies and in associates that we do<br />
not value at equity. These reserves also include unrealised<br />
gains and losses from the valuation of associates at equity,<br />
differences resulting from the currency translation of<br />
foreign subsidiaries’ figures, and the valuation result from<br />
the hedging of cash flows. Write-ups of equity investments<br />
available for sale are also recognised in this equity item.<br />
Non-controlling interests are accounted for in the balance<br />
sheet as part of equity. These are the shares of third<br />
parties in the equity of subsidiaries that are not wholly<br />
owned directly or indirectly by <strong>ERGO</strong> <strong>Versicherungsgruppe</strong><br />
<strong>AG</strong>. Direct minority interests in special funds and in partnerships<br />
are recognised under “other liabilities”. The portion<br />
of the result attributable to non-controlling interests<br />
is shown in the consolidated result.<br />
Subordinated liabilities<br />
Subordinated liabilities are liabilities which, in the event of<br />
liquidation or insolvency, are only satisfied after the claims<br />
of other creditors. They are measured at amortised cost in<br />
accordance with the effective interest method.<br />
Gross technical provisions<br />
The technical provisions are shown as gross figures in the<br />
balance sheet, i. e. before deduction of the ceded share;<br />
cf. the explanatory remarks on assets item D: Reinsurers’<br />
share in technical provisions. The ceded share is calculated<br />
and accounted for on the basis of the individual reinsurance<br />
agreements. Acquisition costs for insurance contracts<br />
are capitalised and amortised over the terms of the contracts;<br />
cf. Notes on assets item G: Deferred acquisition costs. The<br />
measurement of technical provisions is based on US GAAP<br />
FAS 60, FAS 97 and FAS 120.<br />
Unearned premiums<br />
Unearned premiums are accrued premiums already written<br />
for future risk periods. These premiums are calculated<br />
separately for each insurance policy pro rata temporis. The<br />
posting of unearned premiums is restricted to short-term<br />
underwriting business. This concerns both property insurance<br />
and parts of accident and health insurance.<br />
Provision for future policy benefits<br />
The provision for future policy benefits in long-term underwriting<br />
business is posted for the actuarially calculated<br />
value of obligations arising from policyholders’ guaranteed<br />
entitlements. As well as life insurance, this concerns portions<br />
of health and personal accident insurance, insofar as<br />
the business is conducted as life insurance. Measurement<br />
is usually based on the prospective method by determining<br />
the difference between the present values of future<br />
benefits and future premiums. The actuarial biometric<br />
assumptions used for their calculation include, in particular,<br />
assumptions relating to mortality, disablement and<br />
morbidity, as well as assumptions regarding interest-rate<br />
development, lapses and costs. These are estimated on a<br />
realistic basis at the time the insurance contracts are concluded,<br />
and they include adequate provision for adverse<br />
deviation to make allowance for the risks of change, error<br />
and random fluctuations. Biometric accounting principles<br />
based on the tables prepared by the German Association<br />
of Actuaries (Deutschen Aktuarvereinigung e. V.) are used<br />
for German life insurance business. For other insurance<br />
business, it is mainly tables from the respective national<br />
actuary associations which are used. Life insurance is discounted<br />
using a technical interest rate which is limited to<br />
the respective maximum technical interest rate approved<br />
by the regulatory body. In health insurance, discount rates<br />
are chosen that reflect the best estimate of expected<br />
investment income, less a safety margin.<br />
The actuarial assumptions are adjusted if this is shown<br />
to be necessary by a liability adequacy test in accordance<br />
with IFRS 4.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements70<br />
Principles of presentation and consolidation<br />
The measurement of the provisions for future policy<br />
benefits depends on the type of contract, being based<br />
either on FAS 60 (life insurance without performancerelated<br />
participation in surplus, health insurance), on<br />
FAS 97 (life insurance on the universal life model and unitlinked<br />
life insurance) or on FAS 120 (life insurance with<br />
performance-related participation in surplus).<br />
For contracts in accordance with FAS 60, the provision<br />
for future policy benefits is calculated from the present<br />
value of estimated future policy benefits (including claims<br />
adjustment expenses) less the present value of future net<br />
level premiums. Net level premium is that part of the gross<br />
premium that is needed to finance future policy benefits.<br />
Life insurance contracts with limited premium payment are<br />
generally valued in accordance with FAS 97.<br />
For all other contracts as per FAS 97, an account is kept<br />
to which net level premiums and interest earnings are<br />
credited and from which risk premiums and administration<br />
expenses are debited, not all credits and debits being contractually<br />
fixed at the time the contracts are concluded.<br />
The provision for future policy benefits for life insurance<br />
where policyholders bear the investment risk themselves<br />
(unit-linked life insurance) is shown separately under<br />
Equity and liabilities, Item D: Gross technical provisions for<br />
life insurance policies where the investment risk is borne by<br />
the policyholders.<br />
In the case of contracts as per FAS 120, the provision for<br />
future policy benefits comprises the net level premium<br />
reserve and liabilities for terminal dividends. The net level<br />
premium reserve is calculated from the present value of<br />
guaranteed policy benefits (including acquired bonuses but<br />
excluding claims adjustment expenses) less the present<br />
value of future net level premiums. The net level premium<br />
is the net premium less the portion of the premium envisaged<br />
for covering claims adjustment expenses. The actuarial<br />
assumptions are generally the same as those used for<br />
premium calculation. The provision for terminal dividends<br />
is built up proportionally with a fixed share of the expected<br />
gross profit margins. The same method is used for this as<br />
for determining the amortisation of the deferred acquisition<br />
costs.<br />
Here the same technical interest rate and biometric calculation<br />
principles are employed which are used as the basis<br />
to calculate tariff premiums or surrender values. Additionally,<br />
a reserve is set up to cover administration expenses<br />
for non-contributory periods. The calculation principles<br />
of tariffs are regularly verified by the regulatory authorities<br />
or actuarial associations and include safety margins<br />
which take into account risks caused by change, error or<br />
random fluctuations. To the extent that safety margins in<br />
the biometric calculation principles have been used up in<br />
full, there may be a need to set up additional provisions<br />
or to conduct an unscheduled amortisation of deferred<br />
acquisition costs. This kind of adjustment is carried out in<br />
accordance with the IFRS 4 adequacy test if the adequacy<br />
of technical provisions can no longer be guaranteed when<br />
taking all calculation principles into account. A possible<br />
deficit is recognised in the income statement. The adequacy<br />
of the provision for future policy benefits is assessed<br />
on a regular basis using current, realistic estimates on the<br />
calculation principles, the proportionate amount of the<br />
investment return as well as future surplus-sharing for<br />
contracts which include this aspect.<br />
The biometric calculation principles used for life insurance<br />
policies are considered adequate. The actuaries in charge<br />
consider the mortality tables used to be adequate and to<br />
contain a sufficient safety margin for policies with mortality<br />
risk. Should, however, the trend towards a sustained<br />
improvement in life expectancy continue, a transfer of<br />
additional sums to the provision for future policy benefits<br />
cannot be ruled out in future.<br />
The accrual of the provision for terminal bonuses is carried<br />
out as scheduled over the term of the contracts by means<br />
of annual transfers and interest. For life insurance policies<br />
recorded in the balance sheet in accordance with FAS 97<br />
and FAS 120, transfers are based on expectations for<br />
future income which have already been used for capitalising<br />
deferred acquisition costs and on the income already<br />
realised in the past. Assumptions applied here are checked<br />
regularly and adjusted where necessary. The provision<br />
for terminal bonuses is recalculated following a necessary<br />
adjustment to the actuarial calculation principles.<br />
This normally leads to a change in the amount which is<br />
transferred. The revaluation of the provision for terminal<br />
bonuses is carried out within the provision for premium<br />
refunds without affecting profit or loss. It is for this reason<br />
that fluctuations do not have any effect on the consolidated<br />
result.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements71<br />
Principles of presentation and consolidation<br />
As far as contracts of a primarily investment nature<br />
are concerned (e. g. unit-linked life policies and AltZerG<br />
products with prospective entitlement in accordance with<br />
the German law on the Certification of Old-age Provision<br />
Agreements), assessment for the provision for future<br />
policy benefits is based on FAS 97. The provision for future<br />
policy benefits is made up from additions to the amounts<br />
invested, the performance of underlying investments and<br />
withdrawals in line with contracts plus provision for terminal<br />
bonuses and provision for “unearned parts of premiums”<br />
for these products.<br />
The main reasons for using FAS 60 in health insurance are<br />
the absence of causality in the generation and utilisation<br />
of surpluses and the usually lifelong term of health insurance<br />
policies calculated in the same manner as for life insurance<br />
policies.<br />
The provision shown is calculated as the difference<br />
between the present value of future insurance benefits,<br />
including claims adjustment expenses and the present<br />
value of future premiums. Here the share of the gross<br />
premium is taken into account which is required to finance<br />
future insurance benefits including the costs of claims<br />
settle ments (net level premium). The provision is calculated<br />
on current actuarial calculation bases. These include<br />
adequate safety margins in either direction.<br />
The provision which is based on Section 12 a, para. 2 of the<br />
German law on the Supervision of Insurance Companies<br />
(V<strong>AG</strong>), is not part of the provision for future policy benefits,<br />
but rather recorded in the provision for premium refunds.<br />
Provision for outstanding claims<br />
Provisions for outstanding claims are for payment obligations<br />
arising from insurance contracts where the size of the<br />
claim or the timing of the payment is still uncertain. Part<br />
of the provisions is for known claims for which individually<br />
calculated provisions are posted. Another part is for<br />
expenses for claims whose occurrence is not yet known<br />
(e. g. because they have not been reported yet or have not<br />
yet manifested themselves). A third class of provisions<br />
covers claims which are known but whose extent has<br />
turned out to be greater than originally foreseen. All these<br />
provisions include expenses for internal and external loss<br />
adjustment costs. Provisions for outstanding claims are<br />
based on estimates: the actual payments may be higher or<br />
lower. The amounts posted are the realistically estimated<br />
future amounts to be paid; they are calculated on the basis<br />
of past experience and assumptions about future developments<br />
(e. g. social, economic or technological factors).<br />
As regards industrial, property and transport business,<br />
provisions are set up for individual claims. In these lines of<br />
business, provisions for as yet unreported claims are based<br />
on past experience.<br />
Provisions for reinsurance business generally follows<br />
statements made by the ceding insurers. Provisions for<br />
outstanding claims are largely not discounted with the<br />
exception of some provisions concerning occupational disability,<br />
liability and annuities in workers’ compensation and<br />
other property-casualty lines of business. When determining<br />
provisions for outstanding claims, <strong>ERGO</strong> uses a range<br />
of actuarial projection methods, which comprise the chain<br />
ladder method and the Bornhuetter-Ferguson method.<br />
When applying the statistical method, we consider major<br />
losses separately. The standard actuarial methods used<br />
are applied to both the run-off triangles of payments<br />
as well as to the run-off triangles of the claims reported,<br />
meaning that we get a range of estimates for the final<br />
claims. A realistic estimated value is determined for the<br />
final claim within this range.<br />
Provisions for premium refunds<br />
Apart from non-performance-related premium refunds,<br />
this item contains in particular performance-related<br />
premium refunds for life, health and personal accident<br />
insurance. In health insurance, the non-performancerelated<br />
premium refunds also comprise sums which must<br />
be set up in accordance with Section 12 a of the German<br />
Insurance Supervision Act (V<strong>AG</strong>). According to national regulations,<br />
the provision only has to be set up for the German<br />
insurance business. Insofar as the provision for premium<br />
refunds has been set up, a valuation is generally conducted<br />
retrospectively based on regulations imposed by the regulatory<br />
authorities or as a result of provisions governing the<br />
individual contract. For those life insurance and pension<br />
fund companies which are subject to supervision by the<br />
Federal Financial Supervisory Authority (BaFin), the supervisory<br />
regulations of the German Insurance Supervision Act<br />
and the regulation pertaining to minimum appropriation<br />
must be observed.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements72<br />
Principles of presentation and consolidation<br />
In addition, provisions are set up for deferred premium<br />
refunds for the policyholders’ shares in the differences in<br />
valuation between IFRS and local accounting principles<br />
based on the expected future proportions on profit participation.<br />
For unrealised gains and losses from investments<br />
available for sale, which are recognised directly at equity,<br />
provisions for deferred premium refunds are set up without<br />
having an effect on the income statement; otherwise<br />
changes to this provision are charged against the income<br />
statement. To calculate the provision for deferred premium<br />
refunds for the amount stemming from the differences<br />
in valuation, proportions are used of between 50% and<br />
92.5% after tax. We have raised the assumption as to what<br />
degree policyholders will participate in bonuses in German<br />
life insurance in the future. The proportions for calculating<br />
the allocation to the provision for deferred premium<br />
refunds have been adjusted accordingly.<br />
When terminal bonuses are determined, they are reclassified<br />
from the provision for premium refunds to the provision<br />
for future policy benefits without affecting profit or<br />
loss. Here the funds reserved for terminal bonuses and<br />
available funds in the provision for performance-related<br />
premium refunds are used. If the provision for terminal<br />
bonuses exceeds these amounts, parts of the provision for<br />
deferred premium refunds are reclassified as well.<br />
All technical provisions are regularly subjected to a liability<br />
adequacy test in accordance with IFRS 4. If current experience<br />
shows that the provisions posted on the basis of the<br />
original assumptions less the related deferred acquisition<br />
costs and the present value of the related premiums<br />
are inadequate to cover the expected future benefits, we<br />
adjust the relevant technical provisions with recognition<br />
in the income statement and disclose those under impairment<br />
losses/unscheduled changes in the Notes to the<br />
consolidated financial statements; see [2] Other intangible<br />
assets, [10] Deferred acquisition costs and [16] Provision for<br />
future policy benefits. The adequacy of unearned premiums<br />
and of the provision for outstanding claims is checked<br />
for the current realistically estimated future amounts to<br />
be paid. The adequacy of the provision for future policy<br />
benefits is assessed using current, realistic estimates on<br />
the calculation principles, the proportionate amount of the<br />
investment return as well as (for policies with profit participation)<br />
the future surplus-sharing.<br />
Gross technical provisions for life insurance policies<br />
where the investment risk is borne by the policyholders<br />
This item comprises provisions for future policy benefits<br />
in life insurance where policyholders bear the investment<br />
risk themselves (unit-linked life insurance). The value of<br />
the provision for future policy benefits essentially corresponds<br />
to the market value of the relevant investments<br />
shown under Assets, Item C: Investments for the benefit of<br />
life insurance policyholders who bear the investment risk.<br />
Besides this, under FAS 97 and in certain circumstances,<br />
additional premium components may have to be included;<br />
please refer to Notes on Equity and liabilities, Item C: Gross<br />
technical provisions. Changes in this provision are fully<br />
recog nised in the technical result. Insofar as these changes<br />
derive from unrealised gains and losses from alterations<br />
in the fair values of the related investments, they are<br />
matched by opposite changes of the same amount in<br />
the investment result. Recognising these investments at<br />
fair value, with impact on profit or loss, avoids valuation<br />
mismatches that would otherwise occur due to different<br />
measurement of corresponding provisions.<br />
Other provisions<br />
This item includes inter alia the provision for post-employment<br />
benefits. The companies within <strong>ERGO</strong> Insurance<br />
<strong>Group</strong> generally give commitments to their staff in the<br />
form of defined contribution plans or defined benefit plans.<br />
The type and amount of the pension obligations are determined<br />
by the conditions of the respective pension plan.<br />
In general, they are based on the staff member’s length<br />
of service and salary. Under defined contribution plans,<br />
the companies pay fixed contributions to an insurer or a<br />
pension fund. This fully covers the company’s obligations.<br />
Under defined benefit plans, the staff member is promised<br />
a particular level of retirement benefit either by the companies<br />
or by a pension fund. The company’s contributions<br />
needed to finance this are not fixed in advance. Where<br />
assets of a legally independent entity (e. g. a fund) are<br />
matched against pension obligations, which may only be<br />
used to cover the pension promise and the access of any<br />
creditors is denied (plan assets), these pension obligations<br />
are recognised after these assets have been deducted.<br />
Where the fair value of the assets exceeds the related outsourced<br />
pension obligations, this repayment claim must be<br />
shown under “other receivables”.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements73<br />
Principles of presentation and consolidation<br />
Pension obligations are recognised in accordance with<br />
IAS 19, using the projected unit credit method and based<br />
on actuarial studies. The calculation includes not only<br />
the pension entitlements and current pensions known<br />
on the balance sheet date but also their expected future<br />
development.<br />
The interest rate at which the pension obligations are discounted<br />
is based on the yields for long-term high-quality<br />
bonds (e. g. commercial or government bonds). Actuarial<br />
gains or losses from pension obligations and plan assets<br />
result from the deviation of actual risk experience from<br />
estimated risk experience. They are recognised directly in<br />
equity, without impact on profit or loss.<br />
The other provisions included in this item are established<br />
in the amount of the probable requirement. Such amounts<br />
are not discounted if the interest-rate effect is insignificant.<br />
Liabilities<br />
Liabilities comprise deposits retained on ceded business,<br />
current tax liabilities and other liabilities. Financial liabilities<br />
are generally recognised at amortised cost. Derivatives<br />
(financial derivatives, insurance derivatives and derivative<br />
components which have been separated from the host<br />
insurance contract) are recognised at fair value. Details on<br />
the calculation of the fair value are provided under Notes<br />
on assets, Item B: Investments.<br />
Current tax liabilities comprise current taxes on income<br />
of the individual companies, based on their respective<br />
national taxation. Other tax liabilities are shown under<br />
“other liabilities”.<br />
Tax liabilities for current taxes are posted – without discounting<br />
– in accordance with the probable tax payments<br />
for the year under review or previous years. Deferred tax<br />
obligations are shown under Equity and liabilities, Item G:<br />
Deferred tax liabilities.<br />
Direct minority interests in special funds are measured at<br />
fair value.<br />
Deferred tax liabilities<br />
Under IAS 12, deferred tax liabilities must be recognised<br />
if asset items have to be valued higher, or liabilities items<br />
lower, in the consolidated balance sheet than in the tax<br />
accounts of the reporting company and these differences<br />
will be eliminated at a later date with a corresponding<br />
impact on taxable income (temporary differences), see<br />
Notes on assets, Item H: Deferred tax assets.<br />
Foreign currency translation<br />
The currency used by <strong>ERGO</strong> Insurance <strong>Group</strong> in its reports<br />
is the euro (€). The balance sheets of foreign subsidiaries<br />
whose national currency is not the euro are translated in<br />
accordance with the functional currency principle using<br />
the year-end exchange rates, and their income statements<br />
using average quarterly exchange rates. Any exchange<br />
differences arising in the process are recognised in equity<br />
(reserve for currency translation adjustment).<br />
By contrast, currency translation differences are largely<br />
recognised in the income statement of our subsidiaries’<br />
individual financial statements. This involves the translation<br />
of foreign currency items into the respective functional<br />
currency in accordance with IAS 21. An excess of<br />
assets over liabilities in a particular currency results on<br />
balance in a gain if that currency appreciates and in a loss<br />
if it falls in value. The reverse applies if cover is insufficient.<br />
The objective of our asset-liability management is to economically<br />
minimise excess or insufficient cover in foreign<br />
currencies within the <strong>Group</strong>. Insofar as this is done across<br />
<strong>Group</strong> companies with different functional currencies, it<br />
produces economically non-existent fluctuations in the<br />
consolidated result. Where exchange gains or losses occur<br />
in the translation of foreign-currency transactions into the<br />
national currencies of the consolidated companies, they<br />
are accounted for under “other non-operating income” and<br />
“other non-operating expenses” respectively.<br />
Beyond this, the impact of changes in exchange rates is<br />
reflected in period-to-period comparisons of all items in<br />
the income statement.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
74<br />
Consolidated Financial Statements<br />
Notes to the consolidated balance sheet – assets<br />
[1] Goodwill<br />
Major items included here are the goodwill of <strong>ERGO</strong><br />
Previdenza, Milan, from the acquisition in the 2000 financial<br />
year. Goodwill positions which amount to more than<br />
€ 30 million of the total <strong>Group</strong> goodwill are considered to be<br />
significant in line with IAS 36.134 and IAS 36.135.<br />
Allocation of goodwill to cash-generating units<br />
For impairment tests, goodwill is allocated to those cashgenerating<br />
units that derive benefits from the synergies<br />
from the respective business combination. At the same<br />
time, the unit to which the goodwill has been allocated is<br />
the lowest level at which goodwill is monitored for internal<br />
management purposes. We have allocated the goodwill<br />
amounts to legal entities or groups of legal entities.<br />
Our goodwill at 31 December <strong>2012</strong> was allocated to a<br />
cash-generating unit.<br />
Development during the financial year <strong>2012</strong><br />
€ million<br />
Year of acquisition 2000<br />
Cash-generating units or group of cash-generating units<br />
<strong>ERGO</strong><br />
Previdenza<br />
<strong>2012</strong><br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Other Total Total<br />
Gross carrying amount at 31 December previous year 43.1 573.8 616.9 666.8<br />
Accumulated impairment losses at 31 December previous year 10.0 401.3 411.3 389.9<br />
Carrying amount at 31 December previous year 33.1 172.5 205.6 276.9<br />
Currency translation differences − 0.1 0.1 − 0.4<br />
Additions − − − −<br />
Disposals − − − 49.5<br />
Impairment losses − − − 21.4<br />
Carrying amount at 31 December financial year 33.1 172.6 205.7 205.6<br />
Accumulated impairment losses at 31 December financial year 10.0 369.2 379.2 411.3<br />
Gross carrying amount at 31 December financial year 43.1 541.8 584.9 616.9
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements75<br />
Notes to the consolidated balance sheet – assets<br />
The impairment tests of goodwill positions classified as<br />
significant were carried out under the following assumptions:<br />
The recoverable amount of <strong>ERGO</strong> Previdenza, Milan, was<br />
derived on the basis of the market-consistent embedded<br />
value, which is usual in personal lines insurance business.<br />
The capital market parameters and volatilities applied are<br />
based on the cut-off date on 31 December 2011 and were<br />
adapted for changed capital market data in the meantime.<br />
There were also no indications for the recognition of impairment<br />
losses. Sensitivity analyses were carried out on the<br />
assumed technical risks, costs, capital market parameters<br />
and volatilities. The results thereby obtained were always<br />
above the book value of the cash-generating unit.<br />
For the impairment tests on the remaining goodwill<br />
positions the following assumptions were made:<br />
• The recoverable amount was derived on the basis of the<br />
value-in-use method or the market-consistent embedded<br />
value concept.<br />
• The Capital Asset Pricing Model (CAPM) is used to calculate<br />
the discount interest rate. It is calculated from<br />
a risk-free base rate plus a risk premium, taking into<br />
account a beta factor specific to the business. To derive<br />
the capital cost components (risk loading, capital<br />
structure), a peer group of international insurers is used<br />
in accordance with IAS 36. The risk-free base rate as<br />
well as the beta factor are taken from market data. For<br />
periods beyond the detailed cash flow planning growth<br />
rates of between 0.5% and 1.5% were used.<br />
The calculation is carried out before tax. A reconciliation<br />
with the capital costs of the <strong>ERGO</strong> Insurance <strong>Group</strong> is not<br />
possible. Other goodwill figures totalling € 172.6 million<br />
(172.5 m) were allocated to several cash-generating units<br />
or groups of units.<br />
The goodwill impairment tests in the <strong>2012</strong> financial year<br />
showed no recognition of impairment losses (2011: € 21.4 m).<br />
• The discount rate employed to calculate the valuein-use<br />
figure was calculated as cost of capital and<br />
amounts to between 7.2% and 13.2%, depending on<br />
the respective cash-generating unit.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements76<br />
Notes to the consolidated balance sheet – assets<br />
[2] Other intangible assets<br />
[2a]<br />
Development during<br />
the financial year<br />
Acquired<br />
insurance<br />
portfolios<br />
Self-<br />
developed<br />
Software<br />
Other<br />
Acquired<br />
brand<br />
names<br />
Acquired<br />
client<br />
bases<br />
Acquired<br />
licences/<br />
patents<br />
distribution<br />
networks/<br />
Selfdeveloped<br />
Other<br />
Other<br />
€ million € million € million € million € million € million € million € million € million<br />
Gross carrying amount<br />
at 31 December<br />
previous year 586.4 299.9 479.1 48.7 194.4 3.4 0.2 44.7 1,656.7<br />
Accumulated amortisation<br />
and accumulated<br />
impairment losses at<br />
31 December<br />
previous year 391.7 247.7 365.8 33.0 53.1 2.1 0.2 11.5 1,105.0<br />
Carrying amount<br />
at 31 December<br />
previous year 194.7 52.2 113.3 15.8 141.3 1.2 − 33.2 551.7<br />
Currency translation<br />
differences − − 2.4 − − − 0.1 0.7 3.2<br />
Change in<br />
consolidated group − − 1.4 − 1.2 − − − − − 1.0 − 3.6<br />
Additions 1.1 0.9 76.2 0.3 − − − 8.1 86.7<br />
Disposals − − 0.7 6.8 1.7 − − − 0.1 3.9 11.5<br />
Reclassification − 1.2 − 1.1 − − − − − 4.4 − 4.3<br />
Amortisation 37.8 6.7 42.0 1.4 11.5 0.4 − 2.9 102.7<br />
Impairment losses − − 0.1 12.9 − − − − 13.0<br />
Write-ups 12.8 − − − − − − − 12.8<br />
Carrying amount<br />
at 31 December<br />
financial year 170.7 47.1 140.7 0.1 129.8 0.8 − 29.7 519.0<br />
Accumulated amortisation<br />
and accumulated<br />
impairment losses at<br />
31 December<br />
financial year 416.8 252.3 402.8 45.8 61.1 2.6 0.1 18.1 1,199.6<br />
Gross carrying amount<br />
at 31 December<br />
financial year 587.5 299.4 543.5 45.9 191.0 3.4 0.1 47.8 1,718.6<br />
Total<br />
Acquired insurance portfolios comprise amortised book<br />
values of € 143.1 million (161.0 m) which stem from the<br />
acquisition of Bank Austria Creditanstalt Versicherung <strong>AG</strong>.<br />
Other intangible assets include rights equivalent to real<br />
property amounting to € 6.9 million (10.4 m). Additions<br />
mainly represent acquired software which, among other<br />
things, include the extension of portfolio management<br />
systems.<br />
Restrictions on disposals and pledges as security account<br />
for € – million (4.4 m). Commitments to acquire other<br />
intangible assets amount to € 1.0 million (1.7 m). Costs<br />
of € 0.1 million (15.8 m) for research and development<br />
incurred in connection with software projects were not<br />
capitalised but recognised as expenses.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements77<br />
Notes to the consolidated balance sheet – assets<br />
[2b]<br />
Development during<br />
the previous year<br />
Acquired<br />
insurance<br />
portfolios<br />
Self-<br />
developed<br />
Software<br />
Other<br />
Acquired<br />
brand<br />
names<br />
Acquired<br />
client<br />
bases<br />
Acquired<br />
licences/<br />
patents<br />
distribution<br />
networks/<br />
Selfdeveloped<br />
Other<br />
Other<br />
€ million € million € million € million € million € million € million € million € million<br />
Gross carrying amount<br />
at 31 December 2010 639.1 287.5 470.5 51.0 249.6 2.4 − 34.0 1,734.2<br />
Accumulated amortisation<br />
and accumulated<br />
impairment losses at<br />
31 December 2010 400.1 241.8 355.6 29.2 79.6 1.7 − 4.0 1,111.9<br />
Carrying amount at<br />
31 December 2010 239.0 45.8 115.0 21.9 170.0 0.7 − 29.9 622.3<br />
Currency translation<br />
differences − − − 3.6 − 0.4 − 0.8 − − − 0.3 − 5.1<br />
Change in<br />
consolidated group − 10.5 − 1.1 − 3.1 − − 0.1 − − 1.2 − 13.6<br />
Additions − 15.9 75.9 1.8 − 1.0 − 7.5 102.2<br />
Disposals − 1.7 21.3 − − 0.1 − 0.6 23.7<br />
Reclassification − 0.1 − 0.6 − − − − 0.1 − 0.4<br />
Amortisation 46.7 3.3 43.8 6.0 20.0 0.4 − 3.7 123.9<br />
Impairment losses 1.4 3.4 5.1 1.5 7.9 − − 1.0 20.3<br />
Write-ups 14.2 − − − − − − − 14.2<br />
Carrying amount at<br />
31 December 2011 194.7 52.2 113.3 15.8 141.3 1.2 − 33.2 551.7<br />
Accumulated amortisation<br />
and accumulated<br />
impairment losses at<br />
31 December 2011 391.7 247.7 365.8 33.0 53.1 2.1 0.2 11.5 1,105.0<br />
Gross carrying amount<br />
at 31 December 2011 586.4 299.9 479.1 48.7 194.4 3.4 0.2 44.7 1,656.7<br />
Total
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements78<br />
Notes to the consolidated balance sheet – assets<br />
[3] Land and buildings, including buildings on third-party land<br />
Development during the financial year <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Gross carrying amount at 31 December previous year 3,181.5 3,529.3<br />
Accumulated depreciation and impairment losses at 31 December previous year 834.3 810.4<br />
Carrying amount at 31 December previous year 2,347.1 2,718.9<br />
Currency translation differences 0.7 − 8.1<br />
Change in consolidated group − − 268.6<br />
Additions 22.1 34.0<br />
Disposals 33.8 36.9<br />
Write-ups 11.7 3.3<br />
Depreciation 50.8 56.9<br />
Impairment losses 38.8 44.7<br />
Reclassification 12.6 6.0<br />
Carrying amount at 31 December financial year 2,270.8 2,347.1<br />
Accumulated depreciation and impairment losses at 31 December financial year 890.4 834.3<br />
Gross carrying amount at 31 December financial year 3,161.2 3,181.5<br />
Fair value as at 31 December financial year 3,051.4 3,151.6<br />
Restrictions on disposals and pledges as security exist<br />
for land and buildings totalling € 723.4 million (742.2 m).<br />
Capitalised expenditure on buildings under construction<br />
stood at € 1.6 million (8.3 m) on the balance sheet cutoff<br />
date; contractual commitments to acquire property<br />
stood at € 20.3 million (7.6 m).<br />
Buildings are depreciated on a straight-line basis over 40<br />
to 55 years. Impairment losses and write-ups are generally<br />
caused by adjustments to market value. The valuation is<br />
performed for each site individually at the cut-off date,<br />
except where valuation units are formed. Valuations are<br />
mainly conducted by in-house appraisers or, in some<br />
instances, by external experts. They are largely based on<br />
ascertaining the sustainability of income and expenditure<br />
flows while taking into account the development of the<br />
market situation where the respective property is located.<br />
The fair value is calculated for each individual property by<br />
discounting future net payments at the time of valuation.<br />
Interest rates are applied according to the type of property<br />
involved: residential property 3.0% to 5.5%, commercial<br />
property 4.0% to 8.0% and retail property from 4.0% to<br />
8.25%.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements79<br />
Notes to the consolidated balance sheet – assets<br />
[4] Investments in affiliated companies and associates<br />
The fair value of interests in associated companies, which<br />
are generally valued at equity, is € 762.7 million (776.0 m)<br />
at the balance sheet date. The fair value of interests in<br />
associated companies which are valued at equity includes<br />
interests amounting to € 69.0 million (62.2 m) for which<br />
publicly quoted market prices are available. In the financial<br />
year losses of € 4.3 million (11.4 m) incurred by associated<br />
companies were not recognised. Losses caused by associated<br />
companies but not recorded amount to a total of<br />
€ 30.1 million (25.8 m).<br />
The assets of all associated companies total € 5,427.0 million<br />
(5,722.2 m), the liabilities € 4,155.5 million (4,411.3 m),<br />
the annual results € − 20.1 million (7.1 m) and the turnover<br />
€ 1,441.1 million (715.5 m). For associated companies not<br />
valued at equity, the assets total € 87.1 million (91.5 m),<br />
liabilities € 61.2 million (64.6 m), annual results € 0.1 million<br />
(− 1.1 m), and turnover € 116.2 million (111.1 m).<br />
The full list of all shareholdings can be found in the “List of<br />
shareholdings as at 31 December <strong>2012</strong> in accordance with<br />
Section 313 para. 2 of the German Commercial Code”.<br />
Breakdown of investments in affiliated companies and associates <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Affiliated companies<br />
Accounted for at fair value 76.1 120.7<br />
Associates<br />
Accounted for using the equity method 441.9 410.6<br />
Accounted for at fair value 10.2 12.3<br />
452.1 422.9<br />
Total 528.2 543.6<br />
[5] Loans<br />
[5a]<br />
Breakdown of loans Carrying amounts Fair values<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Mortgage loans 4,427.0 4,408.0 5,059.7 4,852.4<br />
Loans and advance payments on insurance policies 598.1 601.0 598.1 601.0<br />
Other loans 49,348.2 48,205.6 57,531.3 51,384.8<br />
Total 54,373.3 53,214.6 63,189.1 56,838.2<br />
Other loans comprise mainly pfandbriefs, government<br />
bonds, and promissory notes by banks.<br />
The fair value of loans is determined by recognised methods<br />
of valuation in line with the present value principle and<br />
taking into account observed market parameters
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements80<br />
Notes to the consolidated balance sheet – assets<br />
[5b]<br />
Rating categories<br />
Carrying amounts<br />
Other securities<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
AAA 21,950.6 23,954.6<br />
AA 20,556.2 17,250.6<br />
A 4,109.7 4,690.6<br />
BBB 1,750.4 804.3<br />
BB and less 544.3 170.8<br />
No rating 437.1 1,334.7<br />
Total 49,348.2 48,205.6<br />
The rating categories are based on those of the leading<br />
international rating agencies. In deviation from the purely<br />
economic view, the carrying amount of the loans represents<br />
the maximum exposure to credit risk at the balance<br />
sheet date, in accordance with IFRS 7. Virtually no credit<br />
risk exists in respect of the mortgage loans or the loans<br />
and advance payments on insurance policies.<br />
[5c]<br />
Maturity structure<br />
Carrying amounts<br />
Fair values<br />
Loans<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Contractual period to maturity<br />
Up to one year 1,248.9 2,009.5 1,267.0 2,021.4<br />
Over one year and up to two years 1,984.7 1,358.1 2,089.5 1,395.9<br />
Over two years and up to three years 2,979.3 2,118.0 3,214.5 2,217.7<br />
Over three years and up to four years 2,014.9 3,013.8 2,202.9 3,221.7<br />
Over four years and up to five years 2,549.3 2,193.2 2,797.4 2,322.3<br />
Over five years and up to ten years 13,019.0 13,428.1 15,231.3 14,255.9<br />
Over ten years 30,577.2 29,093.9 36,386.5 31,403.3<br />
Total 54,373.3 53,214.6 63,189.1 56,838.2<br />
[6] Other securities<br />
[6a]<br />
Other securities –<br />
Carrying amounts<br />
Unrealised<br />
Fair values<br />
held to maturity<br />
gains / losses<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Government bonds − − − − − −<br />
Debt securities of banks 7.3 13.4 0.2 0.1 7.5 13.5<br />
Total 7.3 13.4 0.2 0.1 7.5 13.5
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements81<br />
Notes to the consolidated balance sheet – assets<br />
[6b]<br />
Allocation of investments measured at fair value<br />
to levels of the fair value hierarchy<br />
Other securities, available for sale<br />
Level 1<br />
€ million<br />
Level 2<br />
€ million<br />
Level 3<br />
€ million<br />
<strong>2012</strong><br />
Total<br />
€ million<br />
Fixed-interest securities 42,681.1 11,885.8 812.5 55,379.4<br />
Non-fixed-interest securities 2,478.3 52.2 1,290.4 3,820.9<br />
Investments in affiliated companies and associates<br />
45,159.4 11,938.0 2,102.9 59,200.3<br />
Affiliated companies measured at fair value − − 76.1 76.1<br />
Associates measured at fair value − − 10.2 10.2<br />
Other securities at fair value through profit or loss<br />
− − 86.3 86.3<br />
Held for trading (including derivatives) 1 42.4 1,199.7 1.0 1,243.1<br />
Designated as at fair value through profit or loss − 168.9 − 168.9<br />
42.4 1,368.6 1.0 1,412.0<br />
Investments for the benefit of life insurance<br />
policyholders who bear the investment risk 5,957.0 − − 5,957.0<br />
Total 51,158.7 13,306.6 2,190.2 66,655.5<br />
Breakdown in % 77 20 3 100<br />
1 Including hedging derivatives.<br />
Reconciliation for investments<br />
allocated to Level 3<br />
Other securities –<br />
available for sale<br />
Fixedinterest<br />
Non-fixedinterest<br />
Affiliated<br />
companies<br />
recognised<br />
at fair<br />
value<br />
Investments<br />
Other securities – at fair<br />
value through profit or loss<br />
Associates 1 Held for Designated as at<br />
trading<br />
(including<br />
derivatives) 2<br />
fair value through<br />
profit or loss<br />
Total<br />
€ million € million € million € million € million € million € million<br />
Carrying amount at<br />
31 December 2011 140.6 1,066.3 120.7 12.3 − − 1,339.9<br />
Gains and losses<br />
Gains (losses) recognised<br />
in the income statement − 2.7 − 16.3 − 4.9 − 2.4 − − − 26.3<br />
Gains (losses)<br />
recognised in equity 13.7 23.5 2.1 0.5 − − 39.8<br />
11.0 7.2 − 2.8 − 1.9 − − 13.5<br />
Acquisitions 285.0 263.1 2.5 0.7 − − 551.3<br />
Disposals − 144.9 − 106.0 − 42.0 − 1.1 − 0.1 − − 294.1<br />
Transfer to/out of Level 3 521.0 58.3 − 2.3 − 0.7 − 577.6<br />
Changes in the market<br />
value of derivatives − 0.3 1.5 − 0.1 0.4 − 1.8<br />
Carrying amount at<br />
31 December <strong>2012</strong> 812.5 1,290.4 76.1 10.2 1.0 − 2,190.2<br />
Gains (losses) recognised in the<br />
income statement that are attributable<br />
to investments shown at the<br />
end of the financial year − 11.4 − 7.3 − − 18.8<br />
1 Recognised at fair value.<br />
2 Including hedging derivatives.<br />
In the financial year we reclassified a further part of the<br />
residual mortgage-backed securities (RMBS) in our portfolio<br />
from level 3 to level 2. Increased liquidity meant that we<br />
were able to revert to using only observable market data<br />
for these products. At the same time, some collaterialized<br />
loan obligations (CLO) and commercial mortgage-backed<br />
securities (CMBS) were reclassified from level 2 to level 3,<br />
since we also took into consideration parameters for their<br />
valuation which were not observable on the market due to<br />
a lack of liquidity.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements82<br />
Notes to the consolidated balance sheet – assets<br />
Allocation of investments measured at fair value<br />
to levels of the fair value hierarchy<br />
Other securities, available for sale<br />
Level 1<br />
€ million<br />
Level 2<br />
€ million<br />
Level 3<br />
€ million<br />
2011<br />
Total<br />
€ million<br />
Fixed-interest securities 37,558.1 13,229.9 140.6 50,928.6<br />
Non-fixed-interest securities 1,439.8 155.2 1,066.3 2,661.4<br />
Investments in affiliated companies and associates<br />
38,997.9 13,385.1 1,206.9 53,589.9<br />
Affiliated companies measured at fair value − − 120.7 120.7<br />
Associates measured at fair value − − 12.3 12.3<br />
Other securities at fair value through profit or loss<br />
− − 133.0 133.0<br />
Held for trading (including derivatives) 1 147.1 802.1 − 949.2<br />
Designated as at fair value through profit or loss − 164.5 − 164.5<br />
147.1 966.6 − 1,113.7<br />
Investments for the benefit of life insurance<br />
policyholders who bear the investment risk 5,092.0 − − 5,092.0<br />
Total 44,237.0 14,351.7 1,339.9 59,928.6<br />
Breakdown in % 74 24 2 100<br />
1 Including hedging derivatives.<br />
Reconciliation for investments<br />
allocated to Level 3<br />
Other securities –<br />
available for sale<br />
Fixedinterest<br />
Non-fixedinterest<br />
Affiliated<br />
companies<br />
recognised<br />
at fair<br />
value<br />
Investments<br />
Other securities – at fair<br />
value through profit or loss<br />
Associates 1 Held for Designated as at<br />
trading<br />
(including<br />
derivatives) 2<br />
fair value through<br />
profit or loss<br />
Total<br />
€ million € million € million € million € million € million € million<br />
Carrying amount at<br />
31 December 2010 188.5 441.9 113.6 12.9 − − 756.8<br />
Gains and losses<br />
Gains (losses) recognised<br />
in the income statement 5.2 − 5.1 − 23.0 − 0.1 − − − 23.0<br />
Gains (losses)<br />
recognised in equity − 5.4 30.3 5.9 0.2 − − 31.0<br />
− 0.2 25.2 − 17.1 0.1 − − 8.0<br />
Acquisitions 95.8 203.1 58.0 0.1 − − 357.0<br />
Disposals − 91.9 − 47.6 − 35.8 − 0.8 − − − 176.0<br />
Transfer to/out of Level 3 − 51.6 443.8 1.9 − − − 394.1<br />
Changes in the market<br />
value of derivatives − − − − − − −<br />
Carrying amount at<br />
31 December 2011 140.6 1,066.3 120.7 12.3 − − 1,339.9<br />
Gains (losses) recognised in the<br />
income statement that are attributable<br />
to investments shown at the<br />
end of the financial year 3.5 − 10.8 − − 7.3<br />
1 Recognised at fair value.<br />
2 Including hedging derivatives.<br />
Trading assets allocated to level 3 are exclusively made<br />
up of derivatives with the appropriate level allocation.<br />
The increase in capital investments allocated to level 3 is<br />
largely the result of the reclassification of CMBS.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements83<br />
Notes to the consolidated balance sheet – assets<br />
[6c]<br />
Other securities –<br />
Carrying amounts<br />
Unrealised<br />
Fair values<br />
available for sale<br />
gains/losses<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Fixed-interest securities<br />
Government bonds<br />
Germany 4,648.3 5,467.6 668.7 518.7 5,317.0 5,986.3<br />
Rest of EU 12,500.0 13,183.5 972.8 − 649.5 13,472.8 12,534.0<br />
USA 538.5 83.7 7.8 1.8 546.3 85.5<br />
Other 1,222.7 1,085.7 98.2 − 5.9 1,321.0 1,079.8<br />
18,909.6 19,820.5 1,747.5 − 134.9 20,657.1 19,685.6<br />
Corporate debt securities 24,681.7 23,429.8 2,328.9 730.2 27,010.7 24,160.1<br />
Other 6,982.5 6,745.8 729.1 337.1 7,711.7 7,082.9<br />
50,573.9 49,996.1 4,805.5 932.4 55,379.4 50,928.6<br />
Non-fixed-interest securities<br />
Shares 1,376.4 691.9 160.6 68.1 1,537.0 760.0<br />
Investment funds<br />
Equity funds 285.4 273.8 30.2 11.1 315.6 284.9<br />
Bond funds 599.4 407.8 35.0 − 1.1 634.4 406.7<br />
Real estate funds 477.4 481.7 15.8 10.0 493.3 491.7<br />
1,362.3 1,163.4 81.0 20.0 1,443.3 1,183.4<br />
Other 776.7 670.9 63.9 47.1 840.6 718.0<br />
3,515.4 2,526.2 305.5 135.2 3,820.9 2,661.4<br />
Total 54,089.2 52,522.3 5,111.0 1,067.6 59,200.3 53,589.9<br />
Quoted securities account for 4.0% (2.6%) of the given<br />
balance sheet value.<br />
About two thirds of the debt instruments issued by companies<br />
are pfandbriefs, bank bonds or issues by development<br />
banks and comparable institutions. The remaining portfolio<br />
comprises debt instruments of German local and regional<br />
authorities, with each single risk representing less than<br />
2.0%, issues by companies outside the banking sector and<br />
asset-backed securities/mortgage-backed securities which<br />
have above-average ratings.<br />
A sum of € 1,049.5 million (224.2 m) from unrealised gains/<br />
losses totalling € 5,111.0 million (1,067.6 m) is contained<br />
in equity (other reserves) after deductions were made<br />
for expenditure on deferred premium refunds, deferred<br />
taxes and non-controlling interests as well as effects of<br />
consolidation.<br />
Restrictions on disposals and pledges as security account<br />
for € 188.5 million (102.2 m).<br />
€ 1,272,2 million (1,198.1 m) of securities shown are loaned<br />
to third parties. These securities continue to be recognised<br />
in our balance sheet, as the major opportunities and risks<br />
associated with them remain with the <strong>ERGO</strong> Insurance<br />
<strong>Group</strong>.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements84<br />
Notes to the consolidated balance sheet – assets<br />
[6d]<br />
Other securities – at fair value through profit or loss <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Held for trading<br />
Fixed-interest securities 58.4 59.3<br />
Non-fixed-interest securities 0.2 2.3<br />
58.6 61.6<br />
Derivatives 1,124.6 842.2<br />
Designated as at fair value through profit or loss<br />
Fixed-interest securities 167.0 160.4<br />
Non-fixed-interest securities 2.0 4.1<br />
168.9 164.5<br />
Total 1,352.1 1,068.2<br />
To ascertain the fair values of derivatives, listed prices, option<br />
price models and valuations by external sources were taken<br />
into account. There are no securities lent to third parties.<br />
[6e]<br />
Maturity structure<br />
Carrying amounts<br />
Fair values<br />
Other securities – held to maturity<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Contractual period to maturity<br />
Up to one year 2.9 6.1 2.9 6.1<br />
Over one year and up to two years 4.2 2.9 4.3 2.9<br />
Over two years and up to three years 0.2 4.2 0.2 4.2<br />
Over three years and up to four years − 0.2 − 0.2<br />
Over four years and up to five years − − − −<br />
Over five years and up to ten years − − − −<br />
Over ten years − − − −<br />
Total 7.3 13.4 7.5 13.5<br />
[6f]<br />
Maturity structure<br />
Carrying amounts<br />
Fair values<br />
Other securities – available for sale; fixed-interest securities<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Contractual period to maturity<br />
Up to one year 5,130.7 4,592.3 4,483.8 4,635.5<br />
Over one year and up to two years 3,971.4 4,533.4 4,100.3 4,610.0<br />
Over two years and up to three years 4,111.7 4,249.2 4,460.2 4,405.6<br />
Over three years and up to four years 4,675.0 4,131.4 4,958.9 4,198.3<br />
Over four years and up to five years 4,515.9 3,964.9 4,854.8 4,096.1<br />
Over five years and up to ten years 15,643.2 16,629.1 17,477.5 16,890.6<br />
Over ten years 12,525.8 11,895.8 15,043.9 12,092.4<br />
Total 50,573.9 49,996.1 55,379.4 50,928.6
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements85<br />
Notes to the consolidated balance sheet – assets<br />
[6g]<br />
Rating categories<br />
Carrying amounts<br />
Other securities – held to maturity<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
AAA − −<br />
AA − 0.5<br />
A 7.0 12.5<br />
BBB − −<br />
BB and less − −<br />
No rating 0.3 0.3<br />
Total 7.3 13.4<br />
The rating categories are based on those of the leading<br />
international rating agencies. In deviation from the purely<br />
[6h]<br />
economic view, the carrying amount of the securities<br />
represents the maximum exposure to credit risk at the<br />
balance sheet date, in accordance with IFRS 7.<br />
Rating categories<br />
Fair values<br />
Other securities – available for sale; fixed-interest securities<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
AAA 23,872.8 26,895.5<br />
AA 13,112.8 9,778.0<br />
A 8,842.7 7,835.9<br />
BBB 8,389.1 4,555.2<br />
BB and less 1,034.6 1,739.6<br />
No rating 127.4 124.5<br />
Total 55,379.4 50,928.6<br />
The rating categories are based on those of the leading<br />
international rating agencies. In deviation from the purely<br />
[6i]<br />
economic view, the carrying amount of the securities<br />
represents the maximum exposure to credit risk at the<br />
balance sheet date, in accordance with IFRS 7.<br />
Rating categories<br />
Fair values<br />
Other securities – at fair value through profit or loss; fixed-interest securities<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
AAA 33.8 37.4<br />
AA 52.0 79.7<br />
A 94.3 60.4<br />
BBB 45.3 31.6<br />
BB and less − −<br />
No rating − 10.5<br />
Total 225.3 219.7<br />
The rating categories are based on those of the leading<br />
international rating agencies. In deviation from the purely<br />
economic view, the carrying amount of the securities<br />
represents the maximum exposure to credit risk at the<br />
balance sheet date, in accordance with IFRS 7.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements86<br />
Notes to the consolidated balance sheet – assets<br />
[6j]<br />
Disposal proceeds<br />
Other securities – available for sale<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Fixed-interest securities 17,512.6 12,716.2<br />
Non-fixed-interest securities<br />
Quoted 2,065.5 2,827.9<br />
Unquoted 119.7 84.7<br />
2,185.2 2,912.6<br />
Total 19,697.8 15,628.8<br />
[6k]<br />
Realised gains and losses<br />
Other securities – available for sale<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Gains on disposal<br />
Fixed-interest securities 381.0 429.0<br />
Non-fixed-interest securities 145.3 177.1<br />
526.3 606.1<br />
Losses on disposal<br />
Fixed-interest securities 465.1 195.1<br />
Non-fixed-interest securities 64.2 166.8<br />
529.3 361.8<br />
Total − 3.0 244.3<br />
[6l] Derivatives<br />
Derivatives are financial instruments, the fair value of<br />
which is derived from one or more underlying assets.<br />
Derivatives are used to hedge against currency, interestrate<br />
and market risks. This is done at the individual <strong>Group</strong><br />
company level within the framework of individual supervisory<br />
regulations and additional internal company directives.<br />
The risk of default is virtually non-existent in the case<br />
of products traded on the stock exchange.<br />
Over-the-counter derivatives, on the other hand, harbour<br />
a theoretical risk in the amount of the replacement costs.<br />
Consequently, only top-quality counterparties are chosen<br />
by the <strong>ERGO</strong> Insurance <strong>Group</strong> for these transactions.<br />
For derivatives as at 31 December <strong>2012</strong>, <strong>ERGO</strong> Insurance<br />
<strong>Group</strong> has received collateral in the form of securities with<br />
a minimum rating of AA which may be sold or passed on<br />
as security. The fair value of this collateral is € 621.6 million<br />
(260.9 m).<br />
Disclosure of derivatives by balance sheet item<br />
Fair value<br />
Positive<br />
Negative<br />
Qualifying for hedge<br />
accounting<br />
No<br />
Balance sheet item <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Investments, other<br />
securities, held for trading 1,124.6 842.2<br />
Yes Other assets 59.8 45.4<br />
No<br />
Yes<br />
Liabilities,<br />
other liabilities − 74.0 − 117.9<br />
Total 1,110.5 769.7
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements87<br />
Notes to the consolidated balance sheet – assets<br />
[6m]<br />
Derivatives – open items<br />
The table below shows the fair values and related par<br />
values of all our open items, broken down into risk types.<br />
Positive and negative fair values have been set off against<br />
each other. At € 1,110.5 million (769.7 m), open items<br />
accounted for 0.8% (0.6%) of the balance sheet total on<br />
31 December <strong>2012</strong>.<br />
Interest rate risks associated with life insurance are<br />
hedged using swaptions and total return swaps. These<br />
options for obtaining a fixed interest rate are shown in<br />
the category “interest-rate risks/over-the-counter” At the<br />
reporting date, the fair value of the said derivatives was<br />
€ 427.2 million (537.4 m), while the underlying nominal<br />
amount was € 2,841 million (5,039.8 m). The investment<br />
result from derivatives includes income stemming from<br />
fluctuations in the value of these items amounting to<br />
€ 124.8 million (355.0 m).<br />
Cash flow hedges<br />
Cash flow hedges play a role in countering fluctuations<br />
that may be caused, for example, by variable interest payments.<br />
At <strong>ERGO</strong> Insurance <strong>Group</strong>, cash flow hedges are<br />
largely used to hedge against interest-rate risks. We mainly<br />
use interest-rate swaps for this. Changes to the fair value<br />
of the hedging instrument are recognised directly in equity<br />
for this purpose. Only when the actual cash inflow or outflow<br />
takes place, caused by the hedged circumstance, is<br />
the relevant equity item reversed with recognition in the<br />
income statement.<br />
The change to the fair value of the hedging instrument<br />
assignable to the ineffective portion of the hedging is negligible<br />
on the reporting date. The equity item from cash<br />
flow hedges was € 5.2 million (4.7 m) on the reporting date.<br />
The net fair value of derivatives falling into this category on<br />
the reporting date stood at € 46.8 million (39.1 m).<br />
Although the derivatives basically serve to hedge risks<br />
economically at <strong>ERGO</strong> Insurance <strong>Group</strong>, only a portion of<br />
€ 46.8 million (39.1 m) meets the strict requirements of<br />
IAS 39 for hedge accounting.<br />
IAS 39 distinguishes between fair value hedges, cash flow<br />
hedges and the hedging of a net investment in a foreign<br />
business. For <strong>ERGO</strong> Insurance <strong>Group</strong>, only cash flow hedges<br />
are currently relevant.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements88<br />
Notes to the consolidated balance sheet – assets<br />
Derivatives – open positions Periods to maturity in years Total<br />
< 1 1−2 2−3 3−4 4−5 > 5 <strong>2012</strong> 2011<br />
€ million € million € million € million € million € million € million € million<br />
Interest-rate risks<br />
Traded on the stock exchange<br />
Fair values − 1.3 − − − − − − 1.3 − 4.0<br />
Notional principal amounts 739.4 − − − − − 739.4 602.5<br />
Over-the-counter<br />
Fair values 65.6 107.3 74.9 68.7 45.4 652.5 1,014.4 825.1<br />
Notional principal amounts 524.8 2,087.8 793.8 548.8 440.0 5,541.4 9,936.5 10,016.8<br />
Total<br />
Fair values 64.3 107.3 74.9 68.7 45.4 652.5 1,013.1 821.1<br />
Notional principal amounts 1,264.2 2,087.8 793.8 548.8 440.0 5,541.4 10,675.9 10,619.3<br />
Currency risks<br />
Traded on the stock exchange<br />
Fair values − − − − − − − − 0.1<br />
Notional principal amounts 21.5 − − − − − 21.5 20.0<br />
Over-the-counter<br />
Fair values 49.6 − − − − − 2.8 46.8 − 63.7<br />
Notional principal amounts 3,645.9 − − − − 218.5 3,864.4 2,884.5<br />
Total<br />
Fair values 49.6 − − − − − 2.8 46.8 − 63.8<br />
Notional principal amounts 3,667.4 − − − − 218.5 3,885.9 2,904.5<br />
Equity and index risks<br />
Traded on the stock exchange<br />
Fair values 34.2 − − − − − 34.2 − 0.3<br />
Notional principal amounts 1,174.9 − − − − − 1,174.9 320.9<br />
Over-the-counter<br />
Fair values − 0.6 15.7 0.3 − − 16.6 13.6<br />
Notional principal amounts 58.4 48.2 63.0 3.1 − − 172.7 157.5<br />
Total<br />
Fair values 34.2 0.6 15.7 0.3 − − 50.8 13.3<br />
Notional principal amounts 1,233.3 48.2 63.0 3.1 − − 1,347.6 478.3<br />
Credit risks<br />
Over-the-counter<br />
Fair values − − − − − 1.2 − − 1.2 − 2.2<br />
Notional principal amounts 6.1 − − − 49.0 − 55.1 71.9<br />
Commodity risks<br />
Over-the-counter<br />
Fair values − − − − − − − 0.6<br />
Notional principal amounts 14.4 − − − − − 14.4 14.6<br />
Insurance risks<br />
Over-the-counter<br />
Fair values − − − − − 1.0 1.0 0.7<br />
Notional principal amounts − − − − − 6.7 6.7 6.9<br />
Other Risks<br />
Over-the-counter<br />
Fair values − − − − − − − − 0.1<br />
Notional principal amounts − − − − − − − 1.6<br />
Total<br />
Fair values 148.1 107.9 90.6 69.1 44.2 650.6 1,110.5 769.7<br />
Notional principal amounts 6,185.3 2,135.9 856.7 551.9 489.0 5,766.7 15,985.6 14,097.1
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements89<br />
Notes to the consolidated balance sheet – assets<br />
[6n]<br />
The following table shows the period until maturity and<br />
amount of cash flows hedged at the balance sheet date.<br />
Notional principal amounts of hedged transactions <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Contractual period to maturity<br />
Up to one year – −<br />
Over one year and up to two years 25.0 −<br />
Over two years and up to three years – 25.0<br />
Over three years and up to four years 25.0 −<br />
Over four years and up to five years 25.0 25.0<br />
Over five years 314.0 339.0<br />
Total 389.0 389.0<br />
[7] Other investments<br />
Other investments mainly comprise deposits retained on<br />
assumed reinsurance business at € 152.8 million (171.0 m)<br />
and deposits with banks totalling € 1,520.9 million (1,255.2 m).<br />
The latter includes € 119.4 million (104.3 m) from repurchase<br />
agreements that have been booked by us as the<br />
lender.<br />
By contrast to the purely economic view, the book value<br />
of these other financial assets represents the maximum<br />
credit exposure at the balance sheet date, in accordance<br />
with IFRS 7.<br />
Since deposits with banks predominantly have a term of<br />
less than one year, the fair values are largely the same as<br />
the book values. Restrictions on disposals and pledges as<br />
security exist for deposits with banks totalling € 6.6 million<br />
(27.3 m).<br />
[8] Reinsurers’ share in technical provisions<br />
Reinsurers’ share in technical provisions <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Unearned premiums 122.0 143.1<br />
Provision for future policy benefits 3,627.9 3,586.7<br />
Provision for outstanding claims 638.1 859.4<br />
Other technical provisions 172.5 186.6<br />
Total 4,560.6 4,775.7
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements90<br />
Notes to the consolidated balance sheet – assets<br />
[9] Other receivables<br />
[9a]<br />
Receivables from insurance representatives account for<br />
€ 407.4 million (464.9 m) of amounts receivable from<br />
direct insurance business. Receivables include amounts<br />
of € 265.4 million (377.7 m) which result from contracts<br />
without significant risk transfer. These contracts are not<br />
subject to IFRS 4. By contrast to the purely economic<br />
view, the carrying amount of the receivables represents<br />
the maximum exposure to credit risk at the cut-off date,<br />
in accordance with IFRS 7. As other receivables generally<br />
have a term of less than one year, the fair values largely<br />
correspond to the carrying amounts.<br />
Other receivables <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Interest and rent 2,010.1 2,029.3<br />
Amounts receivable on direct business 1,042.7 1,051.7<br />
Amounts receivable from contracts without significant risk transfer 265.4 377.7<br />
Profit-unrelated tax receivables 121.2 117.6<br />
Accounts receivable on reinsurance business 125.9 109.9<br />
Miscellaneous receivables 856.7 646.0<br />
Total 4,422.0 4,332.2<br />
[9b]<br />
Maturity structure of other receivables<br />
Carrying amounts<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Contractual period to maturity<br />
Up to one year 4,254.8 4,140.9<br />
Over one and up to two years 35.4 31.1<br />
Over two years and up to three years 30.0 37.5<br />
Over three years and up to four years 29.5 28.6<br />
Over four years and up to five years 35.2 29.8<br />
Over five years and up to ten years 0.6 29.4<br />
Over ten years 36.5 34.9<br />
Total 4,422.0 4,332.2
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements91<br />
Notes to the consolidated balance sheet – assets<br />
[10] Deferred acquisition costs<br />
Deferred acquisition costs (gross) <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Status at 31 December previous year 6,413.7 6,522.9<br />
Currency translation differences 21.8 − 25.4<br />
Newly deferred acquisition costs 966.8 1,001.6<br />
Amortisation − 847.0 − 803.9<br />
Impairment losses − 172.6 − 248.8<br />
Change in consolidated group/other effects − 19.7 − 32.7<br />
Carrying amount at 31 December financial year 6,362.9 6,413.7<br />
Scheduled changes include amortisation as well as scheduled<br />
return on interest. Non-scheduled changes comprise writeups<br />
and write-downs resulting from changes made to the<br />
assumptions on which calculations are based and which<br />
need to be readjusted.<br />
Assumptions concerning the long-term interest level had to<br />
be revised in the financial year to take account of the longterm<br />
regular interest return on investments. The current<br />
lower interest margin and the revision of other assumptions<br />
led to impairment losses of deferred acquisition costs.<br />
[11] Deferred tax assets<br />
The deferred tax assets and liabilities recognised in the<br />
consolidated balance sheet concern the following balance<br />
sheet items:<br />
[11a]<br />
Causes of origin Assets Liabilities<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Assets<br />
Intangible assets 15.0 8.2 77.4 89.8<br />
Investments 806.1 1,197.5 1,299.0 1,183.6<br />
Deferred acquisition costs 1.8 1.6 546.7 572.3<br />
Other assets 569.2 513.6 445.5 392.5<br />
Total Assets 1,392.1 1,720.9 2,368.6 2,238.2<br />
Equity and liabilities<br />
Technical provisions (net) 405.1 458.5 369.7 442.4<br />
Other accrued liabilities 404.8 170.8 76.8 86.8<br />
Other liabilities 106.3 91.7 6.7 15.6<br />
Total equity and liabilities 916.2 721.0 453.2 544.8<br />
Off balance sheet<br />
Loss carry-forwards and tax credits 92.6 64.2 − −<br />
Total 2,401.0 2,506.1 2,821.8 2,783.0<br />
Of the change of € − 144.0 million (155.4 m) in net deferred<br />
tax liabilities, € 75.6 million (195.8 m) was recognised in<br />
earnings and € − 219.6 million (− 40.4 m) without impact on<br />
profit or loss.<br />
No deferred taxes were recorded for temporary differences<br />
of € 113.8 million (104.8 m) in conjunction with shares in<br />
subsidiaries and associated companies – so-called outside<br />
basis differences.<br />
Deferred taxes on loss carry-forwards were recognised<br />
as assets to the extent that the tax result planning led<br />
with sufficient certainty to an expected use. We have<br />
broken down the existing deferred tax assets on loss carryforwards<br />
in the following table.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements92<br />
Notes to the consolidated balance sheet – assets<br />
[11b]<br />
Development of deferred tax assets for<br />
loss carry-forwards and tax credits<br />
31 December<br />
previous<br />
Subsequent additions<br />
and reduc<br />
Additions<br />
due to new<br />
Set off<br />
against<br />
31 December<br />
financial year<br />
year tions due to<br />
changes in valuation<br />
allowances<br />
losses income/<br />
Deconsolidation<br />
€ million € million € million € million € million<br />
Deferred tax assets for<br />
Corporation tax loss carry-forwards 58.0 3.7 25.3 − 6.9 80.1<br />
Trade tax loss carry-forwards 6.2 6.3 1.8 − 1.8 12.5<br />
Loss carry-forwards from capital losses − − − − −<br />
Tax credits − − − − −<br />
Total 64.2 10.0 27.1 − 8.7 92.6<br />
[11c]<br />
Tax loss carry-forwards<br />
and tax credits<br />
Corporation tax loss carry-forwards<br />
For which<br />
deferred tax<br />
assets are<br />
recognised<br />
For which<br />
deferred tax<br />
assets are not<br />
recognised<br />
<strong>2012</strong> 2011<br />
Total<br />
For which<br />
deferred tax<br />
assets are<br />
recognised<br />
For which<br />
deferred tax<br />
assets are not<br />
recognised<br />
Total<br />
€ million € million € million € million € million € million<br />
Expiring in up to three years 29.7 118.0 147.7 13.1 67.2 80.3<br />
Expiring in over three years<br />
and up to ten years 103.8 23.7 127.5 112.5 66.4 178.9<br />
Expiring in over ten years − 5.7 5.7 − 2.7 2.7<br />
Not expiring 205.6 201.2 406.8 130.6 252.2 382.8<br />
Trade tax loss carry-forwards<br />
339.1 348.6 687.7 256.2 388.5 644.7<br />
Not expiring 79.7 131.8 211.5 39.5 168.1 207.6<br />
Loss carry-forwards<br />
from capital losses<br />
Expiring in up to three years − − − − − −<br />
Expiring in over three years<br />
and up to ten years − − − − − −<br />
Expiring in over ten years − − − − − −<br />
Not expiring − − − − − −<br />
Tax credits<br />
Expiring in up to three years − − − − − −<br />
Expiring in over three years<br />
and up to ten years − − − − − −<br />
Expiring in over ten years − − − − − −<br />
Not expiring − − − − − −<br />
Total 418.8 480.4 899.2 295.7 556.6 852.3
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements93<br />
Notes to the consolidated balance sheet – assets<br />
[12] Other assets<br />
[12a]<br />
Breakdown <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Tangible assets 1,672.3 1,674.5<br />
Assets from insurance contracts 392.7 436.5<br />
Other 171.9 212.6<br />
Total 2,237.0 2,323.5<br />
[12b]<br />
Tangible assets –<br />
development during the financial year<br />
Owner-<br />
occupied<br />
property<br />
<strong>2012</strong><br />
€ million<br />
Operating<br />
and office<br />
equipment<br />
<strong>2012</strong><br />
€ million<br />
Other<br />
<strong>2012</strong><br />
€ million<br />
Total<br />
<strong>2012</strong><br />
€ million<br />
Gross carrying amount at 31 December previous year 2,084.7 564.8 6.0 2,655.6<br />
Accumulated depreciation and accumulated impairment<br />
losses at 31 December previous year 610.2 365.6 5.3 981.2<br />
Carrying amount at 31 December previous year 1,474.6 199.2 0.7 1,674.5<br />
Currency translation differences 3.8 1.6 − 5.4<br />
Change in consolidated group − − 1.2 − − 1.2<br />
Additions 39.2 61.9 0.3 101.4<br />
Disposals 4.6 5.9 − 10.5<br />
Write-ups 22.4 − − 22.4<br />
Depreciation 40.7 68.1 0.4 109.2<br />
Impairment losses 2.0 − − 2.0<br />
Reclassification − 8.3 − − − 8.3<br />
Carrying amount at 31 December financial year 1,484.3 187.4 0.6 1,672.3<br />
Accumulated depreciation and accumulated impairment<br />
losses at 31 December financial year 625.0 364.9 5.5 995.4<br />
Gross carrying amount at 31 December financial year 2,109.3 552.3 6.1 2,667.8
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements94<br />
Notes to the consolidated balance sheet – assets<br />
Development in 2011<br />
Owner-<br />
occupied<br />
property<br />
2011<br />
€ million<br />
Operating<br />
and office<br />
equipment<br />
2011<br />
€ million<br />
Other<br />
2011<br />
€ million<br />
Total<br />
2011<br />
€ million<br />
Gross carrying amount at 31 December 2010 2,083.9 553.6 6.1 2,643.6<br />
Accumulated depreciation and accumulated<br />
impairment losses at 31 December 2010 577.8 350.1 5.1 932.9<br />
Carrying amount at 31 December 2010 1,506.1 203.5 1.0 1,710.6<br />
Currency translation differences − 6.0 − 1.8 − − 7.7<br />
Change in consolidated group − 21.5 − 11.3 − − 32.9<br />
Additions 49.2 93.5 0.3 142.9<br />
Disposals 5.5 6.7 − 12.1<br />
Write-ups 0.4 − − 0.4<br />
Depreciation 36.3 77.5 0.6 114.3<br />
Impairment losses 5.8 1.5 − 7.3<br />
Reclassification − 6.0 1.0 − − 5.1<br />
Carrying amount at 31 December 2011 1,474.6 199.2 0.7 1,674.5<br />
Accumulated depreciation and accumulated<br />
impairment losses at 31 December 2011 610.2 365.6 5.3 981.2<br />
Gross carrying amount at 31 December 2011 2,084.7 564.8 6.0 2,655.6<br />
The fair value of land and buildings amounts to<br />
€ 1,571.4 million (1,566.7 m).
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
95<br />
Consolidated Financial Statements<br />
Notes to the consolidated balance<br />
sheet – equity and liabilities<br />
[13] Equity<br />
[13a] Issued capital and capital reserve<br />
On the balance sheet date the Company’s issued share<br />
capital was € 196,279,504.20, and was broken down into<br />
75,492,117 individual bearer no-par-value shares.<br />
The authorised capital which allowed the Board of Management<br />
to raise the share capital with the consent of the<br />
Supervisory Board during the period ending on 8 May <strong>2012</strong><br />
in one or more steps by a total of up to € 97.5 million through<br />
the issue of up to € 37.5 million in new bearer no-par-value<br />
shares (authorised capital) has lapsed.<br />
No convertible bonds or bonds with warrants were issued<br />
up until 8 May <strong>2012</strong>. Consequently, the contingent capital<br />
of € 97.5 million earmarked for these convertible bonds or<br />
bonds with warrants can no longer be used.<br />
[13c] Claims equalisation reserves<br />
Retained earnings include € 319.6 million (352.2 m) in<br />
claims equalisation reserves. These reserves are set up<br />
in line with national legal provisions in order to compensate<br />
for fluctuations in claims in future years. Under IFRS<br />
accounting, they are included in equity.<br />
[13d] Other reserves<br />
Other reserves contain € 12.8 million (12.9 m) in unrealised<br />
gains and losses from the valuation at equity of associated<br />
companies and € 1,123.6 million (304.7 m) unrealised gains<br />
and losses from mainly other securities available for sale<br />
as well as interests in unconsolidated affiliates.<br />
[13b] Retained earnings<br />
Retained earnings can be broken down into the statutory<br />
reserve of <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> of € 0.5 million<br />
and other retained earnings of the <strong>Group</strong> whose development<br />
and composition are detailed in the overview on<br />
pages 52 f.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements96<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
[13e]<br />
Unrealised gains and losses on investments and hedging <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Non-consolidated affiliated companies and associates not accounted for using the equity method 77.8 82.8<br />
Associates accounted for using the equity method 23.1 23.1<br />
Hedging 46.6 35.4<br />
Other securities – available for sale<br />
Fixed-interest 4,805.5 932.4<br />
Non-fixed-interest 305.5 135.2<br />
5,111.0 1,067.6<br />
Less:<br />
Provision for deferred premium refunds recognised in equity 3,708.7 856.5<br />
Deferred taxes recognised in equity 432.4 60.3<br />
Non-controlling interests 18.7 10.8<br />
Consolidation and currency translation effects − 42.9 − 40.9<br />
Total 1,141.6 322.2<br />
[13f]<br />
Tax effects in the income and expenses<br />
recognised directly in equity<br />
<strong>2012</strong> 2011<br />
Before tax Tax After tax Before tax Tax After tax<br />
€ million € million € million € million € million € million<br />
Currency translation 34.2 − 34.2 − 43.6 − − 43.6<br />
Unrealised gains and losses on investments 1,200.7 372.2 828.5 − 3.9 1.9 − 5.8<br />
Change resulting from valuation at equity − 0.7 − − 0.7 − − −<br />
Change resulting from hedging 0.3 − 0.1 0.4 10.0 3.1 6.9<br />
Actuarial gains and losses on<br />
defined benefit plans − 506.9 − 158.8 − 348.1 44.8 13.3 31.5<br />
Other changes 5.6 − 5.6 − 8.4 − − 8.4<br />
Income and expenses recognised<br />
directly in equity 733.3 213.4 519.9 − 1.1 18.3 − 19.4
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements97<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
[13g]<br />
Non-controlling interests <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Unrealised gains and losses on investments 18.7 10.8<br />
Share in consolidated result 13.3 15.3<br />
Other equity 115.0 142.9<br />
Total 146.9 168.9<br />
In the <strong>2012</strong> financial year, we acquired an additional 25.4%<br />
of the shares in <strong>ERGO</strong> Versicherung Aktiengesellschaft,<br />
Vienna (previously VICTORIA-VOLKSBANKEN Ver sicherungs<br />
aktien gesellschaft, Vienna).<br />
[14] Subordinated liabilities<br />
Subordinated liabilities include subordinated loans from<br />
Munich Re on the one hand.<br />
On the cut-off date the fair value of subordinated liabilities<br />
came to € 1,225.7 million (971.9 m).<br />
The item also comprises bearer bonds of Bank Austria<br />
Creditanstalt Versicherung <strong>AG</strong> (BA-CA Versicherung) on<br />
paid-in supplementary capital on the other.<br />
[15] Unearned premiums<br />
[15a]<br />
Unearned premiums <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Gross 1,869.9 1,833.8<br />
Reinsurers’ share 122.0 143.1<br />
Net 1,747.9 1,690.7<br />
[15b]<br />
Development of unearned premiums (gross) <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Status at 31 December previous year 1,833.8 1,883.9<br />
Currency translation effects 76.2 − 108.4<br />
Change in consolidated group − 90.0 − 125.1<br />
Addition / disposal portfolio − −<br />
Premiums written 17,091.3 18,518.7<br />
Earned premiums 17,041.4 18,335.3<br />
Status at 31 December financial year 1,869.9 1,833.8
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements98<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
[16] Provision for future policy benefits<br />
[16a]<br />
Provision for future policy benefits <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Gross 95,544.2 94,012.3<br />
Reinsurers’ share 3,627.9 3,586.7<br />
Net 91,916.3 90,425.6<br />
In <strong>2012</strong> the German Federal Court of Justice ruled on a<br />
number of issues of major importance concerning the termination<br />
of life insurance contracts. Important aspects of<br />
its ruling relate to the calculation of acquisition costs and<br />
surrender values. As a result of this ruling, the provision for<br />
future policy benefits has been raised in the German life<br />
insurance sector.<br />
[16b]<br />
Gross provision for future policy benefits according to actuarial interest rates <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Actuarial interest rate ≤ 2.5% 9,375.7 7,330.0<br />
Actuarial interest rate > 2.5% and ≤ 3% 15,696.3 17,775.2<br />
Actuarial interest rate > 3% and ≤ 3.5% 29,229.0 27,136.3<br />
Actuarial interest rate > 3.5% and ≤ 4% 16,575.1 16,571.9<br />
Actuarial interest rate > 4% 20,553.8 20,784.7<br />
Without actuarial interest rate 4,114.2 4,414.2<br />
Total 95,544.2 94,012.3<br />
[16c]<br />
Development of gross provision for future policy benefits <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Status at 31 December previous year 94,012.3 93,617.5<br />
Currency translation differences 10.6 − 16.6<br />
Changes<br />
Scheduled 1,069.4 758.2<br />
Unscheduled − −<br />
In consolidated group − 15.9 − 1,034.1<br />
Other 467.8 687.3<br />
Status at 31 December financial year 95,544.2 94,012.3<br />
The change of € 452.6 million (472.1 m) shown under ‘Other’<br />
represents savings contributions for capitalisation products.<br />
The scheduled changes in the provision for future<br />
policy benefits includes changes resulting from the prospective<br />
calculation due to premium payments, claims<br />
and the unwinding of discounting in the financial year.<br />
In the context of determining the net level premium of a<br />
foreign subsidiary on a non-performance-related basis, the<br />
planned change to the provisions for future policy benefits<br />
for the previous year was adjusted by € 104.1 million and is<br />
now shown under ‘Other’ as savings contributions for capitalisation<br />
products. (For more information, see the section<br />
‘Changes in accounting policies’ on pages 58 f.).
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements99<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
[17] Provision for outstanding claims<br />
[17a]<br />
Provision for outstanding claims <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Gross 8,049.4 7,561.8<br />
Reinsurers’ share 638.1 859.4<br />
Net 7,411.3 6,702.4<br />
The gross provision for outstanding claims comprises level<br />
premium reserve for pensions from health, motor, accident<br />
and liability insurance amounting to € 414.1 million (373.2 m).<br />
These were calculated based on actuarial principles with<br />
a discount rate of up to 4.0%.<br />
[17b]<br />
Development in the financial year <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Status at 31 December previous year 6,702.4 6,766.1<br />
Claims expenses (including expenses for claims settlement)<br />
Financial year 13,417.0 14,958.8<br />
Previous years − 315.8 − 326.7<br />
Total 13,101.1 14,632.1<br />
Thereof: payments (including payment for claims settlement)<br />
Financial year 10,419.9 11,747.8<br />
Previous years 1,991.4 2,576.3<br />
Total 12,411.3 14,324.1<br />
Other changes 41.6 − 56.3<br />
Change in consolidated group − 22.5 − 315.4<br />
Status at 31 December financial year 7,411.3 6,702.4<br />
[17c]<br />
Expected payments from the provisions for outstanding claims<br />
in property-casualty business<br />
<strong>2012</strong><br />
%<br />
2011<br />
%<br />
Up to one year 37.8 41.0<br />
Over one year and up to five years 37.1 35.8<br />
Over five years and up to ten years 14.1 12.8<br />
Over ten years and up to fifteen years 6.3 5.5<br />
Over fifteen years 4.7 4.9<br />
Total 100.0 100.0<br />
When ascertaining the expected payout dates concerning<br />
the provision for outstanding claims, it should be mentioned<br />
that these are of course associated with a considerable<br />
degree of uncertainty.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements100<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
[17d] Net run-off results for business posted in line with property-casualty insurance<br />
Claims payments for the individual accident years (per calender year, net)<br />
€ million Accident year<br />
Calender year ≤ 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 <strong>2012</strong> Total<br />
2002 1,467.0 − − − − − − − − − − −<br />
2003 787.6 987.0 − − − − − − − − − −<br />
2004 376.0 493.3 1,033.9 − − − − − − − − −<br />
2005 256.9 198.2 516.5 1,065.2 − − − − − − − −<br />
2006 189.8 80.5 169.2 553.6 1,053.4 − − − − − − −<br />
2007 138.9 43.0 80.4 176.1 567.0 1,214.7 − − − − − −<br />
2008 110.4 40.3 49.7 88.1 183.4 623.5 1,335.3 − − − − −<br />
2009 99.7 23.5 34.4 48.2 90.3 181.1 670.9 1,443.9 − − − −<br />
2010 72.9 19.2 21.3 35.6 50.1 97.4 201.1 717.3 1,588.4 − − −<br />
2011 70.7 11.4 18.0 28.0 38.1 58.3 108.1 222.9 788.1 1,593.3 − −<br />
<strong>2012</strong> − 96.4 − 26.3 − 2.9 3.2 − 11.2 7.8 39.1 81.4 193.0 769.9 1,586.5 2,544.2<br />
Claims reserve for the individual accident years at the respective reporting dates (net)<br />
€ million Accident year<br />
<strong>Report</strong>ing date ≤ 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 <strong>2012</strong> Total<br />
31 Dec 2002 2,548.4 − − − − − − − − − − −<br />
31 Dec 2003 1,727.9 1,062.8 − − − − − − − − − −<br />
31 Dec 2004 1,294.1 597.1 1,157.9 − − − − − − − − −<br />
31 Dec 2005 1,127.1 319.3 527.2 1,243.1 − − − − − − − −<br />
31 Dec 2006 914.8 249.6 359.4 582.3 1,259.3 − − − − − − −<br />
31 Dec 2007 847.1 193.4 273.1 366.1 565.3 1,319.6 − − − − − −<br />
31 Dec 2008 659.0 185.7 211.0 266.4 357.7 586.7 1,452.9 − − − − −<br />
31 Dec 2009 568.8 123.0 173.1 227.9 261.2 374.5 648.5 1,549.8 − − − −<br />
31 Dec 2010 481.3 104.0 138.8 169.8 214.4 282.7 418.2 677.7 1,637.3 − − −<br />
31 Dec 2011 403.4 76.1 133.0 133.9 157.8 226.0 314.3 434.5 738.8 1,698.8 − −<br />
31 Dec <strong>2012</strong> 495.0 118.7 123.9 132.5 168.6 218.1 297.4 383.1 552.0 787.5 1,694.7 4,971.5<br />
Ultimate loss for the individual accident years at the respective reporting dates (net)<br />
€ million Accident year<br />
<strong>Report</strong>ing date ≤ 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 <strong>2012</strong> Total<br />
31 Dec 2002 4,015.4 − − − − − − − − − − −<br />
31 Dec 2003 3,982.6 2,049.8 − − − − − − − − − −<br />
31 Dec 2004 3,924.8 2,077.5 2,191.8 − − − − − − − − −<br />
31 Dec 2005 4,014.7 1,997.9 2,077.5 2,308.3 − − − − − − − −<br />
31 Dec 2006 3,992.1 2,008.7 2,079.0 2,201.1 2,312.7 − − − − − − −<br />
31 Dec 2007 4,063.3 1,995.5 2,073.1 2,161.0 2,185.7 2,534.3 − − − − − −<br />
31 Dec 2008 3,985.6 2,028.0 2,060.6 2,149.3 2,161.5 2,424.9 2,788.2 − − − − −<br />
31 Dec 2009 3,995.1 1,988.8 2,057.1 2,159.1 2,155.3 2,393.9 2,654.7 2,993.7 − − − −<br />
31 Dec 2010 3,980.5 1,989.0 2,044.1 2,136.6 2,158.5 2,399.4 2,625.6 2,839.0 3,225.7 − − −<br />
31 Dec 2011 3,973.3 1,972.6 2,056.3 2,128.7 2,140.1 2,401.1 2,629.8 2,818.7 3,115.3 3,292.1 − −<br />
31 Dec <strong>2012</strong> 3,968.6 1,988.9 2,044.2 2,130.5 2,139.6 2,401.0 2,652.0 2,848.6 3,121.5 3,150.8 3,281.2 29,726.9<br />
Currencyadjusted<br />
net<br />
run-off result 46.8 60.9 147.6 177.8 173.1 133.3 136.2 145.1 104.3 141.3 n. a. 1,266.3<br />
Change<br />
2011 to <strong>2012</strong> 4.7 − 16.3 12.1 − 1.8 0.4 0.1 − 22.2 − 30.0 − 6.2 141.3 n. a. 82.1
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements101<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
The values in the run-off triangles cover virtually 100% of<br />
our <strong>Group</strong>’s portfolio of property-casualty business. The<br />
final amount in any one year of occurrence comprises all<br />
payments made for that year up to the reporting date,<br />
plus the claims reserve at the reporting date. If all losses<br />
incurred were known on the balance sheet date, the ultimate<br />
loss status for the year in question would remain<br />
the same. The run-off triangles are based on figures<br />
adjusted for exchange rate effects. To this end, all figures<br />
are translated from the respective local currency into the<br />
<strong>Group</strong> currency (euro), consistently using the exchange<br />
rates applicable at the end of the year under review (i. e.<br />
at 31 December <strong>2012</strong>). This also ensures that neutral net<br />
run-off results in the original currency (i. e. where the ultimate<br />
loss originally estimated for the year of occurrence<br />
and current loss estimate concur) do not lead to currencyrelated<br />
run-off effects when expressed in the <strong>Group</strong><br />
currency.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements102<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
[18] Provision for premium refunds and policyholders’ dividends<br />
[18a]<br />
Provision for premium refunds and policyholders’ dividends <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Gross 13,602.9 9,853.9<br />
Reinsurers’ share 66.8 67.5<br />
Net 13,536.2 9,786.4<br />
[18b]<br />
Gross provision for premium refunds and policyholders’ dividends <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Provision for premium refunds (based on national regulations) 6,399.8 5,707.8<br />
Provision for deferred premium refunds<br />
Recognised directly in equity 3,671.2 856.0<br />
Recognised in profit or loss 3,532.0 3,290.1<br />
7,203.2 4,146.1<br />
Total 13,602.9 9,853.9<br />
[18c]<br />
Development during the financial year <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Provision for premium refunds (based on national regulations)<br />
Status at 31 December previous year 5,707.8 5,188.1<br />
Change in provision 692.0 519.7<br />
Status at 31 December financial year 6,399.8 5,707.8<br />
Provision for deferred premium refunds<br />
Status at 31 December previous year 4,146.1 4,014.8<br />
Change in consolidated group − 1.3<br />
Changes resulting from unrealised gains and losses on investments (recognised directly in equity) 2,815.2 236.6<br />
Changes resulting from other revaluations (recognised in profit or loss) 241.8 − 104.0<br />
Status at 31 December financial year 7,203.2 4,146.1<br />
Total provision for premium refunds<br />
Gross 13,602.9 9,853.9<br />
Reinsurers’ share 66.8 67.5<br />
Net 13,536.2 9,786.4<br />
[18d]<br />
The surplus allocation from direct bonuses in life insurance<br />
business amounts to € 198.9 million (257.4 m). It is granted<br />
in addition to the performance-related premium refund.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements103<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
[19] Other technical provisions<br />
Other technical provisions <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Gross 95.5 119.0<br />
Reinsurers’ share 105.8 119.1<br />
Net − 10.3 − 0.1<br />
[20] Gross technical provisions for life insurance policies where the investment risk is borne by policyholders<br />
Development during the financial year <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Status at 31 December previous year 5,371.9 5,209.8<br />
Change in consolidated group − 110.0 − 79.6<br />
Currency translation differences 13.8 − 17.3<br />
Savings premiums 760.4 797.5<br />
Unrealised gains/losses on fund assets 598.6 − 258.8<br />
Withdrawal for expenses and risk 78.5 73.5<br />
Withdrawal for benefits 406.6 309.2<br />
Other 107.6 103.0<br />
Status at 31 December financial year 6,257.2 5,371.9<br />
These provisions are valued retrospectively. The withdrawal<br />
from premiums for technical risks and the provision for<br />
future policy benefits are conducted on the basis of cautious<br />
assumptions concerning anticipated mortality and disability.<br />
Here, as with the provision for future policy benefits<br />
for non-unit-linked life insurance, the underlying calculation<br />
is based on best estimates with adequate provision for<br />
safety margins. The provisions are directly covered by the<br />
investments for the benefit of life insurance policyholders<br />
who bear the investment risk. Marginal amounts in relation<br />
to these investments arise as a result of including unearned<br />
revenue liability in these provisions.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements104<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
[21] Provisions for pensions and similar benefits<br />
[21a]<br />
For the majority of staff employed with the <strong>ERGO</strong> Insurance<br />
<strong>Group</strong>, <strong>Group</strong> companies have either undertaken retirement<br />
provision directly or by means of payments made to<br />
private institutions. The nature and extent of pension sums<br />
are geared towards the respective terms of the pension<br />
scheme in question (pension terms, specific contractual<br />
promises, etc.), and are generally based on the length of<br />
service and salary of the person concerned. A distinction<br />
is made between defined contribution and defined benefit<br />
pension schemes. As far as defined contribution plans are<br />
concerned, member companies within the <strong>Group</strong> pay premiums<br />
to insurers on a voluntary basis as a result of terms<br />
in a contract. After paying the premiums, the companies<br />
do not have any further benefit obligations. Regular premium<br />
payments amounting to € 26.9 million (27.1 m) were<br />
expenses incurred during the current year.<br />
Expenditure on premiums payable to state-run schemes<br />
amounted to € 96.0 million in the financial year. Defined<br />
benefit plans are financed within the <strong>ERGO</strong> Insurance<br />
<strong>Group</strong> by means of provisions for pension fund liabilities,<br />
which consist of both current pensions as well as entitlements<br />
to pensions payable in the future. Provisions for<br />
pension fund liabilities are calculated throughout the<br />
<strong>Group</strong> using the projected unit credit method in line with<br />
IAS 19 (revised in 2004). This involves calculating future<br />
obligations using actuarial methods with a realistic estimate<br />
of relevant variables. Pension benefits anticipated on<br />
the basis of dynamic parameters at the beginning of the<br />
actual retirement period are spread over the employee’s<br />
entire period of active employment.<br />
Change in the present value of defined benefit obligations under defined benefit plans <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Status at 31 December previous year 1,337.4 1,314.2<br />
Currency translation differences 1.8 2.1<br />
Change in consolidated group − − 2.7<br />
Current service cost 36.9 39.7<br />
Interest cost 64.8 60.2<br />
Actuarial gains / losses 556.2 − 42.9<br />
Paid pension benefits − 46.4 − 42.0<br />
Past service cost 11.2 9.5<br />
Other − 3.1 − 0.7<br />
Status at 31 December financial year 1,958.8 1,337.4<br />
[21b]<br />
Change in the plan assets for defined benefit plans in the financial year <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Status at 31 December previous year 146.6 133.4<br />
Currency translation differences 1.4 1.6<br />
Change in consolidated group − − 3.7<br />
Expected return 7.3 6.5<br />
Actuarial gains / losses 8.3 4.8<br />
Capital transfer to plan assets 21.7 11.9<br />
Paid pension benefits − 3.6 − 4.2<br />
Other − 3.5 − 3.7<br />
Status at 31 December financial year 178.2 146.6<br />
The defined benefit pension schemes also include benefits<br />
for medical care. The present value of earned rights for<br />
these benefits was € 152.9 million (95.4 m) on the cut-off<br />
date.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements105<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
[21c]<br />
Change in the reimbursement rights for defined benefit plans in the financial year <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Status at 31 December previous year 91.8 77.3<br />
Currency translation differences − −<br />
Change in consolidated group − −<br />
Expected return 4.7 3.4<br />
Actuarial gains / losses 9.7 − 0.3<br />
Capital transfer 11.5 11.6<br />
Paid pension benefits − 3.0 − 1.5<br />
Other − 13.6 1.3<br />
Status at 31 December financial year 101.1 91.8<br />
Insurance claims stem from reinsurance which has been<br />
taken out to cover the pension obligations.<br />
[21d]<br />
Funded status of the defined benefit plans <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Unfunded obligations<br />
Present value 1,729.1 1,169.3<br />
Past service cost not yet recognised − −<br />
Other 0.1 0.1<br />
Net balance sheet liability 1,729.2 1,169.4<br />
Wholly / partly funded obligations<br />
Present value 229.7 168.1<br />
Fair value of plan assets − 178.2 − 146.6<br />
Past service cost not yet recognised − −<br />
Other receivables − −<br />
Other − −<br />
Net balance sheet liability 51.5 21.5<br />
Total net balance sheet liability 1,780.7 1,190.9<br />
[21e]<br />
Change in the provision for defined benefit plans in the financial year <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Status at 31 December previous year 1,190.9 1,182.5<br />
Currency translation differences 0.6 0.5<br />
Change in consolidated group − − 0.6<br />
Expenses 100.9 101.6<br />
Paid pension benefits − 39.8 − 36.3<br />
Capital transfer to plan assets − 21.7 − 11.9<br />
Transfer to other receivables − −<br />
Actuarial gains / losses recognised in equity 546.3 − 48.4<br />
Other 3.5 3.5<br />
Status at 31 December financial year 1,780.7 1,190.9
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements106<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
[21f]<br />
Breakdown of expenses booked in the financial year <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Current service cost 36.9 39.7<br />
Interest cost 64.8 60.2<br />
Less<br />
Expected return on plan assets − 7.3 − 6.5<br />
Expected return on reimbursements − 4.7 − 3.4<br />
Amortisation of past service cost 11.2 9.5<br />
Other − 2.1<br />
Total 100.9 101.6<br />
The actual return on plan assets amounts to € 15.7 million<br />
(11.4 m), and the actual return on reimbursements<br />
to € 14.4 million (3.1 m). The expenses are shown mainly<br />
under ‘Operating expenses’ and ‘Expenses for claims and<br />
benefits’ in the consolidated income statement.<br />
Actuarial gains/losses included in the income and expenses<br />
for the financial year amount to € 539.3 million (− 46.7 m)<br />
and € 692.7 million (153.4 m) cumulative, taking currency<br />
fluctuations and other changes into account.<br />
[21g]<br />
Breakdown of plan assets to cover pension obligations <strong>2012</strong><br />
%<br />
2011<br />
%<br />
Non-fixed-interest securities 17.2 15.8<br />
Fixed-interest securities and loans 69.5 73.6<br />
Real estate 0.5 0.6<br />
Other 12.8 10.0<br />
Total 100.0 100.0<br />
[21h]<br />
The consolidated companies used the following assumptions<br />
(weighted average values) in order to calculate their<br />
pension obligations:<br />
Assumptions <strong>2012</strong><br />
%<br />
2011<br />
%<br />
Discount rate 3.0 5.0<br />
Expected rate of return on fund assets 3.9 4.9<br />
Expected rate of return on reimbursements 3.0 5.0<br />
Future increases in entitlement / salary 2.3 2.4<br />
Future pension increases 1.9 1.9<br />
Medical cost trend rate 2.8 2.5
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements107<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
[21i]<br />
The expected rate of return on plan assets is determined<br />
on the basis of anticipated long-term capital yields. A one<br />
percent change in costs for medical care would have the<br />
following impact on the amount of pension commitments<br />
and pension expenditure:<br />
Increase by<br />
one percentage point<br />
Reduction by<br />
one percentage point<br />
€ million € million<br />
Present value of defined benefit obligations 34.2 − 26.2<br />
Pension expenses 2.4 − 1.8<br />
Capital transfers to plan assets amounting to € 1.3 million<br />
(1.2 m) are expected for the <strong>2012</strong> financial year.<br />
[21j]<br />
Other figures for the current financial year<br />
and previous years<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
2010<br />
€ million<br />
2009<br />
€ million<br />
2008<br />
€ million<br />
Present value of defined benefit obligations<br />
(excluding medical-care benefits) 1,805.9 1,242.0 1,224.2 1,117.1 883.3<br />
Plan assets 178.2 146.6 133.4 114.4 95.7<br />
Not covered by plan assets 1,627.7 1,095.4 1,090.8 1,002.7 787.6<br />
Experience adjustments arising<br />
on the plan liabilities 1.3 − 4.1 − 2.5 14.1 2.0<br />
Experience adjustments arising on the plan assets − 0.2 − 0.2 − 0.2 0.1 0.1<br />
[22] Other provisions<br />
[22a]<br />
Other provisions <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Provision for<br />
Earned commission 196.0 171.5<br />
Outstanding invoices 110.8 109.7<br />
Early-retirement benefits / semi-retirement 101.9 141.1<br />
Impending losses 70.5 53.0<br />
Other in-house staff and field representatives’ remuneration 57.8 48.6<br />
Holiday and overtime pay 44.9 39.5<br />
Anniversary benefits 44.8 39.4<br />
Bonuses 36.2 34.0<br />
Sales contests 17.2 20.8<br />
Miscellaneous 829.0 649.1<br />
Total 1,509.2 1,306.7<br />
The provisions for early retirement and semi-retirement<br />
and for anniversary benefits are mainly long-term, whereas<br />
the provisions for commissions, outstanding invoices, holiday<br />
and overtime pay and miscellaneous are essentially<br />
short-term.<br />
Other provisions include amounts totalling € 219.1 million<br />
(243.7 m) for restructuring measures as part of the<br />
“Continuous Improvement in Competitiveness” project and<br />
€ 258.1 million (–) for the restructuring of our sales forces in<br />
Germany.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements108<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
[22b]<br />
Other provisions – development during the financial year <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Status at 31 December previous year 1,306.7 1,363.4<br />
Currency translation differences 7.4 − 7.9<br />
Change in consolidated group − 0.5 − 16.1<br />
Consumption 1,172.1 1,031.1<br />
Release 73.2 113.2<br />
Discounting effects 5.4 4.3<br />
Additions 1,435.5 1,107.2<br />
Other changes 0.2 −<br />
Status at 31 December financial year 1,509.2 1,306.7<br />
[23] Other liabilities<br />
[23a]<br />
Other liabilities <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Deposits retained on ceded business 4,101.3 4,179.3<br />
Accounts payable on direct insurance business 3,569.0 3,715.2<br />
Amounts due to banks 282.9 320.8<br />
Profit-unrelated tax liabilities 191.1 162.3<br />
Accounts payable on reinsurance business 85.9 84.5<br />
Interest and rents 53.3 57.1<br />
Accruals and deferred income 11.0 12.5<br />
In connection with social security 6.6 7.6<br />
Miscellaneous other liabilities 1,061.3 1,138.4<br />
Total 9,362.3 9,677.6<br />
Liabilities resulting from direct insurance business mainly<br />
take the form of liabilities vis-à-vis policyholders resulting<br />
from accumulated surplus-sharing, premium deposits<br />
and contracts without a significant risk transfer. Deposits<br />
retained on ceded business serve as collateral for technical<br />
provisions covering business ceded to reinsurers and retrocessionaires,<br />
and therefore do not lead to any cash flows.<br />
Changes to deposits retained on ceded business generally<br />
result from changes in the relevant technical provisions<br />
covering ceded business.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements109<br />
Notes to the consolidated balance sheet – equity and liabilities<br />
[23b]<br />
The table below shows the contractual maturities on<br />
liabilities. As liabilities from direct insurance business are<br />
directly linked to the underlying insurance business, the<br />
resulting liquidity risk can only be explained together with<br />
the corresponding insurance contracts. Deposits retained<br />
on ceded business do not have a fixed maturity date,<br />
their release is generally dependent on the run-off of the<br />
corresponding provisions. Consequently, both items are<br />
not taken into account in the table below.<br />
Other liabilities<br />
Maturity structure<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Contractual period to maturity<br />
Up to one year 1,335.6 1,422.8<br />
Over one year and up to two years 6.7 12.7<br />
Over two years and up to three years 1.6 30.9<br />
Over three years and up to four years 30.7 6.9<br />
Over four years and up to five years 1.2 4.3<br />
Over five years and up to ten years 279.7 213.8<br />
Over ten years 36.4 91.8<br />
Total 1,692.0 1,783.2<br />
[23c]<br />
Allocation of other liabilities measured at fair value<br />
to levels of the fair value hierarchy<br />
Level 1 Level 2 Level 3<br />
€ million € million € million<br />
<strong>2012</strong> 2011<br />
Total Level 1<br />
€ million € million<br />
Level 2 Level 3<br />
€ million € million<br />
Total<br />
€ million<br />
Other liabilities – derivatives 6.7 67.2 − 74.0 9.7 108.3 − 117.9<br />
Only derivatives with a negative market value are currently<br />
valued at fair value under ‘Other liabilities’.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
110<br />
Consolidated Financial Statements<br />
Notes to the consolidated income statement<br />
[24] Premiums<br />
[24a]<br />
Premiums <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Total premiums 18,561.5 20,269.5<br />
Gross premiums written 17,091.3 18,518.7<br />
Change in unearned premiums (− = expense) − 49.9 − 183.5<br />
Gross earned premiums 17,041.4 18,335.3<br />
Ceded premiums written 1,011.7 1,018.9<br />
Change in unearned premiums (reinsurers’ share) (− = income) − 9.4 − 15.0<br />
Ceded premiums 1,002.2 1,004.0<br />
Net earned premiums 16,039.1 17,331.3<br />
In accordance with international accounting principles the<br />
premiums from the gross provision for premium refunds<br />
and policyholders’ dividends are not stated as premiums<br />
but reduced in the change in the provision for future<br />
policy benefits. In German life insurance these amount<br />
to € 62.0 million (76.0 m) and in German health insurance<br />
to € 245.1 million (320.9 m). As regards premiums for life<br />
insurance products where the investment risk is borne by<br />
the policyholder, only those parts of the premiums used to<br />
cover the risks and costs are recorded as the premium.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements111<br />
Notes to the consolidated income statement<br />
[24b]<br />
Gross premiums written<br />
by business areas and lines of business<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Life Germany 3,930.1 4,165.0<br />
Health 4,932.5 5,974.5<br />
Property-casualty Germany 3,137.8 3,087.3<br />
Thereof:<br />
Motor 625.8 623.1<br />
Personal accident 700.2 711.3<br />
Fire and property 558.1 538.0<br />
Liability 505.2 488.1<br />
Transport and aviation 143.5 124.9<br />
Legal expenses 419.3 421.1<br />
Other 185.7 180.8<br />
Direct insurance 956.9 924.3<br />
Thereof:<br />
Life 482.2 497.9<br />
Health 360.7 312.8<br />
Motor 15.6 16.1<br />
Personal accident 37.5 37.2<br />
Other 61.0 60.4<br />
Travel insurance 460.1 485.3<br />
International 3,673.9 3,882.4<br />
Thereof:<br />
Life 1,355.9 1,454.5<br />
Property-casualty 2,318.0 2,427.9<br />
Thereof:<br />
Motor 1,027.3 1,090.9<br />
Legal expenses 625.7 587.2<br />
Other 665.0 749.8<br />
Total 17,091.3 18,518.7<br />
[24c]<br />
Gross premiums written<br />
by countries<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Germany 13,161.0 13,284.6<br />
Poland 1,008.6 1,011.4<br />
Austria 552.0 572.0<br />
Belgium 445.7 844.7<br />
Italy 406.3 497.7<br />
Turkey 301.6 306.3<br />
Great Britain 226.1 209.6<br />
The Netherlands 209.5 208.9<br />
Other 780.5 1,583.5<br />
Total 17,091.3 18,518.7
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements112<br />
Notes to the consolidated income statement<br />
[25] Income from technical interest<br />
The income statement for the <strong>Group</strong> splits the operational<br />
result into the technical and non-technical result, where<br />
the former is allocated an interest component in the<br />
form of a technical interest income. On the one hand, this<br />
interest income results from financial investments which<br />
cover technical provisions. Deposits retained on ceded<br />
business are also used as a reference value for income from<br />
technical interest. Thus the portion of investment income<br />
corresponding to deposit interest expenditure is included<br />
as a component of technical interest and reallocated to the<br />
technical result.<br />
Depending on the type of insurance business and the associated<br />
legal requirements, technical interest income should<br />
be interpreted in different ways in terms of coverage of<br />
technical provisions:<br />
In German life insurance the income from technical<br />
interest comprises gains and losses from unit-linked life<br />
insurance plus the guaranteed interest return and the<br />
profit participation calculated on the basis of non-technical<br />
sources of income. For life insurance business outside<br />
Germany, income from technical interest corresponds to<br />
the risk-free interest return on technical provisions at the<br />
relevant national long-term interest rate, gains and losses<br />
from unit-linked life insurance and the profit participation,<br />
insofar as contracts exist to this effect.<br />
In the health segment, income from technical interest<br />
corresponds to the allocation of interest to the ageing<br />
reserve (technical interest rate) and the allocation to the<br />
provision for premium refunds. This is based on the allocation<br />
of interest to the provision for non-performancerelated<br />
premium refunds, the investment result exceeding<br />
the technical interest rate and on policyholders’ participation<br />
in the other non-technical result components.<br />
In property-casualty insurance we take into account the<br />
fact that provisions created in earlier years were covered<br />
by investments with higher interest rates than are available<br />
on the market today. Consequently, technical interest<br />
income corresponds to the risk-free interest on our<br />
discounted technical provisions at the respective historic<br />
interest rate taking account of the relevant term and currency.<br />
For balance sheet provisions in excess of the discounted<br />
provisions, short-term interest rates are applied.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements113<br />
Notes to the consolidated income statement<br />
[26] Net expenses for claims and benefits<br />
Net expenses for claims and benefits <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Claims and benefits paid 13,542.9 14,999.8<br />
Change in provision for outstanding claims 475.8 336.0<br />
Change in provision for future policy benefits and other provisions 1,428.1 430.2<br />
Expenses for premium refunds and policyholders’ bonuses 1,919.0 1,418.6<br />
Other technical result (− = income) 190.3 184.6<br />
Gross expenses for claims and benefits 17,556.0 17,369.2<br />
Claims and benefits paid 1,131.6 675.7<br />
Change in provision for outstanding claims − 214.1 28.0<br />
Change in provision for future policy benefits and other provisions 39.9 100.4<br />
Expenses for premium refunds and policyholders’ bonuses 3.1 7.5<br />
Other technical result (− = expenses) − 149.0 − 145.5<br />
Reinsurers’ share of expenses for claims and benefits 811.5 666.1<br />
Claims and benefits paid 12,411.3 14,324.1<br />
Change in provision for outstanding claims 689.9 308.0<br />
Change in provision for future policy benefits and other provisions 1,388.1 329.8<br />
Expenses for premium refunds and policyholders’ bonuses 1,915.9 1,411.0<br />
Other technical result (− = income) 339.3 330.1<br />
Net expenses for claims and benefits 16,744.4 16,703.1<br />
[27] Net operating expenses<br />
Net operating expenses <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Acquisition costs 2,597.6 2,819.1<br />
Administrative expenses 1,122.5 1,157.5<br />
Deferred acquisition costs 60.4 55.5<br />
Amortisation of PVFP 19.8 26.5<br />
Gross operating expenses 3,800.2 4,058.6<br />
Reinsurers’ share of acquisition costs 3.3 4.1<br />
Reinsurers’ share of deferred acquisition costs 24.9 − 7.7<br />
Commission received on ceded business 259.6 248.5<br />
Reinsurers’ share of operating expenses 287.8 244.9<br />
Net operating expenses 3,512.3 3,813.6
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements114<br />
Notes to the consolidated income statement<br />
[28] Investment income and expenses (before deduction of technical interest)<br />
Investment income and expenses<br />
<strong>2012</strong><br />
€ million<br />
Regular income<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
Write-ups<br />
2011<br />
€ million<br />
Land and buildings, including buildings on third-party land 198.7 216.2 11.7 3.3<br />
Investments in affiliated companies 6.3 7.3 − −<br />
Investments in associates 77.0 36.2 3.0 −<br />
Loans 2,241.2 2,169.7 1.8 −<br />
Other securities<br />
Held to maturity 0.5 1.1 − −<br />
Available for sale<br />
Non-fixed-interest 153.6 186.6 − 6.3<br />
Fixed-interest 2,031.4 2,289.1 19.0 37.8<br />
At fair value through profit or loss<br />
Held for trading<br />
2,185.0 2,475.7 19.0 44.1<br />
Non-fixed-interest − 0.2 − −<br />
Fixed-interest 0.6 1.1 9.6 10.4<br />
Derivatives 68.5 86.3 453.9 856.0<br />
Designated as at fair value through profit or loss<br />
69.1 87.5 463.5 866.4<br />
Non-fixed-interest − − − −<br />
Fixed-interest 5.5 5.5 19.0 −<br />
5.5 5.5 19.0 −<br />
Total at fair value through profit or loss 74.6 93.0 482.5 866.4<br />
Total other securities 2,260.1 2,569.8 501.5 910.5<br />
Deposits retained on assumed reinsurance, and other investments 30.0 42.8 − −<br />
Subtotal 4,813.4 5,042.1 518.0 913.8<br />
Investments for the benefit of life insurance<br />
policyholders who bear the investment risk − − − −<br />
Expenses for the management of investments, other expenses − − − −<br />
Total 4,813.4 5,042.1 518.0 913.8<br />
In the <strong>2012</strong> financial year we sold our shares in the fully<br />
consolidated subsidiary <strong>ERGO</strong> Daum Direct General<br />
Insurance Co. Ltd., Seoul. For further details on this<br />
transaction, please refer to the Notes on consolidated<br />
group on pages 55 et seq.<br />
The gains from the disposal of shares in associated companies<br />
essentially contain a retrospective purchase price<br />
adjustment of € 10.2 million from the sale of international<br />
health insurance companies to Munich Health Holding<br />
Aktien gesellschaft, Munich, in 2011.<br />
Expenditure on the administration of investments includes<br />
interest expenditure of € 5.8 million (45.8 m), administration<br />
expenses for financial investments of € 200.3 million<br />
(200.9 m) and expenses for repair and maintenance of<br />
property of € 33.4 million (26.3 m).
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements115<br />
Notes to the consolidated income statement<br />
Income Expenses Other<br />
Investment<br />
Gains on disposal Write-downs Losses on disposal<br />
income/expenses<br />
result<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
61.6 54.2 88.7 103.3 − 0.2 − − 183.2 170.4<br />
14.7 497.7 32.2 19.0 0.7 54.2 − 7.3 − 4.1 − 19.3 427.7<br />
0.6 21.9 15.9 6.6 − 4.6 − − 64.7 46.9<br />
131.5 100.8 8.1 58.2 63.5 10.8 − − 2,302.9 2,201.5<br />
− − − − − − − − 0.5 1.1<br />
145.3 177.1 64.6 259.3 64.2 166.8 − − 170.0 − 56.0<br />
381.0 429.0 6.3 1,142.6 465.1 195.1 − − 1,960.0 1,418.2<br />
526.3 606.1 70.9 1,401.9 529.3 361.8 − − 2,130.1 1,362.2<br />
− 0.1 − − − − − − − 0.2<br />
− − 0.1 0.8 − − − − 10.1 10.6<br />
101.8 295.8 189.3 364.5 208.0 421.6 − − 226.9 452.0<br />
101.8 295.9 189.4 365.3 208.0 421.6 − − 237.0 462.8<br />
− − − − 0.1 2.6 − − − 0.1 − 2.6<br />
0.3 4.9 2.4 − 0.4 17.6 − − 21.9 − 7.2<br />
0.3 4.9 2.4 − 0.4 20.2 − − 21.9 − 9.8<br />
102.2 300.8 191.9 365.3 208.5 441.8 − − 258.9 453.1<br />
628.4 906.9 262.8 1,767.2 737.8 803.6 − − 2,389.5 1,816.4<br />
− − 1.4 0.1 − − − − 28.6 42.6<br />
836.9 1,581.5 409.3 1,954.4 802.0 873.4 − 7.3 − 4.1 4,949.6 4,705.5<br />
− − − − − − 602.8 − 262.9 602.8 − 262.9<br />
− − − − − − − 290.8 − 326.6 − 290.8 − 326.6<br />
836.9 1,581.5 409.3 1,954.4 802.0 873.4 304.7 − 593.6 5,261.7 4,116.0
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements116<br />
Notes to the consolidated income statement<br />
[29] Other operating result<br />
Other operating result <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Income from services rendered and from broking funds and insurance policies 172.9 201.4<br />
Income from owner-occupied property 43.8 24.6<br />
Interest from other than investments 27.0 50.7<br />
Income from releases from other non-technical provisions 56.2 59.2<br />
Miscellaneous 52.6 23.7<br />
Other operating income 352.4 359.6<br />
Expenses for services rendered and for broking funds and insurance policies 138.6 140.1<br />
Expenses for owner-occupied property 14.0 33.0<br />
Interest charges and similar expenses 95.9 107.5<br />
Other write-downs 26.6 37.0<br />
Allocation to other non-technical provisions 15.8 11.8<br />
Miscellaneous 154.5 154.6<br />
Other operating expenses 445.5 484.0<br />
Total − 93.1 − 124.4<br />
[30] Other non-operating result<br />
Other non-operating result <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Foreign currency exchange gains 731.9 616.8<br />
Miscellaneous 99.1 103.8<br />
Other non-operating income 831.0 720.6<br />
Foreign currency exchange losses 775.2 630.4<br />
Miscellaneous 559.0 405.4<br />
Other non-operating expenses 1,334.3 1,035.8<br />
Total − 503.3 − 315.2<br />
Other non-operating expenses (‘Miscellaneous’) include<br />
amounts earmarked for restructuring measures in respect<br />
of our sales forces in Germany totalling € 258.1 million (−).<br />
[31] Impairment losses of goodwill<br />
In accordance with IFRS 3, there is no longer a scheduled<br />
amortisation of goodwill stated in the balance sheet. An<br />
impairment test was carried out at the balance sheet date.<br />
Impairment losses of goodwill from capital consolidation<br />
were not necessary in the <strong>2012</strong> financial year (2011:<br />
€ 21.4 m).<br />
[32] Finance costs<br />
Finance costs include all expenditure spent on interest<br />
and other expenses which are directly related to strategic<br />
debt, i. e. debt without an original and direct link to<br />
operative insurance business. Costs totalling € 81.8 million<br />
(65.8 m) stem primarily from liabilities of <strong>ERGO</strong><br />
<strong>Versicherungsgruppe</strong> <strong>AG</strong> due to Munich Re companies.<br />
The loans serve to strengthen the liquidity basis and to<br />
finance strategic assets.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements117<br />
Notes to the consolidated income statement<br />
[33] Taxes on income<br />
[33a]<br />
Current tax and the change in deferred tax together make<br />
up the ‘Taxes on income’ item in the consolidated income<br />
statement. Apart from current tax expenditure there was<br />
income from deferred tax which resulted from changes in<br />
deferred tax items due to revaluations.<br />
Taxes on income <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Current tax for financial year 179.9 331.4<br />
Current tax for other periods − 27.7 − 81.1<br />
Deferred tax resulting from the occurrence or reversal of temporary differences − 43.8 − 211.5<br />
Deferred tax resulting from the occurrence or utilisation of loss carry-forwards and write-downs − 24.9 2.7<br />
Valuation allowances for other deferred taxes − −<br />
Deferred tax for other periods − 7.0 13.0<br />
Total 76.6 54.5<br />
[33b]<br />
The <strong>Group</strong> tax rate corresponds to the average fiscal<br />
charges for all domestic <strong>Group</strong> companies. This amount<br />
is made up of German corporate tax amounting to 15%<br />
(15%) plus a 5.5% (5.5%) solidarity surcharge.<br />
Together with the domestic trade tax the uniform <strong>Group</strong><br />
tax rate is thus 32% (32%). Based on a net operating result<br />
after finance costs, the following table shows the reconciliation<br />
between the expected taxes on income and the<br />
taxes on income actually shown:<br />
Reconciliation to effective tax expenses <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Result before taxes on income (after other tax) 365.9 403.9<br />
x <strong>Group</strong> tax rate 32% (32%)<br />
= Expected taxes on income 117.1 129.3<br />
Tax effect of:<br />
+ Non-deductible expenses 56.5 36.3<br />
− Tax-free income − 59.7 − 58.3<br />
+ Tax rate differences − 2.1 − 13.6<br />
+ Tax for prior years − 34.7 − 68.1<br />
+ Amortisation of goodwill or PVFP − 12.3<br />
+ Miscellaneous − 0.6 16.6<br />
= Taxes on income shown 76.6 54.5
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
118<br />
Consolidated Financial Statements<br />
Disclosures on risks from insurance<br />
contracts and financial instruments<br />
<strong>ERGO</strong>’s reporting is based on various legal regulations<br />
governing risks it is exposed to as a result of its business<br />
operations:<br />
IFRS 4 prescribes disclosures on the type and extent of risks<br />
from insurance contracts. Under IFRS 7, analogous disclosures<br />
on risks from financial instruments are required.<br />
Besides this, Section 315, para. 2, item 2 of the German<br />
Commercial Code prescribes disclosures in the management<br />
report on risk management objectives and methods,<br />
hedging and risks in connection with financial instruments.<br />
These requirements are specified in more detail in the<br />
German Accounting Standard No. 15 (DRS 15) for management<br />
reports, as well as DRS 5 and DRS 5–20 for risk reporting<br />
and risk reporting at insurance companies.<br />
Risk reporting concerns not only accounting but also the<br />
activities of <strong>ERGO</strong>’s integrated risk management (IRM). To<br />
take both perspectives into account, information on risks is<br />
provided in the Risk report within the management report,<br />
in the disclosures on risks from insurance contracts and<br />
financial instruments as well as in the disclosures on financial<br />
instruments in the Notes to the financial statements.<br />
The disclosures in the Risk report largely adopt a purely<br />
economic view. This report provides a detailed account<br />
of the organisation of risk management and of <strong>ERGO</strong>’s<br />
risk strategy, and briefly outlines the main risks we are<br />
exposed to.<br />
The Notes to the financial statements deal in detail with<br />
the various risks from insurance contracts and describe<br />
uncertainties in measuring them. In accordance with the<br />
requirements of IFRS 4, the effects of a change in the<br />
assumptions underlying the measurement of insurance<br />
contracts and in the market environment are also quantified.<br />
For risks from financial instruments, IFRS 7 stipulates<br />
that the disclosures must comprise information on maximum<br />
credit risk exposure, the remaining terms, the rating,<br />
and a sensitivity analysis regarding the market risk. This<br />
information is also relevant for assessing the risk.<br />
To obtain a complete overview of the risks to which <strong>ERGO</strong><br />
is exposed, the reader needs to refer to both the risk report<br />
and the disclosures on risks from insurance contracts and<br />
financial instruments in the Notes to the financial statements,<br />
along with further information on individual items.<br />
Where necessary, we refer to the relevant information in<br />
the risk report or in the Notes.<br />
[34a] Risks from life and health insurance business<br />
Of primary importance for insurance contracts in life<br />
and health insurance are biometric risks, interest-rate<br />
risks and lapse risks. The measurement of technical<br />
provisions and deferred acquisition costs is based on<br />
biometric calculation tables, i. e. on assumptions with<br />
regard to mortality, disable ment and morbidity, and on<br />
the respective contract- or tariff-specific discount rates<br />
and actuarial interest rates. Besides this, measurement<br />
includes assumptions regarding the lapse rate and profit<br />
participation. In addition, other market risks from unitlinked<br />
policies and risks from embedded derivatives, as<br />
well as the liquidity risk, have to be taken into account.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements119<br />
Disclosures on risks from insurance contracts and financial instruments<br />
Biometric risks<br />
Our portfolios’ risk of exposure to biometric risks depends<br />
on the type of insurance contracts:<br />
Product category Features Significant risks<br />
Life insurance<br />
Term life insurance<br />
Annuity insurance<br />
Occupational disability and<br />
disablement insurance<br />
Health insurance<br />
Long-term contracts with death benefit<br />
In most cases with a lump-sum payment on<br />
termination<br />
Actuarial assumptions fixed when contract<br />
is concluded, premium adjustments not<br />
possible<br />
In most cases guaranteed lifelong<br />
annuity payment<br />
Actuarial assumptions mainly fixed<br />
when contract is concluded, premium<br />
adjustments not possible<br />
Long-term policies with a guaranteed<br />
limited annuity in the event of disablement<br />
Actuarial assumptions fixed when contract<br />
is concluded<br />
Largely long-term contracts guaranteeing<br />
assumption of costs for medical treatment;<br />
provisions are established for covering<br />
increased costs on ageing<br />
Variable actuarial assumptions; premium<br />
adjustment possible if there are sustained<br />
changes in the cost structure<br />
Mortality (short-term): increase in claims<br />
expenditure due to exceptional one-off<br />
circumstances (e. g. pandemics)<br />
Mortality (long-term): increase in claims<br />
expenditure due to sustained rise in<br />
mortality in the portfolio<br />
Longevity: increase in expected expenditure<br />
for annuities due to sustained rise in life<br />
expectancy in the portfolio<br />
Disablement: increased expenditure due to<br />
rise in the number of cases of disablement in<br />
the portfolio and a reduction in the average<br />
age at which the insured event occurs.<br />
Longevity: increased expenditure due to rise<br />
in the average duration of annuity period<br />
Morbidity: increase in medical costs that<br />
cannot be absorbed through premium<br />
adjustments<br />
Increase in claims expenditure due to<br />
exceptional, one-off events (e. g. pandemics)<br />
Lapse risk: Deviation of actual lapse behaviour<br />
compared with actuarial assumptions<br />
The biometric assumptions we use for measuring insurance<br />
contracts in our portfolio are regularly reviewed on<br />
the basis of updated portfolio information. This includes<br />
considering country-specific reviews by supervisory authorities<br />
or associations of actuaries.<br />
We also take account of market standards when checking<br />
the adequacy of biometric actuarial assumptions and the<br />
trend assumptions included in them. This may result in a<br />
change in the safety margin allowed for in the actuarial<br />
assumptions. The amount of the technical provisions or<br />
the deferred acquisition costs is not directly affected as<br />
long as safety margins have been included. In the view of<br />
the appointed actuaries, the biometric actuarial assumptions<br />
we use are deemed sufficient. However, in long-term<br />
health insurance, we are proceeding on the assumption<br />
that there will be further advances in medical treatment,<br />
potentially giving rise to higher costs. It is generally<br />
possible to modify the actuarial assumptions for this business<br />
by means of a premium adjustment to reflect the<br />
changes.<br />
For short-term health insurance, on the other hand, the<br />
main risk is a sudden increase in expenses due to exceptional<br />
one-off events.<br />
Interventions by legislators or courts in the distribution<br />
of risks and rewards underlying the contracts concluded<br />
between the parties to insurance may mask or aggravate<br />
the biometric risks described, making it necessary to adjust<br />
the provision.<br />
We measure sensitivity to changes to biometric assumptions<br />
in life insurance and for long-term contracts in<br />
health insurance using an embedded value analysis (see<br />
page 123).
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements120<br />
Disclosures on risks from insurance contracts and financial instruments<br />
Interest-rate risks<br />
A distinction must be made between risks of changes in<br />
interest rates on the one hand and interest-rate guarantee<br />
risks on the other. Risks of changes in interest rates would<br />
result from the discounting of the provision for future<br />
policy benefits and of parts of the provision for outstanding<br />
claims. In accordance with accounting valuation rules, the<br />
discount rate is fixed at contract commencement and will<br />
generally not be adjusted during the term of the contract.<br />
To this extent, the accounting valuation of these technical<br />
provisions does not depend directly on the level of market<br />
interest rates.<br />
Economically, however, an interest-rate risk derives in principle<br />
from the need to earn a return on investment covering<br />
the provision that is commensurate with the discount<br />
rate used in measuring the provision.<br />
In life insurance, an implied or explicit guaranteed interest<br />
rate is normally granted over the whole duration, based<br />
on a fixed interest rate applying at the time the contract is<br />
concluded. The discount rate used to calculate the provision<br />
for future policy benefits is identical with this interest rate<br />
for the majority of contracts in our portfolios. An appropriate<br />
minimum return needs to be earned in the long term<br />
from the investment result (possibly also with assistance<br />
from the technical result) for contractually guaranteed<br />
benefits. In health insurance, a discount rate is used for<br />
calculating the provision for future policy benefits, too; but<br />
for long-term business, this rate can generally be altered<br />
by way of premium adjustment. For short-term business,<br />
there is no direct interest-rate risk.<br />
The discount rates relevant for the portfolio which relate to<br />
provisions for future policy benefits and provisions for outstanding<br />
claims are shown in tables [16b] and [17a] of the<br />
Notes to the consolidated financial statements.<br />
Moreover, in German health insurance, the valid discount<br />
rate is also used to calculate the provision for premium<br />
surcharge provisions and for the provision for the reduced<br />
premiums in later years which, according to the German<br />
Commercial Code, form part of the provision for future<br />
policy benefits and which are to be shown under the provision<br />
for premium refunds under IFRS. In principle, however,<br />
the discount rate can be changed whenever there is an<br />
adjustment made to premiums within the allowed range of<br />
0–3.5%.<br />
Provisions that are not covered by retained deposits are<br />
covered by investments. In the case of a discrepancy<br />
between the durations of these investments and the<br />
liabilities (“duration mismatch”), the main risk lies in the<br />
fact that if interest rates fall markedly over the remaining<br />
settlement period of the liabilities, the return on the<br />
re invested assets may be lower than the discount rates<br />
and thus necessitate further expenses. But a complete<br />
duration matching of liabilities with fixed-interest investments<br />
of identical maturities would not be expedient,<br />
because if interest rates rise significantly, policyholders<br />
might make increasing use of their surrender rights, resulting<br />
in a liquidity requirement for premature payouts.<br />
We measure sensitivity to this interest-rate risk using an<br />
embedded value analysis (see pages 123 f.).<br />
Lapse risks<br />
In reinsurance, a lapse risk derives primarily from the indirect<br />
transfer of lapse risks from cedants. As a rule, both<br />
this risk and the financial risk from extraordinary termination<br />
of reinsurance contracts are largely ruled out through<br />
appropriate contract design.<br />
In life insurance, the reported technical provision in the<br />
case of contracts with a surrender option is generally at<br />
least as high as the relevant surrender value. Expected<br />
surrenders are taken into account in the amortisation of<br />
deferred acquisition costs in life insurance. The policyholder’s<br />
right in some contracts to maintain the contract<br />
with a waiver of premium and an adjustment of the<br />
guaranteed benefits constitutes a partial lapse and is<br />
taken into account in the calculations analogously. The<br />
lump-sum option right for a deferred annuity gives the<br />
policyholder the option to have the annuity paid out in a<br />
lump sum on a given date. There is a potential risk here if,<br />
following a level of interest which is significantly above the
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements121<br />
Disclosures on risks from insurance contracts and financial instruments<br />
level used to calculate the annuity, an unexpectedly large<br />
number of policyholders exercise their lump-sum option.<br />
However, there is no direct interest or market sensitivity<br />
as the exercising of the option is influenced decisively<br />
by individual factors concerning the policyholder because<br />
there is an insurance component involved. Contractual<br />
aspects are also relevant, as the lump-sum option is sometimes<br />
excluded or severely limited, such as with company<br />
pensions or with state-subsidised products. The adequacy<br />
test for underwritten liabilities in accordance with IFRS 4<br />
explicitly takes this policyholders’ option into consideration.<br />
Based on the relevant legal parameters, reserves<br />
for health insurance business are calculated considering<br />
amounts payable due to transfer of policies. The underlying<br />
assumptions are regularly checked.<br />
The sensitivity towards a change in the lapse probability<br />
in life insurance as well as for long-term health insurance<br />
contracts are measured as part of an embedded value<br />
analysis (see page 123).<br />
Other market risks and embedded derivatives<br />
Risks to be considered are – besides the interest-rate<br />
guarantee, which we analyse in the modelling of the<br />
interest-rate risk – are particularly risks from unit-linked life<br />
insurance. Other embedded derivatives are economically<br />
insignificant.<br />
For unit-linked insurance contracts in our portfolios, investments<br />
are held for the benefit of life insurance policyholders<br />
who bear the investment risk, meaning that there is no<br />
direct market risk. Appropriate product design ensures that<br />
the necessary premium portions for payment of a guaranteed<br />
minimum benefit on occurrence of death are based<br />
on the current fund assets. In addition, unit-linked insurance<br />
policies may contain a guaranteed gross premium<br />
which is assured by an issuer in certain cases. As a result,<br />
our market risk is reduced accordingly, although there is<br />
a bad debt risk. In order to reduce this risk, we make high<br />
demands of the creditworthiness of the issuer.<br />
Liquidity risks<br />
For <strong>ERGO</strong>, there could be a liquidity risk if the cash outflow<br />
for insurance claims payments and the costs related to the<br />
business were to exceed the cash inflow from premiums<br />
and investments. For our mainly long-term business, we<br />
therefore analyse the expected future balance from cash<br />
inflows due to premium payments and outflows for payment<br />
of insurance claims and benefits plus costs.<br />
As regards business in force on the balance sheet date, this<br />
results in the future expected technical payment balances<br />
shown in the table on the next page according to duration<br />
bands. As only the technical payment flows are considered,<br />
inflows from investment income and investments<br />
that become free are not included in the quantification.<br />
Taking into account the inflows from investments, whose<br />
cash flows are largely aligned with those of the liabilities<br />
through our asset-liability management, items in the<br />
future expectations are positive throughout, so that the<br />
liquidity risk of these insurance contracts is minimised<br />
accordingly.<br />
With these numerical estimates, it should be borne in mind<br />
that these forward-looking data may involve considerable<br />
uncertainty.<br />
Further information on the liquidity risk is provided in the<br />
risk report on page 37.<br />
Claims risk<br />
The claims risk occurs when benefits have to be paid out<br />
of a previously determined premium. Here the scope of<br />
benefits has been agreed beforehand, but the risk lies<br />
in not knowing how medical expenses and benefits will<br />
develop in the future. The promise of benefits plays an<br />
important role in this aspect. In future, we also expect that<br />
medical possibilities will improve still further with more<br />
applications and, hence, higher costs. Consequently, the<br />
relationship of calculated costs to the benefits required is<br />
constantly monitored. Premiums will be adjusted for those<br />
tariffs where the required benefits deviate from calculated
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements122<br />
Disclosures on risks from insurance contracts and financial instruments<br />
Life insurance – Expected future technical cash flow (gross) 1 <strong>2012</strong> 2011<br />
€ million 2 € million 2<br />
Up to one year − 3,298 − 2,713<br />
Over one year and up to five years − 15,600 − 14,564<br />
Over five years and up to ten years − 18,258 − 17,790<br />
Over ten years and up to twenty years − 29,385 − 27,821<br />
Over twenty years − 37,614 − 35,985<br />
1 Premiums less guaranteed benefits and costs (excl. unit-linked products).<br />
2 After eliminating internal <strong>Group</strong> transactions across all segments.<br />
Health insurance – Expected future technical cash flow (gross) <strong>2012</strong> 2011<br />
€ million 1 € million 1<br />
Up to one year 702 874<br />
Over one year and up to five years 950 2,000<br />
Over five years and up to ten years − 1,477 − 112<br />
Over ten years and up to twenty years − 11,458 − 11,008<br />
Over twenty years − 51,865 − 77,702<br />
1 After eliminating internal <strong>Group</strong> transactions across all segments.<br />
2 The decline of the estimate from 2011 to <strong>2012</strong> results from an adjustment of the underlying assumptions.<br />
benefits on a permanent basis. Actuarial assumptions used<br />
are deemed to be adequate by the appointed actuaries<br />
and the fiduciaries in cases inspected by the latter. These<br />
measures severely limit the risk resulting from expenses for<br />
claims and benefits. The risk of particularly high individual<br />
claims and a dramatic rise in the number of claims as a<br />
result of a pandemic are constrained by means of a special<br />
reinsurance concept.<br />
Risk minimisation measures<br />
The product design itself also ensures a substantial reduction<br />
in risk. For the most part, prudent actuarial assumptions<br />
are used in fixing the guaranteed benefits, in addition<br />
to which policyholders are granted a performance-related<br />
profit participation. Given the relevant margins in the<br />
actuarial assumptions, it is also possible to fulfil future<br />
guaranteed obligations without adjusting the provisions<br />
in the case of moderate changes in assumptions. Of great<br />
significance for risk-balancing in the case of adverse developments<br />
are parts of the provision for premium refunds<br />
based on national regulations, parts of the provision for<br />
deferred premium refunds resulting from other revaluations,<br />
and unrealised gains and losses on investments<br />
taken as a basis for posting the provision for deferred<br />
premium refunds.<br />
In health insurance, there is the additional possibility of<br />
adjusting premiums for most long-term contracts. If it is<br />
foreseeable that the assumptions behind the calculation<br />
are permanently inadequate to cover expenses for claims<br />
or the actual mortalities deviate significantly from the<br />
calculated ones, premiums can be raised accordingly, thus<br />
closely limiting the financial and balance sheet effects of<br />
cost increases in healthcare and permanent changes in<br />
morbidity.<br />
For information on our risk management processes, see<br />
also pages 31 f. in the risk report.<br />
Impact on equity and the consolidated income<br />
statement<br />
In the liability adequacy test pursuant to IFRS 4, technical<br />
provisions and deferred acquisition costs are regularly<br />
tested to ensure they are appropriate. An adjustment is<br />
made if such tests show that, as a whole, the amounts<br />
calculated using the previous assumptions for biometric<br />
actuarial rates, for discounting provisions and for lapses<br />
are no longer sufficient. The possibilities of adjusting the<br />
surplus are taken into account. In health insurance, the<br />
technical interest rate can be adjusted if it is necessary to<br />
alter the assumed technical interest rate within the framework<br />
of a premium adjustment.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements123<br />
Disclosures on risks from insurance contracts and financial instruments<br />
If an adjustment is required, we record any deficit as an<br />
expense in the consolidated income statement.<br />
Quantitative impact of changes in assumptions on longterm<br />
insurance business<br />
The <strong>ERGO</strong> Insurance <strong>Group</strong> measures the sensitivity of its<br />
long-term insurance business in life and health insurance<br />
using an economic valuation on the basis of the CFO’s<br />
Forum’s Market-Consistent Embedded Value Principles<br />
and Guidance (see page 12). This covers more than 97%<br />
(94%) of long-term insurance business. Compared to<br />
incorporating the entire insurance portfolio, the difference<br />
is negligible.<br />
The sensitivities given below measure the impact of<br />
changes in the calculation bases and capital market<br />
parameters on the calculated economic value of our<br />
business. They take account of our risk minimisation<br />
measures and tax effects.<br />
<strong>ERGO</strong> continues to adhere to the strict rules of marketconsistent<br />
evaluation as at the end of the year.<br />
Embedded value sensitivities 1 <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Embedded value on the balance sheet date 2,728 875<br />
Change in the event of a sustained increase in interest rates by 100 BP 2,298 2,369<br />
Change in the event of a sustained decrease in interest rates by 100 BP − 3,769 − 4,009<br />
Change in the event of a 10% decrease in the value of equities and real estate − 176 − 210<br />
Changes in the event of an increase in mortality by 5% in the case of contracts mainly covering the mortality risk − 42 − 48<br />
Changes in the event of an decrease in mortality by 5% in the case of contracts mainly covering the longevity risk − 180 − 186<br />
Change in the event of an increase in morbidity by 5% − 73 − 85<br />
Change in the event of an increase in the lapse rate by 10% 140 112<br />
1 Premiums less guaranteed benefits and costs (excl. unit-linked products).<br />
[34b] Risks arising from property-casualty insurance<br />
business<br />
Of particular importance for these insurance contracts<br />
is the estimation risk with regard to the amount of the<br />
expected claims expenditure for future claims from current<br />
insurance contracts (premium risk) as well as for<br />
claims already incurred (reserve risk). In estimating claims<br />
expenditure, we also take cost increases into account.<br />
There is an interest-rate risk for parts of the portfolio.<br />
Besides this, the liquidity risk has to be taken into account.<br />
The basis for measuring the risk assumed is an estimate of<br />
the claims frequency to be expected for a contract or portfolio<br />
of contracts. In addition, an estimation of the claims<br />
amount is necessary, from which a mathematical distribution<br />
of the expected losses is derived. The result of these<br />
two steps is an estimation of the expected overall claims<br />
in a portfolio. A third element comprises the expected cash<br />
flows to settle claims incurred, a process which frequently<br />
extends over several years.<br />
Premium risks<br />
The degree of exposure to estimation risks differs according<br />
to class of business. On the basis of the loss ratios and<br />
combined ratios of past years, conclusions can be drawn<br />
about the historical volatilities in the different classes of<br />
business and about possible interdependencies. The differences<br />
in volatility are equally due to fluctuations in the<br />
amount of claims and fluctuations in the respective market<br />
price level for the cover granted.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements124<br />
Disclosures on risks from insurance contracts and financial instruments<br />
Premiums, claims and expenses according to lines of business <strong>2012</strong> 2011 2010 2009<br />
Gross premiums € million<br />
Motor 1,669 1,730 1,724 1,534<br />
Thereof motor liability 936 942 910 808<br />
Thereof other motor 733 788 814 726<br />
Accident 838 875 902 888<br />
Fire and property 776 827 773 736<br />
Liability 584 560 532 516<br />
Transport and aviation 187 167 154 127<br />
Other 801 754 735 693<br />
Legal expenses 1,045 1,009 968 942<br />
Total 5,899 5,922 5,787 5,436<br />
Claims ratio % (net)<br />
Motor 79.6 87.2 88.2 83.2<br />
Thereof motor liability 85.1 89.6 90.6 84.7<br />
Thereof other motor 72.1 84.2 85.2 81.3<br />
Accident 41.0 39.9 35.3 33.1<br />
Fire and property 66.4 63.3 68.6 55.4<br />
Liability 62.5 56.8 46.1 55.0<br />
Transport and aviation 58.1 40.1 64.8 67.1<br />
Other 51.9 51.8 52.3 53.0<br />
Legal expenses 55.5 55.0 55.2 57.7<br />
Total 62.2 62.9 62.5 59.8<br />
Combined Ratio % (net)<br />
Motor 105.1 113.2 113.9 108.0<br />
Thereof motor liability 110.3 115.5 115.5 109.6<br />
Thereof other motor 98.1 110.3 112.1 106.0<br />
Accident 78.5 77.0 72.2 68.5<br />
Fire and property 103.8 100.3 104.7 90.7<br />
Liability 95.5 90.8 78.9 86.5<br />
Transport and aviation 99.1 87.8 94.4 93.1<br />
Other 95.4 95.9 96.0 97.0<br />
Legal expenses 97.2 97.5 96.8 97.8<br />
Total 97.2 98.3 97.0 93.5<br />
The estimation of technological, social and demographic<br />
parameters plays an important part in assessing and pricing<br />
risks assumed in all classes of business.<br />
Beyond this, in liability insurance and sections of motor<br />
insurance, the development of economic and legal<br />
parameters is significant. In the lines of business where<br />
there is a high degree of sensitivity regarding the underlying<br />
assumptions about natural catastrophes, we include<br />
expected trends in our considerations when assessing the<br />
risks.<br />
We are convinced that we have calculated our premiums<br />
to include a sufficient margin for risk. The containment<br />
of risk is guaranteed through our targeted underwriting<br />
policy, strict underwriting guidelines and guidelines for the<br />
degree of authority and competency. The systematic controlling<br />
of the portfolios and regular recalculation of premiums<br />
ensure that premium income and claims payments<br />
remain in an appropriate balance.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements125<br />
Disclosures on risks from insurance contracts and financial instruments<br />
Reserve risks<br />
Interest-rate risks<br />
The provision for outstanding claims is subject to the risk<br />
that actual claims settlements may be less than or exceed<br />
the amount reserved (reserve risk). Particular attention<br />
is given to those situations where the funds dedicated to<br />
future claims payments may be inadequate.<br />
The measurement of the provision for outstanding claims<br />
is based on an analysis of the historical loss development<br />
data for the different classes of business. We use a range<br />
of well-established actuarial methods to analyse and value<br />
this data which embed various pricing, coverage, benefit<br />
and inflation levels. In doing so, we draw on the specialist<br />
knowledge present in our claims and underwriting<br />
departments and take all foreseeable future trends into<br />
account. As part of our regular results monitoring process,<br />
we keep a close eye on trends to ensure that the assumptions<br />
underlying the measurement of the provisions always<br />
reflect the latest developments. Consequently, in the<br />
course of reserve run-off, it may be necessary to revise the<br />
original estimates of the claims expenditure required and<br />
to adjust the provisions accordingly.<br />
Actuarial claims requirements can deviate from the<br />
expected claims requirements for future insurance risks<br />
from insurance business that has already been underwritten.<br />
A check is made during an IFRS 4 adequacy test<br />
to find out whether the expected loss requirement, including<br />
costs, is more than expected earned premiums plus<br />
the proportionate amount of investment income. If this<br />
is the case, additional reserves will be set up. Appropriate<br />
reserves are set up based on experience from past years.<br />
There have not been any major fluctuations in the past in<br />
either the claims ratio or run-off results.<br />
The development of our claims reserves and the corresponding<br />
run-off results are shown under [17] Provision for<br />
outstanding claims.<br />
Economically, an interest-rate risk derives in principle from<br />
the need to earn a return on the investment covering the<br />
provision that is commensurate with the discount rate<br />
used in measuring the provision. In balance sheet terms,<br />
the interest-rate risk affects only those parts of the technical<br />
provisions that are discounted. In our case, this risk lies<br />
predominantly with the provisions for personal accident<br />
insurance with premium refunds and annuities.<br />
However, as only around 10.2% of the actuarial and claims<br />
reserves to be considered in this respect are discounted,<br />
this risk can be deemed small. If investment income failed<br />
to cover the expenses arising from discounting, this would<br />
result in losses not included in the calculations. In such<br />
cases, a reserve adjustment may be necessary. Conversely,<br />
if the investment income were higher, this would result in<br />
unforeseen gains.<br />
Liquidity risks<br />
Such risks could result for <strong>ERGO</strong> if the cash outflow for<br />
insurance claims payments and the costs related to the<br />
business were to exceed the cash inflow from premiums<br />
and investments. In property-casualty insurance, a distinction<br />
must be made between payments for claims for which<br />
reserves were posted in previous years and immediate<br />
payments, i. e. payments for claims incurred in the current<br />
financial year. If claims reserves are posted, the liquidity<br />
risk can be minimised through our asset-liability management,<br />
in which investments are geared to the character<br />
of the liabilities. The proportion of immediate claims payments<br />
constitutes only a fraction of the total payments<br />
to be made and is, in our experience, stable over time.<br />
Consequently, the liquidity risks in respect of these payments<br />
can also be minimised by means of asset-liability<br />
management.<br />
The following table shows that in the past calendar years<br />
the liquidity situation has always been positive.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements126<br />
Disclosures on risks from insurance contracts and financial instruments<br />
Cash flows and liquid funds (gross)<br />
<strong>2012</strong><br />
in individual calendar years 1 € million<br />
2011<br />
€ million<br />
2010<br />
€ million<br />
2009<br />
€ million<br />
2008<br />
€ million<br />
Premiums received 5,899 5,922 5,787 5,436 5,041<br />
Claims payments for financial year 1,776 1,828 1,871 1,686 1,430<br />
Claims payments for previous years 1,638 1,605 1,423 1,319 1,267<br />
Costs 2,037 2,039 1,965 1,799 1,601<br />
Liquid funds 448 450 529 632 743<br />
1 After eliminating internal <strong>Group</strong> transactions across all segments.<br />
For more information on the liquidity risk, see page 37 of<br />
the risk report.<br />
Impact of changes in technical assumptions on equity<br />
and the consolidated income statement<br />
As part of the monitoring of our portfolio, we check<br />
whether original assumptions need to be adjusted. By<br />
means of the IFRS 4 liability adequacy test, we review<br />
expected claims expenditure in the light of updated<br />
assumptions, taking into account our risk minimisation<br />
measures. If this test shows that an adjustment to<br />
technical provisions is required, the amount is recognised<br />
in the consolidated income statement.<br />
Risk minimisation measures<br />
With an underwriting policy geared to systematic<br />
diversification, i. e. the greatest possible mix and spread<br />
of individual risks, we substantially reduce the volatility<br />
for our insurance portfolio as a whole.<br />
As a result of the strong focus on business with private<br />
customers, there are, on the one hand, very few risks concerning<br />
future cash flows and, on the other, low exposure<br />
to large and very large losses. High single losses and large<br />
indemnity amounts associated with them, as well as the<br />
effect of cumulative events, are effectively contained<br />
regarding their effect on the income statement by our<br />
reinsurance programmes, meaning that their negative<br />
impact can be planned in the sense of profit-oriented company<br />
management. We make use of risk-based reinsurance<br />
solutions to achieve this goal. As regards ceded insurance,<br />
we pursue the objective of reducing the volatility of net<br />
results. This means that less equity is required for operational<br />
purposes and, at the same time, the results can be<br />
planned more accurately. To calculate our reinsurance<br />
needs, we regularly analyse the gross and net exposure of<br />
our insurance portfolios with a special focus on cumulative<br />
risks. From this analysis, we derive areas of action for steering<br />
our reinsurance programme.<br />
Due to the special significance of insurance against<br />
natural disasters and our companies’ exposure to those<br />
hazards, our portfolios are evaluated on a regular basis<br />
using recognised actuarial methods. The results of these<br />
analyses form the basis for the type and degree of protection<br />
programmes against natural disasters. The respective net<br />
retentions are financially viable sums for the companies.<br />
The portfolios of private customer lines of business are very<br />
homogeneous. Nevertheless, in the context of internal risk<br />
modelling, major, cumulative and basic losses are modelled<br />
and the effect of the current reinsurance structure tested<br />
on them. The normal (Pareto and generalised Pareto)<br />
dis tribution is then used as an assumption for claims<br />
amounts for major and cumulative losses. This internal risk<br />
model is used in addition to gauging reinsurance requirements<br />
and is part of the internal risk management process.<br />
As a result of the very different amounts regarding the<br />
insured values, commercial and industrial lines of business<br />
are characterised by heterogeneity of the portfolios.<br />
In the course of internal risk modelling, major, cumulative<br />
and basic losses are therefore assessed on a highly individual<br />
basis, and, accordingly, the impact of the respective<br />
current and highly individual reinsurance structure is<br />
permanently tested on them and adjusted where required.<br />
Where necessary, high individual risks are diversified using<br />
co-insurance or by taking out facultative reinsurance<br />
solutions.<br />
In addition, we create provisions for fluctuations in the<br />
pattern of results where required by national insurance<br />
supervisory authorities’ regulations and accounting principles.<br />
However, this is not shown in our IFRS consolidated<br />
financial statements.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements127<br />
Disclosures on risks from insurance contracts and financial instruments<br />
[34c] Credit risks from ceded reinsurance business<br />
The credit risk is also of relevance in connection with ceded<br />
business.<br />
For provisions ceded to reinsurers, the creditworthiness of<br />
our reinsurers is outlined in the table below.<br />
Here, 96% is directly collateralised through deposits. A<br />
credit risk can be ignored for this portion. Information on<br />
risks arising from defaults on receivables from insurance<br />
business can be found in the risk report on page 34.<br />
Technical provisions ceded to reinsurers according to rating <strong>2012</strong><br />
%<br />
2011<br />
%<br />
AAA 4 3<br />
AA 80 62<br />
A 15 13<br />
BBB and less − −<br />
No rating available 2 22<br />
[34d] Market risk from financing instruments – sensitivity analysis<br />
The sensitivity analysis shows the effect of capital market<br />
events on the value of investments and the corresponding<br />
impact on the consolidated income statement. Sensitivities<br />
of investments to share prices, interest rates and exchange<br />
rates are analysed independently of one another, i. e.<br />
ceteris paribus, with the change in market value being<br />
determined under selected capital market scenarios, as<br />
follows:<br />
The analysis of equities and equity derivatives is based on<br />
a market value of ± 10%, ± 30% of the delta-weighted exposure.<br />
Investment interests and alternative types of investments<br />
(private equity, hedge funds and commodities)<br />
are analysed together with shares. For interest-sensitive<br />
instruments, on the other hand, the change in market<br />
value resulting from a global change in interest rates of<br />
+ 100 BP, ± 50 BP and − 25 BP is determined using duration<br />
and convexity. The reaction of interest-rate derivatives to<br />
the change in market value of the underlying investments<br />
is taken into account using the delta of the derivative.<br />
Changes in exchange rates affect both interest-sensitive<br />
and equity-sensitive instruments as well as shareholdings.<br />
The sensitivity of instruments in foreign currencies is<br />
established by multiplying the euro market value by the<br />
hypothetical currency fluctuation of ± 10%.<br />
does not take into account the effects resulting from<br />
policy holders’ participation in surplus in dividends in<br />
insurance of the people. The impact on the results and<br />
equity shown below would be substantially reduced if<br />
these effects were considered. It is also assumed that<br />
changes in the capital markets occur instantaneously,<br />
preventing our limit systems and active countermeasures<br />
from taking effect. The analysis considers around 99% of<br />
<strong>ERGO</strong>’s investments.<br />
Market risk – share prices<br />
A rise in share prices does not generally have any effect<br />
on the income statement, but on the equity. Write-downs<br />
on hedging instruments following a rise in the share price<br />
are recorded in the income statement. By contrast, a<br />
drop in share prices leads to the changes of value being<br />
reflected in the income statement. Write-downs on shares<br />
are undertaken which are partly offset by the write-ups<br />
on hedging instruments also recorded in the income<br />
statement.<br />
The non-linear effects of equity options or other asymmetrical<br />
strategies are not taken into account in this presentation<br />
owing to the delta-weighted approach selected.<br />
The effects of events on the capital markets listed below<br />
do not take account of tax or the provision for premium<br />
refunds (gross amounts stated). This means the analysis
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements128<br />
Disclosures on risks from insurance contracts and financial instruments<br />
Change in market value of<br />
Impact on Impact on Impact on Impact on<br />
investments sensitive to share prices<br />
profit or loss 1 equity 1<br />
profit or loss 1<br />
equity 1<br />
Change in share price<br />
<strong>2012</strong><br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
2011<br />
€ million<br />
Increase of 30% − 129 590 − 123 352<br />
Increase of 10% − 53 197 − 41 117<br />
Decrease of 10% − 54 − 88 − 42 − 35<br />
Decrease of 30% − 255 − 169 − 158 − 69<br />
Market values on 31 December 2,674 1,876<br />
1 Gross before tax and policyholder participation in surplus.<br />
Market risk – interest rates<br />
The change in the market price of investments sensitive<br />
to interest rates is calculated using a parallel shift of the<br />
interest-rate curve and a revaluation of the fixed-interest<br />
securities and interest-rate derivatives on the basis of their<br />
duration and convexity. Cash positions and other derivatives<br />
are not included in the calculation. Major strategic<br />
interest-rate derivatives are receiver swaps and swaptions.<br />
Bonds futures are used for tactical controlling.<br />
In terms of their market value, the fixed-interest investments<br />
of the <strong>ERGO</strong> Insurance <strong>Group</strong> react to interest-rate<br />
fluctuations in a way similar to a level-coupon bond with<br />
a residual term of about eight years. As part of the investments<br />
are valued at amortised cost, the effects shown<br />
nevertheless deviate from this.<br />
The impact on the consolidated income statement is<br />
small compared with the impact on equity, as most of<br />
the changes in the value of fixed-interest investments are<br />
accounted for in equity, with no effect on profit or loss.<br />
Also, around 50% of the investments considered in this<br />
analysis are measured at amortised cost, so that changes<br />
in market value have no effect on the financial statements.<br />
Economically speaking, the impact of the fixed-interest<br />
investments on equity is paralleled by a change in the economic<br />
value of the liabilities. Therefore our asset-liability<br />
management steers the investments in such a way that<br />
the effects of interest-rate changes on the value of the<br />
investments and on the economic value of the liabilities<br />
largely cancel each other out. This offsetting does not have<br />
an impact on the balance sheet, however, since significant<br />
portions of the liabilities are not valued on the basis of the<br />
current interest-rate curves.<br />
Change in market value of investments<br />
Impact on Impact on Impact on Impact on<br />
sensitive to interest rates<br />
profit or loss 1 equity 1 profit or loss 1 equity 1<br />
Change in interest rate<br />
<strong>2012</strong><br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
2011<br />
€ million<br />
Increase of 100 BP − 338 − 3,158 − 352 − 2,710<br />
Increase of 50 BP − 188 − 1,633 − 201 − 1,397<br />
Decrease of 25 BP 108 856 119 730<br />
Decrease of 50 BP 224 1,739 251 1,480<br />
Market values on 31 December 122,377 110,487<br />
1 Gross before tax and policyholder participation in surplus.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements129<br />
Disclosures on risks from insurance contracts and financial instruments<br />
Market risk – exchange rates<br />
A little less than half of foreign currency exposures taken<br />
into account come from British pounds and roughly a third<br />
from investments quoted in US dollars. The low sensitivity<br />
towards changes in the exchange rate is due to extensive<br />
currency hedging. In this analysis, a 10% rise in the currency<br />
rate is to be understood as a 10% appreciation in the foreign<br />
currency compared to the euro.<br />
Change in market value of investments<br />
Impact on Impact on Impact on Impact on<br />
sensitive to exchange rates<br />
profit or loss 1 equity 1 profit or loss 1 equity 1<br />
Change in exchange rates<br />
<strong>2012</strong><br />
€ million<br />
<strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
2011<br />
€ million<br />
Increase of 10 % 173 19 154 18<br />
Decrease of 10 % − 173 − 19 − 154 − 18<br />
Market values on 31 December 5,219 3,868<br />
1 Gross before tax and policyholder participation in surplus.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
130<br />
Consolidated Financial Statements<br />
Other information<br />
[35] Personnel expenses<br />
Personnel expenses <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Wages and salaries 1,419.1 1,506.4<br />
Social security contributions and employee assistance 299.6 299.8<br />
Expenses for employees’ pensions 100.9 99.0<br />
Total 1,819.5 1,905.2<br />
[36] Long-term incentive plan<br />
In each of the years 2002 to 2009, <strong>ERGO</strong> <strong>Versicherungsgruppe</strong><br />
<strong>AG</strong> and some subsidiaries initiated long-term<br />
incentive schemes for members of the Board and for<br />
selected managing directors. This remuneration component<br />
with a long-term motivational effect is aimed at a<br />
sustainable rise in the share price of Munich Re. Those<br />
entitled received a defined number of share appreciation<br />
rights which can only be exercised if a waiting period of<br />
two years has expired, the Munich Re share price has risen<br />
by at least 20% since the scheme began, and the Euro<br />
Stoxx 50 index has been surpassed at least twice for three<br />
months each time in the seven years of the scheme. The<br />
gross amount that can be obtained from exercising the<br />
share appreciation rights is limited to a rise of no more<br />
than 150% of the initial share price. Appreciation rights<br />
could so far only be exercised under the schemes initiated<br />
in 2003 to 2006 and in 2009. The tables below show the<br />
long-term incentive schemes which had not expired at the<br />
beginning of the reporting period.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements131<br />
Other information<br />
Incentive plan 2009 2008 2007 2006 2005<br />
Plan commencement 1 July 2009 1 July 2008 1 July 2007 1 July 2006 1 July 2005<br />
Plan end 30 June 2016 30 June 2015 30 June 2014 30 June 2013 30 June <strong>2012</strong><br />
Initial share price 97.57 € 121.84 € 134.07 € 108.87 € 88.10 €<br />
Intrinsic value <strong>2012</strong> for one right 36.83 € 12.56 € 0.33 € 25.53 € 46.30 €<br />
Fair value <strong>2012</strong> for one right 36.83 € 12.99 € 7.06 € 25.53 € −<br />
Number of rights on 31 December 2004 − − − − −<br />
Exercisable at year-end − − − − −<br />
Additions − − − − 158,648<br />
Exercised − − − − −<br />
Forfeited − − − − −<br />
Number of rights on 31 December 2005 − − − − 158,648<br />
Exercisable at year-end − − − − −<br />
Additions − − − 130,667 −<br />
Exercised − − − − −<br />
Forfeited − − − − 3,072<br />
Number of rights on 31 December 2006 − − − 130,667 155,576<br />
Exercisable at year-end − − − − −<br />
Additions − − 94,115 − −<br />
Exercised − − − − 30,486<br />
Forfeited − − 10,422 6,849 −<br />
Number of rights on 31 December 2007 − − 83,693 123,818 125,090<br />
Exercisable at year-end − − − − 125,090<br />
Additions − 132,306 − − −<br />
Exercised − − − − 16,983<br />
Forfeited − − − − −<br />
Number of rights on 31 December 2008 − 132,306 83,693 123,818 108,107<br />
Exercisable at year-end − − − 123,818 108,107<br />
Additions 118,979 5,707 3,605 5,868 −<br />
Exercised − − − − 13,304<br />
Forfeited − − − − −<br />
Number of rights on 31 December 2009 118,979 138,013 87,298 129,686 94,803<br />
Exercisable at year-end − − 87,298 129,686 94,803<br />
Additions − − − − −<br />
Exercised − − − − 43,953<br />
Forfeited − − − − −<br />
Number of rights on 31 December 2010 118,979 138,013 87,298 129,686 50,850<br />
Exercisable at year-end − 138,013 87,298 129,686 50,850<br />
Additions − − − − −<br />
Exercised − − − − 26,957<br />
Forfeited − − − − −<br />
Number of rights on 31 December 2011 118,979 138,013 87,298 129,686 23,893<br />
Exercisable at year-end 118,979 138,013 87,298 129,686 23,893<br />
Additions − − − − −<br />
Exercised 109,813 − − 121,603 23,893<br />
Forfeited − − − − −<br />
Number of rights on 31 December <strong>2012</strong> 9,166 138,013 87,298 8,083 −<br />
Exercisable at year-end 9,166 138,013 87,298 8,083 −
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements132<br />
Other information<br />
[37] Cash flow statementent<br />
For a comment on the cash flow statement, reference<br />
is made to the management report, pages 25 f.<br />
[38] Total remuneration of the Supervisory Board and the Board of Management<br />
Expenditure for the Supervisory Board totalled € 0.7 million<br />
(0.8 m).<br />
Total remuneration for the Board of Management’s members<br />
for their activities on behalf of the holding company<br />
and <strong>Group</strong> companies amounted to € 8.3 million (8.2 m).<br />
Former members of the Board of Management and their<br />
surviving dependants received € 4.4 million (5.1 m) in total;<br />
a provision of € 48.1 million (41.2 m) has been set aside<br />
for current and future pension payments to this group of<br />
people.<br />
An overview of the members of the Company’s Supervisory<br />
Board and Board of Management are on pages 14 and<br />
15. This is part of the Notes to the consolidated financial<br />
statements.<br />
[39] <strong>Group</strong> affiliation<br />
As at 31 December <strong>2012</strong>, Münchener Rückversicherungs-<br />
Gesellschaft <strong>AG</strong>, Munich, controls directly and via its<br />
subsidiary P.A.N. GmbH & Co. KG, Grünwald, 100% of the<br />
issued share capital of <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong>,<br />
Düsseldorf. <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong>, Düsseldorf,<br />
has prepared these consolidated financial statements<br />
as at 31 December <strong>2012</strong> according to International<br />
Financial <strong>Report</strong>ing Standards and is also included in<br />
the consolidated financial statements of Münchener<br />
Rückversicherungs-Gesellschaft <strong>AG</strong>, Munich. The consolidated<br />
financial statements are accessible on the website<br />
of the company register. They are also available from the<br />
companies upon request.<br />
[40] Auditor’s fees<br />
Auditor’s fees were paid for services rendered by the<br />
<strong>Group</strong> auditors KPMG Bayerische Treuhandgesellschaft <strong>AG</strong><br />
Wirtschaftsprüfungsgesellschaft Steuerberatungsgesellschaft,<br />
Munich, and affiliated companies in the meaning<br />
of Section 271 para. 2 of the German Commercial Code,<br />
to the parent company and consolidated subsidiaries in<br />
accordance with the following table:<br />
The affiliated companies of KPMG Bayerische Treuhandgesellschaft<br />
<strong>AG</strong> are the following: KPMG Germany,<br />
KPMG Spain, KPMG Switzerland, KPMG LLP (UK),<br />
KPMG Belgium, KPMG Netherlands, KPMG Luxembourg,<br />
KPMG Turkey, KPMG Russia, KPMG Georgia, KPMG Ukraine,<br />
KPMG Armenia, KPMG Kazakhstan, KPMG Kyrgyzstan,<br />
KPMG Norway, KPMG Kuwait, KPMG Jordan and<br />
KPMG Saudi-Arabia.<br />
Auditor’s fees <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
Audits of financial statements 4.3 1 4.3<br />
Other assurance and appraisal services 1.2 1 1.4<br />
Tax consultancy services 0.1 0.2<br />
Other services 1.2 0.6<br />
Total 6.8 6.6<br />
1 Thereof fees totalling € 4.6 million for KPMG Bayerische Treuhandgesellschaft <strong>AG</strong> Wirtschaftsprüfungsgesellschaft Steuerberatungsgesellschaft.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements133<br />
Other information<br />
[41] Related parties<br />
<strong>ERGO</strong> Insurance <strong>Group</strong> maintains various reinsurance<br />
relationships with the Münchener Rückversicherungs-<br />
Gesellschaft <strong>AG</strong>, Munich, as well as with some of its<br />
reinsurance subsidiaries.<br />
In the year under review, premiums totalling € 597.2 million<br />
(639.5 m), i.e. 59.0% (62.8%) of total reinsurance premiums,<br />
were reinsured with them. In the reporting year<br />
a total of € 422.4 million (358.1 m) in claims expenditure<br />
came from these reinsurers.<br />
These companies’ share in deposits retained on ceded<br />
business is € 2,221.6 million (2,325.3 m). The share in receivables<br />
on reinsurance business accounts for € 52.0 million<br />
(55.9 m), and € 18.2 million (2.1 m) in accounts payable.<br />
Reinsurance relationships with Münchener Rückversicherungs-Gesellschaft<br />
<strong>AG</strong>, Munich, were reorganised<br />
in the reporting year. The agreed transfer price was<br />
€ 472.5 million.<br />
Besides the subordinated liabilities due to the Munich Re<br />
<strong>Group</strong> at the balance sheet date, there are further loan<br />
liabilities due to subsidiary companies of Münchener<br />
Rückversicherungs-Gesellschaft <strong>AG</strong> in Munich. <strong>ERGO</strong> <strong>Versicherungsgruppe</strong><br />
<strong>AG</strong> has been lent € 30.0 million(180.0 m)<br />
by Itus Verwaltungs <strong>AG</strong>, Grünwald, and € 65.0 million<br />
(65.0 m) by Proserpina Vermögensverwaltungsgesellschaft<br />
mbH, Munich.<br />
In the context of an outsourcing contract, <strong>ERGO</strong> Insurance<br />
<strong>Group</strong> has transferred its portfolio management and<br />
administration of financial investments to ME<strong>AG</strong> MUNICH<br />
<strong>ERGO</strong> AssetManagement GmbH. The outsourcing agreement<br />
covers the administration of land and buildings,<br />
of all domestic and foreign marketable securities and of<br />
loans. In addition, ME<strong>AG</strong> MUNICH <strong>ERGO</strong> AssetManagement<br />
GmbH is assuming remits in property construction auditing.<br />
ME<strong>AG</strong> MUNICH <strong>ERGO</strong> AssetManagement GmbH is an<br />
associated company of <strong>ERGO</strong> Insurance <strong>Group</strong>. Remuneration<br />
of € 11.1 million (8.2 m) for services rendered and for<br />
insurance brokerage is attributable to ME<strong>AG</strong> companies.<br />
Expenses for services rendered and for insurance brokerage<br />
amounted to € 14.1 million (12.7 m).<br />
A retrospective purchase price adjustment from the sale of<br />
international health insurance companies to Munich Health<br />
Holding Aktiengesellschaft, Munich, in 2011 led to gains on<br />
the disposal of shares in affiliated companies amounting<br />
to € 10.2 million.<br />
No major reportable transactions between corporate<br />
bodies and the <strong>ERGO</strong> Insurance <strong>Group</strong> took place.<br />
[42] Contingent liabilities and other financial commitments<br />
The details below regarding contingent liabilities and other<br />
financial commitments refer to items in terms of IAS 37<br />
and Sections 251 and 285 no. 3 of the German Commercial<br />
Code (HGB) which go beyond the disclosure requirements<br />
under IAS 37. Under these provisions, financial commitments<br />
only need to be revealed where the likelihood of an<br />
outflow of funds is not minimal. It is not expected that the<br />
following disclosed contingent liabilities and secondary<br />
liabilities will be utilised.<br />
<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> issued a letter of comfort<br />
amounting to € 4.3 million (4.3 m) for a non-affiliated<br />
company.<br />
In addition, guarantees of € 18.5 million (20.0 m) and<br />
DKK260.3 million (245.8 m) were given for non-affiliated<br />
companies. Guarantees to other companies amounted<br />
to € 10.3 million (10.3 m) and DKK16.0 million (20.0 m).<br />
Contingent repayment obligations to other companies<br />
stood at € 1.1 million (16.0 m).
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements134<br />
Other information<br />
Assurances and guarantees resulting from the disposal of<br />
Capital Square Pte. Ltd. expired on schedule in July <strong>2012</strong>.<br />
<strong>ERGO</strong> Versicherung <strong>AG</strong> is member of several insurance<br />
pools, which means that if any other pool member became<br />
insolvent, it would be called upon to meet the policy claims<br />
against that member on a pro rata basis in accordance<br />
with its stake in the pool.<br />
As a result of their stakes in the Protektor Lebens versicherungs-<strong>AG</strong>,<br />
Berlin, <strong>ERGO</strong> Lebensversicherung <strong>AG</strong>,<br />
Hamburg, Victoria Lebensversicherung <strong>AG</strong>, Düsseldorf,<br />
<strong>ERGO</strong> Direkt Lebensversicherung <strong>AG</strong>, Fürth, Vorsorge<br />
Lebens versicherung <strong>AG</strong>, Düsseldorf, and Neckermann<br />
Lebens ver sicherung <strong>AG</strong>, Fürth, are required – in the event<br />
of a German life insurer becoming insolvent – to meet<br />
the latter’s policy claims on a pro rata basis according<br />
to the stake held. As in the previous year, <strong>ERGO</strong><br />
Insurance <strong>Group</strong> thus has a 10.76% stake in Protektor<br />
Lebensversicherungs-<strong>AG</strong>.<br />
Under Sections 124 et seq. of the German Insurance<br />
Supervision Act (V<strong>AG</strong>), German life and health insurers<br />
are obliged to become members of a protection fund. The<br />
protection fund is entitled to claim – in addition to the<br />
regular fees – extraordinary fees of 1‰ in the case of life<br />
insurers or 2‰ in the case of health insurers of net technical<br />
provisions. In addition, the Company has pledged to<br />
provide funding to the protection fund or, alternatively, to<br />
Protektor Lebensversicherungs-<strong>AG</strong> in case the protection<br />
fund’s financial resources should be insufficient. This obligation<br />
amounts to 1% of net technical provisions, taking<br />
into account the amounts already paid to the protection<br />
fund. This means that the <strong>ERGO</strong> Insurance <strong>Group</strong> may be<br />
required to pay € 525.5 million (531.2 m).<br />
[43] Investment and other financial liabilities<br />
Commitments of <strong>Group</strong> companies to non-affiliated companies<br />
stemming from work and service contracts came to<br />
€ 122.7 million (144.9 m) at the end of <strong>2012</strong>. Further, investment<br />
obligations (including additional payment obligations)<br />
to non-affiliated companies stood at € 479.1 million<br />
(581.5 m). These include INR1,329.0 million, or the equivalent<br />
of € 18.4 million, from a company start-up agreement<br />
in India. Moreover, investment obligations (including additional<br />
payment obligations) to associated companies stood<br />
at € 215.6 million (145.3 m). These include CNY700.0 million,<br />
or € 85.2 million, from the setting-up of a company in<br />
China. Credit facilities committed to non-affiliated companies<br />
totalled € 1.0 million (500.4 m).<br />
The aforementioned figures represent non-discounted<br />
nominal amounts.<br />
<strong>ERGO</strong> Versicherung <strong>AG</strong> and <strong>ERGO</strong> Direkt Versicherung <strong>AG</strong>,<br />
Fürth, have pledged contributions to an organisation set up<br />
to assist traffic accident victims (Verkehrsopferhilfe e.V.);<br />
each member company’s contribution is calculated on<br />
the basis of its share of the total membership’s premium<br />
income from direct motor third-party liability insurance<br />
in the calendar year before last (“direct” meaning: net of<br />
reinsurance accepted).
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements135<br />
Other information<br />
[44] Leasing<br />
The <strong>ERGO</strong> Insurance <strong>Group</strong> as lessee<br />
At the balance sheet date, future minimum lease payments<br />
under non-cancellable operating leases totalled<br />
€ 215.8 million (248.6 m). Payments from operating<br />
leases concern in particular rents for offices and business<br />
premises of the <strong>Group</strong>. At € 0.5 million (0.6 m) on the<br />
balance sheet date, the sum of liabilities from financial<br />
leases only accounts for a subordinate amount.<br />
The <strong>ERGO</strong> Insurance <strong>Group</strong> as lessor<br />
Operating leases mainly involve leased property. The total<br />
of future minimum lease payments under non- cancellable<br />
leases at the balance sheet date was € 572.9 million<br />
(578.3 m). The total of contingent rental payments recorded<br />
in the financial year as income was € 0.4 million (0.7 m).<br />
Maturity of leasing relationships <strong>2012</strong><br />
€ million<br />
2011<br />
€ million<br />
<strong>ERGO</strong> as lessee<br />
Not later than one year 46.7 52.1<br />
Later than one year and not later than five years 100.1 133.7<br />
Later than five years 69.0 62.8<br />
Total 215.8 248.6<br />
<strong>ERGO</strong> as lessor<br />
Not later than one year 111.3 113.0<br />
Later than one year and not later than five years 311.3 283.4<br />
Later than five years 150.4 181.9<br />
Total 572.9 578.3<br />
[45] Liabilities secured by liens<br />
<strong>Group</strong> real estate holdings are encumbered by mortgages,<br />
land charges and annuity charges to a total value of<br />
€ 19.7 million (20.1 m).<br />
[46] Number of employees<br />
Employees (year-end) <strong>2012</strong> 2011<br />
In-house employees 24,166 25,352<br />
Salaried sales force 5,602 5,959<br />
Total 29,768 31,311<br />
The number of staff employed by the <strong>Group</strong> at year-end<br />
totalled 19,191 (19,731) in Germany and 10,577 (11,580) in<br />
other countries.<br />
[47] Events after the balance sheet date<br />
No events have occurred since the balance sheet date<br />
which require separate disclosure.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
136<br />
Consolidated Financial Statements<br />
List of shareholdings as at 31 December<br />
<strong>2012</strong> in accordance with Section 313 para. 2<br />
of the German Commercial Code (HGB)<br />
Company name and registered office Footnote Stake held<br />
Consolidated affiliated companies Germany<br />
AEVG 2004 GmbH, Frankfurt a 0.00%<br />
aktiva Vermittlung von Versicherungen und Finanz-Dienstleistungen GmbH, Cologne 100.00%<br />
ALICE GmbH, Düsseldorf 100.00%<br />
almeda GmbH, Munich 1, 8 100.00%<br />
almeda Versicherungs-Aktiengesellschaft, Munich 1, 8 100.00%<br />
avanturo GmbH, Düsseldorf 100.00%<br />
CAPITAL PLAZA Holding GmbH & Co. Singapore KG, Düsseldorf 100.00%<br />
D. A. S. Deutscher Automobil Schutz Allgemeine Rechtsschutz-Versicherungs-Aktiengesellschaft, Munich 2, 8 100.00%<br />
DKV Deutsche Krankenversicherung Aktiengesellschaft, Cologne 1, 8 100.00%<br />
DKV Pflegedienste & Residenzen GmbH, Cologne 100.00%<br />
<strong>ERGO</strong> Direkt Krankenversicherung <strong>AG</strong>, Fürth 1 100.00%<br />
<strong>ERGO</strong> Direkt Lebensversicherung <strong>AG</strong>, Fürth 1 100.00%<br />
<strong>ERGO</strong> Direkt Versicherung <strong>AG</strong>, Fürth 1 100.00%<br />
<strong>ERGO</strong> Elfte Beteiligungsgesellschaft mbH, Düsseldorf 100.00%<br />
<strong>ERGO</strong> Eurosolar GmbH & Co. KG, Nuremberg 100.00%<br />
<strong>ERGO</strong> Grundstücksverwaltung GbR, Düsseldorf 100.00%<br />
<strong>ERGO</strong> Immobilien-GmbH 14.Victoria & Co. KG, Kreien 9 100.00%<br />
<strong>ERGO</strong> Immobilien-GmbH 5.Hamburg-Mannheimer & Co.KG, Kreien 9 100.00%<br />
<strong>ERGO</strong> International Aktiengesellschaft, Düsseldorf 1, 8 100.00%<br />
<strong>ERGO</strong> International Services GmbH, Düsseldorf 1 100.00%<br />
<strong>ERGO</strong> Lebensversicherung Aktiengesellschaft, Hamburg 1, 8 100.00%<br />
<strong>ERGO</strong> Neunte Beteiligungsgesellschaft mbH, Düsseldorf 1 100.00%<br />
<strong>ERGO</strong> Pensionsfonds Aktiengesellschaft, Düsseldorf 3, 8 100.00%<br />
<strong>ERGO</strong> Pensionskasse <strong>AG</strong>, Düsseldorf 100.00%<br />
<strong>ERGO</strong> Private Capital Gesundheit GmbH & Co. KG, Düsseldorf 100.00%<br />
<strong>ERGO</strong> Private Capital Leben GmbH & Co. KG, Düsseldorf 100.00%<br />
<strong>ERGO</strong> Private Equity Gesundheit GmbH, Düsseldorf 100.00%<br />
<strong>ERGO</strong> Private Equity Komposit GmbH, Düsseldorf 100.00%<br />
<strong>ERGO</strong> Private Equity Leben GmbH, Düsseldorf 100.00%<br />
<strong>ERGO</strong> Versicherung Aktiengesellschaft, Düsseldorf 1, 8 100.00%<br />
<strong>ERGO</strong> Zweite Beteiligungsgesellschaft mbH, Düsseldorf 100.00%<br />
EUROPÄISCHE Reiseversicherung Aktiengesellschaft, Munich 1, 8 100.00%<br />
FAIRANCE GmbH, Düsseldorf 1 100.00%<br />
Flexitel Telefonservice GmbH, Berlin 100.00%<br />
Hamburg-Mannheimer Pensionskasse <strong>AG</strong>, Hamburg 100.00%<br />
HMV GFKL Beteiligungs GmbH, Düsseldorf 100.00%<br />
IDEENKAPITAL Financial Engineering GmbH, Düsseldorf 100.00%<br />
IDEENKAPITAL Financial Service GmbH, Düsseldorf 100.00%<br />
IDEENKAPITAL GmbH, Düsseldorf 100.00%<br />
IDEENKAPITAL Media Finance GmbH, Düsseldorf 50.10%<br />
IDEENKAPITAL Metropolen Europa GmbH & Co. KG, Düsseldorf 72.35%<br />
iii, Munich 100.00%<br />
IK Einkauf Objekt Eins GmbH & Co. KG, Düsseldorf 100.00%
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements137<br />
List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />
Section 313 para. 2 of the German Commercial Code (HGB)<br />
Company name and registered office Footnote Stake held<br />
IK Einkauf Objektmanagement GmbH, Düsseldorf 100.00%<br />
IK Einkaufsmärkte Deutschland GmbH & Co. KG, Düsseldorf 52.04%<br />
IK Premium Fonds GmbH & Co. KG, Düsseldorf 100.00%<br />
IK Premium Fonds zwei GmbH & Co. KG, Düsseldorf 100.00%<br />
IRIS Capital Fund II German Investors GmbH & Co. KG, Düsseldorf 85.71%<br />
IT<strong>ERGO</strong> Informationstechnologie GmbH, Düsseldorf 1, 8 100.00%<br />
K & P Pflegezentrum IMMAC Uelzen Renditefonds GmbH & Co. KG, Düsseldorf 84.84%<br />
LEGIAL <strong>AG</strong>, Munich 100.00%<br />
Longial GmbH, Düsseldorf 100.00%<br />
ME<strong>AG</strong> Anglo Celtic Fund, Munich 100.00%<br />
ME<strong>AG</strong> BLN 2, Munich 100.00%<br />
ME<strong>AG</strong> EDL CurryGov, Munich 100.00%<br />
ME<strong>AG</strong> EDL EuroValue, Munich 100.00%<br />
ME<strong>AG</strong> EDS <strong>AG</strong>IL, Munich 100.00%<br />
ME<strong>AG</strong> Euro 1, Munich 100.00%<br />
ME<strong>AG</strong> Euro 2, Munich 100.00%<br />
ME<strong>AG</strong> Eurostar (Spezialfonds), Munich 100.00%<br />
ME<strong>AG</strong> German Prime Opportunities (GPO), Munich 100.00%<br />
ME<strong>AG</strong> Gilagrent, Munich 100.00%<br />
ME<strong>AG</strong> Golf 1, Munich 100.00%<br />
ME<strong>AG</strong> HBG 1, Munich 100.00%<br />
ME<strong>AG</strong> HM Renten, Munich 100.00%<br />
ME<strong>AG</strong> HM Sach 1, Munich 100.00%<br />
ME<strong>AG</strong> HM Sach Rent 1, Munich 100.00%<br />
ME<strong>AG</strong> HM2000, Munich 100.00%<br />
ME<strong>AG</strong> HMR1, Munich 100.00%<br />
ME<strong>AG</strong> HMR2, Munich 100.00%<br />
ME<strong>AG</strong> IREN, Munich 100.00%<br />
ME<strong>AG</strong> Kapital 2, Munich 100.00%<br />
ME<strong>AG</strong> Kapital 5, Munich 100.00%<br />
ME<strong>AG</strong> Multi Sach 1, Munich 100.00%<br />
ME<strong>AG</strong> OptiMax, Munich 100.00%<br />
ME<strong>AG</strong> PK-NORD, Munich 100.00%<br />
ME<strong>AG</strong> PK-WEST, Munich 100.00%<br />
ME<strong>AG</strong> PREMIUM, Munich 100.00%<br />
ME<strong>AG</strong> RenditePlus, Munich 100.00%<br />
ME<strong>AG</strong> REVO, Munich 100.00%<br />
ME<strong>AG</strong> S<strong>AG</strong> 1, Munich 100.00%<br />
ME<strong>AG</strong> Sustainability, Munich 100.00%<br />
ME<strong>AG</strong> Vidas 4, Munich 100.00%<br />
ME<strong>AG</strong> Vidas Rent 3, Munich 100.00%<br />
ME<strong>AG</strong> Vigifonds, Munich 100.00%<br />
ME<strong>AG</strong> VLA, Munich 100.00%<br />
Merkur Grundstücks- und Beteiligungs-Gesellschaft mit beschränkter Haftung, Düsseldorf 2 100.00%<br />
Neckermann Lebensversicherung <strong>AG</strong>, Fürth 100.00%<br />
Neckermann Versicherung <strong>AG</strong>, Nuremberg 100.00%<br />
OIK Mediclin, Wiesbaden 66.67%<br />
Seminaris Hotel- und Kongreßstätten-Betriebsgesellschaft mbH, Lüneburg 100.00%<br />
VHDK Beteiligungsgesellschaft mbH, Düsseldorf 100.00%<br />
VICTORIA Asien Immobilienbeteiligungs GmbH & Co. KG, Munich 100.00%<br />
Victoria Italy Property GmbH, Düsseldorf 100.00%<br />
Victoria Lebensversicherung Aktiengesellschaft, Düsseldorf 1, 8 100.00%<br />
Victoria US Property Investment GmbH, Düsseldorf 100.00%
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements138<br />
List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />
Section 313 para. 2 of the German Commercial Code (HGB)<br />
Company name and registered office Footnote Stake held<br />
Victoria US Property Zwei GmbH, Düsseldorf 100.00%<br />
Victoria Vierte Beteiligungsgesellschaft mbH, Düsseldorf 100.00%<br />
Victoria Vierter Bauabschnitt GmbH & Co. KG, Düsseldorf 100.00%<br />
Vorsorge Lebensversicherung Aktiengesellschaft, Düsseldorf 1, 8 100.00%<br />
welivit <strong>AG</strong>, Nuremberg 100.00%<br />
wse Solarpark Spanien 1 GmbH & Co. KG, Fürth 65.17%<br />
Consolidated affiliated companies International<br />
ADB <strong>ERGO</strong> Lietuva, Vilnius 100.00%<br />
Amicus Legal Ltd., Bristol 100.00%<br />
Bank Austria Creditanstalt Versicherung <strong>AG</strong>, Vienna 90.00%<br />
Bos Incasso B. V., Groningen 89.76%<br />
CJSIC “European Travel Insurance”, Moscow 100.00%<br />
Compagnie Européenne d`Assurances, Nanterre 100.00%<br />
Compania Europea de Seguros S. A., Madrid 100.00%<br />
D. A. S. Defensa del Automovilista y de Siniestros – Internacional, S. A. de Seguros y Reaseguros, Barcelona 100.00%<br />
D. A. S. HELLAS Allgemeine Rechtsschutz-Versicherungs-<strong>AG</strong>, Athens 100.00%<br />
D. A. S. Jogvédelmi Biztosíto Részvénytársaság, Budapest 100.00%<br />
D. A. S. Luxembourg Allgemeine Rechtsschutz-Versicherung S. A., Strassen 99.95%<br />
D. A. S. Oigusabikulude Kindlustuse AS, Tallinn 100.00%<br />
D. A. S. Österreichische Allgemeine Rechtsschutz-Versicherungs-Aktiengesellschaft, Vienna 99.98%<br />
D. A. S. poist'ovna právnej ochrany, a. s., Bratislava 100.00%<br />
D. A. S. pojišt'ovna právní ochrany, a. s., Prague 100.00%<br />
D. A. S. Société anonyme belge d'assurances de Protection Juridique, Brussels 99.98%<br />
D. A. S. Towarzystwo Ubezpieczen Ochrony Prawnej S. A., Warszawa 99.95%<br />
DAS Assistance Limited, Bristol 100.00%<br />
DAS Holding N. V., Amsterdam 51.00%<br />
DAS Legal Expenses Insurance Co., Ltd., Seoul 100.00%<br />
DAS Legal Expenses Insurance Company Limited, Bristol 100.00%<br />
DAS Legal Finance B. V., Amsterdam 100.00%<br />
DAS Legal Protection Insurance Company Ltd., Toronto 100.00%<br />
DAS LEGAL SERVICES LIMITED, Bristol 100.00%<br />
DAS Nederlandse Rechtsbijstand Verzekeringmaatschappij N. V., Amsterdam 100.00%<br />
DAS Rechtsschutz-Versicherungs-<strong>AG</strong>, Lucerne 100.00%<br />
DAS Services Limited, Bristol 100.00%<br />
DAS Support B. V., Amsterdam 100.00%<br />
DAS UK Holdings Limited, Bristol 100.00%<br />
DB Platinum IV SICAV (Subfonds Institutional Fixed Income, Inhaber-Anteile I2D), Luxembourg a 100.00%<br />
<strong>ERGO</strong> ASIGURARI DE VIATA SA, Bucharest 100.00%<br />
<strong>ERGO</strong> Assicurazioni S. p. A., Milan 100.00%<br />
<strong>ERGO</strong> Austria International <strong>AG</strong>, Vienna 100.00%<br />
<strong>ERGO</strong> Direkt Lebensversicherung <strong>AG</strong>, Schwechat 100.00%<br />
<strong>ERGO</strong> Élétbiztosító Zrt., Budapest 100.00%<br />
<strong>ERGO</strong> Emeklilik ve Hayat A. S., Istanbul 100.00%<br />
<strong>ERGO</strong> Eurosolar S. a. s. di welivit Solar Italia S. r. l., Bozen 100.00%<br />
<strong>ERGO</strong> Funds AS, Tallinn 100.00%<br />
<strong>ERGO</strong> General Insurance Company S. A., Athens 100.00%<br />
<strong>ERGO</strong> Grubu Holding A. Ş., Istanbul 100.00%<br />
<strong>ERGO</strong> Insurance N. V., Brussels 100.00%<br />
<strong>ERGO</strong> Invest SIA, Riga 100.00%<br />
<strong>ERGO</strong> Italia Business Solutions S. c. r. l., Milan 100.00%<br />
<strong>ERGO</strong> Italia Direct Network s. r. l., Milan 100.00%<br />
<strong>ERGO</strong> Italia S. p. A., Milan 100.00%
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements139<br />
List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />
Section 313 para. 2 of the German Commercial Code (HGB)<br />
Company name and registered office Footnote Stake held<br />
<strong>ERGO</strong> Kindlustuse AS, Tallinn 100.00%<br />
<strong>ERGO</strong> Latvija Versicherung <strong>AG</strong> (<strong>ERGO</strong> Latvija Apdrosinasanas Akciju Sabiedriba), Riga 100.00%<br />
<strong>ERGO</strong> Life Insurance Company S. A., Salonika 100.00%<br />
<strong>ERGO</strong> Life Insurance SE, Vilnius 100.00%<br />
<strong>ERGO</strong> osiguranje d.d, Zagreb 100.00%<br />
<strong>ERGO</strong> Partners N. V., Brussels 100.00%<br />
<strong>ERGO</strong> pojišt´ovna, a. s., Prague 100.00%<br />
<strong>ERGO</strong> Previdenza S. p. A., Milan 100.00%<br />
<strong>ERGO</strong> RUSS Versicherung <strong>AG</strong>, St. Petersburg 100.00%<br />
<strong>ERGO</strong> Shisn, Moscow 100.00%<br />
<strong>ERGO</strong> SIGORTA A. S., Istanbul 100.00%<br />
<strong>ERGO</strong> Versicherung Aktiengesellschaft, Vienna 100.00%<br />
<strong>ERGO</strong> Zivljenjska zavarovalnica d. d., Ljubljana 100.00%<br />
<strong>ERGO</strong> životná poisťovňa, a. s., Bratislava 100.00%<br />
<strong>ERGO</strong> Zivotno osiguranje d.d, Zagreb 100.00%<br />
ERV Försäkringsaktiebolag (publ), Stockholm 100.00%<br />
ERV pojišt'ovna, a. s., Prague 90.00%<br />
Europaeiske Rejseforsikring A/S, Copenhagen 100.00%<br />
European International Holding A/S, Copenhagen 100.00%<br />
Everything Legal Ltd., Bristol 100.00%<br />
Geschlossene Aktiengesellschaft Europäische Reiseversicherung, Kiev 100.00%<br />
GF 65, Vienna 100.00%<br />
Habiriscos – Investimentos Imobiliarios e Turisticos, S. A., Lisbon 100.00%<br />
Ibero Property Portugal – Investimentos Imobiliarios S. A., Lisbon 100.00%<br />
Ibero Property Trust S. A., Madrid 100.00%<br />
IKFE Properties I <strong>AG</strong>, Zurich 63.55%<br />
Imofloresmira – Investimentos Imobiliarios S. A., Lisbon 100.00%<br />
InsuranceAssistance FLLC, Minsk 100.00%<br />
Joint Stock Insurance Company <strong>ERGO</strong>, Minsk 92.31%<br />
Kapdom-Invest GmbH, Moscow 100.00%<br />
Landelijke Associatie van Gerechtsdeurwaarders B. V., Groningen c 89.76%<br />
LAVG Associatie van Gerechtsdeurwaarders Zuid Holding B. V., Breda c 80.00%<br />
Marina Sp. z. o. o., Sopot 100.00%<br />
MTU Moje Towarzystwo Ubezpieczeniowe S. A., Sopot 100.00%<br />
Nightingale Legal Services Ltd., Bristol 100.00%<br />
Queensley Holdings Limited, Singapore a, d 100.00%<br />
Renaissance Hotel Realbesitz GmbH, Vienna 60.00%<br />
Sopocki Instytut Ubezpieczeń S. A., Sopot 100.00%<br />
Sopockie Towarzystwo Ubezpieczen Ergo Hestia Spolka Akcyjna, Sopot 100.00%<br />
Sopockie Towarzystwo Ubezpieczen na Zycie Ergo Hestia Spolka Akcyjna, Sopot 100.00%<br />
Union Beteiligungsholding GmbH, Vienna 100.00%<br />
Van Arkel Gerechtsdeurwaarders B. V., Leiden c 79.90%<br />
Victoria Investment Properties Two L. P., Atlanta 100.00%<br />
Victoria US Holdings, Inc., Wilmington, Delaware 100.00%<br />
VICTORIA-VOLKSBANKEN Eletbiztosító Zrt., Budapest 100.00%<br />
VICTORIA-VOLKSBANKEN Poist´ovna, a. s., Bratislava 100.00%<br />
VICTORIA-VOLKSBANKEN Biztosító Zrt., Budapest 100.00%<br />
Vorsorge Luxembourg Lebensversicherung S. A., Munsbach 100.00%<br />
Non-consolidated affiliated companies Germany<br />
ARTES Assekuranzservice GmbH, Düsseldorf 100.00%<br />
ArztPartner almeda <strong>AG</strong>, Munich 100.00%<br />
BioEnergie Elbe-Elster GmbH & Co. KG, Elsterwerda 100.00%
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements140<br />
List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />
Section 313 para. 2 of the German Commercial Code (HGB)<br />
Company name and registered office Footnote Stake held<br />
BioEnergie Verwaltungs-GmbH, Elsterwerda 100.00%<br />
Blitz 01–807 GmbH, Munich 100.00%<br />
CAPITAL PLAZA Holding GmbH, Düsseldorf 100.00%<br />
CarePlus Gesellschaft für Versorgungsmanagement mbH, Cologne 100.00%<br />
Ciborum GmbH, Munich 100.00%<br />
DKV – Beta Vermögensverwaltungs GmbH, Cologne 100.00%<br />
DKV Gesundheits Service GmbH, Cologne 100.00%<br />
DKV Immobilienverwaltungs GmbH, Cologne 100.00%<br />
DKV Residenz am Tibusplatz gGmbH, Münster 100.00%<br />
DKV-Residenz in der Contrescarpe GmbH, Bremen 100.00%<br />
<strong>ERGO</strong> Alpha GmbH, Düsseldorf 100.00%<br />
<strong>ERGO</strong> Gourmet GmbH, Düsseldorf 100.00%<br />
<strong>ERGO</strong> Immobilien-GmbH 1. DKV & Co. KG, Kreien 100.00%<br />
<strong>ERGO</strong> Immobilien-GmbH 15.Victoria & Co. KG, Kreien 100.00%<br />
<strong>ERGO</strong> Immobilien-GmbH 4. DKV & Co. KG, Kreien 100.00%<br />
<strong>ERGO</strong> Immobilien-GmbH 6.Hamburg-Mannheimer & Co. KG, Kreien 100.00%<br />
<strong>ERGO</strong> Immobilien-GmbH 7.Hamburg-Mannheimer & Co. KG, Kreien 100.00%<br />
<strong>ERGO</strong> Immobilien-Verwaltungs-GmbH, Kreien 100.00%<br />
<strong>ERGO</strong> Leben Asien Verwaltungs GmbH, Munich 100.00%<br />
<strong>ERGO</strong> Private Capital GmbH, Düsseldorf 100.00%<br />
<strong>ERGO</strong> Private Capital Zweite GmbH & Co. KG, Düsseldorf 100.00%<br />
<strong>ERGO</strong> Specialty GmbH, Hamburg 100.00%<br />
<strong>ERGO</strong> Versicherungs- und Finanzierungs-Vermittlung GmbH, Hamburg 100.00%<br />
<strong>ERGO</strong> Zehnte Beteiligungsgesellschaft mbH, Düsseldorf 100.00%<br />
EUREKA GmbH, Düsseldorf 100.00%<br />
European Assistance Holding GmbH, Munich 100.00%<br />
EVV Logistik Management GmbH, Düsseldorf 100.00%<br />
Exolvo GmbH, Hamburg 100.00%<br />
GBG Vogelsanger Straße GmbH, Cologne 94.00%<br />
Gebäude Service Gesellschaft Überseering 35 mbH, Hamburg 100.00%<br />
GEMEDA Gesellschaft für medizinische Datenerfassung und Auswertung<br />
sowie Serviceleistungen für freie Berufe mbH, Cologne 100.00%<br />
goDentis – Gesellschaft für Innovation in der Zahnheilkunde mbH, Cologne 100.00%<br />
goMedus Gesellschaft für Qualität in der Medizin mbH, Cologne 100.00%<br />
goMedus GmbH & Co. KG, Cologne 100.00%<br />
Hamburg-Mannheimer Rechtsschutz Schaden-Service GmbH, Hamburg 100.00%<br />
Horbach GmbH Versicherungsvermittlung und Finanzdienstleistungen, Düsseldorf 70.10%<br />
IDEENKAPITAL Anlagebetreuungs GmbH, Düsseldorf 4 100.00%<br />
Ideenkapital Client Service GmbH, Düsseldorf 4 100.00%<br />
Ideenkapital erste Investoren Service GmbH, Düsseldorf 100.00%<br />
Ideenkapital Fonds Treuhand GmbH, Düsseldorf 100.00%<br />
Ideenkapital Media Treuhand GmbH, Düsseldorf 100.00%<br />
IDEENKAPITAL Metropolen Europa Verwaltungsgesellschaft mbH, Düsseldorf 100.00%<br />
IDEENKAPITAL PRORENDITA EINS Treuhandgesellschaft mbH, Düsseldorf 100.00%<br />
IDEENKAPITAL Schiffsfonds Treuhand GmbH, Düsseldorf 100.00%<br />
Ideenkapital Treuhand GmbH, Düsseldorf 100.00%<br />
IDEENKAPITAL Treuhand US Real Estate eins GmbH, Düsseldorf 100.00%<br />
IK Einkauf Objektverwaltungsgesellschaft mbH, Düsseldorf 100.00%<br />
IK Einkaufsmärkte Deutschland Verwaltungsgesellschaft mbH, Düsseldorf 100.00%<br />
IK FE Fonds Management GmbH, Düsseldorf 100.00%<br />
IK FE Management GmbH, Düsseldorf 100.00%<br />
IK Komp GmbH, Düsseldorf 100.00%<br />
IK Objekt Bensheim GmbH, Düsseldorf 100.00%
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements141<br />
List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />
Section 313 para. 2 of the German Commercial Code (HGB)<br />
Company name and registered office Footnote Stake held<br />
IK Objekt Frankfurt Theodor-Heuss-Allee GmbH, Düsseldorf 100.00%<br />
IK Pflegezentrum Uelzen Verwaltungs-GmbH, Düsseldorf 100.00%<br />
IK Property Eins Verwaltungsgesellschaft mbH, Hamburg 100.00%<br />
IK Property Treuhand GmbH, Düsseldorf 100.00%<br />
IK US Portfolio Invest DREI Verwaltungs-GmbH, Düsseldorf 100.00%<br />
IK US Portfolio Invest Verwaltungs-GmbH, Düsseldorf 100.00%<br />
IK US Portfolio Invest ZWEI Verwaltungs-GmbH, Düsseldorf 100.00%<br />
InterAssistance Gesellschaft für Dienstleistungen mit beschränkter Haftung, Munich 100.00%<br />
Juventus Vermögensverwaltungs <strong>AG</strong>, Hamburg 100.00%<br />
K & P Objekt Hamburg Hamburger Straße GmbH, Düsseldorf 100.00%<br />
K & P Objekt Munich Hufelandstraße GmbH, Düsseldorf 100.00%<br />
KQV Solarpark Franken 1 GmbH & Co. KG, Fürth 100.00%<br />
Legal Net GmbH, Munich 100.00%<br />
m:editerran POWER FRANCE GmbH, Nuremberg 100.00%<br />
m:editerran POWER GmbH & Co. KG, Nuremberg 100.00%<br />
MAYFAIR Holding GmbH, Düsseldorf 100.00%<br />
Mediastream Consulting GmbH, Grünwald 100.00%<br />
Mediastream Dritte Film GmbH, Grünwald 100.00%<br />
Mediastream Film GmbH, Grünwald 100.00%<br />
Mediastream Vierte Medien GmbH, Grünwald 100.00%<br />
Mediastream Zweite Film GmbH, Grünwald 100.00%<br />
MedWell Gesundheits-<strong>AG</strong>, Cologne 100.00%<br />
miCura Pflegedienste Berlin GmbH, Berlin 100.00%<br />
miCura Pflegedienste Bremen GmbH, Bremen 100.00%<br />
miCura Pflegedienste Düsseldorf GmbH, Düsseldorf 100.00%<br />
miCura Pflegedienste GmbH, Cologne 100.00%<br />
miCura Pflegedienste Hamburg GmbH, Hamburg 100.00%<br />
miCura Pflegedienste Krefeld GmbH, Krefeld 100.00%<br />
miCura Pflegedienste Munich / Dachau GmbH, Dachau 51.00%<br />
miCura Pflegedienste Munich GmbH, Munich 100.00%<br />
miCura Pflegedienste Munich Ost GmbH, Munich 65.00%<br />
miCura Pflegedienste Münster GmbH, Münster 100.00%<br />
miCura Pflegedienste Nuremberg GmbH, Nuremberg 51.00%<br />
PLATINIA Verwaltungs-GmbH, Munich 100.00%<br />
PRORENDITA DREI Verwaltungsgesellschaft mbH, Hamburg 100.00%<br />
PRORENDITA EINS Verwaltungsgesellschaft mbH, Hamburg 100.00%<br />
PRORENDITA FÜNF Verwaltungsgesellschaft mbH, Hamburg 100.00%<br />
PRORENDITA VIER Verwaltungsgesellschaft mbH, Hamburg 100.00%<br />
PRORENDITA ZWEI Verwaltungsgesellschaft mbH, Hamburg 100.00%<br />
Quirinus <strong>AG</strong>, Düsseldorf 100.00%<br />
Schrömbgens & Stephan GmbH, Versicherungsmakler, Düsseldorf 100.00%<br />
Seldac 1. Kommunaler-Rendite-Fonds GmbH & Co. KG, Düsseldorf 100.00%<br />
Seldac 1. Verwaltungs-GmbH, Düsseldorf 100.00%<br />
Solarfonds Garmisch-Partenkirchen 2011 GmbH & Co. KG, Nuremberg 99.75%<br />
TAS Assekuranz Service GmbH, Frankfurt/Main 100.00%<br />
TAS Touristik Assekuranz Service International GmbH, Frankfurt/Main 5 100.00%<br />
TAS Touristik Assekuranzmakler und Service GmbH, Frankfurt/Main 5 100.00%<br />
Titus <strong>AG</strong>, Düsseldorf 100.00%<br />
Trusted Documents GmbH, Nuremberg 100.00%<br />
US PROPERTIES VA Verwaltungs-GmbH, Düsseldorf 100.00%<br />
Verwaltungsgesellschaft “PORT VICTORIA” GmbH, Hamburg 100.00%<br />
Victoria Erste Beteiligungsgesellschaft mbH, Düsseldorf 100.00%<br />
Victoria Immobilien-Fonds GmbH, Düsseldorf 100.00%
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements142<br />
List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />
Section 313 para. 2 of the German Commercial Code (HGB)<br />
Company name and registered office Footnote Stake held<br />
VICTORIA US Beteiligungsgesellschaft mbH, Munich 100.00%<br />
Victoria Vierter Bauabschnitt Management GmbH, Düsseldorf 100.00%<br />
Viwis GmbH, Munich 6 100.00%<br />
Vorsorge Service GmbH, Düsseldorf 100.00%<br />
welivit New Energy GmbH, Fürth 100.00%<br />
welivit Solar España GmbH, Nuremberg 100.00%<br />
WNE Solarfonds Süddeutschland 2 GmbH & Co. KG, Nuremberg 100.00%<br />
Wohnungsgesellschaft Brela mbH, Hamburg 7 100.00%<br />
Non-consolidated affiliated companies International<br />
80e LIMITED, Bristol 100.00%<br />
Acalater 140014 S. L., Playa del Inglés 100.00%<br />
Aitesacho 5005 S. L., Playa del Inglés 100.00%<br />
Albulzaga 8008 S. L., Playa del Inglés 100.00%<br />
Aleama 150015 S. L., Madrid 100.00%<br />
Amicus Ltd., Bristol 100.00%<br />
Amladeza 7007 S. L., Playa del Inglés 100.00%<br />
Arridabra 130013 S. L., Madrid 100.00%<br />
B&D Acquisition B. V., Amsterdam 80.00%<br />
B&D Business Solutions B. V., Utrecht 100.00%<br />
Badozoc 1001 S. L., Madrid 100.00%<br />
Bank Austria Creditanstalt Versicherungsdienst GmbH, Vienna 100.00%<br />
Baqueda 7007 S. L., Madrid 100.00%<br />
Bobasbe 6006 S. L., Madrid 100.00%<br />
Botedazo 8008 S. L., Madrid 100.00%<br />
Bureau voor kredietinformaties Janssen B. V., s-Gravenhage 100.00%<br />
Bureau voor kredietinformaties Janssen Holding B. V., s-Gravenhage 100.00%<br />
Callopio 5005 S. L., Madrid 100.00%<br />
Camcichu 9009 S. L., Madrid 100.00%<br />
Caracuel Solar Catorce S. L., Madrid 100.00%<br />
Caracuel Solar Cinco S. L., Madrid 100.00%<br />
Caracuel Solar Cuatro S. L., Madrid 100.00%<br />
Caracuel Solar Dieciocho S. L., Madrid 100.00%<br />
Caracuel Solar Dieciseis S. L., Madrid 100.00%<br />
Caracuel Solar Diecisiete S. L., Madrid 100.00%<br />
Caracuel Solar Diez S. L., Madrid 100.00%<br />
Caracuel Solar Doce S. L., Madrid 100.00%<br />
Caracuel Solar Dos S. L., Madrid 100.00%<br />
Caracuel Solar Nueve S. L., Madrid 100.00%<br />
Caracuel Solar Ocho S. L., Madrid 100.00%<br />
Caracuel Solar Once S. L., Madrid 100.00%<br />
Caracuel Solar Quince S. L., Madrid 100.00%<br />
Caracuel Solar Seis S. L., Madrid 100.00%<br />
Caracuel Solar Siete S. L., Madrid 100.00%<br />
Caracuel Solar Trece S. L., Madrid 100.00%<br />
Caracuel Solar Tres S. L., Madrid 100.00%<br />
Caracuel Solar Uno S. L., Madrid 100.00%<br />
Chobocuga 150015 S. L., Playa del Inglés 100.00%<br />
Cotatrillo 100010 S. L., Madrid 100.00%<br />
DAS Consultancy & Detachering Rotterdam B. V., Rotterdam 75.02%<br />
DAS Financial Services B. V., Amsterdam 51.00%<br />
DAS Incasso Arnhem B. V., Arnheim 100.00%<br />
DAS Incasso Eindhoven B. V., s-Hertogenbosch 80.00%
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements143<br />
List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />
Section 313 para. 2 of the German Commercial Code (HGB)<br />
Company name and registered office Footnote Stake held<br />
DAS Incasso Rotterdam B. V., Rotterdam 80.00%<br />
DAS Law Limited, Bristol 100.00%<br />
DAS Legal Protection Ireland Limited, Dublin 100.00%<br />
DAS Legal Protection Limited, Christchurch, New Zealand 100.00%<br />
DAS Legal Protection Limited, Vancouver 100.00%<br />
DAS Legal Protection Pty. Ltd., Sydney 100.00%<br />
DAS Lex Assistance, S. L., L´Hospitalet de Llobregat 100.00%<br />
De Wit Vissers Incasso Holding B. V., Breda 95.00%<br />
DRA Debt Recovery Agency B. V., s-Gravenhage 100.00%<br />
Economic Data Research B. V., Leidschendam 100.00%<br />
Economic Data Resources B. V., Leidschendam 100.00%<br />
EDR Acquisition B. V., Amsterdam 100.00%<br />
EDR Credit Services B. V., s-Gravenhage 100.00%<br />
<strong>ERGO</strong> Asia Management Pte. Ltd., Singapore 100.00%<br />
<strong>ERGO</strong> GmbH, Herisau 100.00%<br />
<strong>ERGO</strong> Insurance Service GmbH, Vienna 99.60%<br />
<strong>ERGO</strong> PORTFÖY YÖNETIMI A. S., Istanbul 100.00%<br />
<strong>ERGO</strong> Pro Sp. z o. o., Warsaw 100.00%<br />
<strong>ERGO</strong> Pro, spol. s r. o., Prague 100.00%<br />
ERIN Sigorta Aracilik Hizmetleri Limited Sirketi, Istanbul 100.00%<br />
ERV (China) Travel Service and Consulting Ltd., Beijing 100.00%<br />
ERV (India) Travel Service and Consulting Private Limited, Mumbai 100.00%<br />
ERV Seyahat Sigorta Aracilik Hizmetleri ve Danismanlik Ltd.Sti., Istanbul 99.00%<br />
Esoleme 120012 S. L., Playa del Inglés 100.00%<br />
Etics, s. r. o., Prague 100.00%<br />
Etoblete 160016 S. L., Madrid 100.00%<br />
Etogibon 100010 S. L., Playa del Inglés 100.00%<br />
Etolede 6006 S. L., Playa del Inglés 100.00%<br />
Euro Alarm Assistance Pragueue, Prague 100.00%<br />
Euro-Center (Cyprus) Ltd., Larnaca 100.00%<br />
Euro-Center (Thailand) Co. Ltd., Bangkok 100.00%<br />
Euro-Center Cape Town (Pty.) Ltd., Cape Town 100.00%<br />
Euro-Center China (HK) Co., Ltd., Beijing 100.00%<br />
Euro-Center Holding A/S, Copenhagen 83.33%<br />
Euro-Center Holding North Asia (HK) Pte. Ltd., Hong Kong 100.00%<br />
Euro-Center Ltda., Rio de Janeiro 100.00%<br />
Euro-Center USA, Inc., New York 100.00%<br />
Euro-Center Yerel Yardim, Istanbul 100.00%<br />
Euro-Center, S. A. (Spain), Palma de Mallorca 100.00%<br />
Europäische (UK) Ltd., London 100.00%<br />
First Legal Protection Limited, Bristol 100.00%<br />
Gamaponti 140014 S. L., Madrid 100.00%<br />
GRANCAN Sun-Line S. L., Madrid 100.00%<br />
Guanzu 2002 S. L., Madrid 100.00%<br />
Hamburg-Mannheimer ForsikringService A/S, Copenhagen 100.00%<br />
Health OÜ, Tallinn 100.00%<br />
Hestia Advanced Risk Solutions Sp. z. o. o., Sopot 100.00%<br />
Hestia Loss Control Sp. z o. o., Sopot 100.00%<br />
HMI S. r. l., Verona 100.00%<br />
Humanity B. V., s-Gravenhage 100.00%<br />
Ibero Property Guadalix S. A., Madrid 100.00%<br />
Kuik & Partners Credit Management BVBA, Brussels 98.90%<br />
Kuik & Partners Gerechtsdeurwaarders & Incassobureau B. V., Eindhoven 100.00%
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements144<br />
List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />
Section 313 para. 2 of the German Commercial Code (HGB)<br />
Company name and registered office Footnote Stake held<br />
LAVG Zuid B. V., Breda 100.00%<br />
LawAssist Limited, Bristol 100.00%<br />
m:editerran Power S. a. s. di welivit Solar Italia S. r. l., Bozen 100.00%<br />
MESA ASISTENCIA, S. A., Madrid 99.90%<br />
Naretoblera 170017 S. L., Madrid 100.00%<br />
Nassau Incasso Services Den Haag B. V., s-Gravenhage 100.00%<br />
Nerruze 120012 S. L., Madrid 100.00%<br />
Nicamballo 1001 S. L., Playa del Inglés 100.00%<br />
Olbodeca 4004 S. L., Playa del Inglés 100.00%<br />
Oracuet 160016 S. L., Playa del Inglés 100.00%<br />
Oragulno 9009 S. L., Playa del Inglés 100.00%<br />
Oraunte 130013 S. L., Playa del Inglés 100.00%<br />
Orrazipo 110011 S. L., Madrid 100.00%<br />
Otusleme 3003 S. L., Playa del Inglés 100.00%<br />
ProContact Sp. z o. o., Gdansk 100.00%<br />
SAINT LEON ENERGIE S. A. R. L., Strasbourg 100.00%<br />
Sopockie Towarzystwo Doradcze Sp. z o. o., Sopot 100.00%<br />
Stichting Aandelen Beheer D. A. S. Holding, Amsterdam 100.00%<br />
Sydney Euro-Center Pty. Ltd., Sydney 100.00%<br />
Teginago 2002 S. L., Playa del Inglés 100.00%<br />
Tenoslema 110011 S. L., Playa del Inglés 100.00%<br />
TGR Biztosítás Többesügynöki Zrt., Budapest 100.00%<br />
Tillobesta 180018 S. L., Madrid 100.00%<br />
VB Victoria Zastupanje u Osiguranju d. o. o., Zagreb 74.90%<br />
VFG Vorsorge-Finanzierungsconsulting GmbH, Vienna 100.00%<br />
Victoria VIP II, Inc., Wilmington, Delaware 100.00%<br />
VV-Consulting Gesellschaft für Risikoanalyse, Vorsorgeberatung und Versicherungsvermittlung GmbH, Vienna 100.00%<br />
VV-Consulting Többesügynöki Kft., Budapest 100.00%<br />
welivit Solar Italia s. r. l., Bozen 100.00%<br />
Zacobu 110011 S. L., Madrid 100.00%<br />
Zacuba 6006 S. L., Madrid 100.00%<br />
Zacubacon 150015 S. L., Madrid 100.00%<br />
Zafacesbe 120012 S. L., Madrid 100.00%<br />
Zagacobi 180018 S. L., Playa del Inglés 100.00%<br />
Zapaceba 170017 S. L., Playa del Inglés 100.00%<br />
Zapacubi 8008 S. L., Madrid 100.00%<br />
Zarzucolumbu 100010 S. L., Madrid 100.00%<br />
Zetaza 4004 S. L., Madrid 100.00%<br />
Zicobucar 140014 S. L., Madrid 100.00%<br />
Zucaelo 130013 S. L., Madrid 100.00%<br />
Zucampobi 3003 S. L., Madrid 100.00%<br />
Zucarrobiso 2002 S. L., Madrid 100.00%<br />
Zucobaco 7007 S. L., Madrid 100.00%<br />
Zulazor 3003 S. L., Madrid 100.00%<br />
Zumbicobi 5005 S. L., Madrid 100.00%<br />
Zumcasba 1001 S. L., Madrid 100.00%<br />
Zuncabu 4004 S. L., Madrid 100.00%<br />
Zuncolubo 9009 S. L., Madrid 100.00%<br />
Associates valued at equity Germany<br />
Dovull SPV GmbH & Co. KG, Frankfurt/Main 20.06%<br />
HighTech Beteiligungen GmbH und Co. KG, Düsseldorf 23.10%<br />
KarstadtQuelle Finanz Service GmbH, Düsseldorf 50.00%
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements145<br />
List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />
Section 313 para. 2 of the German Commercial Code (HGB)<br />
Company name and registered office Footnote Stake held<br />
MAYFAIR Holding GmbH & Co. Singapore KG, Düsseldorf e 71.43%<br />
MCAF Verwaltungs-GmbH & Co.KG, Düsseldorf 50.00%<br />
ME<strong>AG</strong> Cash Management GmbH, Munich 40.00%<br />
ME<strong>AG</strong> MUNICH <strong>ERGO</strong> AssetManagement GmbH, Munich 40.00%<br />
MEDICLIN Aktiengesellschaft, Offenburg 35.00%<br />
MEGA 4 GbR, Berlin 34.26%<br />
Rendite Partner Gesellschaft für Vermögensverwaltung mbH, Frankfurt/Main 33.33%<br />
RP Vilbeler Fondsgesellschaft mbH, Frankfurt/Main 40.00%<br />
Sana Kliniken <strong>AG</strong>, Munich 21.70%<br />
TERTIANUM Besitzgesellschaft Berlin Passauer Strasse 5− 7 mbH, Munich 25.00%<br />
TERTIANUM Besitzgesellschaft Konstanz Marktstätte 2− 6 und Sigismundstrasse 5− 9 mbH, Munich 25.00%<br />
TERTIANUM Besitzgesellschaft Munich Jahnstrasse 45 mbH, Munich 33.33%<br />
US PROPERTIES VA GmbH & Co. KG, Düsseldorf 46.09%<br />
U. S. Property Fund IV GmbH & Co. KG, Munich b 9.78%<br />
VV Immobilien GmbH & Co. United States KG, Munich 28.95%<br />
VV Immobilien GmbH & Co. US City KG, Munich 23.10%<br />
VV Immobilien Verwaltungs GmbH & Co. Zentraleuropa KG, Munich 20.41%<br />
WISMA ATRIA Holding GmbH & Co. Singapore KG, Düsseldorf e 65.00%<br />
Associates valued at equity International<br />
D. A. S. Difesa Automobilistica Sinistri, S. p. A. di Assicurazione, Verona 49.99%<br />
<strong>ERGO</strong> China Life Insurance Co., Ltd., Jinan, Shandong Province 50.00%<br />
Europai Utazasi Biztosito Rt., Budapest 26.00%<br />
Europäische Reiseversicherungs-Aktiengesellschaft, Vienna 25.01%<br />
Global Insurance Company, Ho Chi Minh City 25.00%<br />
HDFC <strong>ERGO</strong> General Insurance Company Ltd., Mumbai 26.00%<br />
Millennium Entertainment Partners II L. P., New York f 42.30%<br />
Millennium Entertainment Partners L. P., New York g 27.54%<br />
Millennium Partners LLC, New York h 20.30%<br />
Property Finance France S. A., Luxembourg 45.46%<br />
SAS Le Point du Jour, Paris 50.00%<br />
VICTORIA-VOLKSBANKEN Pensionskassen Aktiengesellschaft, Vienna 47.50%<br />
VICTORIA-VOLKSBANKEN Vorsorgekasse <strong>AG</strong>, Vienna 50.00%<br />
Other associated companies Germany<br />
“PORT ELISABETH” GmbH & Co. KG, Hamburg 31.97%<br />
“PORT LOUIS” GmbH & Co. KG, Hamburg 25.82%<br />
Assistance Partner GmbH & Co. KG, Munich 21.66%<br />
BF.direkt <strong>AG</strong>, Stuttgart 27.20%<br />
carexpert Kfz-Sachverständigen GmbH, Walluf 25.00%<br />
Fernkälte Geschäftsstadt Nord Gesellschaft bürgerlichen Rechts, Hamburg 39.34%<br />
Hannover Finanz-Umwelt Beteiligungsgesellschaft mbH, Hillerse 20.00%<br />
IK Objektgesellschaft Frankfurt Theodor-Heuss-Allee GmbH & Co. KG, Düsseldorf 47.40%<br />
K & P Objekt Hamburg Hamburger Straße Immobilienfonds GmbH & Co.KG, Düsseldorf 36.69%<br />
MCAF Management GmbH, Düsseldorf 50.00%<br />
Reisegarant, Vermittler von Insolvenzversicherungen mbH, Hamburg 24.00%<br />
Teko – Technisches Kontor für Versicherungen Gesellschaft mit beschränkter Haftung, Düsseldorf 30.00%<br />
TERTIANUM Seniorenresidenz Betriebsgesellschaft Munich mbH, Munich 33.33%<br />
TERTIANUM Seniorenresidenzen Betriebsgesellschaft mbH, Konstanz 25.00%<br />
Verwaltungsgesellschaft “PORT ELISABETH” mbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “Port Hedland” mbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “PORT KELANG” mbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “Port Lincoln” mbH, Hamburg 50.00%
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Consolidated Financial Statements146<br />
List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />
Section 313 para. 2 of the German Commercial Code (HGB)<br />
Company name and registered office Footnote Stake held<br />
Verwaltungsgesellschaft “PORT LOUIS” GmbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “PORT MAUBERT” mbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “PORT MELBOURNE” mbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “PORT MENIER” mbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “PORT MOODY” mbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “PORT MORESBY” mbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “PORT MOUTON” mbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “PORT NELSON” mbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “PORT RUSSEL” GmbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “PORT SAID” GmbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “PORT STANLEY” GmbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “PORT STEWART” mbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “PORT UNION” mbH, Hamburg 50.00%<br />
Verwaltungsgesellschaft “Port Williams” mbH, Hamburg 50.00%<br />
VV Immobilien GmbH & Co. GB KG, Düsseldorf 40.92%<br />
WISMA ATRIA Holding GmbH, Düsseldorf 50.00%<br />
Other associated companies International<br />
POOL Sp. z o. o., Warsaw 33.75%<br />
Secundi CBVA, Brussels 33.00%<br />
Triple IP B. V., Amsterdam 50.00%<br />
Volksbanken-Versicherungsdienst GmbH, Vienna 25.23%<br />
Other shareholdings<br />
– – –<br />
a) Consolidation pursuant to SIC 12<br />
b) Significant influence pursuant to IAS 28.7<br />
Differing voting power:<br />
c) 49.00%<br />
d) 0.00%<br />
e) 50.00%<br />
f) 42.34%<br />
g) 42.36%<br />
h) 25.00%<br />
1 Domination and profit transfer agreement with <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />
2 Domination and profit transfer agreement with <strong>ERGO</strong> Versicherung Aktiengesellschaft<br />
3 Domination agreement with <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />
4 Profit transfer agreement with IDEENKAPITAL GmbH<br />
5 Profit transfer agreement with EUROPÄISCHE Reiseversicherung Aktiengesellschaft<br />
6 Profit transfer agreement with D.A.S. Deutscher Automobil Schutz Allgemeine Rechtsschutz-Versicherungs-Aktiengesellschaft<br />
7 Profit transfer agreement with <strong>ERGO</strong> Versicherung Aktiengesellschaft<br />
8 This fully consolidated subsidiary make full or partial use of the exemption in accordance with Section 264 para. 3<br />
of the German Commercial Code for their own financial statements.<br />
9 This fully consolidated subsidiary with the legal form of a partnership as defined in Section 264a of the German Commercial Code make full or<br />
partial use of the exemption in accordance with Section 264b of the German Commercial Code for their own financial statements.
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
147<br />
Düsseldorf, 12 February 2013<br />
<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />
Board of Management<br />
Dr. Torsten Oletzky<br />
Dr. Bettina Anders<br />
Dr. Daniel von Borries<br />
Christian Diedrich<br />
Dr. Christoph Jurecka<br />
Dr. Ulf Mainzer<br />
Dr. Jochen Messemer<br />
Dr. Clemens Muth<br />
Dr. Rolf Wiswesser
<strong>ERGO</strong> Insurance <strong>Group</strong><br />
<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
148<br />
Auditor’s report<br />
We have duly audited the consolidated financial statements<br />
comprising the consolidated balance sheet, the consolidated<br />
income statement, the statement of recognised<br />
income and expense, the <strong>Group</strong> statement of changes<br />
in equity, the consolidated cash flow statement and the<br />
notes to the consolidated financial statements, together<br />
with the <strong>Group</strong> management report prepared by <strong>ERGO</strong> <strong>Versicherungsgruppe</strong><br />
<strong>AG</strong> in Düsseldorf for the financial year<br />
from 1 January to 31 December <strong>2012</strong>. The responsibility for<br />
preparing consolidated financial statements in line with<br />
IFRS, as adopted by the EU, and the additional provisions<br />
stated in Section 315a, para. 1 of the German Commercial<br />
Code (HGB) lies with the Company’s Board of Management.<br />
Our task is to form, on the basis of our audit, an assessment<br />
of the consolidated financial statements.<br />
We conducted our audit of the consolidated annual financial<br />
statements in accordance with Section 317 of the<br />
German Commercial Code (HGB), paying due regard to the<br />
generally accepted German standards concerning accounting<br />
principles as set out by the Institute of Public Auditors<br />
in Germany (IDW). These standards require that we plan<br />
and perform the audit such that misstatements materially<br />
affecting the presentation of net assets, financial position<br />
and earnings situation in the consolidated financial statements<br />
in accordance with the applicable financial reporting<br />
framework are detected with reasonable assurance. When<br />
determining the audit procedures, the knowledge of the<br />
<strong>Group</strong>’s field of business, its economic and legal environment<br />
and expectations regarding possible mistakes have<br />
to be taken into account. During the audit the effectiveness<br />
of the accounting-related internal control systems as well<br />
as evidence supporting the disclosures in the consolidated<br />
financial statements and <strong>Group</strong> management report are<br />
judged primarily on the basis of spot checks. The audit<br />
comprises the assessment of the financial statements<br />
of the individual companies included in the consolidated<br />
financial statements, definition of consolidated group,<br />
accounting and consolidating principles used and significant<br />
estimates made by the Board of Management, as<br />
well as an evaluation of the overall presentation of the<br />
consolidated financial statements and <strong>Group</strong> management<br />
report. We believe the audit we have conducted provides a<br />
sufficiently secure basis for our professional opinion.<br />
We have no objections to raise following our audit.<br />
In our opinion, based on the results of our audit, the<br />
consolidated financial statements conform to IFRS, as<br />
adopted by the EU, and the additional provisions stated in<br />
Section 315a, para. 1 HGB, and give a fair and true view of<br />
the net assets, financial position and earnings situation of<br />
the <strong>Group</strong> in accordance with these provisions. The <strong>Group</strong><br />
management report is in keeping with the consolidated<br />
financial statements and provides an accurate overall<br />
picture of the <strong>Group</strong>’s situation and suitably portrays the<br />
opportunities and risks inherent in future developments.<br />
Munich, 5 March 2013<br />
KPMG Bayerische Treuhandgesellschaft<br />
Aktiengesellschaft<br />
Wirtschaftsprüfungsgesellschaft<br />
Steuerberatungsgesellschaft<br />
Martin Berger<br />
Chartered accountant<br />
Roland Hansen<br />
Chartered accountant
Detailed contact information of our companies can<br />
be found on our website<br />
www.ergo.com<br />
under Company/<strong>ERGO</strong> Germany and <strong>ERGO</strong> International.<br />
Print<br />
compensated<br />
Id-No. 1325898<br />
www.bvdm-online.de<br />
Published by:<br />
<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />
Victoriaplatz 2<br />
40198 Düsseldorf<br />
Tel + 49 211 477− 0<br />
Fax + 49 211 477− 1500<br />
www.ergo.com<br />
This edition of the <strong>Group</strong> <strong>Annual</strong> <strong>Report</strong><br />
has been translated into English from the German original.<br />
Concept, content and design:<br />
<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />
Photos: Robert Brembeck, Christoph Bünten<br />
Lithography:<br />
Vignold <strong>Group</strong> GmbH, Ratingen<br />
Printed: August Lönneker GmbH & Co. KG,<br />
Stadtoldendorf
50064953 | <strong>ERGO</strong>48